Autonomous Communities;Age ranges;Cohorts;Sex;Demographic Concepts;Periodo;Total
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.019.665
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.964.241
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.997.941
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;2.916.799
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;2.884.077
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;2.807.861
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;2.819.891
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;2.800.408
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;2.748.666
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.739.925
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.728.428
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.673.302
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.647.603
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.648.989
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.597.708
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,59
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,3
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,66
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,38
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,47
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,69
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,74
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,04
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,17
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,68
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,36
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,65
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.909.026
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.887.020
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.906.102
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;1.847.447
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;1.837.622
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;1.792.773
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;1.791.684
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;1.787.670
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;1.758.590
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.744.993
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.744.182
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.714.569
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.689.196
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.695.728
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.668.962
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,77
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,38
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,05
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,85
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,74
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,26
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,41
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,43
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,95
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,48
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,86
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,56
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.110.639
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.077.221
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.091.839
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.069.352
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.046.455
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.015.088
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.028.207
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.012.738
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;990.076
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;994.932
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;984.246
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;958.733
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;958.407
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;953.261
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;928.746
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,28
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,14
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,97
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,58
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,01
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,68
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,58
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,37
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,81
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,29
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,49
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,06
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.031.866
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.993.411
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.938.754
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;2.923.775
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;2.898.267
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;2.872.111
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.835.984
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.818.087
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.784.268
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.734.804
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.730.809
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.700.506
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;2.652.858
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;2.641.443
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,43
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,82
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,73
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,54
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,14
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,74
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,2
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,23
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,89
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,62
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,88
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.914.547
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.903.642
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.870.987
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;1.851.965
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;1.846.341
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;1.832.190
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.800.503
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.797.629
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.780.128
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.739.459
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.744.399
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.729.570
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;1.697.878
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;1.693.393
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,73
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,99
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,93
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,04
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,43
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,14
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,85
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,63
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,44
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,19
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,51
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.117.319
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.089.769
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.067.767
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.071.810
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.051.926
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.039.921
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.035.481
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.020.458
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.004.140
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;995.345
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;986.410
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;970.936
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;954.980
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;948.050
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,93
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,53
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,39
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,68
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,64
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,04
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,08
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,52
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,93
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,63
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,79
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.046.771
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.022.855
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.962.399
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.940.248
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.925.120
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.860.164
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.823.656
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.823.859
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.767.434
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;2.739.262
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;2.704.508
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;2.659.900
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;2.637.789
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,5
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,77
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,55
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,68
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,42
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,42
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,62
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,29
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,99
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,04
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.922.877
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.919.112
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.889.600
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.860.586
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.859.912
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.828.450
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.790.526
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.798.405
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.772.072
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;1.747.885
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;1.733.404
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;1.701.538
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;1.693.305
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,76
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,92
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,76
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,12
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,71
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,78
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,08
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,73
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,66
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,61
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.123.894
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.103.743
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.072.799
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.079.662
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.065.208
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.031.714
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.033.130
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.025.454
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;995.362
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;991.377
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;971.104
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;958.362
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;944.484
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,06
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,51
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,17
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,92
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,91
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,78
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,82
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,52
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,83
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,04
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.034.840
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.022.819
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.963.105
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.907.085
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.909.698
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.856.926
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;2.818.422
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;2.787.463
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;2.732.251
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;2.714.054
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.658.652
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.648.744
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,79
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,26
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,42
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,24
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,07
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,39
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,59
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,95
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,39
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.914.605
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.915.994
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.889.503
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.837.768
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.847.288
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.824.876
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;1.792.791
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;1.782.187
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;1.742.733
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;1.738.227
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.699.638
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.698.640
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,99
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,41
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,58
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,57
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,32
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,96
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,99
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,71
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,9
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.120.235
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.106.825
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.073.602
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.069.317
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.062.410
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.032.050
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.025.631
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.005.276
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;989.518
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;975.827
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;959.014
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;950.104
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,45
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,99
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,13
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,66
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,64
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,4
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,89
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,65
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,5
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;198.868
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;189.916
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;156.708
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;183.803
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;178.450
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;136.941
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;171.004
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;166.854
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;131.786
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;160.060
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;156.448
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;124.315
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;149.805
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;147.070
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;117.601
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,42
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,96
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,39
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,99
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,86
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,1
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,49
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,38
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,33
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,33
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,44
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,04
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;121.737
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;118.096
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;97.866
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;112.762
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;111.037
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;85.937
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;105.252
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;103.921
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;82.868
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;98.860
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;97.616
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;78.534
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;92.841
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;91.952
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;74.474
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,63
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,02
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,81
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,46
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,67
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,21
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,66
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,25
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,26
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,86
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,1
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;77.131
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;71.820
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;58.842
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;71.041
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;67.413
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;51.004
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;65.752
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;62.933
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;48.918
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;61.200
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;58.832
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;45.781
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;56.964
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;55.118
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;43.127
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,1
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,86
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,68
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,25
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,63
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,13
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,35
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,92
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,8
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,85
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;76,74
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,29
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;175.453
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;170.321
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;158.893
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;161.810
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;157.209
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;152.252
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;150.540
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;145.911
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;142.745
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;139.969
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;136.172
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;134.403
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;127.320
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;128.207
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,22
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,3
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,82
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,8
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,67
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,84
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,78
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,95
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,59
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,75
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,69
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;107.977
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;106.510
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;99.208
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;99.851
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;98.314
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;95.200
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;93.196
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;91.392
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;89.622
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;86.935
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;85.515
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;84.565
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;80.201
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;80.766
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,47
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,3
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,96
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,31
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,81
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,34
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,51
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,29
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,24
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,3
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,41
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;67.476
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;63.811
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;59.685
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;61.959
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;58.895
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;57.052
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;57.344
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;54.519
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;53.123
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;53.034
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;50.657
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;49.838
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;47.119
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;47.441
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,82
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,3
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,59
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,98
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,44
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,01
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,6
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;79,39
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,5
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,84
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,49
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;186.480
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;183.031
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;168.357
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;170.876
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;167.232
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;155.457
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;157.922
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;155.043
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;145.606
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;144.564
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;138.543
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;135.558
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;131.224
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,63
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,37
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,34
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,69
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,71
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,49
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,98
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,29
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,06
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,94
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;114.737
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;113.608
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;105.595
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;105.464
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;103.859
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;97.788
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;97.748
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;96.570
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;91.723
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;90.301
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;87.381
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;84.988
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;82.919
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,92
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,42
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,61
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,19
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,86
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,48
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,75
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,81
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,53
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;71.743
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;69.423
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;62.762
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;65.412
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;63.373
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;57.669
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;60.174
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;58.473
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;53.883
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;54.263
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;51.162
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;50.570
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;48.305
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,18
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,29
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,89
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,87
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,23
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,85
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,16
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,52
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,84
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,97
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;192.026
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;189.202
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;177.790
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;176.565
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;174.449
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;165.050
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;162.210
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;156.380
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;151.682
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;147.381
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;142.422
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;138.935
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,95
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,2
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,83
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,73
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,96
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,17
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,9
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,28
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,15
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;117.893
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;116.500
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;111.248
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;108.658
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;107.665
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;103.384
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;100.396
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;98.083
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;94.201
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;92.593
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;88.782
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;87.432
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,17
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,42
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,93
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,18
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,17
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,86
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,23
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,21
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,59
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;74.133
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;72.702
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;66.542
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;67.907
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;66.784
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;61.666
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;61.814
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;58.297
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;57.481
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;54.788
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;53.640
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;51.503
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,6
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,86
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,67
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,02
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,61
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,06
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,34
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,78
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,4
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;558.701
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;562.747
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;548.319
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;534.988
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;544.487
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;505.328
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;512.740
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;525.185
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;492.865
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;494.772
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;508.706
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;476.088
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;476.078
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;491.406
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;460.343
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,76
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,76
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,16
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,77
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,33
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,89
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,56
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,4
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,83
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,21
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,32
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,96
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;333.853
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;340.592
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;330.292
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;320.403
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;329.849
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;306.109
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;308.209
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;318.656
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;299.361
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;298.259
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;309.081
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;290.116
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;287.626
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;299.001
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;281.106
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,97
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,85
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,68
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,32
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,56
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,64
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,34
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,75
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,84
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,15
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,79
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,11
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;224.848
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;222.155
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;218.027
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;214.585
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;214.638
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;199.219
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;204.531
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;206.529
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;193.504
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;196.513
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;199.625
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;185.972
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;188.452
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;192.405
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;179.237
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,44
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,62
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,37
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,96
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,97
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,75
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,4
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,86
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,3
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,81
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,61
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,21
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;528.099
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;534.325
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;540.235
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;503.828
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;512.689
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;525.938
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;484.358
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;494.381
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;506.652
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;464.083
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;475.715
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;488.734
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;458.569
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;476.009
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,4
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,95
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,35
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,72
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,52
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,78
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,88
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,03
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,47
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,82
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,11
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;313.948
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;321.652
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;326.187
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;300.514
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;309.001
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;318.357
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;289.630
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;298.281
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;307.661
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;278.108
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;287.377
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;297.351
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;277.753
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;289.978
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,72
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,07
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,6
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,25
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,73
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,32
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,58
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,34
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,16
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,35
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,9
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;214.151
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;212.673
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;214.048
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;203.314
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;203.688
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;207.581
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;194.728
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;196.100
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;198.991
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;185.975
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;188.338
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;191.383
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;180.816
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;186.031
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,94
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,78
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,98
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,93
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,21
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,97
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,84
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,56
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,41
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,02
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,91
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;536.903
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;546.696
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;549.416
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;513.449
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;524.529
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;527.066
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;489.722
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;502.633
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;507.054
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;483.591
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;493.261
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;465.918
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;478.431
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,63
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,93
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,21
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,94
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,29
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,46
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,78
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,22
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,08
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;319.185
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;328.527
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;332.967
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;306.031
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;315.508
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;320.335
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;292.523
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;302.714
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;308.663
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;291.997
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;300.599
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;282.265
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;292.009
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,88
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,04
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,21
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,65
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,14
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,7
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,88
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,28
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,92
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,7
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;217.718
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;218.169
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;216.449
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;207.418
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;209.021
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;206.731
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;197.199
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;199.919
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;198.391
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;191.594
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;192.662
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;183.653
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;186.422
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,27
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,81
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,51
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,58
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,63
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,66
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,82
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,01
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,18
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,13
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;539.767
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;552.193
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;555.513
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;513.433
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;527.430
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;532.370
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;506.560
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;516.799
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;487.044
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;500.170
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;470.823
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;485.539
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,12
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,52
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,83
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,74
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,03
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,2
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,04
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,26
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,4
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;320.784
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;331.164
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;336.917
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;305.750
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;316.652
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;323.354
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;304.876
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;314.246
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;294.116
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;304.628
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;285.095
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;296.108
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,31
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,62
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,97
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,06
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,27
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,81
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,42
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,09
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,89
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;218.983
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;221.029
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;218.596
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;207.683
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;210.778
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;209.016
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;201.684
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;202.553
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;192.928
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;195.542
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;185.728
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;189.431
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,84
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,36
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,62
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,25
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,66
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,29
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,45
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,03
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,66
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;955.598
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;952.274
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;957.747
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;927.460
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;931.271
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;900.276
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;900.542
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;908.813
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;883.970
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;879.577
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;890.178
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;863.969
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;856.691
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;869.496
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;844.153
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,06
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,79
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,24
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,44
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,3
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,04
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,48
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,21
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,65
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,31
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,14
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;607.355
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;610.203
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;612.456
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;590.658
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;597.270
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;578.378
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;575.438
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;584.085
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;569.184
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;563.306
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;572.852
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;557.600
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;549.715
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;560.205
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;545.781
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,25
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,88
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,74
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,72
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,93
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,75
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,88
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,04
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,51
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,81
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,11
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;348.243
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;342.071
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;345.291
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;336.802
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;334.001
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;321.898
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;325.104
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;324.728
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;314.786
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;316.271
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;317.326
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;306.369
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;306.976
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;309.291
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;298.372
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,71
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,64
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,23
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,36
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,93
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,17
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,82
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,77
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,73
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,15
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,42
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,41
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;937.068
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;942.311
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;938.218
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;906.849
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;916.602
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;919.803
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;883.557
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;895.619
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;896.953
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;858.120
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;872.521
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;874.793
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;851.256
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;859.509
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,78
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,27
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,29
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,04
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,6
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,57
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,59
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,24
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,34
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,61
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;592.966
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;601.852
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;600.888
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;575.764
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;586.584
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;590.404
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;562.264
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;573.852
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;577.022
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;547.196
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;559.730
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;563.834
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;547.244
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;554.543
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,1
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,46
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,26
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,82
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,35
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,03
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,28
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,83
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,93
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,29
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;344.102
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;340.459
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;337.330
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;331.085
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;330.018
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;329.399
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;321.293
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;321.767
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;319.931
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;310.924
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;312.791
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;310.959
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;304.012
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;304.966
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,22
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,93
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,65
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,37
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,51
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,84
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,36
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,87
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,18
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,29
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,41
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;942.176
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;952.523
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;947.899
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;913.860
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;926.973
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;921.053
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;883.890
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;899.800
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;896.194
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;876.690
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;879.837
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;854.796
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;862.040
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,99
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,32
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,17
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,81
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,46
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,55
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,04
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,82
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,74
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,94
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;596.025
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;607.775
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;608.366
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;579.599
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;592.323
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;592.446
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;561.879
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;575.742
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;577.512
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;562.131
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;567.524
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;549.527
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;556.978
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,24
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,46
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,38
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,27
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,73
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,93
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,49
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,29
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,42
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,55
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;346.151
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;344.748
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;339.533
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;334.261
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;334.650
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;328.607
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;322.011
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;324.058
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;318.682
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;314.559
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;312.313
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;305.269
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;305.062
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,57
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,07
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,78
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,03
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,86
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,24
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,98
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,55
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,85
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;940.434
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;954.786
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;950.501
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;907.302
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;924.236
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;921.815
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;899.371
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;903.737
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;875.512
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;884.111
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;856.220
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;867.142
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,48
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,8
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,98
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,08
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,7
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,02
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,68
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,23
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;594.620
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;608.470
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;609.912
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;574.992
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;589.805
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;592.630
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;575.094
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;581.551
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;561.449
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;569.955
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;550.258
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;559.724
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,7
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,93
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,17
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,51
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,35
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,27
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,45
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,43
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,77
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;345.814
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;346.316
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;340.589
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;332.310
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;334.431
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;329.185
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;324.277
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;322.186
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;314.063
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;314.156
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;305.962
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;307.418
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,1
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,57
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,65
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,64
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,6
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,69
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,24
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,35
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,26
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;884.556
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;859.507
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;877.549
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;864.604
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;844.454
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;837.119
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;845.228
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;828.681
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;824.923
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;829.799
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;815.652
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;810.136
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;811.874
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;800.689
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;795.534
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,74
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,39
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,55
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,41
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,81
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,9
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,32
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,78
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,16
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,65
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;569.638
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;556.014
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;566.720
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;557.473
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;546.791
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;542.289
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;546.312
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;537.423
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;535.184
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;537.181
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;529.473
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;526.525
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;526.508
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;520.312
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;517.649
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,86
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,34
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,69
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,91
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,66
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,44
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,3
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,23
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,91
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,43
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,58
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,34
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;314.918
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;303.493
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;310.829
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;307.131
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;297.663
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;294.830
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;298.916
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;291.258
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;289.739
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;292.618
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;286.179
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;283.611
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;285.366
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;280.377
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;277.885
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,53
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,08
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,85
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,92
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,97
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,21
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,92
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,3
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,24
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,62
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,38
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,4
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;909.180
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;887.892
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;862.462
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;886.861
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;869.522
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;848.899
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;869.366
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;854.771
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;831.387
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;849.181
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;837.769
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;815.359
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;821.721
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;803.727
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,55
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,93
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,43
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,62
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,27
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,4
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,4
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,35
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,54
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,55
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,19
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;584.050
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;573.327
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;557.722
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;571.162
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;562.337
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;549.767
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;560.789
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;553.321
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;539.214
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;548.782
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;542.909
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;529.432
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;533.229
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;522.376
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,79
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,08
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,57
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,02
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,51
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,68
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,96
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,69
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,93
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,01
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,66
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;325.130
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;314.565
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;304.740
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;315.699
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;307.185
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;299.132
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;308.577
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;301.450
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;292.173
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;300.399
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;294.860
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;285.927
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;288.492
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;281.351
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,1
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,65
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,16
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,91
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,83
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,88
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,39
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,74
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,83
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,71
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,32
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;909.069
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;891.052
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;866.169
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;887.913
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;873.138
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;845.917
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;864.374
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;853.296
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;827.982
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;836.306
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;815.703
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;820.091
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;802.573
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,67
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,99
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,66
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,08
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,76
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,59
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,86
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,17
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,04
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,66
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;583.871
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;574.876
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;560.822
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;571.410
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;564.036
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;548.605
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;557.467
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;551.921
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;537.590
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;541.630
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;530.113
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;532.074
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;522.180
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,87
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,11
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,82
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,48
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,01
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,86
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,22
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,52
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,55
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,11
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;325.198
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;316.176
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;305.347
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;316.503
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;309.102
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;297.312
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;306.907
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;301.375
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;290.392
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;294.676
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;285.590
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;288.017
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;280.393
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,33
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,76
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,37
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,38
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,32
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,1
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,2
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,53
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,09
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,83
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;903.694
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;888.774
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;863.213
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;878.067
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;866.817
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;842.709
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;848.800
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;829.357
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;831.433
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;815.205
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;816.964
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;803.074
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,16
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,53
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,62
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,5
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,08
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,55
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,44
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,92
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,03
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;580.440
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;573.017
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;558.796
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;565.182
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;559.652
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;546.224
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;548.737
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;538.073
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;538.600
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;529.585
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;530.048
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;522.166
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,37
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,67
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,75
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,76
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,29
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,99
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,77
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,5
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,44
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;323.254
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;315.757
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;304.417
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;312.885
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;307.165
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;296.485
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;300.063
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;291.284
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;292.833
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;285.620
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;286.916
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;280.908
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,79
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,28
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,39
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,03
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,69
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,74
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,83
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,87
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,28
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;421.942
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;399.797
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;457.618
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;405.944
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;385.415
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;428.197
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;390.377
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;370.875
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;415.122
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;375.717
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;357.444
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;398.794
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;353.155
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;340.328
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;380.077
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,21
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,4
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,57
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,52
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,77
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,71
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,04
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,41
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,15
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,7
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,13
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,06
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;276.443
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;262.115
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;298.768
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;266.151
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;252.675
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;280.060
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;256.473
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;243.585
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;271.993
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;247.387
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;235.160
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;261.794
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;232.506
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;224.258
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;249.952
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,4
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,74
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,78
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,93
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,04
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,49
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,72
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,62
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,11
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,56
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,66
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;145.499
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;137.682
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;158.850
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;139.793
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;132.740
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;148.137
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;133.904
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;127.290
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;143.129
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;128.330
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;122.284
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;137.000
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;120.649
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;116.070
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;130.125
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,41
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,26
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,03
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,45
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,1
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,2
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,82
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,24
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,92
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,3
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,92
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;482.066
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;458.562
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;438.946
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;464.427
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;442.245
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;425.219
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;448.163
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;427.405
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;406.531
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;423.451
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;408.632
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;387.217
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;393.992
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;373.991
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,34
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,44
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,87
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,97
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,21
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,62
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,84
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,11
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,22
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,92
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,2
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;315.606
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;300.301
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;286.982
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;304.674
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;290.105
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;278.462
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;294.624
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;280.783
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;266.609
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;278.438
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;268.868
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;254.388
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;259.451
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;245.730
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,54
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,6
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,03
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,35
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,5
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,9
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,22
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,53
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,64
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,4
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,63
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;166.460
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;158.261
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;151.964
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;159.753
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;152.140
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;146.757
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;153.539
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;146.622
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;139.922
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;145.013
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;139.764
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;132.829
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;134.541
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;128.261
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,13
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,57
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,24
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,65
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,08
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,12
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,31
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,41
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,01
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,4
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;472.143
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;449.553
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;430.558
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;454.150
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;433.248
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;410.671
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;427.748
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;413.087
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;390.598
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;398.111
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;377.164
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;383.537
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;363.521
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,19
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,37
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,38
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,6
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,89
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,72
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,56
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,6
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,32
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,43
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;309.059
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;294.326
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;281.850
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;298.082
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;284.186
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;269.276
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;280.909
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;271.458
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;256.584
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;261.826
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;247.787
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;252.684
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;239.219
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,45
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,55
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,54
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,89
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,23
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,04
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,96
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,91
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,85
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,87
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;163.084
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;155.227
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;148.708
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;156.068
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;149.062
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;141.395
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;146.839
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;141.629
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;134.014
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;136.285
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;129.377
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;130.853
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;124.302
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,7
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,08
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,04
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,24
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,12
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,8
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,3
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,59
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;458.919
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;437.864
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;416.088
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;431.718
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;416.766
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;394.982
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;401.481
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;381.190
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;386.580
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;367.187
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;372.223
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;354.054
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,07
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,18
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,93
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,69
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,61
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,29
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,25
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,01
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,09
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;300.868
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;286.843
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;272.630
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;283.186
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;273.514
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;259.284
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;263.688
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;250.234
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;254.367
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;241.466
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;245.455
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;233.210
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,12
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,35
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,1
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,93
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,79
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,68
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,57
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,57
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,54
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;158.051
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;151.021
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;143.458
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;148.532
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;143.252
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;135.698
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;137.793
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;130.956
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;132.213
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;125.721
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;126.768
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;120.844
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,98
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,86
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,59
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,24
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,29
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,55
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,64
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,94
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,24
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;496.829
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;483.827
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;482.617
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;478.985
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;470.284
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;448.114
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;462.071
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;456.000
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;438.724
01 Andalucía;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;448.023
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;443.792
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;426.245
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;432.464
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;430.498
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;414.287
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,41
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,2
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,85
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,25
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,91
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,18
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,73
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,32
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,04
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,98
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,84
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;315.738
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;310.257
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;309.243
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;305.228
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;301.986
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;288.711
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;295.585
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;293.451
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;283.162
01 Andalucía;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;287.518
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;286.118
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;276.044
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;278.283
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;278.087
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;268.962
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,67
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,33
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,36
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,62
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,58
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,57
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,06
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,22
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,26
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,14
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,63
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,97
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;181.091
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;173.570
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;173.374
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;173.757
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;168.298
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;159.403
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;166.486
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;162.549
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;155.562
01 Andalucía;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;160.505
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;157.674
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;150.201
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;154.181
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;152.411
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;145.325
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,95
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,96
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,94
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,93
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,65
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,73
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,63
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,84
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,63
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,14
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,81
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,82
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;499.267
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;489.771
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;471.703
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;480.272
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;473.453
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;460.933
01 Andalucía;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;464.798
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;459.753
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;446.363
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;447.652
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;445.058
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;432.930
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;431.502
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;423.550
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Andalucía;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,2
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,67
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,72
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,1
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,87
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,63
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,66
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,87
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,78
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,1
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,79
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;317.037
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;313.702
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;302.562
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;306.164
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;303.851
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;296.196
01 Andalucía;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;297.216
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;295.604
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;287.792
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;287.018
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;286.720
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;279.825
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;278.744
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;274.109
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Andalucía;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,57
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,86
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,9
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,75
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,23
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,12
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,53
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,4
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,49
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,86
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,6
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;182.230
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;176.069
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;169.141
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;174.108
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;169.602
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;164.737
01 Andalucía;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;167.582
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;164.149
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;158.571
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;160.634
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;158.338
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;153.105
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;152.758
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;149.441
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Andalucía;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,54
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,33
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,4
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,96
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,23
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,75
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,15
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,93
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,52
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,76
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,35
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;502.222
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;496.823
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;479.987
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;483.189
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;479.704
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;462.471
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;463.523
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;462.513
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;447.155
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;447.816
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;436.953
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;433.869
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;425.863
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,21
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,55
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,35
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,29
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,09
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,16
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,14
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,03
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,33
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,72
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;318.854
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;317.505
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;308.340
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;307.843
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;307.237
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;298.049
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;296.081
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;296.754
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;288.826
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;288.120
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;282.599
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;280.103
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;275.941
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,55
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,77
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,66
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,86
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,46
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,67
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,75
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,65
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,22
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,49
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;183.368
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;179.318
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;171.647
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;175.346
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;172.467
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;164.422
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;167.442
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;165.759
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;158.329
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;159.696
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;154.354
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;153.766
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;149.922
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,63
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,18
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,79
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,31
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,44
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,24
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,06
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,93
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,75
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,34
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;500.999
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;497.219
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;481.509
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;479.155
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;477.878
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;463.731
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;462.071
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;452.261
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;446.987
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;439.948
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;434.008
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;428.911
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,64
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,11
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,31
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,93
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,93
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,9
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,37
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,29
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,08
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;317.689
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;317.064
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;309.366
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;304.561
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;305.265
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;298.558
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;295.966
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;291.585
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;287.344
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;284.219
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;279.874
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;277.555
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,87
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,28
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,51
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,35
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,25
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,63
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,87
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,27
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,72
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;183.310
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;180.155
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;172.143
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;174.594
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;172.613
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;165.173
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;166.105
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;160.676
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;159.643
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;155.729
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;154.134
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;151.356
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,25
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,81
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,95
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,2
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,34
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,61
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,46
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,56
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,92
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;37.247
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;35.860
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.761
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;34.527
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;33.722
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;25.116
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;32.060
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;31.549
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;24.266
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;29.949
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;29.629
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.896
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;28.022
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;27.895
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.755
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,7
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,04
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,33
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,07
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,98
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,37
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,41
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,62
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,61
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,23
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,79
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,64
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;22.333
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;21.907
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;17.555
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;20.825
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;20.631
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;15.391
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;19.412
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;19.287
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;14.897
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;18.180
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;18.146
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.169
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;17.097
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;17.141
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.492
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,25
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,18
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,67
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,92
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,04
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,86
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,4
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,83
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,71
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,55
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;78,24
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,86
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;14.914
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.953
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;11.206
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;13.702
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;13.091
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;9.725
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;12.648
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;12.262
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;9.369
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.769
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.483
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.727
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;10.925
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;10.754
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.263
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,87
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,82
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,78
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,81
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,88
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,61
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;78,91
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,3
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,88
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,25
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,07
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,74
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;32.479
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;31.842
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;29.370
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;29.903
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;29.412
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;28.251
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;27.765
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.342
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;26.487
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.821
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;25.589
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;25.057
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;23.954
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;23.986
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,07
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,37
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,19
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,49
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,87
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,18
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,5
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,36
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,31
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;75,23
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,67
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;19.667
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;19.579
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;17.888
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;18.169
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;18.041
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;17.244
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;16.924
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.781
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;16.288
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.803
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.765
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;15.442
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;14.866
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;14.794
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,38
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,14
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,4
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,05
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,71
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,06
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,35
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,52
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;86,33
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,93
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;82,7
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.812
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.263
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.482
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;11.734
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;11.371
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;11.007
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;10.841
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;10.561
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.199
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.018
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;9.824
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;9.615
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;9.088
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;9.192
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Andalucía;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,59
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,73
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,86
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,62
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,12
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,83
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,19
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,11
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,74
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,11
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,06
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;34.241
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;34.400
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;31.546
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;31.371
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;31.476
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;29.120
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;29.054
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;29.294
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;27.376
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;27.380
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;26.124
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;25.584
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;24.809
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,62
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,5
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,31
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,85
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,16
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,78
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,59
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,81
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,37
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,64
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;20.780
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;20.937
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;19.340
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;19.085
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;19.143
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.951
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.726
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.882
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.899
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;16.826
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;16.148
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;15.803
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;15.359
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,84
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,43
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,82
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,3
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,41
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,38
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,36
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;83,5
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,48
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;79,42
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;13.461
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;13.463
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.206
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.286
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.333
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;11.169
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.328
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.412
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.477
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;10.554
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;9.976
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;9.781
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;9.450
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,27
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,61
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,5
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,15
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,77
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,83
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,39
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,73
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,65
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,42
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;35.425
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;35.682
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;33.349
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;32.659
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;33.045
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;31.067
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;30.850
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;29.476
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;28.763
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;27.839
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;26.939
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;26.285
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,19
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,61
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,16
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,46
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,39
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,61
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,48
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,5
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,82
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;21.343
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;21.493
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;20.475
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;19.712
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;19.959
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;19.083
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;18.746
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;18.141
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;17.560
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;17.140
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.489
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.204
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,36
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,86
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,2
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,22
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,6
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,7
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,71
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,72
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,14
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.082
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;14.189
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.874
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.947
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;13.086
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;11.984
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;12.104
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;11.335
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;11.203
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;10.699
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;10.450
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;10.081
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,94
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,23
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,09
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,31
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,05
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;78,96
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,11
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,65
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,31
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;101.982
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;101.836
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;98.333
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;97.682
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;98.620
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;90.040
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;93.560
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;95.229
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;87.926
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;90.121
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;92.200
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;84.826
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;86.706
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;89.022
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;82.066
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,78
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,84
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,57
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,74
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,51
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,42
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,37
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,54
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,26
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,02
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,42
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,46
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;60.597
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;61.308
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;58.986
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;58.187
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;59.475
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;54.282
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;55.959
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;57.553
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;53.140
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;54.097
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;55.800
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;51.461
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;52.188
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;54.016
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;49.895
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,02
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,01
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,03
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,35
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,88
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,09
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,27
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,02
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,24
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,12
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,11
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,59
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;41.385
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;40.528
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;39.347
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;39.495
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;39.145
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;35.758
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;37.601
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;37.676
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;34.786
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;36.024
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;36.400
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;33.365
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;34.518
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;35.006
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;32.171
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,43
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,59
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,88
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,86
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,96
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,41
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,05
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,81
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,8
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,41
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,37
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,76
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;96.600
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;97.372
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;96.608
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;92.105
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;93.548
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;94.151
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;88.395
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;90.181
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;90.589
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;84.741
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;86.747
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;87.453
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;83.592
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;85.321
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,35
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,07
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,46
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,51
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,61
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,77
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,72
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,09
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,52
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,85
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,32
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;57.105
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;58.288
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;58.019
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;54.663
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;56.093
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;56.676
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;52.599
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;54.146
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;54.738
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;50.563
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;52.195
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;52.944
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;50.439
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;51.752
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,72
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,23
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,69
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,11
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,89
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,34
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,54
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,55
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,25
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,53
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,2
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;39.495
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;39.084
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;38.589
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;37.442
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;37.455
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;37.475
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;35.796
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;36.035
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;35.851
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;34.178
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;34.552
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;34.509
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;33.153
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;33.569
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Andalucía;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,8
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,83
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,11
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,63
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,2
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,9
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,54
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,4
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,43
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,82
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,99
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;98.149
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100.064
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;99.194
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;93.636
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;95.936
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;95.008
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;89.394
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;91.902
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;91.415
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;88.445
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;89.054
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;85.081
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;86.483
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,4
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,87
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,78
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,08
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,84
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,16
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,39
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,78
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,03
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,19
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;58.087
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;59.859
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;59.759
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;55.555
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;57.452
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;57.426
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;53.166
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;55.130
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;55.332
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;53.215
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;54.001
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;51.406
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;52.555
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,64
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,98
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,1
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,53
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,1
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,59
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,9
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,36
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,88
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,94
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;40.062
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;40.205
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;39.435
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;38.081
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;38.484
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;37.582
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;36.228
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;36.772
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;36.083
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;35.230
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;35.053
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;33.675
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;33.928
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,06
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,72
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,3
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,43
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,46
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,5
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,63
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,89
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,76
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,04
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;98.582
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100.932
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100.304
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;93.850
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;96.369
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;96.154
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;92.595
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;93.445
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;88.935
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;90.562
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;85.801
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;87.868
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,2
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,48
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,86
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,74
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,16
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,11
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,29
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,01
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,6
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;58.273
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;60.189
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;60.516
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;55.586
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;57.553
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;58.070
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;55.456
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;56.545
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;53.488
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;54.926
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;51.778
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;53.369
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,39
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,62
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,96
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,14
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,44
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,87
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,76
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,03
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,19
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;40.309
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;40.743
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;39.788
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;38.264
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;38.816
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;38.084
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;37.139
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;36.900
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;35.447
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;35.636
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;34.023
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;34.499
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,93
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,27
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,72
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,15
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,74
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,56
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,51
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,71
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;158.994
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;157.039
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;156.955
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;154.132
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;153.527
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;146.118
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;149.363
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;149.652
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;143.461
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;145.617
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;146.436
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;140.024
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;141.630
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;142.878
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;136.812
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,94
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,76
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,1
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,94
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,3
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,4
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,59
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,25
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,21
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,08
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,98
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,17
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;101.788
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;101.480
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;101.149
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;98.888
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;99.350
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;94.739
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;96.232
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;97.093
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;93.199
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;94.171
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;95.193
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;91.277
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;91.844
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;93.016
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;89.445
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,15
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,9
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,66
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,54
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,68
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,14
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,52
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,8
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,24
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,23
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,66
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,43
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;57.206
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;55.559
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;55.806
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;55.244
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;54.177
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;51.379
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;53.131
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;52.559
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;50.262
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;51.446
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;51.243
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;48.747
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;49.786
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;49.862
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;47.367
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,57
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,51
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,07
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,88
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,6
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,07
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,93
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,23
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,35
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,03
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,75
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,88
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;157.392
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;156.644
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;152.907
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;151.945
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;152.168
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;149.862
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;147.702
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;148.500
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;145.922
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;143.157
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;144.482
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;142.263
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;140.809
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;139.872
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,54
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,14
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,01
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,84
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,8
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,43
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,96
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,24
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,04
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,89
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,48
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100.185
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100.704
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;98.697
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;97.136
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;98.080
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;96.932
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;94.792
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;95.928
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;94.715
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;92.134
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;93.509
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;92.622
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;91.344
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;91.198
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,96
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,39
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,21
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,62
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,26
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,97
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,96
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,86
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,84
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,71
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,4
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;57.207
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;55.940
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;54.210
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;54.809
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;54.088
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;52.930
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;52.910
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;52.572
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;51.207
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;51.023
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;50.973
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;49.641
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;49.465
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;48.674
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Andalucía;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,81
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,69
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,64
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,49
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,98
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,46
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,19
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,12
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,57
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,43
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,79
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;158.261
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;158.816
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;155.910
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;153.023
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;154.239
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;151.112
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;147.729
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;149.459
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;146.885
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;145.439
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;144.266
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;141.562
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;141.250
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,69
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,12
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,92
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,35
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,11
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,21
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,58
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,53
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,14
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,6
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100.769
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;102.040
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100.805
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;97.873
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;99.370
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;98.031
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;94.743
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;96.451
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;95.572
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;94.072
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;94.005
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;91.876
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;92.230
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,13
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,38
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,25
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,02
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,52
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,81
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,19
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,25
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,04
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,49
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;57.492
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;56.776
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;55.105
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;55.150
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;54.869
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;53.081
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;52.986
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;53.008
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;51.313
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;51.367
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;50.261
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;49.686
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;49.020
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,93
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,64
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,33
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,16
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,36
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,12
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,47
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,21
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,51
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,96
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;158.080
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;159.075
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;156.493
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;152.145
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;153.673
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;151.538
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;149.364
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;148.600
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;145.145
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;145.232
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;141.677
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;142.284
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,25
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,6
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,83
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,9
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,96
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,24
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,8
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,06
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,92
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100.642
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;102.124
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;101.230
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;97.109
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;98.820
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;98.295
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;96.247
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;96.532
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;93.884
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;94.558
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;91.986
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;92.812
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,49
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,76
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,1
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,25
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,36
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,93
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,41
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,07
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,68
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;57.438
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;56.951
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;55.263
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;55.036
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;54.853
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;53.243
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;53.117
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;52.068
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;51.261
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;50.674
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;49.691
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;49.472
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,82
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,32
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,34
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,27
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,22
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,01
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,7
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,25
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,52
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;139.225
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;133.501
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;135.486
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;135.694
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;130.960
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;128.127
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;132.367
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;128.281
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;126.217
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;129.818
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;126.136
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;123.887
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;126.671
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;123.675
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;121.531
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,46
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,1
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,57
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,07
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,09
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,16
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,24
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,48
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,44
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,98
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,64
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,7
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;91.556
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;88.523
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;89.706
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;89.425
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;86.949
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;85.238
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;87.500
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;85.312
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;84.059
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;86.003
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;83.969
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;82.665
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;84.108
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;82.453
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;81.254
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,67
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,22
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,02
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,57
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,37
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,7
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,93
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,86
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,15
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,87
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,14
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,58
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;47.669
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;44.978
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;45.780
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;46.269
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;44.011
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;42.889
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;44.867
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;42.969
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;42.158
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;43.815
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;42.167
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;41.222
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;42.563
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;41.222
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;40.277
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,06
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,85
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,69
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,12
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,53
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,09
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,92
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,75
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,04
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,29
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,65
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,98
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;144.376
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;139.615
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;132.443
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;140.499
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;136.465
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;130.261
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;137.570
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;133.982
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;127.488
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;133.995
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;131.115
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;124.871
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;128.232
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;123.000
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,31
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,74
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,35
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,29
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,97
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,26
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,81
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,91
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,28
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,85
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,87
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;94.645
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;92.288
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;87.851
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;92.386
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;90.344
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;86.507
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;90.653
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;88.791
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;84.809
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;88.497
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;87.021
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;83.231
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;85.290
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;82.081
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,61
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,89
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,47
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,78
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,21
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,54
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,5
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,29
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,74
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,42
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,43
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;49.731
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;47.327
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;44.592
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;48.113
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;46.121
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;43.754
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;46.917
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;45.191
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;42.679
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;45.498
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;44.094
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;41.640
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;42.942
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;40.919
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Andalucía;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,75
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,45
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,12
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,34
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,49
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,71
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,49
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,17
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,38
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,73
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,76
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;144.490
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;140.412
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;133.937
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;140.843
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;137.317
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;130.586
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;136.709
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;133.952
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;127.544
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;130.912
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;125.533
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;128.077
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;123.348
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,48
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,8
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,5
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,61
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,4
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,23
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,23
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,73
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,22
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,09
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;94.681
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;92.661
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;88.946
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;92.532
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;90.759
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;86.875
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;90.032
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;88.644
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;84.997
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;86.817
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;83.756
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;85.160
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;82.386
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,73
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,95
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,67
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,09
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,66
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,56
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,69
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,16
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,9
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,62
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;49.809
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;47.751
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;44.991
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;48.311
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;46.558
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;43.711
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;46.677
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;45.308
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;42.547
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;44.095
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;41.777
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;42.917
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;40.962
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,99
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,5
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,15
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,71
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,88
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,57
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,34
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,86
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,88
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,04
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;143.754
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;140.019
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;133.806
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;139.172
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;136.272
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;130.281
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;133.057
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;128.078
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;130.057
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;125.712
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;127.645
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;123.714
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,81
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,32
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,37
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,03
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,72
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,89
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,95
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,16
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,46
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;94.146
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;92.299
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;88.810
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;91.352
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;89.945
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;86.614
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;88.013
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;85.256
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;86.265
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;83.793
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;84.850
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;82.537
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,03
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,45
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,53
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,36
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,46
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,35
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,93
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,94
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;49.608
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;47.720
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;44.996
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;47.820
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;46.327
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;43.667
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;45.044
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;42.822
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;43.792
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;41.919
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;42.795
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;41.177
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,4
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,08
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,05
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,39
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,17
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,77
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,16
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,68
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,51
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;59.381
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;55.591
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;63.082
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;56.950
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;53.455
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;58.713
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;54.721
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;51.289
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;56.854
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;52.518
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;49.391
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;54.612
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;49.435
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;47.028
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;52.123
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,91
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,16
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,07
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,15
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,26
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,13
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,44
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,85
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,57
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,25
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,6
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,63
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;39.464
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;37.039
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;41.847
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;37.903
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;35.581
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;39.061
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;36.482
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;34.206
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;37.867
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;35.067
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;33.010
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;36.472
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;33.046
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;31.461
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;34.876
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,04
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,06
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,34
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,44
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,35
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,49
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,86
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,12
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,16
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,74
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,94
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,34
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;19.917
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;18.552
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;21.235
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;19.047
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;17.874
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;19.652
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;18.239
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;17.083
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;18.987
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;17.451
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;16.381
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;18.140
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;16.389
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;15.567
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;17.247
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,63
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,35
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,55
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,58
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,08
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,41
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,62
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,3
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,43
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,29
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,91
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,22
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;68.420
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;64.298
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;60.375
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;65.820
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;61.860
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;58.408
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;63.366
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;59.748
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;55.877
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;59.938
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;57.125
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;53.286
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;54.915
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;51.371
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
01 Andalucía;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,2
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,21
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,74
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,61
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,92
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,55
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,6
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,84
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,26
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,41
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,09
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;45.435
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;42.843
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;40.107
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;43.810
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;41.293
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;38.837
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;42.248
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;39.958
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;37.242
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;40.021
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;38.230
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;35.586
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;36.805
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;34.284
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
01 Andalucía;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,42
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,38
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,83
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,99
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,27
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,86
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,08
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,23
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,73
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,91
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,48
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;22.985
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;21.455
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;20.268
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;22.010
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;20.567
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;19.571
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;21.118
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.790
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;18.635
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;19.917
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;18.895
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;17.700
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;18.110
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;17.087
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
01 Andalucía;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,76
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,86
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,56
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,88
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,24
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,94
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,65
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,07
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,33
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,41
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,31
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;67.081
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;63.131
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;59.400
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;64.316
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;60.736
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;56.645
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;60.637
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;57.906
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;53.935
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;55.640
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;51.976
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;53.565
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;49.973
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,88
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,21
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,36
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,39
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,72
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,8
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,13
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,5
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,85
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,13
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;44.537
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;42.008
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;39.490
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;42.798
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;40.513
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;37.766
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;40.414
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;38.647
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;36.026
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;37.190
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;34.689
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;35.858
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;33.411
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,1
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,44
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,63
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,74
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,23
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,53
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,84
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,36
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,61
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;22.544
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;21.123
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;19.910
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;21.518
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.223
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;18.879
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;20.223
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.259
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;17.909
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;18.450
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;17.287
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;17.707
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;16.562
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,45
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,74
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,82
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,7
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,18
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,95
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,35
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,83
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,83
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,18
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;65.158
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;61.511
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;57.557
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;61.329
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;58.519
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;54.691
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;56.205
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;52.662
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;54.087
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;50.603
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;51.946
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;48.760
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,12
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,14
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,02
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,37
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,5
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,93
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,92
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,45
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,72
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;43.285
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;40.959
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;38.335
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;40.802
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;38.988
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;36.496
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;37.504
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;35.111
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;36.147
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;33.802
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;34.771
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.633
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,26
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,19
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,2
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,56
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,59
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,25
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,18
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,89
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,13
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;21.873
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;20.552
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;19.222
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;20.527
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;19.531
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;18.195
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;18.701
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;17.551
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;17.940
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;16.801
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;17.175
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;16.127
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,85
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,03
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,66
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,99
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,31
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,29
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,41
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,57
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,9
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
01 Andalucía;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;81.031
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;80.465
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;82.794
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;78.568
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;78.408
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;77.568
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;76.253
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;76.382
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;76.046
02 Aragón;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;74.376
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;74.699
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;74.085
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;71.888
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;72.755
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;72.036
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,96
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,44
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,69
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,1
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,93
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,85
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,79
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,83
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,48
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,72
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,42
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,01
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;50.710
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;50.545
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;51.891
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;49.232
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;49.324
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;48.902
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;47.896
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;48.140
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;48.044
02 Aragón;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;46.803
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;47.135
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;46.881
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;45.289
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;45.959
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;45.651
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,09
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,58
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,24
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,45
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,24
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,59
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,3
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,25
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,35
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,31
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,93
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,97
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;30.321
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;29.920
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;30.903
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;29.336
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;29.084
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;28.666
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;28.357
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;28.242
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;28.002
02 Aragón;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;27.573
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;27.564
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;27.204
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;26.599
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;26.796
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;26.385
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,75
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,21
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,76
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,52
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,39
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,61
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,94
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,13
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,03
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,72
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,56
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,38
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;81.032
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;80.859
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;80.443
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;78.415
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;78.525
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;78.683
02 Aragón;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;76.373
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;76.643
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;76.387
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;73.720
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;74.549
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;74.167
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;72.682
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;72.657
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Aragón;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,77
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,11
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,81
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,25
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,79
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,96
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,98
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,2
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,2
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,89
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,32
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;50.655
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;50.795
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;50.558
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;49.146
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;49.421
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;49.604
02 Aragón;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;47.959
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;48.282
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;48.230
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;46.346
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;47.012
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;46.886
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;45.897
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;46.017
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Aragón;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,02
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,3
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,11
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,68
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,05
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,4
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,49
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,55
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,74
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,36
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,02
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;30.377
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;30.064
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;29.885
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;29.269
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;29.104
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;29.079
02 Aragón;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;28.414
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;28.361
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;28.157
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;27.374
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.537
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;27.281
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;26.785
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;26.640
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Aragón;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,35
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,81
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,3
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,54
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,34
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,22
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,11
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,59
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,29
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,09
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,14
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;81.210
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;81.387
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;81.181
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;78.593
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;78.942
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;78.476
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;75.653
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;76.568
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;76.056
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;74.558
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;74.439
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;72.688
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;72.861
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,78
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,67
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,16
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,08
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,69
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,61
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,7
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,31
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,75
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;50.732
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;51.102
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;51.100
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;49.250
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;49.641
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;49.456
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;47.474
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;48.212
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;47.995
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;47.013
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;47.062
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;45.918
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;46.139
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,08
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,14
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,78
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,58
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,34
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,92
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,1
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,86
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,29
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;30.478
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;30.285
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;30.081
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;29.343
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;29.301
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;29.020
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;28.179
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;28.356
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;28.061
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;27.545
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;27.377
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;26.770
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;26.722
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,28
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,75
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,47
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,46
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,63
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,28
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,95
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,01
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,39
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,83
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;80.834
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;81.225
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;80.822
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;77.570
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;78.533
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;78.043
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;76.369
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;76.267
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;74.355
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;74.524
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;72.609
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;73.007
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,96
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,69
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,56
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,02
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,36
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,54
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,21
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,39
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,33
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;50.512
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;50.930
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;50.858
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;48.545
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;49.308
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;49.181
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;48.019
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;48.137
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;46.844
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;47.115
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;45.817
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;46.213
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,11
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,82
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,7
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,28
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,65
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,98
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,64
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,96
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,87
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;30.322
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;30.295
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;29.964
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;29.025
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;29.225
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;28.862
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;28.350
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;28.130
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;27.511
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;27.409
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;26.792
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;26.794
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,72
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,47
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,32
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,58
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,88
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,81
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,47
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,44
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,42
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.013
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.812
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.094
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;4.628
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;4.495
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;3.479
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;4.337
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;4.182
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;3.355
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.080
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.947
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.149
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.856
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.738
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.983
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,32
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,41
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;84,98
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,52
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,91
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;81,95
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,39
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;82,02
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,92
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,92
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,68
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;72,86
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.104
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.051
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.558
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.867
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.840
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;2.189
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;2.695
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.642
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;2.115
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.543
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.502
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.993
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.409
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.360
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.887
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,36
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,08
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,57
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,82
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,59
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,68
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,93
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,01
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;77,91
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,61
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,35
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;73,77
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.909
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.761
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.536
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.761
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.655
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.290
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.642
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.540
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.240
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.537
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.445
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.156
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.447
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.378
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.096
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,25
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,98
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;83,98
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,01
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,45
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;80,73
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,51
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,06
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;75,26
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,8
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,25
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,35
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.392
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.366
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.993
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;4.060
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;3.985
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;3.830
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.789
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.707
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.560
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.548
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.494
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.346
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;3.270
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;3.201
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Aragón;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,44
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,27
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,92
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,27
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,91
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,16
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,78
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;80,03
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,8
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,9
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,17
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.734
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.769
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.518
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.539
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;2.524
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;2.423
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.370
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.355
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.262
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.225
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.212
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.124
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;2.069
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;2.035
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Aragón;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,87
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,15
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,23
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,69
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,05
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,83
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,38
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,88
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,35
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,72
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,82
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.658
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.597
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.475
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.521
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.461
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.407
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.419
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.352
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.298
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.323
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.282
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.222
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.201
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.166
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Aragón;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,74
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,48
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,39
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,59
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,66
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,79
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,28
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,85
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,2
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,05
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.702
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.679
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.373
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.270
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.209
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.947
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.978
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.942
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.698
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;3.683
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;3.525
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;3.478
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;3.347
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,81
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,96
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,26
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;84,6
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,25
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,56
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,71
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,61
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,33
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,54
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.941
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.939
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.780
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.687
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.659
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.508
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.511
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.485
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.349
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;2.327
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;2.240
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;2.204
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;2.131
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,36
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,47
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;90,22
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,38
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,55
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;84,5
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,18
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;80,58
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,99
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;76,65
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.761
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.740
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.593
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.583
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.550
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.439
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.467
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.457
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.349
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.356
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.285
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.274
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.216
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,89
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;89,08
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,33
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,3
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,74
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,68
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,93
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,67
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,22
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;76,33
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.773
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.788
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.519
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.402
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.429
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.193
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;4.122
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;3.970
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;3.886
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;3.746
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.669
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.559
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,23
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,5
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,79
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,09
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,85
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,16
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,89
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,63
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;78,76
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.969
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.995
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.894
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.748
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.764
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.679
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;2.579
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;2.530
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;2.437
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;2.392
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.305
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.284
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,56
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,29
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,57
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,11
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,42
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,37
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,65
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,96
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,92
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.804
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.793
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.625
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.654
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.665
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.514
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.543
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.440
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.449
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.354
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.364
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.275
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,69
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,86
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,17
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,06
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,62
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,81
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,32
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;76,07
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,46
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;13.324
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.729
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.524
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;12.848
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;13.281
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;12.460
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;12.412
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;12.861
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;12.154
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.066
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.533
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.744
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.672
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.182
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.365
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,43
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,74
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,13
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,16
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,68
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,87
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,56
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,29
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,84
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,6
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,73
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,04
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.862
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.163
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.005
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;7.598
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;7.900
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;7.420
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;7.373
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;7.652
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;7.264
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.187
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.466
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.053
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.964
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.271
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.842
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,64
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,78
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,69
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,78
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,74
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,74
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,41
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,46
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,11
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,58
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,07
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,47
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.462
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.566
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.519
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.250
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;5.381
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;5.040
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;5.039
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;5.209
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.890
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.879
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.067
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.691
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.708
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.911
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.523
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,12
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,68
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,32
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,26
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,59
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,6
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,33
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,03
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,2
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,23
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,95
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.504
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.830
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.205
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;12.029
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;12.374
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;12.851
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.639
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.003
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.387
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.236
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.612
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.961
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;11.269
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;11.668
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Aragón;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,2
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,45
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,32
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,08
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,55
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,81
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,86
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,51
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,58
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,83
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,36
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.363
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.604
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.835
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;7.114
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;7.337
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;7.659
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.909
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.124
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.422
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.682
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.902
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.178
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;6.712
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;7.013
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Aragón;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,62
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,49
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,75
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,83
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,69
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,73
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,75
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,77
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,61
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,27
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,51
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.141
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.226
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.370
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;4.915
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;5.037
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;5.192
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.730
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.879
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.965
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.554
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.710
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.783
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.557
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.655
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Aragón;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,6
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,38
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,69
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,01
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,36
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,46
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,58
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,13
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,07
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,2
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,69
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.713
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.060
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.519
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.226
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.574
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.974
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.751
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.119
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.500
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;11.741
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;12.170
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;11.402
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;11.852
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,17
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,28
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,97
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,43
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,79
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,46
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,9
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,02
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,3
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,67
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.485
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.747
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.042
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.232
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.468
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.757
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.968
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.212
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.481
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;7.001
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;7.296
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;6.818
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;7.111
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,62
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,4
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,46
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,09
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,09
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,02
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,37
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,72
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,01
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,42
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.228
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.313
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.477
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.994
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.106
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.217
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.783
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.907
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.019
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.740
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.874
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.584
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.741
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,52
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,1
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,25
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,49
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,36
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,64
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,22
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,99
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,28
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,56
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.832
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.178
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.570
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.297
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.658
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;13.025
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;12.249
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;12.647
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;11.877
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;12.289
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.563
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.003
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,83
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,05
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,98
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,95
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,2
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,13
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,56
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,74
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,45
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.584
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.799
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.105
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.284
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.503
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.790
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;7.276
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;7.574
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;7.079
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;7.360
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.904
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.199
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,04
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,2
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,11
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,29
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,45
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,77
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,81
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,52
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,82
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.248
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.379
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.465
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.013
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.155
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.235
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.973
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;5.073
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.798
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.929
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.659
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.804
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,52
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,84
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,79
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,45
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,83
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,2
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,19
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,61
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,9
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;24.541
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.858
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.290
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;23.915
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;24.336
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;23.803
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;23.287
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;23.844
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;23.440
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;22.808
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;23.408
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.959
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.302
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;22.960
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;22.477
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,45
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,9
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,12
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,89
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,92
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,68
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,94
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,17
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,78
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,88
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,36
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,88
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;15.506
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.784
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;15.985
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;15.132
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;15.478
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;15.193
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;14.762
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;15.194
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;14.990
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;14.479
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.925
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.703
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.199
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.643
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;14.418
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,59
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,06
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,05
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,2
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,26
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,78
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,38
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,56
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,98
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,57
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,77
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,2
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.035
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.074
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.305
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;8.783
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;8.858
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;8.610
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;8.525
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;8.650
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;8.450
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.329
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.483
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.256
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.103
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.317
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.059
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,21
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,62
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,53
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,36
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,33
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,81
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,19
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,49
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,73
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,68
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,66
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,61
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.773
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.231
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;24.668
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;23.066
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;23.649
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;24.229
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.549
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;23.182
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.660
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.992
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;22.704
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;23.139
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;22.244
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;22.745
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Aragón;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,03
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,6
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,22
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,85
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,67
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,91
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,51
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,7
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,8
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,8
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,2
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;14.914
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;15.389
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.686
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;14.495
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;15.047
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;15.456
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;14.188
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;14.753
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.111
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;13.873
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;14.455
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.800
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;14.179
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;14.563
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Aragón;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,19
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,78
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,53
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,13
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,87
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,33
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,02
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,93
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,35
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,14
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,84
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.859
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.842
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.982
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;8.571
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;8.602
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;8.773
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.361
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.429
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.549
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.119
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.249
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.339
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;8.065
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;8.182
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Aragón;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,75
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,29
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,67
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,38
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,33
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,18
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,65
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,29
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,84
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,21
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,09
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;23.875
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.501
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.933
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;23.200
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.897
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.287
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.560
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;23.332
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.707
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;22.827
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;23.293
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;22.320
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;22.910
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,17
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,53
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,41
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,49
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,23
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,08
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,17
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,42
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,1
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,89
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;14.946
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;15.550
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.869
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;14.550
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.179
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.474
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;14.195
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;14.830
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;15.129
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;14.528
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;14.879
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;14.229
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;14.652
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,35
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,61
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,51
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,98
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,37
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,34
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,43
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,76
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,5
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,33
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.929
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.951
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.064
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.650
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.718
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.813
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.365
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.502
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.578
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;8.299
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;8.414
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;8.091
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;8.258
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,88
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,4
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,23
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,68
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,98
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,64
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,72
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,83
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,39
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,11
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;23.806
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.527
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.903
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.071
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.870
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;24.208
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;23.321
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;23.766
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;22.774
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;23.347
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;22.329
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.961
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,91
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,32
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,21
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,08
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,43
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,85
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,75
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,04
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,2
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;14.884
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;15.540
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.822
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;14.471
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.139
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.414
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;14.810
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;15.148
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;14.483
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;14.902
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;14.220
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;14.665
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,23
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,42
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,42
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,3
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,74
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,2
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,19
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,51
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,69
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.922
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.987
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.081
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.600
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.731
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.794
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;8.511
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;8.618
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;8.291
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;8.445
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.109
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.296
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,39
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,15
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,84
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,7
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,9
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,26
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,23
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,36
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.524
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;25.125
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.895
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;25.047
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;24.769
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;24.795
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;24.564
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;24.383
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;24.500
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;24.164
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;24.059
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;24.118
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;23.715
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;23.708
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;23.722
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,13
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,58
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,75
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,24
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,05
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,61
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,67
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,76
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,14
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,91
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,36
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,61
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;16.048
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.859
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;16.341
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;15.768
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;15.660
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;15.694
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;15.491
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;15.448
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;15.535
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.265
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;15.260
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;15.310
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;15.016
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;15.056
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.077
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,26
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,75
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,04
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,53
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,41
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,07
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,12
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,22
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,69
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,57
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,94
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,26
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.476
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.266
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.554
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;9.279
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;9.109
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;9.101
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;9.073
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;8.935
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;8.965
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.899
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.799
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.808
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.699
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.652
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.645
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,92
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,31
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,26
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,75
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,43
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,84
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,91
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,96
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,19
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,8
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,37
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,49
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;25.978
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.654
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;25.320
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;25.401
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;25.214
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;24.970
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;24.972
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;24.836
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;24.513
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;24.479
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;24.441
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;24.090
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;24.068
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;23.802
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Aragón;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,78
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,28
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,62
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,13
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,81
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,81
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,23
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,27
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,14
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,82
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;16.324
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.150
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.970
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;15.999
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;15.905
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;15.796
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;15.763
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.683
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.524
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.495
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.447
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;15.278
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;15.237
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;15.124
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Aragón;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,01
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,48
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,91
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,56
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,11
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,21
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,92
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,65
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,67
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,35
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,7
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.654
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.504
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.350
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;9.402
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;9.309
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;9.174
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.209
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.153
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.989
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.984
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.994
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.812
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;8.831
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;8.678
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Aragón;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,39
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,95
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,12
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,39
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,31
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,14
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,06
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,63
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,25
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,92
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,81
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.874
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;25.685
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;25.421
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;25.340
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;25.224
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.898
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;24.795
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;24.777
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;24.441
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;24.380
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;24.134
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;23.990
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;23.822
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,94
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,21
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,94
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,83
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,46
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,14
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,92
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,94
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,4
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,71
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.254
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;16.168
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;16.057
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;15.971
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.895
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.746
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;15.669
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;15.630
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;15.482
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;15.402
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;15.319
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;15.179
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;15.143
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,26
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,31
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,4
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,67
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,42
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,26
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,4
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,88
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,31
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.620
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.517
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.364
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.369
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.329
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.152
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.126
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.147
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.959
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;8.978
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;8.815
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;8.811
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;8.679
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,39
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,02
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,74
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,86
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,11
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,67
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,34
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,14
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,58
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,68
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;25.742
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;25.593
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;25.311
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;25.132
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;25.093
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;24.783
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;24.671
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;24.451
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;24.254
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;24.107
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;23.872
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;23.805
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,63
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,05
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,91
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,4
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,6
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,77
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,24
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,28
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,05
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.202
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.095
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.976
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.858
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.798
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.672
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;15.556
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;15.491
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;15.320
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;15.297
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.105
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.121
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,88
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,15
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,1
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,65
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,96
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,18
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,75
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,85
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,65
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.540
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.498
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.335
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.274
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.295
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.111
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;9.115
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;8.960
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.934
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;8.810
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.767
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.684
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,21
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,86
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,6
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,97
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,98
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,06
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,38
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,3
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,03
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.629
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.941
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.991
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;12.130
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;11.527
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;13.031
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;11.653
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;11.112
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;12.597
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.258
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.752
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.115
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.343
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.167
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.489
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,05
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,53
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,14
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,27
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,06
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,04
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,14
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,04
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,59
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,9
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,14
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,12
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.190
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.688
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;9.002
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.867
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.446
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;8.406
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.575
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;7.204
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;8.140
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.329
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.982
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.822
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.701
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.629
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.427
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,06
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,85
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,38
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,49
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,7
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,42
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,49
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,82
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,89
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,82
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,23
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,5
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.439
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.253
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.989
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;4.263
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;4.081
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.625
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;4.078
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.908
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.457
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.929
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.770
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.293
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.642
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.538
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.062
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,04
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,96
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,7
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,87
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,89
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,34
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,51
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,64
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,05
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,05
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,19
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,42
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.385
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.778
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.257
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.859
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;13.303
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;12.803
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.424
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.915
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.267
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.465
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.298
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.631
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.831
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;11.241
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
02 Aragón;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,34
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,55
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,58
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,32
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,74
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,53
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,65
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,26
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,73
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,87
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,79
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.320
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.883
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.549
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.999
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.608
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;8.270
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.729
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.367
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.911
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.071
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.996
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.506
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.700
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;7.282
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
02 Aragón;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,56
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,9
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,74
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,66
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,19
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,54
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,6
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,01
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,8
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,68
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,18
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.065
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.895
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.708
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.860
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.695
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.533
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.695
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.548
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.356
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.394
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.302
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.125
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;4.131
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.959
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
02 Aragón;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,95
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,91
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,28
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,69
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,91
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,52
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,75
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,89
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,62
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,39
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,09
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.046
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.462
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.935
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;13.557
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.038
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.370
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.569
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.398
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.710
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.927
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;11.317
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;11.498
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.930
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,52
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,85
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,63
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,48
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,1
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,53
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,6
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,49
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,41
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,5
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.106
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.698
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.352
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.810
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.440
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.971
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.131
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;8.055
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.554
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.755
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;7.328
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.488
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;7.102
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,75
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,03
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,44
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,29
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,61
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,45
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,16
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,74
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,09
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,03
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.940
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.764
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.583
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.747
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.598
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.399
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.438
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.343
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.156
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;4.172
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.989
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;4.010
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.828
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,09
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,52
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,99
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,84
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,16
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,68
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,57
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,04
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,17
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,53
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.681
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.139
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.519
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.668
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.483
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.834
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;12.006
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;11.433
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;11.564
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;11.035
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.176
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.679
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,6
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,01
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,53
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,38
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,33
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,01
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,15
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,06
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,3
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.873
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.501
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.061
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.184
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;8.104
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.626
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.798
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.394
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.525
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;7.164
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.283
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.944
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,23
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,33
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,6
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,73
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,73
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,52
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,87
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,67
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,14
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.808
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.638
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.458
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.484
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.379
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.208
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;4.208
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;4.039
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;4.039
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.871
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.893
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.735
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,26
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,42
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,39
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,73
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,6
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,08
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,83
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,94
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,78
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
02 Aragón;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;63.454
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;63.205
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;64.351
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;61.710
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;61.792
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;60.846
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;59.892
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;60.207
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;59.721
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;58.290
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;58.846
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;58.359
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;56.334
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;57.242
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;56.840
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,25
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,76
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,55
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,39
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,26
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,81
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,86
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,1
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,69
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,78
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,57
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,33
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;37.970
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;37.977
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;38.539
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;36.899
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;37.125
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;36.483
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;35.882
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;36.205
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;35.875
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;34.987
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;35.408
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;35.162
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;33.835
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;34.491
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;34.297
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,18
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,76
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,67
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,5
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,33
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,09
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,14
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,24
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,24
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,11
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,82
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,99
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;25.484
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;25.228
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;25.812
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;24.811
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;24.667
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;24.363
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;24.010
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;24.002
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;23.846
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;23.303
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;23.438
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;23.197
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;22.499
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;22.751
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;22.543
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,36
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,78
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,39
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,22
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,14
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,38
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,44
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,9
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,87
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,29
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,18
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,34
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;63.584
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;63.557
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;63.096
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;61.556
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;61.798
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;61.860
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;59.810
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;60.303
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;60.308
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;57.732
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;58.582
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;58.648
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;57.237
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;57.597
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,81
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,23
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,04
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,06
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,88
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,58
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,8
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,17
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,95
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,06
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,28
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;37.967
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;38.176
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;37.782
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;36.814
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;37.145
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;37.104
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.832
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;36.261
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;36.274
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;34.614
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;35.271
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;35.324
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;34.459
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;34.702
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,96
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,3
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,21
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,38
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,98
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,01
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,17
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,39
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,49
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,26
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,85
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;25.617
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;25.381
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;25.314
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;24.742
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;24.653
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;24.756
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;23.978
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;24.042
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;24.034
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;23.118
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;23.311
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;23.324
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;22.778
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;22.895
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,58
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,13
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,8
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,6
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,72
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,94
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,24
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,84
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,14
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,74
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,44
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;63.602
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;63.866
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;63.450
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;61.487
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;62.077
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;61.641
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;59.187
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;60.165
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;59.811
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;58.712
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;58.705
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;57.196
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;57.427
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,67
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,2
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,15
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,06
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,21
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,26
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,93
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,52
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,56
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,51
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;37.921
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;38.280
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;38.088
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;36.730
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;37.237
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;37.101
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;35.393
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;36.143
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;36.039
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;35.261
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;35.381
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;34.403
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;34.637
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,86
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,28
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,41
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,33
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,42
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,62
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,11
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,89
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,87
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,94
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;25.681
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;25.586
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;25.362
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;24.757
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;24.840
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;24.540
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;23.794
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;24.022
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;23.772
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;23.451
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;23.324
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;22.793
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;22.790
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,4
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,08
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,76
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,65
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,89
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,73
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,66
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,96
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,08
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,86
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;63.122
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;63.711
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;63.448
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;60.611
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;61.603
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;61.372
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;60.044
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;60.157
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;58.419
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;58.775
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;56.939
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;57.527
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,02
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,69
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,73
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,24
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,81
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,69
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,63
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,37
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,67
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;37.599
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;38.184
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;38.143
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;36.151
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;36.976
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;36.934
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;36.018
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;36.209
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;35.091
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;35.400
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;34.258
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;34.671
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,15
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,84
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,83
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,33
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,93
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,9
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,81
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,72
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,9
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;25.523
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;25.527
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;25.305
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;24.460
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;24.627
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;24.438
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;24.026
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;23.948
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;23.328
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;23.375
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;22.681
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;22.856
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,84
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,47
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,57
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,12
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,64
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,39
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,37
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,85
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,32
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.146
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.152
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.578
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.912
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.928
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;2.262
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.719
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.738
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;2.187
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.538
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.560
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.053
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.353
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.402
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.963
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,56
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,89
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,74
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,43
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,87
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,83
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,67
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,22
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,64
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,79
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,21
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,14
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.919
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.921
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.573
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.763
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.790
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.368
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.648
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.675
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.323
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.531
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.566
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.248
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.421
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.470
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.201
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,87
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,18
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,97
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,88
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,19
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,11
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,78
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,52
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,34
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,05
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,52
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,35
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.227
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.231
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.005
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.149
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.138
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;894
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.071
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.063
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;864
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.007
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;994
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;805
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;932
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;932
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;762
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,64
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,45
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,96
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,29
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,35
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,97
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,07
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,75
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,1
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,96
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,71
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,82
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.760
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.731
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.640
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.544
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.525
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.531
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.341
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.325
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;2.359
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.162
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.162
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.241
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;2.045
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;2.124
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,17
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,46
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,87
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,82
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,13
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,36
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,33
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,17
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,89
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,88
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,45
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.697
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.693
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.603
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.560
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.566
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.539
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.424
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.446
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.436
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.317
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.347
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.369
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.262
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.308
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,93
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,5
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,01
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;83,91
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,41
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,58
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;77,61
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,56
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,4
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,54
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,6
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.063
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.038
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.037
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;984
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;959
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;992
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;917
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;879
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;923
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;845
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;815
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;872
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;783
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;816
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,57
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,39
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,66
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,27
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,68
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,01
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,49
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,52
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,09
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,43
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,69
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.902
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.940
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.787
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.629
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.680
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.564
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.420
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.478
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.415
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.330
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;2.284
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;2.195
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;2.174
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,59
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,16
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,39
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,29
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,65
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,25
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,95
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,66
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,01
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.759
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.809
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.711
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.581
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.651
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.572
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.457
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.533
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.482
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.428
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.410
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.343
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.342
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;89,88
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,27
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,88
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;82,83
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,74
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,62
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,94
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,41
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,24
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,43
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.143
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.131
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.076
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.048
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.029
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;992
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;963
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;945
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;933
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;902
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;874
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;852
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;832
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,69
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,98
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,19
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,25
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,55
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,71
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,75
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,23
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,33
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,32
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.987
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.034
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.948
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.727
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.785
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.748
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.605
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.584
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.451
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.441
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.298
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.299
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,3
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,79
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,22
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,86
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,65
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,78
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,8
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,74
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,99
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.788
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.864
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.810
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.639
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.716
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.689
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.589
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.596
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.493
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.506
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.395
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.422
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,67
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,06
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,31
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,25
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,18
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,1
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,2
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,84
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,56
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.199
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.170
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.138
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.088
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.069
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.059
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.016
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;988
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;958
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;935
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;903
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;877
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,74
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,37
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,06
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,84
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,82
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,88
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;82,16
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,18
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;77,07
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;10.356
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;10.803
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.531
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;10.013
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;10.533
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;9.836
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;9.651
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;10.193
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;9.643
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;9.326
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.939
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.365
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.983
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.629
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,69
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,5
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,4
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,19
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,35
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,57
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,05
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,93
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,74
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,13
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,41
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.898
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;6.222
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.008
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;5.697
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;6.063
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;5.610
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;5.501
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;5.874
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;5.513
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.342
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;5.727
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.384
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;5.161
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;5.545
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.243
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,59
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,44
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,38
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,27
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,41
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,76
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,57
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,04
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,61
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,5
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,12
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,27
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.458
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.581
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.523
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;4.316
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;4.470
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.226
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.150
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.319
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.130
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.984
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.212
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.981
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.822
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.084
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.857
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,81
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,58
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,43
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,09
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,28
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,31
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,37
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,94
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,02
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,73
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,15
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,28
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.634
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.030
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.388
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;9.232
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;9.651
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;10.174
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;8.886
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;9.369
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.863
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.523
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.052
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.568
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;8.802
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;9.387
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,83
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,22
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,94
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,24
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,41
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,95
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,47
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,25
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,11
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,76
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,36
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;5.472
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;5.769
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.908
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;5.250
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;5.550
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;5.803
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;5.085
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.382
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.659
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.895
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.196
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.500
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;5.057
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;5.398
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,94
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,2
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,22
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,93
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,29
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,79
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,46
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,07
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,09
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,66
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,37
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.162
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.261
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.480
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;3.982
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.101
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;4.371
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;3.801
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.987
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.204
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.628
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.856
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.068
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;3.745
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;3.989
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,68
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,25
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,57
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,33
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,57
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,84
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,17
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,5
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,8
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,89
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,04
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.749
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.171
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.568
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.325
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;9.827
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;10.204
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.916
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.463
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.872
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;9.191
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;9.678
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;8.905
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;9.424
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,65
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,62
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,56
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,46
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,04
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,41
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,36
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,58
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,55
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,17
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.541
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.826
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.041
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;5.334
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.627
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.859
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.117
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.415
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.676
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;5.261
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;5.567
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;5.108
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;5.429
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,26
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,58
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,99
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,35
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,95
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,96
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,3
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,15
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,68
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,87
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.208
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.345
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.527
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.991
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.200
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.345
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;3.799
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.048
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.196
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;3.930
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.111
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;3.797
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;3.995
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,84
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,66
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,98
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,28
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,16
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,69
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,45
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,81
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,39
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,25
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.749
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.249
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;10.671
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.302
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.846
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.282
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;9.544
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;10.059
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;9.232
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;9.778
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.942
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.555
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,41
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,07
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,35
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,12
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,26
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,08
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,63
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,25
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,54
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.538
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.873
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;6.142
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.305
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.638
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.924
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;5.459
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;5.794
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;5.286
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;5.641
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.143
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;5.513
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,79
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,45
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,95
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,33
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,01
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,84
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,57
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,76
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.211
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.376
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.529
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.997
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.208
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.358
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.085
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.265
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;3.946
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.137
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.799
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.042
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,92
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,16
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,22
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,35
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,17
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,17
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,34
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,81
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,25
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.599
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.756
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;20.865
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;20.133
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;20.394
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;19.807
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;19.590
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;19.994
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;19.494
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.144
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.664
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.171
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.686
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;19.277
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.810
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,74
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,26
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,93
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,1
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,33
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,43
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,94
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,74
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,88
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,71
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,87
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,15
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.471
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.674
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.729
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;12.183
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;12.455
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;12.093
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;11.895
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;12.218
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;11.930
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.645
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.023
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.768
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.388
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.806
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.558
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,69
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,27
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,38
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,4
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,72
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,38
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,86
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,45
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,32
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,15
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,8
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.128
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.082
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.136
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;7.950
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;7.939
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;7.714
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;7.695
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;7.776
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;7.564
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.499
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.641
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.403
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.298
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.471
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.252
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,81
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,23
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,81
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,67
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,21
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,97
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,26
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,54
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,99
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,79
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,44
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,13
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.890
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.319
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.490
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;19.312
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;19.875
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;20.153
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.845
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.516
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.784
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.359
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.083
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.383
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;18.721
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;19.114
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,09
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,81
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,36
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,75
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,05
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,55
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,3
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,92
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,6
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,14
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,28
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;11.979
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.379
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.491
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;11.656
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;12.120
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;12.311
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.392
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.901
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.121
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.117
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.647
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.890
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;11.428
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;11.725
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,3
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,91
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,56
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,1
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,14
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,04
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,8
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,09
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,19
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,32
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,87
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.911
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.940
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.999
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;7.656
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;7.755
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;7.842
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.453
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.615
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.663
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.242
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.436
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.493
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;7.293
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;7.389
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,78
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,67
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,04
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,21
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,91
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,8
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,54
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,65
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,67
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,85
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,37
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.965
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.498
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.712
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.394
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.057
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.253
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.822
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.566
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.788
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;19.180
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;19.500
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;18.740
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;19.178
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,14
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,85
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,78
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,27
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,45
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,54
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,57
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,15
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,42
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,59
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.006
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.465
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.664
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.676
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.199
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.422
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.356
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.909
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.146
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;11.676
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;11.969
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;11.441
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;11.776
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,25
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,87
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,09
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,59
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,54
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,91
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,67
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,51
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,78
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,99
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.959
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.033
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.048
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.718
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.858
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.831
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.466
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.657
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.642
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;7.504
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;7.531
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;7.299
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;7.402
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,97
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,82
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,3
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,81
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,32
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,96
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,41
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,58
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,86
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,97
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.860
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.565
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.780
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.225
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;20.024
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;20.246
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;19.609
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;19.937
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;19.126
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;19.592
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.709
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.281
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,8
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,37
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,43
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,35
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,94
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,28
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,97
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,79
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;11.921
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.485
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.709
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.564
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.163
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.390
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;11.911
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;12.203
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;11.651
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;11.995
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.412
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.810
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,01
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,42
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,49
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,4
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,02
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,32
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,38
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,41
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,93
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.939
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.080
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.071
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.661
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.861
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.856
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;7.698
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;7.734
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;7.475
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;7.597
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.297
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.471
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,5
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,29
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,34
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,27
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,82
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,51
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,13
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,31
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,57
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;19.497
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;19.087
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.441
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;19.163
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;18.844
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;18.664
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;18.783
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;18.541
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;18.446
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.479
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;18.296
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.215
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.115
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.007
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.924
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,29
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,73
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,34
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,14
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,88
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,78
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,86
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,69
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,91
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,34
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,2
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;11.851
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.618
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.790
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;11.642
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;11.466
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;11.357
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;11.427
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;11.299
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;11.233
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.248
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.157
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.111
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.034
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.996
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.953
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,24
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,69
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,33
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,42
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,25
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,28
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,91
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,03
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,24
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,11
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,65
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,9
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.646
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.469
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.651
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;7.521
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;7.378
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;7.307
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;7.356
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;7.242
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;7.213
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.231
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.139
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.104
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.081
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.011
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.971
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,37
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,78
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,5
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,21
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,96
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,28
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,57
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,58
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,85
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,61
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,87
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,11
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.086
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.619
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;19.096
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;19.640
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;19.279
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;18.861
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.289
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.004
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;18.595
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.898
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;18.687
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.278
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;18.408
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;18.092
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,78
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,27
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,77
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,03
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,87
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,38
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,09
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,25
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,72
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,83
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,74
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.148
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.912
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.603
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;11.906
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;11.720
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;11.463
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.700
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.562
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.319
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.469
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.390
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.145
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;11.220
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;11.031
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,01
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,39
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,79
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,31
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,06
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,55
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,41
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,62
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,05
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,19
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,07
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.938
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.707
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.493
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;7.734
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;7.559
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;7.398
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.589
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.442
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.276
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.429
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.297
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.133
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;7.188
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;7.061
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,43
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,08
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,73
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,6
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,56
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;97,1
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,59
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,68
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,2
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,27
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,23
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.026
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.659
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;19.158
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.602
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;19.322
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;18.849
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.170
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.973
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;18.508
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;18.672
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;18.316
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;18.343
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;18.053
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,88
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,29
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,39
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,73
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,51
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,61
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,98
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,6
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,31
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,23
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.108
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;11.919
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;11.641
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;11.861
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.734
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.476
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.611
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.548
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.289
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;11.363
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;11.170
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;11.175
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;11.027
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,96
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,45
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,58
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,9
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,89
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,98
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,34
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,95
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,76
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,73
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.918
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.740
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.517
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.741
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.588
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.373
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.559
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.425
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.219
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;7.309
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;7.146
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;7.168
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;7.026
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,76
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,04
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,08
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,47
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,93
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,04
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,43
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,06
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,61
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,47
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.892
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.588
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.177
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.418
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.198
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.785
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;18.888
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;18.571
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;18.543
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;18.296
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.261
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.070
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,62
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,01
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,96
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,43
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,84
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,67
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,41
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,23
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,23
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.018
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;11.889
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.657
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.744
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;11.688
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.443
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;11.497
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;11.312
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;11.300
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;11.161
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.132
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.029
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,72
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,31
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,16
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,7
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,04
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,05
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,75
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,63
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,61
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.874
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.699
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.520
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.674
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.510
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.342
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;7.391
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;7.259
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;7.243
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;7.135
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.129
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.041
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,46
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,55
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,63
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,53
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,08
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,88
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,6
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,63
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.856
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;9.407
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;10.936
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;9.489
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;9.093
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;10.277
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;9.149
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;8.741
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;9.951
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;8.803
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;8.387
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;9.555
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;8.197
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.927
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;9.043
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,28
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,66
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,97
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,83
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,92
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,99
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,32
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,16
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,37
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,17
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,27
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,69
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.831
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.542
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.439
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.614
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.351
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;6.055
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.411
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.139
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.876
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.221
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.935
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.651
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.831
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.674
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.342
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,55
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,04
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,8
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,73
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,26
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,54
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,05
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,76
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,85
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,34
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,96
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.025
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.865
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.497
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.875
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.742
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.222
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.738
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.602
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.075
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.582
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.452
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.904
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.366
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.253
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.701
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,27
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,82
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,88
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,87
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,2
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,62
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,99
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,31
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,81
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,63
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,17
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,3
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.214
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;10.858
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;10.482
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;10.828
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;10.468
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;10.141
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.449
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;10.089
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;9.707
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;9.790
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;9.598
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;9.178
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;9.261
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;8.880
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,56
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,41
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,75
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,18
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,92
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,61
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,3
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,4
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,56
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,29
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,72
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.671
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.423
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;6.177
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.442
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.189
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.988
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.231
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.970
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.739
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.816
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.691
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.420
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.492
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.240
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,57
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,36
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,94
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,4
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,95
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,91
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,18
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,6
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,74
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,51
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,83
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.543
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.435
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.305
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.386
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.279
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.153
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.218
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.119
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.968
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.974
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.907
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.758
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.769
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.640
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,54
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,48
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,47
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,85
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,87
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,17
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,48
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,09
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,29
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,98
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,55
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;10.960
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;10.598
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;10.225
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;10.537
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;10.191
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;9.771
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;9.859
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;9.685
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;9.228
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;9.339
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;8.927
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;9.013
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;8.598
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,14
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,16
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,56
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,95
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,39
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,25
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,12
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,31
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,04
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,09
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.507
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.261
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;6.031
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.278
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;6.026
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.772
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.852
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.738
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.446
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.533
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.265
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.336
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;5.063
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,48
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,25
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,71
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,93
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,65
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,3
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,37
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,3
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,23
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,95
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.453
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.337
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.194
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.259
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.165
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.999
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.007
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.947
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.782
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.806
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.662
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.677
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.535
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,64
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,35
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,98
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,01
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,18
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,76
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,32
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,78
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,29
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;10.634
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;10.275
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;9.872
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;9.939
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;9.750
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;9.311
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;9.398
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;9.006
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;9.067
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;8.668
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;8.729
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;8.322
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,46
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,89
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,32
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,46
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,23
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,24
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,8
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,95
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,3
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.334
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;6.073
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.825
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.899
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.771
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.488
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.562
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.304
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.361
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;5.097
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.176
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.897
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,13
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,03
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,21
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,59
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,06
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,28
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,5
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,23
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,07
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.300
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.202
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.047
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.040
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.979
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.823
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.836
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.702
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.706
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.571
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.553
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.425
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,95
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,69
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,47
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,29
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,48
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,2
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,24
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,55
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,63
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
03 Asturias, Principado de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;88.063
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;85.651
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;88.568
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;84.955
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;82.911
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;81.734
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;82.073
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;80.462
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;79.679
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;79.621
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;78.166
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;76.163
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;76.180
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;75.241
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;73.298
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,47
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,8
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,28
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,2
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,94
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,96
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,41
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,26
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,99
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,51
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,85
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,76
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;56.860
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;55.547
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;57.271
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;54.974
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;53.804
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;53.216
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;53.228
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;52.318
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;51.964
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;51.746
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;50.906
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;49.814
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;49.697
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;49.149
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;48.003
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,68
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,86
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,92
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,61
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,19
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,73
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,01
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,64
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,98
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,4
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,48
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,82
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;31.203
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;30.104
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;31.297
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;29.981
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;29.107
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;28.518
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;28.845
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;28.144
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;27.715
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;27.875
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;27.260
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;26.349
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;26.483
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;26.092
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;25.295
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,69
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,12
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,44
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,49
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,55
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,33
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,55
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,19
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,87
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,67
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,82
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;89.950
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;86.819
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;86.846
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;86.655
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;83.983
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;84.489
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;83.897
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;81.437
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;80.270
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;79.331
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;77.923
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;76.833
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;75.697
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;74.858
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,34
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,73
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,29
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,27
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,8
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,43
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,19
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,75
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,47
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,19
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,2
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;57.972
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;56.303
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;56.415
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;55.941
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;54.553
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;54.954
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;54.279
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;52.961
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;52.349
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;51.573
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;50.847
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;50.201
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;49.503
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;48.930
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,89
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,41
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,63
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,06
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,79
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,96
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,31
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,99
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,92
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,73
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;31.978
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;30.516
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;30.431
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;30.714
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;29.430
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;29.535
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;29.618
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;28.476
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;27.921
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;27.758
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.076
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;26.632
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;26.194
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;25.928
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,05
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,44
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,06
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,62
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,31
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,75
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,8
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,73
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,52
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,84
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,2
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;95.764
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;91.877
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;89.297
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;91.535
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;88.159
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;83.861
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;83.471
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;81.786
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;79.384
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;79.274
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;77.226
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;76.930
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;75.257
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,58
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,95
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,91
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;87,16
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,02
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,9
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,28
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,48
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,73
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,28
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;61.057
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;59.083
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;57.947
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;58.575
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;56.818
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;54.581
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;53.953
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;53.133
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;51.825
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;51.623
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;50.432
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;50.193
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;49.237
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,93
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,17
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,19
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,36
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;89,93
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,44
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,37
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,03
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,95
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,97
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;34.707
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;32.794
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;31.350
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;32.960
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;31.341
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;29.280
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;29.518
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;28.653
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;27.559
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;27.651
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;26.794
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;26.737
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;26.020
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,97
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,57
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,4
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,05
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;87,37
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,91
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,32
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,47
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;81,53
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;94.892
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;92.127
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;88.207
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;86.289
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;84.757
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;82.548
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;82.006
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;80.122
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;79.415
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;77.936
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;77.182
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;75.840
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,93
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,58
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,01
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,83
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,2
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,36
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,78
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,98
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;60.503
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;59.096
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;57.090
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;55.588
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;54.855
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;53.713
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;53.195
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;52.156
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;51.630
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;50.838
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;50.280
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;49.543
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,88
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,82
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,08
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,01
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,36
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,37
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,05
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,08
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,78
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;34.389
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;33.031
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;31.117
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;30.701
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;29.902
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;28.835
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;28.811
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;27.966
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;27.785
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;27.098
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;26.902
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;26.297
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,28
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,53
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,67
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,22
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,87
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;84,12
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,08
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,44
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,51
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.564
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.200
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.308
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;5.132
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;4.862
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;3.690
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;4.737
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;4.517
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;3.539
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;4.444
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.218
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.291
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.133
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.940
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.094
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,24
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,5
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,65
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,14
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,87
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,15
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,87
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,12
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,39
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,28
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;75,77
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;71,82
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.597
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.355
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.797
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;3.326
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;3.152
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;2.403
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;3.070
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.944
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;2.314
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.889
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.759
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.154
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.698
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.609
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.036
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,47
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,95
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,91
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,35
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,75
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;82,73
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,32
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,24
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;77,01
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,01
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,76
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;72,79
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.967
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.845
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.511
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.806
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.710
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.287
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.667
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.573
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.225
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.555
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.459
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.137
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.435
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.331
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.058
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,81
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,68
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,18
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,75
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,26
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,07
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,05
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;79,08
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;75,25
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;72,95
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;72,14
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;70,02
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.021
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.744
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.376
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;4.579
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;4.352
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;4.175
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.261
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.010
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.870
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.878
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.693
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.597
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;3.464
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;3.404
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,2
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,74
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,41
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;84,86
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,53
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,44
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;77,24
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,85
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;82,2
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,02
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;77,79
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.236
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.092
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.845
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.949
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;2.852
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;2.716
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.759
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.623
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.512
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.518
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.441
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.350
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;2.294
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;2.236
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,13
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,24
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,47
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,26
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,83
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;88,3
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;77,81
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,95
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;82,6
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,19
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;78,59
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.785
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.652
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.531
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.630
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.500
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.459
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.502
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.387
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.358
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.360
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.252
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.247
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.170
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.168
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,32
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;90,8
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,3
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,15
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,96
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,7
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,19
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;75,79
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,45
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;70,82
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;76,29
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.820
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.391
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.817
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.237
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.811
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.339
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;4.590
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.282
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.976
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;4.000
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;3.753
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;3.720
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;3.534
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,98
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;89,24
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,08
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;78,87
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;79,43
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;82,54
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;74,2
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;77,91
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;69
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;73,37
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.670
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.486
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.143
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.328
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.127
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.823
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.925
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.817
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.606
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;2.643
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;2.471
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;2.459
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;2.329
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,68
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,7
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,82
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;79,7
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;80,81
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;82,91
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;75,82
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;78,62
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;70,54
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;74,1
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.150
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.905
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.674
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.909
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.684
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.516
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.665
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.465
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.370
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.357
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.282
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.261
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.205
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;88,79
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;88,4
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;90,56
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;77,44
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;76,9
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;81,84
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;71,23
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;76,58
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;66,19
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;71,98
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.924
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;5.543
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.097
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.157
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.881
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.591
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;4.545
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;4.313
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;4.203
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;4.032
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.964
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.774
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;87,05
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;88,06
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;90,07
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;82
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;84,62
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;75,83
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;79,11
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;71,51
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;74,04
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.740
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.556
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.277
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.269
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.174
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.980
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;2.964
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;2.814
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;2.745
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;2.642
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.595
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.483
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;87,41
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;89,26
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;90,94
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;83,35
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;85,87
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,19
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;80,62
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;72,98
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;75,77
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.184
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.987
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.820
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.888
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.707
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.611
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.581
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.499
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.458
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.390
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.369
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.291
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;86,45
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;85,91
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;88,52
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;79,57
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;82,36
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;73,38
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;76,37
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;68,9
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;70,93
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;16.659
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;16.551
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;16.405
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;15.930
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;15.910
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;14.823
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;15.269
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;15.345
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;14.345
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;14.705
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;14.833
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;13.675
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;13.920
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.135
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;13.081
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,62
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,13
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,36
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,66
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,71
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;87,44
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,27
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,62
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,36
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,56
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,4
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,74
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;10.374
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;10.393
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.242
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;9.945
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;9.998
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;9.369
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;9.562
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;9.672
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;9.105
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;9.242
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;9.391
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.737
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;8.808
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;8.976
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.370
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,86
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,2
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,48
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,17
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,06
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,9
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,09
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,36
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,31
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,9
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,37
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,72
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.285
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.158
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.163
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.985
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;5.912
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;5.454
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;5.707
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;5.673
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;5.240
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.463
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.442
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.938
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.112
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.159
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.711
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,23
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,01
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,5
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,8
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,12
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;85,02
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,92
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,37
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,12
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,34
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,78
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,44
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;15.998
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;15.647
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;16.177
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;15.272
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;15.014
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;15.614
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;14.659
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;14.460
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;14.784
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;13.691
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;13.665
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;14.069
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;13.161
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;13.630
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,46
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,95
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,52
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,63
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,41
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,39
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;85,58
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,33
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,97
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,11
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,26
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.912
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;9.779
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.148
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;9.477
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;9.404
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;9.831
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;9.125
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.102
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;9.363
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.587
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;8.644
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;8.931
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;8.351
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;8.657
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,61
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,17
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,88
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,06
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,08
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,26
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,63
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,39
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,01
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,4
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,31
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.086
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.868
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.029
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;5.795
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;5.610
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;5.783
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.534
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.358
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.421
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.104
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.021
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.138
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.810
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.973
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,22
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,6
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,92
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,93
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,31
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,92
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,86
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85,57
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,22
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,97
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,48
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.413
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;16.897
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;16.697
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.493
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;16.105
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;15.631
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;14.882
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;14.798
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;14.730
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;14.213
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;14.241
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;13.677
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;13.811
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,72
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,31
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,62
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,46
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,58
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,22
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,12
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,29
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,94
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,72
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.666
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.482
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.499
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;10.153
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.041
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;9.884
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.264
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.300
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;9.339
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;8.958
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;9.028
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;8.645
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;8.786
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,19
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,79
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,14
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,86
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,72
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,95
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,46
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,99
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;82,47
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,68
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.747
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.415
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.198
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.340
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.064
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.747
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.618
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.498
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.391
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;5.255
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;5.213
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;5.032
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;5.025
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,97
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,53
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,72
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,27
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,71
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,98
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;81,92
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;84,11
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;78,44
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,07
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.441
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.220
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;16.788
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;15.707
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;15.693
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;15.644
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;15.051
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;15.096
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;14.462
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;14.602
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;13.957
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;14.147
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,06
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,13
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,19
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,4
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,92
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,98
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,98
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,05
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,27
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.654
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;10.652
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.559
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.709
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;9.798
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;9.879
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;9.421
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;9.534
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;9.081
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;9.254
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;8.794
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.006
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,13
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,98
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,56
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,44
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,29
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,25
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,64
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;82,56
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,29
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.787
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.568
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.229
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.998
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.895
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.765
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;5.630
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;5.562
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;5.381
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;5.348
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.163
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.141
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;88,37
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;89,75
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,55
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,72
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,29
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,93
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,86
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;78,61
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,53
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;28.269
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.031
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.812
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;27.394
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;27.239
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;26.677
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;26.567
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;26.562
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;26.109
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;25.884
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;25.907
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.094
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;24.921
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;25.041
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;24.264
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,9
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,17
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,59
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,98
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,76
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,62
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,56
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,42
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,1
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,16
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,33
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,21
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.467
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;18.420
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.874
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;17.950
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;17.910
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;17.615
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;17.436
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;17.491
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;17.262
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;17.002
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.076
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.644
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.435
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.555
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.118
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,2
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,23
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,33
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,42
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,96
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,46
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,07
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,7
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,18
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,88
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,4
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.802
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.611
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.938
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;9.444
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;9.329
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;9.062
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;9.131
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;9.071
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;8.847
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.882
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.831
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.450
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.486
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.486
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.146
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,35
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,07
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,19
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,15
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,38
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,02
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,61
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,88
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,03
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,57
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,29
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,97
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.359
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;27.752
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;28.234
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;27.404
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;26.975
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;27.577
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.623
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;26.237
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;26.362
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.274
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;25.190
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;25.342
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;24.574
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;24.784
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,63
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,2
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,67
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,88
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,54
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,37
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,12
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,77
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,76
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,55
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,78
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;18.458
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.211
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.599
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;17.859
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;17.726
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;18.186
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.379
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.250
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.440
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.598
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;16.615
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.806
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;16.254
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;16.442
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,75
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,34
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,78
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,15
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,72
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,77
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,92
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,24
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,36
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,25
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,4
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.901
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.541
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.635
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;9.545
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;9.249
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;9.391
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.244
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.987
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.922
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.676
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.575
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.536
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;8.320
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;8.342
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,4
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,94
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,47
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,36
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,19
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,6
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,63
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,88
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,59
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,2
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,58
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;30.158
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;29.404
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;29.090
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;28.977
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.334
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.518
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.547
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;26.394
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;26.182
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;25.690
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;25.570
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;25.017
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;25.014
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,08
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,36
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,6
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,03
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,76
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,37
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,9
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,08
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,99
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;19.407
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;19.119
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;19.129
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;18.707
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.441
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;18.159
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.333
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.326
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.337
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;16.913
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;16.938
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;16.489
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;16.598
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,39
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,45
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,93
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,31
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;90,62
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,63
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,46
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,55
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,24
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,77
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.751
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.285
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.961
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.270
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.893
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.359
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.214
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.068
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.845
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;8.777
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;8.632
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;8.528
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;8.416
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,53
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,19
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,96
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,7
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;88,17
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,8
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;85,34
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,66
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,92
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,49
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;29.993
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;29.493
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.768
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.404
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;27.257
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.077
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;26.482
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;26.384
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;25.743
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;25.780
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.124
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;25.186
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,37
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,42
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,12
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,79
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,71
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,29
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,61
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,19
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,55
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;19.305
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;19.135
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.860
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.840
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.842
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;17.855
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;17.388
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;17.404
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;16.925
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;17.037
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.532
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.663
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,41
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,24
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,67
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,87
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,28
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,45
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,33
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,4
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,35
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.688
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.358
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.908
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.564
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.415
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.222
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;9.094
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;8.980
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;8.818
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;8.743
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.592
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.523
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;89,48
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;90,9
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,08
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,8
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,63
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,13
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,24
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,95
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,02
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.111
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.023
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.095
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;24.501
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;23.520
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;23.632
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;23.949
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;23.082
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;23.215
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.476
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.633
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.390
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.776
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;22.090
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.786
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,57
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,91
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,17
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,37
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,08
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,51
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,49
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,21
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,22
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,7
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,95
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,81
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;16.358
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.716
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;16.370
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;15.989
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;15.391
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;15.489
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;15.669
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;15.121
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;15.227
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.383
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.842
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.705
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.963
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.506
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;14.319
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,74
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,62
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,79
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,21
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,02
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,04
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,44
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,83
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,47
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,3
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,47
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.753
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.307
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.725
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;8.512
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;8.129
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;8.143
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;8.280
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;7.961
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;7.988
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.093
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.791
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.685
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.813
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.584
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.467
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,25
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,86
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,33
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,6
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,83
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,55
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,46
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,79
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,08
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,26
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,3
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,58
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;26.373
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.182
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;24.687
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;25.717
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;24.640
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;24.221
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;25.153
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;24.155
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.228
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;24.159
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;23.439
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;22.500
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;22.977
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;22.130
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,51
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,85
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,11
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,37
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,92
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,09
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,61
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,08
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,14
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,24
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,64
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.160
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.476
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;16.165
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;16.765
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;16.134
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;15.868
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;16.413
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.829
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;15.241
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.829
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.388
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.780
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;15.114
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;14.536
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,7
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,92
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,16
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,65
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,07
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,28
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,24
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,4
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,43
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,73
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,92
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.213
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.706
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.522
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;8.952
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;8.506
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;8.353
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.740
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.326
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.987
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.330
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.051
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.720
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;7.863
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;7.594
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,17
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,7
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,02
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,87
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,64
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,72
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,42
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,48
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,59
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,32
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,11
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.686
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.332
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;25.290
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;26.813
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;25.633
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.009
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;24.908
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;24.143
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.000
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;23.636
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;22.595
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;23.186
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;22.220
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,85
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,35
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,93
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,97
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,69
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,95
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,76
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,34
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,05
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,86
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;17.850
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;17.085
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;16.526
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.319
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;16.659
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.728
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;16.258
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;15.796
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;15.108
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;15.497
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;14.843
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;15.236
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;14.610
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,03
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,51
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,17
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,08
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,46
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,42
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,71
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,82
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,18
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,41
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.836
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.247
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.764
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.494
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.974
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.281
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.650
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.347
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.892
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;8.139
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;7.752
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;7.950
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;7.610
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,52
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,05
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,49
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,94
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,27
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,05
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,02
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,45
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,97
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,83
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;27.352
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;26.327
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;24.843
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;25.355
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;24.610
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.540
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;24.059
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;23.081
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;23.560
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;22.683
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;23.115
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.269
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,7
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,48
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,76
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,39
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,91
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,49
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,31
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,8
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,64
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.631
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;17.044
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;16.190
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;16.522
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;16.062
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.425
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;15.733
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;15.128
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;15.449
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;14.881
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.182
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;14.617
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,71
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,24
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,27
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,31
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,44
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,64
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,91
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,08
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,28
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.721
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.283
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.653
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.833
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.548
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.115
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;8.326
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;7.953
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.111
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;7.802
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.933
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.652
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,87
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,08
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,78
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;89,69
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,91
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,37
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,17
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,46
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,43
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.460
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.846
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.948
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.998
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;11.380
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;12.912
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;11.551
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.956
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;12.471
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.112
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.575
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.713
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.430
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.035
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.073
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,29
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,07
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,57
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,7
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,49
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,41
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,18
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,27
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,98
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,71
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,71
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,39
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.064
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.663
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.988
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.764
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.353
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;8.340
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.491
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;7.090
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;8.056
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.230
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.838
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.574
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.793
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.503
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.160
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,28
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,95
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,79
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,89
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,52
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,63
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,66
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,23
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;84,27
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,24
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,86
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,66
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.396
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.183
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.960
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;4.234
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;4.027
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.572
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;4.060
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.866
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;4.415
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.882
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.737
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.139
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.637
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.532
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.913
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,31
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,27
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,18
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,36
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,42
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,01
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,31
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,34
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,45
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,73
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,44
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;78,89
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;14.199
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;13.494
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.372
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.683
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;13.002
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;12.902
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;13.201
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.575
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.026
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.329
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.936
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;11.325
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.521
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.910
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,37
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,35
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,49
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,97
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,19
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,93
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,83
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,45
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,69
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,38
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,59
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.206
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.745
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.658
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.891
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.437
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;8.353
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.603
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.157
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.793
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.041
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.759
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.334
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.490
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;7.059
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,48
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,48
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,45
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,28
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,01
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,35
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,72
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,71
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,65
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,53
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.993
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.749
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.714
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.792
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.565
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;4.549
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.598
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.418
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.233
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.288
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.177
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.991
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;4.031
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.851
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,13
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,5
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,09
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,03
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,8
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,88
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,96
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,66
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,88
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,69
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;14.687
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;13.853
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.403
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;14.015
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;13.276
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.364
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.544
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.169
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.496
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.735
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;11.067
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;11.330
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.678
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,42
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,83
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,25
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,41
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,84
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,77
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,71
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,57
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;81,79
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,67
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;9.464
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.911
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.650
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.068
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.550
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.987
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.173
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.894
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.435
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.612
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;7.152
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.364
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.914
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,82
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,95
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,34
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,36
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,59
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,95
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,42
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,68
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;82,64
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;79,93
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.223
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.942
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.753
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.947
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.726
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.377
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.371
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.275
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.061
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;4.123
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.915
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.966
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.764
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,72
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,63
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,09
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,69
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,5
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,44
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;83,43
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,37
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;80,25
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,19
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;14.182
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;13.544
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.711
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.666
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.316
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.696
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.869
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;11.248
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;11.447
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.839
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.022
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.464
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;89,31
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;90,93
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,01
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,63
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,49
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,52
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,27
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,38
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,32
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;9.173
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.709
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.204
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.248
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.979
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.574
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.689
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.276
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.430
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;7.024
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.177
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.774
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;89,92
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,62
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,32
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,29
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,69
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;85,31
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,62
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;82,41
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,57
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.009
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.835
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.507
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.418
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.337
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.122
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;4.180
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.972
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;4.017
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.815
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.845
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.690
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;88,2
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;89,7
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,46
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,45
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,13
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,08
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,65
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,52
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;81,87
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
04 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;128.026
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;122.895
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;124.377
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;123.399
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;119.168
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;115.625
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;118.969
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;115.482
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;112.774
05 Canarias;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;115.244
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;112.454
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;109.151
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;111.489
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;109.060
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;105.805
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,39
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,97
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,96
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,93
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,97
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,67
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,02
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,5
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,76
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,08
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,74
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,07
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;80.323
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;77.862
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;78.708
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;77.642
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;75.638
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;73.611
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;75.096
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;73.487
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;71.920
05 Canarias;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;72.999
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;71.701
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;69.824
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;70.741
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;69.663
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;67.809
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,66
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,14
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,52
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,49
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,38
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,38
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,88
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,09
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,71
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,07
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,47
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,15
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;47.703
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;45.033
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;45.669
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;45.757
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;43.530
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;42.014
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;43.873
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;41.995
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;40.854
05 Canarias;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;42.245
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;40.753
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;39.327
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;40.748
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;39.397
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;37.996
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,92
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,66
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,97
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,25
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,46
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,56
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,5
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,11
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,42
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,48
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,2
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;129.209
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;124.137
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;122.018
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;124.313
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;120.005
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;118.839
05 Canarias;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;120.214
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;116.647
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;114.653
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;116.123
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;112.980
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;110.955
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;109.591
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;108.188
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Canarias;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,21
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,67
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,39
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,04
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,97
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,96
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,87
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,01
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,93
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,28
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,67
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;80.909
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;78.495
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;77.375
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;78.087
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;76.064
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;75.497
05 Canarias;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;75.776
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;74.072
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;73.031
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;73.328
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;71.868
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;70.815
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;69.897
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;69.167
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Canarias;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,51
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,9
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,57
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,66
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,37
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,39
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,63
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,56
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,52
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,05
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,39
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;48.300
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;45.642
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;44.643
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;46.226
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;43.941
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;43.342
05 Canarias;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;44.438
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;42.575
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;41.622
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;42.795
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;41.112
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;40.140
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;39.694
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;39.021
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Canarias;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,71
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,27
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,09
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,28
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,23
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,6
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,07
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,91
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,97
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,41
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;130.104
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;125.404
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;122.008
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;125.490
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;121.556
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;117.459
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;120.992
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;117.488
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;113.492
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;113.782
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;110.567
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;110.156
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;107.588
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,45
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,93
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,27
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,69
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,02
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,73
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,62
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,84
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,18
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;81.443
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;79.124
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;77.504
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;78.835
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;76.835
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;74.806
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;76.153
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;74.386
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;72.413
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;72.230
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;70.665
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;70.122
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;68.924
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,8
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,11
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,52
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,5
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,01
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,43
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,29
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,18
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,62
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,93
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;48.661
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;46.280
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;44.504
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;46.655
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;44.721
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;42.653
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;44.839
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;43.102
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;41.079
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;41.552
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;39.902
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;40.034
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;38.664
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,88
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,63
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,84
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,15
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,13
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,3
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,78
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,66
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,5
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,88
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;130.632
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;126.873
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;122.632
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;125.644
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;122.304
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;118.088
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;118.241
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;114.847
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;114.293
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;111.577
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;110.860
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;108.828
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,18
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,4
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,29
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,2
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,65
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,08
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,99
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,38
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,74
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;81.780
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;79.904
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;77.835
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;78.819
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;77.160
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;75.110
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;74.801
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;73.184
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;72.512
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;71.276
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;70.577
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;69.651
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,38
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,57
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,5
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,61
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,02
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,75
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,57
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,33
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,49
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;48.852
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;46.969
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;44.797
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;46.825
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;45.144
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;42.978
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;43.440
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;41.663
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;41.781
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;40.301
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;40.283
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;39.177
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,85
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,11
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,94
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,49
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,95
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,96
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,77
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,45
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.209
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.536
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.092
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;7.536
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;7.035
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.324
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.043
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;6.587
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.094
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.600
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.168
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.772
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.181
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.770
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.480
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,8
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,35
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,39
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,8
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,41
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,62
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,4
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,85
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,33
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,3
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,57
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,54
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.842
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.554
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.728
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;4.459
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.276
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.288
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.162
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.004
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.153
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.920
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.765
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.965
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.690
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.543
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.794
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,09
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,9
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,2
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,96
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,92
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,58
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,96
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,67
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,53
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,21
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,8
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;74,95
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.367
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.982
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.364
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;3.077
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.759
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.036
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.881
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.583
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.941
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.680
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.403
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.807
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.491
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.227
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.686
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,39
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;92,52
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,13
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,57
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,62
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,11
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,6
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,58
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,44
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,98
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;74,68
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,32
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.295
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.604
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.249
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;6.756
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;6.127
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;5.965
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.290
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.679
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.556
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.866
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.279
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.196
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;4.925
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;4.924
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Canarias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,61
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,78
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,46
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,22
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,99
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,91
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,41
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,94
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,15
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,58
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;78,8
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.322
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.004
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.824
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;4.003
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;3.712
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;3.660
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.742
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.449
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.421
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.508
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.228
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.211
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.007
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.062
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Canarias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,62
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,71
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,71
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,58
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;86,14
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,46
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,17
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,62
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;83,97
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;75,1
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,07
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.973
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.600
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.425
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.753
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.415
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.305
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.548
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.230
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.135
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.358
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.051
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.985
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.918
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.862
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Canarias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,6
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,88
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,05
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,7
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;85,77
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,04
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,31
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,88
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,86
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,77
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;76,78
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.768
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.160
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.506
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.186
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.582
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.011
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.693
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.093
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.607
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;5.664
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;5.296
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;5.336
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.008
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,51
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,93
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,39
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,16
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,1
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,18
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,11
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,4
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,53
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,98
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.619
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.270
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.995
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.287
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.929
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.700
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.009
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.660
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.458
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.396
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.284
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.201
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.110
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,81
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,01
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,62
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,79
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,71
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,56
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,53
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,2
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,96
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,85
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.149
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.890
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.511
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.899
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.653
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.311
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.684
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.433
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.149
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.268
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.012
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.135
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.898
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,06
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,8
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,04
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,23
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,19
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,58
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,48
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,13
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,88
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,59
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.178
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.674
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.982
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.567
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.070
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.461
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;6.536
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.086
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.145
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;5.740
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.771
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.420
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,53
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,13
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,54
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,17
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,17
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,08
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,21
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,2
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,63
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.885
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.536
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.225
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.538
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.204
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.925
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;3.889
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;3.723
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;3.651
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.513
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.454
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.326
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,9
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,68
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,9
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,74
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,12
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,49
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,15
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,15
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;78,72
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.293
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.138
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.757
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.029
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.866
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.536
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.647
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.363
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.494
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.227
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.317
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.094
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,98
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,33
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,98
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,35
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;85,71
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,48
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;80,78
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;73,84
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;75,95
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;24.632
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;23.976
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.309
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;23.543
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;23.164
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;21.260
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;22.477
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;22.309
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;20.645
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.628
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;21.558
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.856
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.822
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.768
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.141
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,58
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,61
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,21
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,25
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,05
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,57
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,8
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,91
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,19
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,53
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,62
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,12
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.075
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.839
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.323
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;13.494
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;13.379
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;12.256
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;12.934
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;12.930
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;11.923
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.482
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.494
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.493
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.014
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;12.060
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.101
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,87
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,68
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,99
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,89
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,43
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,49
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,68
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,28
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,26
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,36
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,15
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,32
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.557
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.137
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.986
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;10.049
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;9.785
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;9.004
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;9.543
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;9.379
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;8.722
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.146
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.064
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.363
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.808
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.708
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.040
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,19
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,53
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,17
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,39
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,52
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,34
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,63
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,42
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,75
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,43
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,9
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,51
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.477
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.844
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.041
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;22.360
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;21.900
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;22.329
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.424
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.076
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.424
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.539
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.250
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.620
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;19.464
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;20.021
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Canarias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,24
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,87
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,91
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,26
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,26
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,98
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,49
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,64
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,49
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,2
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,89
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.325
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.138
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.260
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;12.739
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;12.640
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;12.874
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.240
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.165
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.380
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.729
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.702
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.938
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;11.297
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;11.602
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Canarias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,6
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,21
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,09
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,86
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,59
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,36
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,02
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,07
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,03
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,99
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,5
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.152
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.706
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.781
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;9.621
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;9.260
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;9.455
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.184
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.911
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;9.044
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.810
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.548
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.682
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;8.167
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;8.419
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Canarias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,77
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,4
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,67
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,46
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,81
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,46
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,78
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,07
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,76
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,14
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,08
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;24.040
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;23.489
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.145
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;22.977
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;22.544
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.147
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;21.972
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.613
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.275
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;20.737
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;20.646
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;19.870
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;19.973
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,58
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,98
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,69
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,4
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,01
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,92
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,28
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,2
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,59
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,3
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.649
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.504
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.352
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.080
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.959
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.800
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.509
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.431
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.323
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;11.977
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;11.969
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;11.521
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;11.610
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,83
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,96
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,87
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,65
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,05
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,29
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,69
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,64
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,32
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,95
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.391
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.985
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.793
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.897
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.585
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.347
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.463
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.182
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.952
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;8.760
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;8.677
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;8.349
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;8.363
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,25
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,99
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,45
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,07
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,96
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,41
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,73
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,6
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,62
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,4
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.442
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.061
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;23.648
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.323
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.993
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.621
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;22.023
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;21.916
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;21.062
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;21.166
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.284
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.487
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,42
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,56
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,66
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,53
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,68
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,54
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,5
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,3
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,63
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.879
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.804
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.655
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.253
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.192
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;13.092
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;12.685
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;12.693
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;12.179
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;12.298
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.757
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.911
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,49
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,57
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,88
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,89
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,95
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,23
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,06
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,17
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,23
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.563
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.257
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.993
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.070
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.801
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.529
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;9.338
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;9.223
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;8.883
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;8.868
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.527
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.576
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,33
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,55
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,36
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,04
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,29
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,6
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,74
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,13
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,82
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;40.155
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;39.305
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;39.800
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;38.907
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;38.302
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;36.985
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;37.679
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;37.282
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;36.155
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;36.642
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;36.445
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;35.124
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;35.600
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;35.527
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;34.192
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,89
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,45
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,93
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,83
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,85
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,84
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,25
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,72
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,25
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,66
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,39
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,91
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;25.064
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;24.968
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;25.185
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;24.342
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;24.352
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;23.559
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;23.656
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;23.755
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;23.073
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;23.084
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;23.264
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;22.511
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;22.478
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;22.708
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;21.952
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,12
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,53
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,54
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,38
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,14
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,61
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,1
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,18
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,38
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,68
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,95
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,16
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;15.091
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.337
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;14.615
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;14.565
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;13.950
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;13.426
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;14.023
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;13.527
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;13.082
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.558
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.181
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.613
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.122
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.819
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.240
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,51
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,3
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,86
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,92
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,35
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,51
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,84
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,94
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,3
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,95
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,41
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,75
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;39.495
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;38.838
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;38.893
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;38.109
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;37.713
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;37.972
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;36.977
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;36.790
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;36.799
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;35.854
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;35.783
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;35.759
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;34.868
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;35.026
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Canarias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,49
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,1
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,63
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,62
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,73
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,62
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,78
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,13
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,94
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,78
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,06
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;24.458
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;24.404
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;24.672
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;23.669
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;23.742
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;24.130
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;23.039
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;23.198
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;23.471
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;22.387
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;22.591
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;22.857
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;22.065
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;22.409
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Canarias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,77
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,29
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,8
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,2
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,06
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,13
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,53
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,57
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,64
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,42
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,83
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;15.037
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;14.434
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;14.221
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;14.440
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;13.971
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;13.842
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.938
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.592
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;13.328
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.467
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.192
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.902
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;12.803
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;12.617
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Canarias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,03
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,79
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,33
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,69
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,17
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,72
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,56
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,4
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,72
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,7
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,72
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;39.817
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;39.308
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;38.995
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;38.545
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;38.253
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;37.715
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;37.305
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;37.132
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;36.598
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;36.125
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;35.817
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;35.114
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;34.981
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,81
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,32
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,72
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,69
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,46
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,85
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,9
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,85
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,33
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,71
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;24.639
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;24.659
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;24.789
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;23.934
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;24.030
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;24.062
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;23.216
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;23.352
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;23.395
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;22.768
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;22.918
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;22.195
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;22.439
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,14
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,45
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,07
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,22
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,7
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,38
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,33
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,45
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,01
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,52
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;15.178
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;14.649
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.206
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.611
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.223
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;13.653
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;14.089
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.780
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;13.203
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;13.357
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;12.899
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;12.919
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;12.542
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,26
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,09
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,11
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,83
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,07
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,94
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,18
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,8
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,19
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,29
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;40.048
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;39.758
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;39.233
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;38.676
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;38.512
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;37.956
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;37.418
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;37.089
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;36.325
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;36.167
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;35.376
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;35.390
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,57
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,87
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,75
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,11
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,54
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,37
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,19
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,98
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,2
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;24.792
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;24.929
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;24.966
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;24.000
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;24.171
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;24.202
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;23.538
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;23.672
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;22.918
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;23.134
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;22.395
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;22.680
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,81
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,96
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,94
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,42
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,82
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,93
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,66
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,84
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,84
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;15.256
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;14.829
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.267
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.676
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.341
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;13.754
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;13.880
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;13.417
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;13.407
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;13.033
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.981
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;12.710
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,2
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,71
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,4
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,6
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,04
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,41
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,35
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,54
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,09
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;36.633
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;34.868
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;35.817
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;35.665
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;34.060
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;33.856
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;34.664
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;33.330
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;33.229
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;33.876
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;32.789
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;32.446
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;33.074
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;32.098
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;31.757
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,36
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,68
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,52
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,63
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,59
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,77
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,47
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,04
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,59
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,28
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,06
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,66
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;23.871
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;22.775
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.362
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;23.289
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;22.287
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;22.158
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;22.706
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;21.860
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;21.784
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;22.247
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;21.542
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;21.300
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;21.762
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;21.115
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;20.867
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,56
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,86
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,85
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,12
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,98
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,25
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,2
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,59
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,17
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,17
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,71
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,32
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;12.762
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;12.093
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.455
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;12.376
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;11.773
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;11.698
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;11.958
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;11.470
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;11.445
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.629
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.247
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;11.146
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;11.312
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;10.983
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.890
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,98
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,35
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,92
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,7
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,85
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,89
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,12
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,49
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,64
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,82
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,43
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;38.036
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;36.291
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;35.122
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;36.919
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;35.422
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;34.430
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;36.049
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;34.797
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;33.529
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;35.155
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;34.027
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;32.772
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;33.257
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;32.158
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Canarias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,06
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,61
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,03
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,78
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,88
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,46
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,43
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,76
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,31
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,64
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,56
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;24.660
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;23.703
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;22.946
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;24.016
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;23.185
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;22.533
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;23.520
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;22.813
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;21.959
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;22.989
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;22.342
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;21.482
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;21.887
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;21.113
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Canarias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,39
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,81
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,2
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,38
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,25
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,7
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,22
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,26
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,62
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,34
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,01
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;13.376
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.588
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;12.176
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;12.903
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;12.237
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;11.897
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;12.529
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.984
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;11.570
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;12.166
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;11.685
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.290
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;11.370
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;11.045
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Canarias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,46
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,21
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,71
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,67
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,2
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,02
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,95
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,83
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,72
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,32
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,71
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;37.984
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;36.338
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;35.047
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;37.012
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;35.633
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;34.089
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;36.044
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;34.798
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;33.273
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;33.980
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;32.626
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;33.151
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;32.029
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,44
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,06
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,27
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,89
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,76
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,94
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,51
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,09
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,23
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,39
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;24.665
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;23.736
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;22.946
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;24.106
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;23.314
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;22.336
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;23.531
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;22.806
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;21.819
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;22.322
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;21.427
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;21.829
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;21.071
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,73
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,22
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,34
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,4
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,08
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,09
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,04
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,38
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,97
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,83
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;13.319
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.602
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.101
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.906
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.319
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;11.753
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;12.513
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.992
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.454
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;11.658
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;11.199
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;11.322
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;10.958
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,9
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,75
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,12
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,95
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,16
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,65
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,51
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,55
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,84
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,55
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;37.946
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;36.577
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;35.006
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;36.888
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;35.645
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;34.077
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;34.773
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;33.356
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;33.873
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;32.704
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;33.134
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;32.204
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,21
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,45
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,35
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,07
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,29
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,61
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,42
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,59
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;24.643
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;23.870
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;22.903
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;24.009
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;23.308
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;22.317
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;22.785
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;21.882
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;22.256
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;21.499
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;21.825
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;21.201
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,43
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,65
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,44
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,45
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,54
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,24
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,87
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,43
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,57
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;13.303
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.707
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.103
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.879
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.337
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;11.760
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;11.988
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;11.474
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;11.617
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;11.205
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;11.309
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.003
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,81
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,09
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,17
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,34
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,8
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,42
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,58
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,91
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.397
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;17.210
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.359
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;17.748
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;16.607
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;18.200
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;17.106
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;15.974
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;17.651
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;16.498
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;15.494
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.953
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.812
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.897
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.235
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,47
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,5
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,01
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,98
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,82
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,18
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,68
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,03
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,57
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,95
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,56
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,86
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.471
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.726
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.110
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;12.058
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;11.344
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;12.350
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;11.638
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;10.938
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;11.987
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.266
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.636
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.555
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.797
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.237
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.095
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,69
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,74
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,2
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,32
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,28
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,43
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,34
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,7
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,14
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,58
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,3
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,63
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.926
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.484
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.249
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;5.690
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;5.263
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;5.850
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;5.468
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;5.036
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;5.664
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.232
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.858
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.398
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.015
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.660
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.140
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,02
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,97
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,61
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,27
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,83
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,64
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,29
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,58
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,38
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,63
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,97
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,25
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.906
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.560
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.713
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;20.169
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;18.843
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;18.143
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.474
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;18.305
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.345
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.709
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.641
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;16.608
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;17.077
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;16.059
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
05 Canarias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,47
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,33
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,95
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,15
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,58
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,69
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,49
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,19
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,75
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,31
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,82
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;14.144
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.246
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.673
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;13.660
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;12.785
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;12.300
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.235
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.447
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.800
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.715
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.005
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.327
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;11.641
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;10.981
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
05 Canarias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,52
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,06
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,57
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,97
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,11
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,9
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,63
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,38
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,88
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,65
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.762
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.314
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.040
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;6.509
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;6.058
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;5.843
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.239
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.858
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.545
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.994
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.636
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.281
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;5.436
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;5.078
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
05 Canarias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,26
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,95
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,74
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,27
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,78
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,8
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,64
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,26
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,43
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,09
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,07
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.495
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.109
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.315
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.770
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.544
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.497
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.978
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.852
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.739
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;17.276
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;16.182
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;16.685
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;15.597
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,46
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,04
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,53
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,6
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,42
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,4
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,41
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,35
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,31
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,16
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.871
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.955
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.422
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.428
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.603
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.908
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.888
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.137
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.418
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;11.767
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;11.067
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;11.376
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;10.694
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,28
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,86
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,91
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,69
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,92
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,83
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,09
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,81
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,09
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.624
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.154
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.893
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.342
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.941
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.589
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.090
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.715
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.321
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;5.509
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;5.115
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;5.309
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;4.903
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,74
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,54
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,84
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,94
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,87
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,29
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,52
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,8
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,27
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,2
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.018
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.803
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.763
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.190
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.084
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;16.973
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;17.491
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;16.400
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;16.888
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;15.800
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;16.295
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.327
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,86
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,18
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,55
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,02
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,33
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,82
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,95
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,66
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,29
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.581
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.765
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.086
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.019
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.285
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.574
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;11.904
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;11.214
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;11.508
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;10.832
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.146
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.533
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,86
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,24
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,76
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,25
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,79
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,15
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,62
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,32
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,15
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.437
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.038
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.677
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.171
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.799
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.399
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;5.587
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;5.186
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;5.380
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;4.968
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.149
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.794
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,87
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,04
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,1
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,53
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,35
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,1
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,51
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,28
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,45
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
05 Canarias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;36.852
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;36.407
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;36.854
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;35.892
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;35.662
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;35.021
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;34.981
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;34.907
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;34.413
06 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;34.293
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;34.209
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;33.748
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;33.346
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;33.431
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;32.958
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,39
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,95
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,03
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,92
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,88
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,38
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,06
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,96
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,57
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,49
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,83
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,43
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;22.940
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;22.770
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;23.067
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;22.367
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;22.298
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;21.928
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;21.843
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;21.868
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;21.591
06 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;21.433
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;21.438
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;21.193
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;20.829
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;20.952
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;20.719
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,5
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,93
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,06
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,22
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,04
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,6
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,43
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,15
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,88
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,8
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,02
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,82
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;13.912
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.637
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;13.787
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;13.525
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;13.364
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;13.093
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;13.138
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;13.039
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;12.822
06 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;12.860
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;12.771
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;12.555
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;12.517
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.479
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;12.239
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,22
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,97
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,44
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,61
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,44
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,65
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,06
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,97
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,51
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,77
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;36.949
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;36.645
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;36.196
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;35.959
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;35.788
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;35.538
06 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;35.208
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;35.040
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;34.772
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;34.181
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;34.204
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;33.929
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;33.420
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;33.345
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,32
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,66
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,18
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,29
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,62
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,07
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,51
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,34
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,74
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,2
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,12
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;23.000
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;22.900
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;22.634
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;22.422
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;22.403
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;22.262
06 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;21.973
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;21.937
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;21.787
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;21.322
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;21.415
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;21.286
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;20.958
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;20.925
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,49
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,83
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,36
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,53
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,79
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,26
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,7
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,52
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,04
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,52
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,45
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;13.949
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;13.745
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;13.562
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;13.537
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;13.385
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;13.276
06 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;13.235
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;13.103
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;12.985
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;12.859
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;12.789
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;12.643
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;12.462
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;12.420
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,05
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,38
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,89
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,88
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,33
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,75
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,19
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,04
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,22
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,67
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,58
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;37.238
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;37.080
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;36.501
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;36.225
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;36.125
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;35.564
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;35.062
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;35.142
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;34.621
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;34.299
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;34.001
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;33.533
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;33.355
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,28
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,42
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,43
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,16
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,77
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,85
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,5
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,15
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,43
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,38
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;23.165
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;23.188
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;22.860
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;22.573
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;22.603
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;22.284
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;21.849
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;22.004
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;21.722
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;21.508
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;21.339
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;21.052
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;20.970
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,44
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,48
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,48
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,32
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,89
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,02
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,75
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,35
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,79
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,73
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;14.073
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;13.892
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;13.641
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;13.652
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;13.522
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;13.280
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;13.213
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;13.138
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;12.899
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;12.791
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;12.662
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;12.481
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;12.385
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,01
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,34
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,35
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,89
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,57
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,56
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,07
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,82
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,84
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,79
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;37.084
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;37.027
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;36.568
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;35.816
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;35.907
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;35.491
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;35.017
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;34.828
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;34.195
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;34.138
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;33.563
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;33.485
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,58
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,98
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,05
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,57
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,24
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,35
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,35
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,64
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,57
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;23.040
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;23.110
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;22.844
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;22.251
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;22.429
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;22.212
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;21.904
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;21.801
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;21.424
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;21.414
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;21.045
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;21.018
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,58
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,05
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,23
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,78
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,43
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,7
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,74
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,06
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,01
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;14.044
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;13.917
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;13.724
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;13.565
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;13.478
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;13.279
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;13.113
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;13.027
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;12.771
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;12.724
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;12.518
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;12.467
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,59
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,85
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,76
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,22
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,92
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,77
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,71
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,95
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,84
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.800
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.730
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.450
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.699
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.650
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.305
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.622
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.584
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.260
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.546
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.523
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.209
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.464
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.462
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.159
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,39
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,38
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,11
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,56
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,9
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,89
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,03
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;83,38
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,33
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,51
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,93
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.123
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.080
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;897
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.058
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.022
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;807
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.007
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;979
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;779
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;968
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;941
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;747
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;911
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;907
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;715
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,21
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,63
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,97
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,67
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,65
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;86,85
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;86,2
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;87,13
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,28
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;81,12
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83,98
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,71
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;677
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;650
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;553
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;641
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;628
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;498
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;615
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;605
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;481
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;578
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;582
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;462
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;553
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;555
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;444
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,68
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,62
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,05
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,84
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,08
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;86,98
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,38
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,54
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,54
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,68
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,38
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,29
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.577
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.506
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.474
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;1.496
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;1.418
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;1.421
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.420
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.357
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.360
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.329
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.297
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.301
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.234
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.252
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,86
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,16
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,4
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,04
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;90,11
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,27
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,27
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;86,12
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,26
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;81,94
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,94
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;983
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;941
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;907
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;931
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;879
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;873
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;890
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;838
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;834
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;831
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;802
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;796
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;760
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;762
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,71
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,41
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,25
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;90,54
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,05
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,95
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;84,54
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;85,23
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,76
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;80,77
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,01
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;594
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;565
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;567
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;565
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;539
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;548
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;530
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;519
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;526
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;498
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;495
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;505
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;474
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;490
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,12
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,4
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,65
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,23
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,86
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,77
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;83,84
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,61
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,07
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,89
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,42
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.704
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.638
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.556
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.591
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.533
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.461
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.482
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.458
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.391
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;1.383
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.334
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.325
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.294
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,37
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,59
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,89
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,97
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,01
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,4
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;84,43
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,73
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,89
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,16
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.061
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.030
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;965
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;995
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;958
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;900
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;923
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;915
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;855
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;868
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;815
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;828
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;789
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,78
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,01
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,26
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,99
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,83
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,6
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;84,27
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,46
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;80,39
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,76
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;643
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;608
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;591
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;596
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;575
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;561
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;559
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;543
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;536
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;515
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;519
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;497
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;505
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,69
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,57
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,92
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;86,94
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,31
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,69
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,7
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,82
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;81,74
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,45
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.769
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.713
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.649
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.640
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.609
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.555
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;1.523
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;1.489
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;1.456
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;1.443
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.387
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.390
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,71
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,93
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,3
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;88,91
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,3
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;85
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,51
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;80,97
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,29
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.101
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.061
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.023
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.016
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.000
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;962
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;947
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;916
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;901
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;887
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;867
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;855
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,28
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,25
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,04
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;89,26
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,54
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;84,92
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,71
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;81,72
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,58
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;668
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;652
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;626
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;624
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;609
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;593
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;576
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;573
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;555
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;556
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;520
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;535
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,41
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,4
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,73
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,34
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,53
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,12
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,82
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,75
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,46
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.062
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.240
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.044
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;5.886
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;6.087
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;5.700
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;5.692
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;5.933
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;5.582
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.563
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.794
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.468
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.387
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.646
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.324
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,1
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,55
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,31
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,9
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,08
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,36
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,77
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,85
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,47
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,87
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,48
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,09
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.595
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.743
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.633
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;3.493
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;3.651
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;3.423
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;3.388
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;3.560
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;3.354
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.319
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.474
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.294
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.210
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.389
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.217
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,16
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,54
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,22
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,24
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,11
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,32
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,32
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,81
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,67
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,29
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,54
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,55
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.467
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.497
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.411
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.393
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.436
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.277
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.304
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.373
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.228
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.244
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.320
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.174
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.177
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.257
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.107
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,56
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,44
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,39
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,03
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,41
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,96
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,91
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,17
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,24
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,39
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,39
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.603
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.796
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.968
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;5.409
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;5.633
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;5.837
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.267
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.484
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.712
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.093
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.329
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.558
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;5.192
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;5.442
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,54
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,19
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,8
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,62
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,71
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,9
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,94
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,13
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,58
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,19
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.303
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.453
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.581
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;3.191
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;3.360
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;3.504
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.108
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.270
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.437
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.996
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.182
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.354
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;3.110
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.289
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,61
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,85
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,1
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,7
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,98
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,71
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,15
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,66
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,07
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,85
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.300
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.343
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.387
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.218
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.273
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.333
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.159
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.214
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.275
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.097
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.147
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.204
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.082
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.153
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,43
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,01
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,74
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,87
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,49
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,31
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,17
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,63
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,33
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,86
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,2
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;5.715
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;5.948
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.069
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.538
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.776
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.908
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.340
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.597
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.740
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;5.444
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;5.613
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;5.282
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;5.488
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,9
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,11
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,35
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,44
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,1
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,58
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,53
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,49
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,8
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,43
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.372
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.544
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.643
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.267
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.439
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.554
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.143
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.339
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.461
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.254
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;3.389
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;3.163
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.313
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,04
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,56
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,21
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,22
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,82
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,03
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,25
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,94
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.343
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.404
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.426
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.271
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.337
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.354
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.197
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.258
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.279
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.190
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.224
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.119
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.175
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,93
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,21
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,03
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,77
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,93
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,94
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,1
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,67
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,14
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,65
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;5.762
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.019
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.171
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.543
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.815
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.984
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;5.655
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;5.849
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;5.479
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;5.710
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.366
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.587
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,2
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,61
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,97
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,95
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,78
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,03
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,53
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,15
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,54
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.390
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.588
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.687
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.258
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.470
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.586
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;3.380
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;3.508
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.283
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;3.428
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.221
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.351
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,11
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,71
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,26
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,2
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,15
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,5
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,98
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,77
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,89
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.372
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.431
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.484
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.285
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.345
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.398
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.275
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.341
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.196
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.282
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.145
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.236
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,33
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,46
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,54
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,58
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,24
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,33
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,87
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,24
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,02
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.647
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.592
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.617
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;11.386
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;11.383
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;11.065
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;11.119
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;11.204
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;10.904
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.959
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.031
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.727
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.748
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.840
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.545
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,76
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,2
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,25
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,47
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,65
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,86
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,09
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,16
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,34
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,28
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,51
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,77
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.315
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.327
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.357
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.163
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;7.198
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.001
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.012
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;7.103
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;6.908
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.915
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.999
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.800
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.785
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.883
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.692
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,92
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,24
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,16
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,86
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,94
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,9
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,53
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,52
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,43
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,75
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,94
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,96
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.332
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.265
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.260
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.223
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.185
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.064
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.107
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.101
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;3.996
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.044
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.032
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.927
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.963
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.957
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.853
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,48
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,12
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,4
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,81
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,15
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,8
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,35
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,54
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,18
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,48
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,78
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,45
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.384
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.447
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.403
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;11.096
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;11.248
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;11.228
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;10.931
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.063
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.034
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;10.692
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;10.848
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.837
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;10.634
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;10.676
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,47
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,26
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,47
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,02
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,65
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,76
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,92
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,77
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,04
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,9
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,62
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.157
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.219
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.198
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;6.993
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.108
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;7.095
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.897
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;6.990
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.977
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.748
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.857
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.862
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;6.736
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;6.764
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,71
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,46
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,57
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,37
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,83
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,93
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,29
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,99
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,33
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,31
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,97
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.227
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.228
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.205
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.103
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.140
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.133
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.034
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.073
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.057
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;3.944
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.991
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.975
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;3.898
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;3.912
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,07
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,92
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,29
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,43
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,33
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,48
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,3
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,39
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,53
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,19
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,03
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.499
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.653
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.548
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.249
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.409
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.309
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;10.968
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.149
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;11.075
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;10.912
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;10.903
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;10.697
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;10.746
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,83
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,91
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,93
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,38
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,67
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,9
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,64
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,41
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,8
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,06
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.235
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.354
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.289
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.094
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.209
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.151
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;6.921
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.049
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.015
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;6.912
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;6.910
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;6.792
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;6.830
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,05
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,03
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,11
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,66
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,85
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,24
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,99
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,8
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,36
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,7
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.264
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.299
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.259
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.155
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.200
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.158
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.047
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.100
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.060
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.000
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;3.993
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;3.905
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;3.916
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,44
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,63
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,91
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,37
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,33
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,04
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,75
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,84
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,95
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.499
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.669
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.582
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.184
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.366
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.308
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;11.121
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;11.125
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;10.888
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;10.962
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.742
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.801
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,26
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,4
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,63
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,3
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,05
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,31
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,65
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,06
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,26
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.225
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.353
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.319
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.025
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.168
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.158
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.025
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;7.047
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;6.897
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;6.962
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.808
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.868
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,23
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,48
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,8
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,54
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,28
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,8
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,12
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,59
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,84
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.274
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.316
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.263
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.159
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.198
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.150
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.096
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.078
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;3.991
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.000
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.934
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.933
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,31
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,27
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,35
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,9
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,66
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,47
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,83
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,15
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,26
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.507
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.292
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;11.423
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;11.298
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;11.160
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;10.988
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;11.129
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;11.012
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;10.871
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.969
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;10.867
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.744
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;10.791
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;10.720
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.594
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,18
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,83
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,19
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,72
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,52
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,17
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,32
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,24
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,06
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,78
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,93
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,74
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.205
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.098
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;7.186
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;7.089
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;7.017
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;6.919
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;6.998
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;6.941
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;6.863
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;6.904
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.850
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;6.795
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.800
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.751
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.701
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,39
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,86
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,28
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,13
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,79
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,51
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,82
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,51
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,56
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,38
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,11
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,25
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.302
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.194
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.237
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.209
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.143
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.069
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.131
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.071
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.008
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.065
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.017
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.949
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.991
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.969
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.893
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,84
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,78
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,03
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,03
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,07
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,6
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,49
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,78
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,2
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,77
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,64
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,88
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;11.732
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;11.520
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.277
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;11.530
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;11.336
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;11.153
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.352
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.178
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;10.988
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.148
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.023
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.822
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;10.853
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;10.725
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,28
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,4
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,9
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,76
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,03
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,44
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,02
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,69
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,97
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,21
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;95,11
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.340
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.237
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.094
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;7.230
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.142
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;7.033
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.128
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.047
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;6.934
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.015
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;6.946
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;6.833
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;6.852
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;6.773
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,5
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,69
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;99,14
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,11
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,37
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,74
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,57
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,98
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,32
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,68
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,48
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.392
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.283
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.183
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.300
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.194
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;4.120
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.224
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.131
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.054
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.133
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.077
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.989
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;4.001
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;3.952
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,91
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,92
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,49
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,17
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,45
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,92
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,1
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,19
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,36
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,42
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,48
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;11.782
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;11.579
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.356
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;11.545
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;11.374
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.153
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.306
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.178
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.964
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;11.004
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;10.862
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;10.867
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;10.733
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,99
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,23
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,21
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,96
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,54
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,55
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,03
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,65
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,85
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,51
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.359
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.283
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.157
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.230
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.160
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.039
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.102
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.040
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;6.925
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;6.944
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;6.863
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;6.863
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;6.795
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,25
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,31
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,35
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,51
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,66
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,76
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,35
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,89
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,23
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,94
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.423
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.296
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.199
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.315
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.214
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.114
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.204
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.138
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.039
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.060
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;3.999
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.004
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;3.938
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,56
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,09
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,98
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,05
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,32
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,19
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,51
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,24
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,2
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,78
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;11.699
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;11.546
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.368
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;11.437
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.321
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;11.139
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;11.129
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;11.025
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;10.983
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;10.885
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.838
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;10.744
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,76
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,05
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,99
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,39
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,98
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,12
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,75
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,87
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,51
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.308
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.243
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.144
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.169
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.110
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.016
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;7.004
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;6.947
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;6.920
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;6.875
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.834
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.788
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,1
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,16
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,21
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,7
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,24
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,54
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,23
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,35
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,02
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.391
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.303
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.224
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.268
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.211
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.123
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.125
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.078
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;4.063
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.010
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.004
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.956
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,2
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,86
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,61
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,86
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,54
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,42
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,93
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,05
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,66
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;5.836
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.553
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.320
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.623
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;5.382
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;5.963
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;5.419
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;5.174
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;5.796
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.256
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.994
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.600
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;4.956
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.763
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.336
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,35
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,92
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,35
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,85
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,17
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,71
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,06
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,93
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,61
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,92
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,77
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,43
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.702
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.522
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.994
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.564
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.410
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;3.778
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.438
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.285
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;3.687
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.327
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.174
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.557
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.123
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.022
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.394
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,27
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,82
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,59
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,87
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,27
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,31
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,87
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,12
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,06
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,36
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,8
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,98
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.134
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.031
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.326
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.059
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.972
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.185
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.981
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.889
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.109
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.929
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.820
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.043
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.833
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.741
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.942
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,49
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,1
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,94
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,83
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,01
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,67
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,39
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,61
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,83
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,9
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,72
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,49
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.653
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.376
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.074
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;6.428
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;6.153
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;5.899
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.238
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.958
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.678
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.919
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.707
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.411
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;5.507
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;5.250
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
06 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,62
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,5
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,12
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,76
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,44
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,48
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,97
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,51
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,08
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,37
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,43
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.217
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.050
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.854
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;4.077
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;3.914
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;3.757
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.950
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.792
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.605
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.732
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.628
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.441
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.500
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.337
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
06 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,68
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,64
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,48
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,67
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,63
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,54
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,5
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,58
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,28
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,42
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,59
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.436
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.326
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.220
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.351
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.239
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.142
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.288
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.166
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.073
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.187
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.079
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.970
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.007
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.913
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
06 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,51
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,26
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,49
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,92
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,12
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,38
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,78
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,38
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,74
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,29
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,17
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.538
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.262
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.972
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.302
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.033
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.733
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.966
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.760
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.451
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.556
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;5.289
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;5.362
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.094
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,39
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,34
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,25
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,98
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,28
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,73
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,56
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,63
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,3
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.138
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.977
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.806
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.987
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.837
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.640
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.760
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.661
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.466
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.530
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.362
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.406
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.243
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,35
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,48
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,64
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,87
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,05
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,07
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,76
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,33
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,64
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,21
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.400
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.285
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.166
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.315
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.196
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.093
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.206
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.099
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.985
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.026
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.927
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.956
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.851
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,46
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,11
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,63
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,92
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,86
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,64
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,67
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,97
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,6
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,46
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.355
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.080
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;5.798
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.012
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;5.796
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.505
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.589
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;5.340
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;5.389
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.138
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.230
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.963
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,6
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,33
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,95
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,92
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,1
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,63
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,62
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,02
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,6
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.016
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.865
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.671
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.783
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.681
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.490
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.548
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.383
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.423
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.262
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.315
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.156
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,2
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,24
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,07
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,8
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,15
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,56
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,86
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,77
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,97
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.339
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.215
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.127
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.229
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.115
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.015
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.041
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.957
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.966
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.876
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.915
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.807
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,3
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,49
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,73
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,14
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,01
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,76
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,2
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,46
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,96
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
06 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;149.832
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;149.511
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;153.461
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;145.929
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;146.200
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;145.655
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;142.057
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;142.838
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;142.976
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;138.721
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;139.804
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;139.649
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;134.480
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;136.411
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;136.292
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,4
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,79
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,91
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,81
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,54
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,17
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,58
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,51
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,75
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,24
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,81
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;95.504
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;95.669
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;98.153
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;93.135
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;93.624
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;93.442
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;90.928
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;91.692
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;91.898
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;89.017
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;89.884
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;89.991
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;86.401
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;87.809
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;87.958
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,52
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,86
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,2
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,21
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,84
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,63
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,21
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,95
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,68
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,47
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,78
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,61
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;54.328
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;53.842
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;55.308
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;52.794
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;52.576
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;52.213
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;51.129
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;51.146
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;51.078
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;49.704
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;49.920
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;49.658
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;48.079
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;48.602
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;48.334
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,18
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,65
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,4
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,11
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,99
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,35
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,49
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,72
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,78
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,5
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,27
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,39
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;149.874
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;150.028
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;150.362
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;145.593
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;146.245
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;147.439
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;141.973
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;142.937
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;143.640
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;137.438
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;139.279
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;139.992
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;136.278
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;137.477
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Castilla y León;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,14
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,48
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,06
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,73
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,27
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,53
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,7
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,84
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,1
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,84
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,43
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;95.418
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;95.982
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;96.160
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;92.942
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;93.787
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;94.466
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;90.860
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;91.802
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;92.248
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;88.055
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;89.550
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;90.046
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;87.749
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;88.493
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Castilla y León;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,41
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,71
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,24
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,22
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,65
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,93
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,28
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,3
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,64
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,42
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,03
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;54.456
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;54.046
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;54.202
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;52.651
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;52.458
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;52.973
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;51.113
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;51.135
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;51.392
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;49.383
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;49.729
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;49.946
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;48.529
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;48.984
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Castilla y León;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,69
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,06
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,73
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,86
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,61
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,82
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,68
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,01
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,15
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,79
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,37
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;150.181
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;150.942
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;150.776
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;145.617
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;146.818
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;146.400
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;140.574
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;142.711
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;142.413
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;139.456
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;139.757
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;136.257
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;136.983
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,96
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,27
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,1
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,6
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,55
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,45
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,39
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,69
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,27
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,85
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;95.587
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;96.624
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;96.632
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;92.945
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;94.143
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;94.047
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;89.837
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;91.607
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;91.605
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;89.641
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;89.962
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;87.750
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;88.345
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,24
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,43
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,32
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,98
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,81
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,8
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,77
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,1
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,82
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,42
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;54.594
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;54.318
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;54.144
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;52.672
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;52.675
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;52.353
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;50.737
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;51.104
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;50.808
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;49.815
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;49.795
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;48.507
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;48.638
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,48
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,98
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,69
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,94
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,08
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,84
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,71
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,97
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,3
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,83
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;148.961
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;150.610
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;150.489
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;143.492
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;146.014
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;145.965
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;142.517
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;143.052
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;139.080
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;140.073
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;135.970
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;137.236
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,33
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,95
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,99
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,63
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,06
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,34
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,08
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,28
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,19
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;94.787
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;96.271
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;96.456
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;91.422
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;93.452
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;93.652
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;91.347
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;91.856
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;89.328
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;90.123
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;87.532
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;88.434
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,45
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,07
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,09
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,89
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,23
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,79
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,43
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,92
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,68
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;54.174
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;54.339
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;54.033
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;52.070
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;52.562
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;52.313
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;51.170
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;51.196
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;49.752
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;49.950
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;48.438
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;48.802
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,12
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,73
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,82
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,17
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,75
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,56
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,44
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,14
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,32
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.638
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.433
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.270
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;7.114
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;6.981
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.545
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;6.650
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;6.559
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.317
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.219
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.197
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.006
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.884
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.854
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.774
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,14
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,92
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,44
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,06
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,24
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,8
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,42
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,37
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,84
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,04
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;78,76
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,14
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.777
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.623
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.927
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;4.451
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.350
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.492
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.168
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.097
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.357
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.918
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.869
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.165
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.707
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.666
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.021
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,18
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,09
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,92
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,25
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,62
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,49
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,02
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;83,69
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,6
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,6
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,3
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,93
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.861
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.810
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.343
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;2.663
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.631
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.053
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.482
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.462
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.960
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.301
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.328
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.841
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.177
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.188
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.753
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,08
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,63
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,62
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,75
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,62
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,65
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,43
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,85
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,57
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;76,09
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;77,86
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;74,82
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.641
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.557
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.334
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;6.116
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;6.079
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;6.060
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.676
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.694
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.656
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.324
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.330
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.368
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;5.047
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;5.133
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,09
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,71
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,67
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,47
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,84
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,3
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,17
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,29
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,75
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,97
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;81,04
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.153
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.147
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.979
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;3.822
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;3.859
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;3.814
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.559
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.614
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.565
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.344
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.388
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.389
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.215
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.239
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,03
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,06
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,85
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,7
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,15
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,6
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,52
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,7
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,17
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;77,53
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,4
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.488
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.410
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.355
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.294
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.220
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.246
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.117
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.080
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.091
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.980
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.942
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.979
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.832
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.894
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,2
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,12
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,37
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,09
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,31
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,79
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,58
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,58
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,03
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,02
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,42
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.179
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.096
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.770
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.455
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.443
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.162
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.010
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.993
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.807
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;5.651
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;5.535
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;5.337
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.266
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;89,92
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,8
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,02
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,72
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,46
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,78
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,64
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,76
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,21
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;77,78
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.474
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.502
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.292
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.045
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.085
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.904
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.772
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.805
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.683
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.593
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.507
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.399
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.347
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;90,41
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;90,74
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;90,96
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,31
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,52
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,81
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,81
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,71
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,5
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,98
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.705
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.594
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.478
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.410
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.358
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.258
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.238
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.188
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.124
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.058
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.028
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.938
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.919
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,09
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,9
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,12
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,74
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,35
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,71
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,34
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,84
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,71
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,44
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.203
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.351
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.067
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.654
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.788
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.591
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;6.369
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.253
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.003
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;5.930
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.632
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.628
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,38
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,34
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,26
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,64
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,48
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,66
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,91
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,62
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,64
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.498
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.618
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.435
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.161
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.281
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.125
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.025
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;3.915
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;3.797
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.725
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.582
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.533
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,51
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,7
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,01
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,16
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,28
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,22
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,99
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;77,57
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,66
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.705
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.733
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.632
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.493
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.507
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.466
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.344
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.338
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.206
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.205
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.050
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.095
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,16
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,73
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,69
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;85,77
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,83
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,72
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,78
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,01
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,6
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;23.723
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;24.175
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.852
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;22.941
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;23.557
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;22.331
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;22.187
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;22.899
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;21.873
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;21.546
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.335
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;21.241
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;20.877
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;21.754
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.669
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,7
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,44
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,62
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,53
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,72
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,7
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,82
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,39
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,05
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,99
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,66
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.171
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.622
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.341
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;13.750
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;14.262
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;13.476
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;13.346
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;13.905
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;13.241
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.003
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.590
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.916
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.646
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.251
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.605
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,03
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,54
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,97
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,18
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,1
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,33
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,76
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,94
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,06
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,24
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,62
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,89
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.552
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;9.553
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.511
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;9.191
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;9.295
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;8.855
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;8.841
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;8.994
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;8.632
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.543
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.745
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.325
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.231
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.503
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.064
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,22
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,3
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,1
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,56
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,15
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,76
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,44
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,54
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,53
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,17
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,01
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,79
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;22.042
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.738
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.498
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;21.235
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;21.999
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;22.983
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;20.532
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.360
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;22.273
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.832
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.751
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;21.636
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;20.182
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;21.207
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,34
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,75
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,81
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,15
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,94
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,79
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,97
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,26
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,08
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,76
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,25
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.211
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.703
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;14.140
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;12.778
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;13.289
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;13.863
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.397
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.933
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.488
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.004
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.568
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;13.141
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;12.261
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;12.894
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,72
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,98
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,04
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,84
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,38
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,39
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,86
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,72
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,93
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,48
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,19
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.831
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.035
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.358
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;8.457
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;8.710
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;9.120
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.135
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.427
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.785
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.828
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.183
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.495
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;7.921
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;8.313
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,76
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,4
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,46
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,12
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,27
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,88
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,64
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,57
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,78
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,67
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,83
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;22.414
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;23.231
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;23.778
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;21.525
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;22.442
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.956
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;20.694
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;21.722
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;22.268
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;21.086
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;21.809
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;20.496
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;21.294
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,03
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,6
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,54
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,33
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,5
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,65
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,77
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,72
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,23
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,55
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.440
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;14.011
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.378
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.939
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.557
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.924
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.465
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.124
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.540
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;12.785
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;13.276
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;12.461
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;12.994
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,27
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,76
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,84
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,75
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,67
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,17
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,25
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,34
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,94
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,37
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.974
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.220
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.400
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.586
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.885
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.032
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.229
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.598
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.728
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;8.301
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;8.533
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;8.035
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;8.300
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,68
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,37
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,09
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,7
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,25
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,85
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,03
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,78
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,15
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,3
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;22.443
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.492
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;23.992
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;21.520
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.641
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.200
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;21.944
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;22.685
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;21.290
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;22.116
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.718
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;21.599
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,89
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,38
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,7
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,41
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,55
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,63
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,18
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,19
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,03
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.394
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;14.125
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.529
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.874
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.610
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.076
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;13.240
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;13.783
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;12.878
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;13.476
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.571
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;13.190
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,12
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,35
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,88
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,73
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,87
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,17
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,75
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,78
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.049
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.367
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.463
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.646
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.031
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.124
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;8.704
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;8.902
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;8.412
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;8.640
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.147
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.409
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,55
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,41
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,42
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,92
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,07
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,8
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,3
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,98
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,86
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;43.443
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;44.276
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;44.619
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;42.479
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;43.562
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;42.539
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;41.520
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;42.747
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;41.908
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;40.750
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;42.054
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;41.173
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;39.942
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;41.330
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;40.473
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,78
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,39
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,34
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,57
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,55
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,92
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,8
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,98
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,28
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,94
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,35
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,71
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;27.562
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;28.297
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;28.436
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;26.982
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;27.872
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;27.236
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;26.456
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;27.423
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;26.906
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;26.035
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;27.040
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;26.505
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;25.568
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;26.597
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;26.099
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,9
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,5
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,78
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,99
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,91
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,62
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,46
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,56
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,21
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,77
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,99
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,78
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;15.881
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;15.979
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;16.183
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;15.497
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;15.690
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;15.303
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;15.064
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;15.324
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;15.002
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;14.715
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;15.014
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;14.668
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;14.374
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;14.733
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;14.374
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,58
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,19
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,56
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,86
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,9
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,7
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,66
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,96
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,64
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,51
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,2
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,82
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;42.032
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;42.956
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;43.884
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;40.972
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;42.038
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;43.180
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;40.138
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;41.288
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;42.346
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;39.282
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;40.497
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;41.547
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;39.772
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;41.033
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,48
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,86
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,4
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,49
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,12
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,5
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,46
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,28
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,67
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,59
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,5
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;26.518
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;27.346
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;27.993
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;25.914
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;26.831
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;27.626
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;25.451
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;26.398
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;27.163
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;24.954
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;25.922
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;26.696
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;25.500
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;26.409
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,72
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,12
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,69
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,98
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,53
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,03
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,1
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,79
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,37
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,25
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,34
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;15.514
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;15.610
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;15.891
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;15.058
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;15.207
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;15.554
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;14.687
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;14.890
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;15.183
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;14.328
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;14.575
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;14.851
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;14.272
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;14.624
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,06
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,42
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,88
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,67
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,39
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,54
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,36
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,37
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,46
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,43
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,03
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;42.209
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;43.334
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;44.132
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;41.169
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;42.397
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;43.168
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;40.173
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;41.492
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;42.267
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;40.698
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;41.712
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;39.900
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;41.059
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,54
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,84
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,82
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,18
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,75
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,77
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,92
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,52
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,08
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,04
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;26.595
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;27.594
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;28.239
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;26.010
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;27.052
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;27.696
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;25.432
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;26.505
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;27.159
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;26.035
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;26.845
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;25.583
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;26.485
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,8
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,04
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,08
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,63
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,05
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,18
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,35
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,06
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,71
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,79
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;15.614
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;15.740
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;15.893
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;15.159
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;15.345
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;15.472
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;14.741
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;14.987
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;15.108
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;14.663
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;14.867
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;14.317
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;14.574
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,09
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,49
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,35
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,41
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,22
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,06
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,16
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,54
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,96
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,7
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;42.076
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;43.415
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;44.332
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;40.968
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;42.387
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;43.291
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;41.540
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;42.668
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;40.683
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;41.953
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;39.969
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;41.309
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,37
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,63
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,65
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,68
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,25
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,71
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,63
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,06
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,18
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;26.506
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;27.620
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;28.365
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;25.864
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;26.999
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;27.735
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;26.496
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;27.375
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;26.014
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;26.975
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;25.614
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;26.624
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,58
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,75
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,78
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,93
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,51
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,19
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,1
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,74
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,86
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;15.570
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;15.795
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;15.967
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;15.104
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;15.388
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;15.556
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;15.044
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;15.293
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;14.669
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;14.978
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;14.355
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;14.685
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,01
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,42
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,43
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,25
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,78
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,87
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,81
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,88
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,97
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;48.490
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;48.418
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;49.511
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;47.739
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;47.773
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;47.774
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;46.963
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;47.115
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;47.169
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;46.353
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;46.551
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;46.561
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;45.591
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;45.882
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;45.943
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,45
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,67
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,49
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,85
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,31
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,27
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,59
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,14
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,04
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;94,02
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,76
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,79
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;31.331
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;31.329
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;32.004
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;30.869
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;30.939
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;30.937
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;30.454
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;30.567
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;30.599
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;30.111
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;30.241
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;30.269
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;29.652
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;29.854
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;29.893
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,53
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,76
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,67
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;97,2
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,57
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,61
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;96,11
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,53
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,58
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;94,64
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,29
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,4
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;17.159
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;17.089
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;17.507
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;16.870
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;16.834
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;16.837
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;16.509
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;16.548
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;16.570
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;16.242
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;16.310
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;16.292
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;15.939
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;16.028
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;16.050
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,32
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,51
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,17
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,21
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,83
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,65
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,66
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,44
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,06
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,89
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,79
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,68
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;48.789
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;48.821
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;48.777
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;47.920
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;48.068
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;48.123
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;47.229
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;47.443
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;47.418
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;46.380
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;46.705
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;46.743
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;46.096
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;46.225
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,22
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,46
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,66
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,8
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,18
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,21
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;95,06
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,67
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,83
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,42
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,77
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;31.343
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;31.527
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;31.512
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;30.872
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;31.100
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;31.145
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;30.489
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;30.748
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;30.745
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;29.983
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;30.315
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;30.332
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;29.950
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;30.018
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,5
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,65
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,84
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;97,28
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,53
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,57
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,66
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;96,16
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;96,26
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;95
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,26
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;17.446
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;17.294
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;17.265
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;17.048
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;16.968
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;16.978
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;16.740
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;16.695
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;16.673
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;16.397
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;16.390
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;16.411
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;16.146
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;16.207
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,72
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,11
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,34
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,95
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,54
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,57
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,99
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,77
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,05
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,36
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,87
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;48.719
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;48.943
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;48.787
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;47.850
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;48.170
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;48.000
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;46.901
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;47.332
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;47.240
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;46.680
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;46.699
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;46.043
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;46.138
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,22
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,42
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,39
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,27
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,71
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,83
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,38
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,72
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,07
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,57
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;31.322
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;31.642
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;31.560
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;30.845
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;31.214
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;31.120
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;30.282
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;30.712
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;30.648
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;30.312
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;30.322
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;29.948
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;29.994
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,48
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,65
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,61
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,68
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,06
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;97,11
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,8
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;96,08
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,65
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;95,04
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;17.397
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;17.301
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;17.227
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;17.005
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;16.956
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;16.880
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;16.619
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;16.620
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;16.592
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;16.368
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;16.377
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;16.095
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;16.144
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,75
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,01
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,99
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,53
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,06
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,31
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,61
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,07
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,03
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,71
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;48.407
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;48.799
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;48.732
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;47.391
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;47.873
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;47.855
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;47.185
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;47.273
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;46.504
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;46.686
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;45.924
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;46.145
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,9
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,1
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,2
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,69
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,01
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,3
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,8
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;94,11
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,69
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;31.164
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;31.567
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;31.567
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;30.558
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;31.018
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;31.023
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;30.596
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;30.670
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;30.212
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;30.325
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;29.887
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;30.010
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,06
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,26
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,28
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,92
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,16
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,71
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,07
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,68
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,07
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;17.243
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;17.232
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;17.165
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;16.833
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;16.855
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;16.832
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;16.589
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;16.603
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;16.292
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;16.361
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;16.037
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;16.135
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,62
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,81
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,06
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,27
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,73
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,55
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,32
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,07
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;26.538
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;25.209
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;29.209
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;25.656
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;24.327
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;27.466
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;24.737
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;23.518
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;26.709
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.853
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.667
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.668
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.186
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;21.591
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;24.433
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,68
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,5
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,03
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,21
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,29
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,44
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,88
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,92
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,88
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,6
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,65
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,65
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.663
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;16.798
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;19.445
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;17.083
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;16.201
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;18.301
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;16.504
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;15.700
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;17.795
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.950
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;15.144
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;17.136
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.828
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.441
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.340
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,72
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,45
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,12
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,44
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,46
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,51
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,3
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,15
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,13
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;83,95
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,97
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,03
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.875
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.411
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.764
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;8.573
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;8.126
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;9.165
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;8.233
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;7.818
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;8.914
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.903
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.523
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.532
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.358
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.150
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.093
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,6
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,61
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,87
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,77
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,95
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,29
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,05
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,44
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,38
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,91
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,01
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,89
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;30.370
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;28.956
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;27.869
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;29.350
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;28.061
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;27.093
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;28.398
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.152
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;25.947
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.620
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;25.996
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;24.698
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;25.181
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;23.879
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,64
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,91
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,22
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,51
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,77
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,1
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,65
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,78
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,62
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,96
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,68
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;20.193
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;19.259
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.536
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;19.556
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;18.708
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;18.018
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;18.964
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;18.109
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.287
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;17.770
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;17.357
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.488
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;16.823
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;15.933
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,85
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,14
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,21
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,91
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,03
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,26
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,12
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,95
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,35
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,96
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.177
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.697
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.333
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;9.794
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;9.353
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;9.075
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.434
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.043
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.660
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.850
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.639
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.210
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;8.358
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;7.946
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
07 Castilla y León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,24
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,45
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,24
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,7
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,26
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,79
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,96
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,09
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,97
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,19
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,14
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;29.660
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;28.338
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;27.309
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;28.618
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;27.366
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;26.114
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.796
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;26.172
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;24.831
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;25.341
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;24.002
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;24.481
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;23.226
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,49
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,57
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,62
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,34
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,36
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,93
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,42
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,89
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,39
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,05
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;19.756
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.875
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.163
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;19.106
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.235
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.403
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.886
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.461
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.575
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;16.916
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;16.012
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;16.359
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;15.525
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,71
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,61
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,82
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,53
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,51
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,26
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,62
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,16
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,67
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,48
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.904
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.463
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.146
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.512
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.131
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.711
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.910
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.711
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.256
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;8.425
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;7.990
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;8.122
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;7.701
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,04
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,49
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,24
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,96
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,05
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,27
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,03
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,36
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,83
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,2
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.832
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;27.553
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;26.366
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;26.959
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;26.325
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;25.028
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;25.479
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;24.173
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;24.600
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;23.388
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;23.727
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.555
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,5
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,54
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,93
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,47
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,68
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,28
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,71
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,11
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,55
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;19.225
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.341
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;17.560
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.965
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.544
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;16.693
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;16.990
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;16.113
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;16.427
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;15.622
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.878
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.077
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,45
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,65
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,06
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,63
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,76
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,56
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,96
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,57
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,86
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.607
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.212
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.806
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.994
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.781
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.335
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;8.489
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;8.060
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;8.173
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;7.766
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.849
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.478
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,62
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,32
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,65
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,15
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,53
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,72
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,19
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,2
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,92
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
07 Castilla y León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;124.729
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;122.806
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;124.434
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;120.915
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;120.053
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;116.289
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;117.236
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;116.840
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;114.102
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;114.212
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;114.155
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;111.528
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;110.680
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;111.266
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;108.996
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,94
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,76
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,45
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,99
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,14
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,7
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,57
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,96
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,63
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,74
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,6
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,59
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;82.650
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;81.999
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;83.286
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;80.373
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;80.259
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;78.154
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;78.266
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;78.327
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;76.860
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;76.431
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;76.698
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;75.293
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;74.217
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;74.853
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;73.691
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,25
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,88
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,84
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,7
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,52
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,28
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,48
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,54
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,4
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,8
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,29
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,48
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;42.079
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;40.807
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;41.148
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;40.542
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;39.794
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;38.135
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;38.970
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;38.513
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;37.242
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;37.781
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;37.457
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;36.235
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;36.463
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;36.413
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;35.305
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,35
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,52
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,68
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,61
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,38
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,51
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,79
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,79
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,06
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,65
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,23
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,8
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;124.965
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;124.083
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;120.860
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;120.880
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;120.455
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;118.430
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;117.566
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;117.473
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;115.485
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;113.770
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;114.301
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;112.724
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;111.422
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;110.715
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,73
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,08
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,99
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,08
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,67
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,55
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,04
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,12
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,27
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,8
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,61
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;82.783
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;82.767
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;80.918
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;80.430
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;80.564
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;79.470
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;78.413
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;78.741
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;77.647
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;76.023
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;76.704
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;75.891
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;74.992
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;74.630
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,16
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,34
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,21
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,72
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,14
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,96
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,83
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,67
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,79
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,61
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,23
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;42.182
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;41.316
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;39.942
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;40.450
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;39.891
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;38.960
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;39.153
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;38.732
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;37.838
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;37.747
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;37.597
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;36.833
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;36.430
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;36.085
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,89
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,55
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,54
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,82
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,75
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,73
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,49
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,22
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,17
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,34
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;125.415
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;124.898
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;122.504
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;121.252
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;121.161
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;118.893
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;117.056
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;117.574
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;115.737
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;114.467
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;113.588
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;111.464
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;110.955
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,68
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,01
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,05
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,33
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,14
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,48
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,65
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,72
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,24
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,57
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;83.075
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;83.213
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;82.215
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;80.565
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;80.925
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;79.942
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;77.914
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;78.641
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;77.899
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;76.798
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;76.537
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;75.037
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;74.932
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,98
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,25
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,24
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,79
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,51
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,75
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,29
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,09
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,17
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,14
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;42.340
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;41.685
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;40.289
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;40.687
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;40.236
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;38.951
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;39.142
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;38.933
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;37.838
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;37.669
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;37.051
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;36.427
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;36.023
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,1
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,52
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,68
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,45
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,4
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,92
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,37
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,96
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,39
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,41
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;124.459
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;124.764
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;122.830
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;119.830
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;120.706
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;119.148
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;117.334
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;116.758
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;114.065
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;113.900
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;111.268
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;111.415
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,28
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,75
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,04
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,06
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,42
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,73
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,18
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,71
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;82.412
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;83.011
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;82.327
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;79.471
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;80.437
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;79.927
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;78.429
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;78.419
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;76.527
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;76.687
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;74.816
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;75.169
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,43
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,9
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,08
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,48
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,25
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,19
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,15
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,13
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,31
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;42.047
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;41.753
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;40.503
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;40.359
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;40.269
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;39.221
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;38.905
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;38.339
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;37.538
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;37.213
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;36.452
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;36.246
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,99
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,45
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,83
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,18
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,66
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,9
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,88
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,3
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,49
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.237
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.961
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.765
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;7.658
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;7.551
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.888
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.179
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;7.146
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.692
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.756
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.732
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.442
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.380
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.413
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.202
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,97
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,85
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,04
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,16
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,76
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,14
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,02
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,56
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,44
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,46
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,56
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;76,9
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.210
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.099
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.393
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;4.861
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.835
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.843
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.578
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.576
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.714
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.326
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.322
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.566
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.097
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.123
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.415
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,3
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,82
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,48
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,87
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;89,74
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,54
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;83,03
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,76
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,17
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,64
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;80,86
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,74
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.027
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.862
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.372
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;2.797
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.716
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.045
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.601
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.570
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.978
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.430
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.410
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.876
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.283
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.290
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.787
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,4
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,9
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,21
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,93
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,8
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,39
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,28
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;84,21
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,09
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,42
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;80,01
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,34
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.173
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.010
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.762
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;6.634
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;6.561
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;6.496
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.204
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.128
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.164
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.830
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.805
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.857
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;5.477
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;5.650
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,49
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,59
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,07
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,49
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,42
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,16
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,28
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,81
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,62
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;78,13
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,56
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.562
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.528
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.386
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;4.250
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;4.243
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;4.213
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.995
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.977
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.009
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.768
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.774
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.816
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.573
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.687
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,16
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,71
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,06
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,57
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,83
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,4
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,6
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,35
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,91
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,06
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.611
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.482
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.376
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.384
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.318
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.283
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.209
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.151
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.155
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.062
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.031
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.041
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.904
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.963
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,31
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,39
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,09
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,6
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,66
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,7
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;78,97
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,83
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;85,9
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,71
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,62
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.674
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.625
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.198
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.980
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.947
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.692
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.524
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.527
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.312
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;6.136
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;6.074
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;5.813
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.803
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,96
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,11
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,97
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,01
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,6
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,69
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,47
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,38
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,24
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,62
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.879
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.884
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.700
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.464
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.460
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.376
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.181
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.198
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.128
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.957
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.977
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.769
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.797
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,49
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,32
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,11
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,69
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,95
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,83
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,02
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,62
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,17
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,79
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.795
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.741
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.498
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.516
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.487
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.316
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.343
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.329
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.184
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.179
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.097
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.044
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;2.006
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,02
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,73
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,71
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,83
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,97
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,43
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,5
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,95
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,57
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;80,3
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;7.772
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.790
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.569
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.213
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.265
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.071
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;6.810
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.766
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.433
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;6.439
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.075
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.084
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,81
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,26
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,42
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,42
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,39
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,58
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,07
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,98
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,38
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.935
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.985
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.919
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.584
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.659
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.589
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.381
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;4.395
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;4.159
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;4.184
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.943
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.959
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,89
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,46
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,29
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,88
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,35
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,43
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,06
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;79,1
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;80,48
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.837
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.805
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.650
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.629
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.606
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.482
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.429
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.371
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.274
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.255
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.132
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.125
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,67
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,91
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,66
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,6
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,47
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,07
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,09
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;76,01
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;80,19
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.856
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;23.126
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;22.850
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;21.968
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;22.570
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;20.889
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;21.117
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;21.823
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;20.446
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.494
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;21.231
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.885
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;19.785
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;20.627
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;19.397
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,11
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,6
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,42
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,39
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,37
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,48
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,67
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,81
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,02
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,56
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,19
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,89
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;14.238
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.624
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.393
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;13.755
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;14.305
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;13.216
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;13.291
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;13.865
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;12.972
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;12.946
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;13.538
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.658
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.517
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.158
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;12.373
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,61
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,82
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,82
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,35
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,81
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,13
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,93
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,57
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,95
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,91
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,98
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,97
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.618
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.502
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.457
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;8.213
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;8.265
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;7.673
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;7.826
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;7.958
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;7.474
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.548
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.693
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.227
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.268
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.469
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.024
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,3
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,21
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,73
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,81
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,6
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,38
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,58
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,48
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,46
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;84,34
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,85
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,06
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;21.440
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;22.051
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;22.059
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;20.556
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;21.239
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;21.573
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.871
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;20.555
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;20.940
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.120
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.909
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;20.396
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;19.263
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;20.004
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,88
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,32
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,8
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,68
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,22
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,93
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,18
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,29
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,46
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,36
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,68
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;13.280
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.826
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.924
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;12.789
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;13.333
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;13.655
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.404
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.950
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.299
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.938
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.534
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.977
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;12.190
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;12.758
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,3
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,43
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,07
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,4
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,66
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,51
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,89
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,66
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,2
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,17
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,63
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;8.160
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.225
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.135
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;7.767
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;7.906
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;7.918
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.467
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.605
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.641
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.182
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.375
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.419
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;7.073
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;7.246
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,18
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,12
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,33
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,51
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,46
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,93
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,01
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,67
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,2
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,99
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,07
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;21.722
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;22.430
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;22.607
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.888
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;21.585
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;21.840
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;20.052
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;20.840
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.201
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;20.139
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;20.779
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;19.447
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;20.179
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,16
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,23
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,61
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,31
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,91
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,78
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,79
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,91
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,7
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,26
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.460
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;14.056
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;14.344
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.989
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;13.571
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;13.898
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.467
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.096
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.507
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;12.722
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;13.266
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;12.343
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;12.917
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,5
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,55
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,89
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,62
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,17
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,16
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,51
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,48
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,81
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,05
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.262
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.374
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.263
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.899
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.014
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.942
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.585
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.744
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.694
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;7.417
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;7.513
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;7.104
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;7.262
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,61
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,7
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,12
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,81
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,48
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,11
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,57
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,92
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,83
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,89
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;21.695
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;22.559
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.899
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.777
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;21.709
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;22.147
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;20.935
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;21.666
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;20.178
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;21.012
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;19.620
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;20.469
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,77
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,23
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,72
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,8
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,62
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,45
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,76
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,97
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,39
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.453
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;14.140
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;14.545
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.877
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;13.595
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.076
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;13.178
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;13.806
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;12.765
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;13.424
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.457
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;13.122
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,72
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,15
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,78
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,2
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,92
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,28
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,29
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,1
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,22
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.242
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.419
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.354
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.900
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;8.114
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.071
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;7.757
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;7.860
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;7.413
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;7.588
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.163
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.347
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,85
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,38
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,61
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,14
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,09
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,05
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,83
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,08
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,95
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;38.163
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;38.148
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;38.227
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;37.183
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;37.446
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;35.905
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;36.196
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;36.605
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;35.317
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;35.406
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;35.932
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;34.702
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;34.611
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;35.226
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;34.092
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,43
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,16
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,93
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,85
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,96
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,39
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,78
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,19
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,78
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,69
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,34
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,18
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;25.435
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;25.598
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;25.752
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;24.844
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;25.160
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;24.283
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;24.308
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;24.690
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;23.960
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;23.818
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;24.277
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;23.572
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.358
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.829
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;23.182
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,68
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,29
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,3
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,57
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,45
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,04
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,64
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,84
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,53
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,83
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,09
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,02
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;12.728
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;12.550
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.475
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;12.339
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;12.286
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;11.622
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;11.888
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;11.915
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;11.357
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.588
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.655
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;11.130
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;11.253
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;11.397
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.910
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,94
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,9
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,16
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,4
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,94
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,04
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,04
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,87
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,22
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,41
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,81
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,45
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;37.473
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;37.772
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;37.232
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;36.349
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;36.802
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;36.568
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;35.485
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;36.058
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;35.881
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;34.626
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;35.266
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;35.222
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;34.519
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;34.725
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,43
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,22
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,69
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,46
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,37
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,4
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,37
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,6
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,39
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,27
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;24.922
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;25.301
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;25.057
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;24.314
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;24.746
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;24.687
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;23.775
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;24.281
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;24.247
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;23.274
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;23.785
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;23.824
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;23.338
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;23.522
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,56
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,81
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,52
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,4
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,97
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,77
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,39
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,01
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,08
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,24
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,87
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.551
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.471
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;12.175
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;12.035
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;12.056
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;11.881
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.710
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.777
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;11.634
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;11.352
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;11.481
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.398
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;11.181
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;11.203
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,89
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,67
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,59
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,3
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,44
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,56
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,45
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,06
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,62
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,66
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,02
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;37.621
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;37.989
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;37.831
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;36.559
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;37.084
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;36.987
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;35.587
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;36.194
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;36.200
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;35.383
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;35.652
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;34.595
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;34.980
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,18
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,62
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,77
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,59
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,27
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,69
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,14
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,24
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,07
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,46
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;25.062
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;25.433
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;25.553
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;24.403
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;24.886
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;25.010
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;23.832
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.339
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;24.487
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;23.854
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;24.146
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;23.419
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;23.763
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,37
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,85
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,88
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,09
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,7
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,83
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,79
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,49
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,08
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,99
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.559
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.556
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.278
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.156
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.198
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;11.977
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.755
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.855
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.713
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;11.529
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;11.506
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;11.176
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;11.217
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,79
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,15
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,55
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,6
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,42
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,4
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,82
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,71
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,01
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,36
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;37.428
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;38.093
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;38.035
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;36.338
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;37.059
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;37.112
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;36.189
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;36.511
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;35.313
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;35.774
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;34.587
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;35.154
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,09
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,29
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,57
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,99
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,7
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,06
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,8
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,43
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;24.911
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;25.458
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;25.622
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;24.265
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;24.827
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;25.013
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;24.306
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;24.640
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;23.824
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;24.223
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;23.364
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.843
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,41
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,52
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,62
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,47
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,17
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,58
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,54
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,77
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,06
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.517
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.635
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.413
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.073
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.232
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;12.099
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;11.883
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;11.871
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;11.489
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;11.551
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;11.223
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.311
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,45
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,81
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,47
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,05
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,63
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,93
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,06
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,82
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,12
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;37.769
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;37.134
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;37.853
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;37.017
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;36.607
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;36.067
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;36.308
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;35.953
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;35.603
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;35.715
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;35.464
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;35.068
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;35.033
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;34.888
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;34.595
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,01
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,58
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,28
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,13
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,82
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,06
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,56
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,5
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,64
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,76
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,95
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,39
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;25.454
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;25.256
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;25.796
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;25.011
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;24.922
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;24.656
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;24.609
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;24.516
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;24.373
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;24.255
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;24.223
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;24.040
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.832
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.863
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;23.742
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,26
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,68
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,58
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,68
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,07
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,48
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,29
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,91
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,19
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,63
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,48
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,04
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;12.315
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;11.878
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.057
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;12.006
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;11.685
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;11.411
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;11.699
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;11.437
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;11.230
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.460
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;11.241
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;11.028
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;11.201
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;11.025
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.853
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,49
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,38
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,64
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,29
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,14
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,06
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,64
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,47
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,95
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,82
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,01
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;38.303
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;38.057
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;36.943
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;37.497
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;37.310
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;36.442
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;36.824
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;36.749
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;35.820
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;36.077
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;36.094
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;35.311
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;35.501
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;34.919
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,9
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,04
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,64
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,14
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,56
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,96
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,19
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,84
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,58
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,28
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,52
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;25.713
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;25.780
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;25.188
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;25.234
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;25.317
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;24.881
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;24.829
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;24.973
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;24.478
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;24.359
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;24.555
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;24.155
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;24.210
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;23.906
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,14
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,2
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,78
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,56
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,87
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,18
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,73
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,25
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,9
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,91
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,91
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.590
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.277
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.755
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;12.263
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;11.993
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;11.561
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.995
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.776
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;11.342
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;11.718
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;11.539
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.156
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;11.291
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;11.013
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,4
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,69
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,35
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,27
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,92
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,49
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,07
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,99
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,9
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,97
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,69
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;38.316
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;38.047
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;37.279
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;37.464
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;37.358
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;36.514
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;36.628
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;36.622
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;35.936
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;35.995
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;35.520
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;35.409
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;34.963
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,78
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,19
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,95
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,59
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,25
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,4
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,61
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,28
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,07
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,79
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;25.704
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;25.761
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;25.423
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;25.197
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;25.332
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;24.923
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;24.669
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.862
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;24.558
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;24.500
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;24.293
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;24.145
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;23.940
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,03
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,33
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,03
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,97
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,51
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,6
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,11
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,56
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,73
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,17
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.612
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.286
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.856
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;12.267
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.026
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;11.591
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.959
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.760
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.378
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;11.495
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;11.227
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;11.264
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;11.023
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,26
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,88
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,76
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,82
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,72
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,97
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,56
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,69
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,68
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,97
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;38.020
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;37.952
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;37.238
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;37.093
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;37.136
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;36.545
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;36.457
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;36.084
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;35.826
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;35.491
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;35.262
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;35.033
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,56
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,85
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,14
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,06
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,9
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,4
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,31
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,91
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,08
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;25.502
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;25.648
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;25.360
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;24.906
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;25.131
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;24.913
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;24.735
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;24.619
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;24.362
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;24.244
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;24.026
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.971
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,66
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,98
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,24
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,44
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,08
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,99
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,6
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,68
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,52
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.518
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.304
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;11.878
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.187
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.005
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;11.632
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;11.722
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;11.465
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;11.464
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;11.247
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;11.236
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.062
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,36
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,57
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,93
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,27
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,52
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,17
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,69
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,32
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,13
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;17.704
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;16.437
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.739
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;17.089
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;15.879
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;17.540
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;16.436
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;15.313
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;17.044
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.841
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;14.796
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;16.431
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;14.871
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;14.112
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.710
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,53
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,61
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,6
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,84
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,16
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,95
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,48
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,02
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,68
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,86
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,84
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.313
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.422
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.952
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;11.902
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;11.037
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;12.156
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;11.480
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;10.680
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;11.841
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.086
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.338
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.457
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.413
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.880
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;10.979
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,66
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,63
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,85
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,23
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,5
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,42
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,03
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,51
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,46
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,57
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,5
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,77
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.391
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.015
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.787
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;5.187
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;4.842
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;5.384
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;4.956
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;4.633
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;5.203
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.755
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.458
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.974
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.458
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.232
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.731
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,22
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,55
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,04
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,93
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,38
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,91
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,2
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,89
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,95
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,69
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,39
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,75
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.576
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.193
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.864
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;19.844
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;18.543
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;17.351
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.182
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.983
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.680
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;18.117
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.227
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.938
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;16.662
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;15.417
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,44
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,61
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,13
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,23
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,7
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,37
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,05
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,76
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,22
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,81
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,3
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;14.306
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.332
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.363
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;13.843
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;12.925
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;12.034
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.410
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.560
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.614
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.684
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.056
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.119
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;11.681
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;10.757
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,76
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,95
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,34
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,74
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,21
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,94
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,66
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,43
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,94
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,62
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,01
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.270
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;5.861
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.501
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;6.001
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;5.618
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;5.317
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;5.772
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.423
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.066
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.433
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.171
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.819
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;4.981
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;4.660
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,71
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,85
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,66
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,06
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,53
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,09
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,65
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,23
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,6
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,99
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,71
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.082
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.807
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.589
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.361
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.187
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;16.860
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.265
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.391
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.088
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;16.814
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;15.563
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;16.200
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;15.030
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,41
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,7
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,86
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,95
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,47
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,47
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,4
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,48
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,14
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,45
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.970
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.079
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.195
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.512
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.676
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.735
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.765
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.146
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.219
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;11.765
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;10.855
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;11.361
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;10.515
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,72
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,92
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,23
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,37
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,87
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,95
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,01
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,86
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,22
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.112
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.728
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.394
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;5.849
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;5.511
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.125
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.500
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.245
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.869
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;5.049
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;4.708
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;4.839
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;4.515
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,7
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,21
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,01
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,99
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,57
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,27
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,15
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,28
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,48
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,7
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;19.544
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.370
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.089
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.409
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.537
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;16.273
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;16.943
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;15.731
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;16.315
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;15.184
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.724
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;14.675
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,19
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,47
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,22
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,23
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,05
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,81
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,85
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,6
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,87
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.611
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.780
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;11.881
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.839
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.225
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.336
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;11.829
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;10.959
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;11.417
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;10.612
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.026
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;10.274
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,33
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,66
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,41
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,56
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,24
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,33
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,32
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,28
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,47
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.933
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.590
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.208
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;5.570
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;5.312
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.937
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;5.114
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;4.772
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;4.898
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;4.572
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.698
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.401
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,88
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,03
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,8
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,48
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,63
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,62
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,79
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,04
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,5
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
08 Castilla - La Mancha;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;530.248
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;520.114
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;525.883
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;510.771
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;505.736
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;493.132
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;493.138
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;490.757
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;482.682
09 Cataluña;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;478.545
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;477.311
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;469.214
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;461.391
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;462.223
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;455.426
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,33
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,24
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,77
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,36
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,79
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,25
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,77
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,22
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,01
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,87
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,6
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;335.530
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;331.613
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;334.548
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;323.669
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;322.544
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;315.044
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;313.211
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;313.305
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;309.022
09 Cataluña;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;304.589
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;305.052
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;301.032
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;294.091
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;295.656
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;292.658
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,46
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,27
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,17
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,35
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,48
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,37
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,78
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,99
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,98
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,65
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,16
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,48
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;194.718
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;188.501
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;191.335
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;187.102
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;183.192
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;178.088
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;179.927
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;177.452
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;173.660
09 Cataluña;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;173.956
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;172.259
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;168.182
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;167.300
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;166.567
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;162.768
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,09
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,18
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,08
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,4
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,14
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,76
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,34
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,38
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,9
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,92
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,36
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,07
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;531.849
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;526.881
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;516.864
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;512.126
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;509.704
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;504.939
09 Cataluña;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;496.062
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;494.583
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;489.097
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;477.261
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;477.934
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;473.764
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;463.344
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;462.996
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Cataluña;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,29
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,74
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,69
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,27
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,87
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,63
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,74
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,71
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,66
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,94
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,58
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;336.235
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;335.311
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;329.523
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;324.463
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;324.628
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;322.569
09 Cataluña;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;314.979
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;315.306
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;313.066
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;303.536
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;304.994
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;303.749
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;296.060
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;296.953
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Cataluña;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,81
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,89
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,68
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,03
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,01
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,27
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,96
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,18
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,29
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,12
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;195.614
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;191.570
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;187.341
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;187.663
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;185.076
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;182.370
09 Cataluña;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;181.083
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;179.277
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;176.031
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;173.725
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;172.940
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;170.015
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;167.284
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;166.043
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Cataluña;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,94
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,61
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,35
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,57
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,58
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,96
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,81
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,28
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,75
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,32
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,63
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;534.057
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;532.016
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;519.304
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;514.757
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;513.686
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;501.099
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;493.264
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;494.708
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;484.364
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;478.791
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;472.996
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;464.248
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;460.999
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,39
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,55
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,49
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,36
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,99
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,27
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,08
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,26
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,77
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;337.262
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;337.809
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;331.547
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;325.914
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;326.572
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;320.655
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;312.910
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;314.881
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;310.462
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;305.146
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;303.270
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;296.445
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;295.857
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,64
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,67
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,71
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,78
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,21
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,64
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,33
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,47
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,76
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,24
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;196.795
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;194.207
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;187.757
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;188.843
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;187.114
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;180.444
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;180.354
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;179.827
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;173.902
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;173.645
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;169.726
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;167.803
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;165.142
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,96
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,35
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,11
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,65
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,6
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,62
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,41
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,4
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,4
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,96
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;531.534
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;530.674
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;519.209
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;508.083
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;509.803
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;500.276
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;492.563
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;487.848
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;476.851
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;474.658
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;463.505
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;462.584
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,59
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,07
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,35
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,82
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,96
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,86
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,42
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,34
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,09
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;335.701
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;336.610
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;331.497
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;321.512
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;323.760
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;319.966
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;313.248
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;312.120
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;303.882
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;303.991
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;295.968
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;296.513
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,77
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,18
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,52
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,06
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,15
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,28
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,7
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,93
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,45
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;195.833
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;194.064
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;187.712
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;186.571
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;186.043
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;180.310
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;179.315
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;175.728
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;172.969
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;170.667
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;167.537
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;166.071
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,27
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,87
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,06
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,4
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,62
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,13
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,92
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,33
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,47
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;36.596
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;34.467
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.274
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;33.500
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;32.332
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;24.565
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;31.001
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;30.107
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;23.573
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;28.880
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;28.056
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.136
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;26.805
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;26.142
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;20.789
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,54
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,81
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,88
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,71
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,35
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,37
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;78,92
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,4
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,29
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;73,25
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;75,85
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,53
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;22.612
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;21.748
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;17.925
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;20.729
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;20.406
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;15.644
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;19.273
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;19.024
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;15.043
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;18.030
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.739
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.197
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.826
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.539
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.378
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,67
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,83
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,27
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,23
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,47
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,92
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,74
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,57
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,2
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,41
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,05
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;74,63
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;13.984
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;12.719
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;10.349
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;12.771
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;11.926
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;8.921
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;11.728
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;11.083
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;8.530
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;10.850
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;10.317
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.939
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.979
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.603
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.411
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,33
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,77
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,2
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;83,87
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,14
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,42
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;77,59
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,11
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,71
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;71,36
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,5
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,61
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;32.234
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;31.403
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;28.585
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;29.572
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;28.870
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;27.294
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;27.401
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;26.599
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;25.471
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.265
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;24.559
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;23.797
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;22.733
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;22.600
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,74
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,93
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,48
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,01
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;84,7
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,11
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,38
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;78,21
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,25
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;72,39
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,06
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;20.025
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;19.889
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.061
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;18.447
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;18.286
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;17.266
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.165
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.867
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;16.199
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.913
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.598
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;15.184
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;14.459
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;14.436
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,12
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,94
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,6
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,72
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;84,81
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,69
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,47
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;78,43
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,07
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;72,7
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;79,93
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.209
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;11.514
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;10.524
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;11.125
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;10.584
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;10.028
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;10.236
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.732
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;9.272
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.352
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.961
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.613
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;8.274
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;8.164
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Cataluña;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,12
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,92
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,29
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,84
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,52
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,1
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,6
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,83
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;81,84
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;71,86
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;77,58
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;34.060
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;33.744
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;30.084
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;31.149
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;30.700
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.722
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;28.539
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;28.179
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;25.782
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;26.014
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;24.423
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;24.276
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;23.045
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,45
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,98
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,15
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,79
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,51
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,7
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;77,09
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,18
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;71,94
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,6
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;21.168
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;21.207
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;19.075
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;19.447
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;19.300
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.677
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.903
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.751
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.473
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;16.412
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;15.624
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;15.385
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;14.767
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,87
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,01
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,67
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,58
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;83,7
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,36
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;77,39
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,91
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;72,55
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,42
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.892
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.537
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.009
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;11.702
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;11.400
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.045
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;10.636
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.428
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;9.309
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;9.602
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;8.799
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;8.891
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;8.278
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,77
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,93
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,24
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,5
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,18
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;84,56
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,59
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;79,93
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;70,92
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,19
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;35.089
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;34.668
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;32.064
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;32.003
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;31.703
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;29.615
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;29.177
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;27.988
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;27.144
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;26.273
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.344
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;24.623
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,21
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,45
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,36
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,16
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,29
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;78,3
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,94
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,1
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;76,79
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;21.772
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;21.603
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;20.332
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;19.935
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;19.781
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.813
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;18.241
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;17.809
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;17.060
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;16.745
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.999
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.697
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,56
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;91,57
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,53
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;84,44
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,59
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;78,97
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,36
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;74,06
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,2
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;13.317
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;13.065
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;11.732
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;12.068
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;11.922
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.802
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;10.936
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;10.179
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;10.084
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;9.528
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.345
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.926
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,62
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,25
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,07
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;83,7
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,76
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;77,18
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,21
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;71,53
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,08
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;93.563
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;93.881
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;91.102
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;89.021
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;90.643
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;83.748
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;84.993
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;87.124
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;81.512
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;81.751
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;84.028
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;78.504
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;78.185
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;80.825
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;75.718
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,15
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,55
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,93
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,84
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,8
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,47
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,38
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,5
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,17
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,56
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,09
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,11
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;56.703
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;57.612
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;55.673
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;54.083
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;55.666
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;51.535
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;51.803
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;53.485
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;50.334
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;49.979
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;51.681
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;48.611
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;47.848
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;49.792
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;46.983
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,38
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,62
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,57
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,36
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,84
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,41
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,14
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,71
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,32
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,38
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,43
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,39
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;36.860
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;36.269
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;35.429
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;34.938
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;34.977
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;32.213
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;33.190
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;33.639
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;31.178
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;31.772
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;32.347
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;29.893
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;30.337
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;31.033
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;28.735
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,79
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,44
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,92
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,04
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,75
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,2
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,19
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,37
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,3
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,56
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,11
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;88.731
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;89.534
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;90.116
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;84.242
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;85.512
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;87.508
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;80.694
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;82.046
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;84.076
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;76.730
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;78.542
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;80.838
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;75.366
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;78.562
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,94
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,51
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,11
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,94
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,64
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,3
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,47
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,72
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,7
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,18
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,18
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;53.402
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;54.521
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;55.237
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;50.826
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;52.028
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;53.830
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;48.846
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;49.978
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;51.860
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;46.538
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;47.934
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;49.959
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;46.090
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;48.590
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,18
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,43
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,45
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,47
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,67
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,89
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,15
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;87,92
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,44
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,54
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,97
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;35.329
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;35.013
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;34.879
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;33.416
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;33.484
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;33.678
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;31.848
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;32.068
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;32.216
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;30.192
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;30.608
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;30.879
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;29.276
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;29.972
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Cataluña;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,59
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,63
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,56
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,15
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,59
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,37
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,46
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,42
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,53
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,61
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,93
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;90.239
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;91.566
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;91.240
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;85.977
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;87.397
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;87.310
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;81.411
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;83.357
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;83.732
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;79.779
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;81.298
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;76.604
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;78.589
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,28
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,45
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,69
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,22
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,03
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,77
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,13
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,1
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;83,66
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,13
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;54.271
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;55.538
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;56.097
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;51.897
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;53.086
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;53.851
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;49.238
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;50.733
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;51.743
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;48.662
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;50.271
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;46.854
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;48.604
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,63
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,59
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,73
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,35
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,24
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,62
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,61
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,36
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,64
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;35.968
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;36.028
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;35.143
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;34.080
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;34.311
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;33.459
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;32.173
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;32.624
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;31.989
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;31.117
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;31.027
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;29.750
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;29.985
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,75
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,23
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,21
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,45
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,55
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,03
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,37
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,29
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,57
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,32
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;90.750
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;92.362
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;92.347
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;85.691
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;87.851
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;88.216
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;83.878
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;85.480
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;80.366
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;82.434
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;77.459
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;79.713
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,43
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,12
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,53
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;90,81
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,56
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,01
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,27
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,86
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,32
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;54.655
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;56.016
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;56.801
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;51.711
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;53.400
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;54.363
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;51.108
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;52.708
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;49.112
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;50.830
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;47.476
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;49.218
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,61
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,33
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,71
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,24
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,79
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,67
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,49
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,75
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,65
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;36.095
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;36.346
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;35.546
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;33.980
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;34.451
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;33.853
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;32.770
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;32.772
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;31.254
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;31.604
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;29.983
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;30.495
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,14
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,79
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,24
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,16
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,2
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,99
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,91
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,49
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,79
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;165.868
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;165.484
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;166.290
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;160.475
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;161.762
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;156.638
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;155.691
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;157.813
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;153.813
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;151.906
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;154.343
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;150.154
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;147.538
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;150.359
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;146.453
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,75
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,75
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,2
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,86
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,36
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,5
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,58
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,27
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,3
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,95
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,86
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,07
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;106.293
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;107.185
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;107.452
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;102.985
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;104.802
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;101.724
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;100.096
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;102.330
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;100.119
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;97.856
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;100.171
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;97.924
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;95.153
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;97.629
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;95.648
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,89
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,78
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,67
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,17
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,47
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,18
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,06
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,46
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,13
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,52
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,08
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,01
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;59.575
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;58.299
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;58.838
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;57.490
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;56.960
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;54.914
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;55.595
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;55.483
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;53.694
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;54.050
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;54.172
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;52.230
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;52.385
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;52.730
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;50.805
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,5
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,7
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,33
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,32
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,17
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,26
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,73
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,92
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,77
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,93
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,45
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,35
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;161.572
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;163.804
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;163.329
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;156.225
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;159.211
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;160.102
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;151.999
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;155.262
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;155.976
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;147.208
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;150.857
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;151.872
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;146.816
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;149.147
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,69
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,2
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,02
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,08
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,79
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,5
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,11
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,1
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,99
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,63
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,32
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;103.326
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;105.719
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;105.854
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;100.087
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;102.816
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;103.985
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;97.587
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;100.352
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;101.494
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;94.626
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;97.546
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;98.978
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;95.071
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;97.230
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,87
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,25
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,23
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,45
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,92
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,88
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,58
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,27
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,5
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,93
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,85
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;58.246
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;58.085
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;57.475
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;56.138
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;56.395
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;56.117
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;54.412
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;54.910
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;54.482
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;52.582
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;53.311
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;52.894
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;51.745
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;51.917
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Cataluña;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,38
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,09
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,64
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,42
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,53
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,79
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,28
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,78
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,03
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,08
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,33
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;162.539
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;165.716
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;164.523
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;157.415
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;160.889
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;159.717
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;151.856
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;155.851
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;155.226
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;151.448
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;152.333
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;147.499
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;149.184
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,85
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,09
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,08
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,43
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,05
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,35
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,39
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,59
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,01
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,68
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;103.797
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;106.708
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;106.766
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;100.762
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;103.704
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;103.854
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;97.350
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;100.504
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;101.101
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;97.806
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;99.238
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;95.401
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;97.263
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,08
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,18
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,27
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,79
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,19
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,69
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,66
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,95
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,4
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,1
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;58.742
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;59.008
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;57.757
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;56.653
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;57.185
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;55.863
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;54.506
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;55.347
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;54.125
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;53.642
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;53.095
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;52.098
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;51.921
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,44
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,91
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,72
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,79
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,8
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,71
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,91
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,93
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,29
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,9
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;162.070
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;165.684
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;164.933
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;155.958
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;160.102
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;159.827
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;155.348
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;156.641
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;151.096
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;153.185
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;147.645
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;150.064
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,23
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,63
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,9
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,76
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,97
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,2
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,88
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,11
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,98
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;103.465
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;106.573
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;106.989
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;99.716
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;103.032
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;103.873
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;100.108
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;101.824
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;97.519
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;99.665
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;95.468
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;97.704
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,38
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,68
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,09
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,93
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,17
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,5
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,15
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,58
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,32
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;58.605
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;59.111
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;57.944
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;56.242
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;57.070
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;55.954
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;55.240
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;54.817
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;53.577
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;53.520
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;52.177
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;52.360
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,97
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,55
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,57
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,45
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,6
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,64
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,37
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,27
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,36
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;153.664
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;149.453
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;152.480
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;150.222
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;146.833
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;145.881
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;146.891
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;144.205
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;143.895
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;144.191
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;141.902
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;141.472
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;141.122
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;139.224
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;138.968
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,76
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,67
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,59
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,49
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,37
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,84
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,95
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,78
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,84
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,16
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,14
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;98.262
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;95.768
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;97.498
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;96.118
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;94.096
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;93.517
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;94.127
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;92.530
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;92.372
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;92.488
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;91.079
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;90.963
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;90.672
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;89.392
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;89.436
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,82
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,25
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,92
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,79
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,62
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,74
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,12
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,1
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,3
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,28
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,34
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,73
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;55.402
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;53.685
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;54.982
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;54.104
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;52.737
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;52.364
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;52.764
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;51.675
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;51.523
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;51.703
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;50.823
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;50.509
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;50.450
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;49.832
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;49.532
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,66
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,23
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,24
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,24
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,26
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,71
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,32
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,67
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,86
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,06
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,82
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,09
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;157.760
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;154.444
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;150.292
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;153.857
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;151.378
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;148.043
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;150.764
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;148.738
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;145.145
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;147.285
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;145.667
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;142.395
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;142.894
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;140.318
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,53
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,01
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,5
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,57
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,31
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,58
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,36
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,32
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,75
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,52
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,36
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100.779
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;98.999
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;96.269
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;98.456
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;97.144
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;94.957
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;96.579
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;95.473
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;93.231
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;94.516
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;93.549
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;91.544
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;91.832
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;90.226
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,69
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,13
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,64
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,83
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,44
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,84
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,79
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,49
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,09
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,76
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,72
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;56.981
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;55.445
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;54.023
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;55.401
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;54.234
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;53.086
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;54.185
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;53.265
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;51.914
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;52.769
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;52.118
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;50.851
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;51.062
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;50.092
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Cataluña;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,23
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,82
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,27
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,09
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,07
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,1
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,61
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,13
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,09
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,72
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;157.657
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;154.980
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;150.595
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;153.968
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;151.778
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;147.265
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;149.951
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;148.265
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;144.239
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;145.332
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;142.073
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;142.474
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;139.844
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,66
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,93
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,79
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,11
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,67
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,78
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,77
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,34
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,93
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,86
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100.650
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;99.292
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;96.554
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;98.420
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;97.291
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;94.582
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;96.058
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;95.101
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;92.721
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;93.273
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;91.343
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;91.547
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;89.995
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,78
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,98
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,96
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,44
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,78
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,03
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,94
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,6
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,2
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,21
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;57.007
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;55.688
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;54.041
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;55.548
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;54.487
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;52.683
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;53.893
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;53.164
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;51.518
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;52.059
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;50.730
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;50.927
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;49.849
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,44
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,84
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,49
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,54
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,47
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,33
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,48
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,87
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,45
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;92,24
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;156.582
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;154.312
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;149.934
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;152.243
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;150.493
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;146.556
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;147.391
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;144.239
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;144.353
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;141.854
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;141.859
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;139.751
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,23
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,53
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,75
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,51
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,2
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,55
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,61
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,93
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,21
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;99.945
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;98.795
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;96.152
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;97.388
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;96.411
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;94.074
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;94.485
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;92.599
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;92.653
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;91.170
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;91.134
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;89.835
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,44
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,59
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,84
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,64
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,3
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,78
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,82
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,25
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,43
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;56.637
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;55.517
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;53.782
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;54.855
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;54.082
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;52.482
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;52.906
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;51.640
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;51.700
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;50.684
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;50.725
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;49.916
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,85
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,42
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,58
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,3
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,02
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,12
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,24
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,37
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,81
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;80.557
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;76.829
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;87.737
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;77.553
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;74.166
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;82.300
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;74.562
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;71.508
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;79.889
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;71.817
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;68.982
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;76.948
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;67.741
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;65.673
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;73.498
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,27
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,53
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,8
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,56
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,07
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,06
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,15
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,79
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,7
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,09
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,48
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,77
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;51.660
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;49.300
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;56.000
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;49.754
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;47.574
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;52.624
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;47.912
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;45.936
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;51.154
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;46.236
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;44.382
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;49.337
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;43.592
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;42.304
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;47.213
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,31
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,5
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,97
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,74
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,18
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,35
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,5
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,02
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,1
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,38
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,81
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,31
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;28.897
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;27.529
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;31.737
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;27.799
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;26.592
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;29.676
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;26.650
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;25.572
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;28.735
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;25.581
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;24.600
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;27.611
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;24.149
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;23.369
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;26.285
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,2
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,6
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,51
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,22
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,89
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,54
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,52
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,36
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,57
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,89
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,82
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;91.552
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;87.696
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;84.542
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;88.230
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;84.733
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;81.992
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;85.204
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;81.938
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;78.429
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;80.773
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;78.309
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;74.862
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;75.535
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;72.369
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
09 Cataluña;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,37
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,62
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,98
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,07
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,43
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,77
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,23
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,3
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,55
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,13
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,6
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;58.703
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;56.183
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;54.102
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;56.647
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;54.354
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;52.531
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;54.802
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;52.636
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;50.282
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;51.943
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;50.367
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;48.084
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;48.608
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;46.471
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
09 Cataluña;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,74
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,1
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,35
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,69
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,94
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,48
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,65
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,88
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,52
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,9
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;32.849
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;31.513
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;30.440
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;31.583
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;30.379
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;29.461
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;30.402
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;29.302
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;28.147
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;28.830
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.942
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;26.778
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;26.927
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;25.898
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
09 Cataluña;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,15
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,4
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,78
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,55
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,98
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,47
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,77
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,67
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87,97
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,45
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,08
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;89.562
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;86.010
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;82.862
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;86.248
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;82.922
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;79.085
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;81.507
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;79.056
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;75.385
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;76.218
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;72.869
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;73.395
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;70.337
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,3
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,41
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,44
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,01
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,91
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,98
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,62
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,94
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,33
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,88
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;57.376
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;55.064
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;53.055
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;55.388
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;53.191
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;50.691
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;52.361
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;50.792
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;48.424
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;48.993
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;46.794
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;47.258
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;45.228
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,54
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,6
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,54
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,26
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,24
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,27
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,97
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,2
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,82
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,25
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;32.186
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;30.946
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;29.807
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;30.860
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;29.731
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;28.394
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;29.146
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;28.264
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;26.961
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;27.225
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;26.075
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;26.137
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;25.109
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,88
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,07
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,26
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,55
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,33
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,45
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,98
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,48
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,46
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,24
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;87.043
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;83.648
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;79.931
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;82.188
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;79.654
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;76.062
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;76.769
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;73.500
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;73.892
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;70.912
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;71.198
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;68.433
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,42
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,23
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,16
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,78
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,95
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,34
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,72
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,12
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,62
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;55.864
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;53.623
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;51.223
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;52.762
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;51.136
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;48.843
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;49.306
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;47.180
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;47.538
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;45.581
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;45.891
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;44.059
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,45
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,36
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,35
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,95
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,11
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,65
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,99
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,58
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,01
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;31.179
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;30.025
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;28.708
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;29.426
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;28.518
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;27.219
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;27.463
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;26.320
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;26.354
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;25.331
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;25.307
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;24.374
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,38
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,98
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,81
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,47
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,68
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,77
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,24
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,29
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,9
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
09 Cataluña;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;341.580
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;334.968
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;338.396
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;329.460
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;325.195
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;315.678
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;317.980
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;315.206
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;308.767
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;308.262
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;306.398
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;299.680
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;297.526
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;297.076
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;290.183
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,45
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,08
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,29
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,09
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,1
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,24
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,25
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,47
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,56
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,1
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,69
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,75
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;215.043
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;211.917
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;213.745
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;207.799
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;205.911
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;200.454
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;201.217
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;199.993
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;196.416
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;195.563
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;194.740
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;191.104
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;189.050
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;189.157
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;185.468
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,63
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,17
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,78
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,57
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,37
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,89
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,94
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,89
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,41
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,91
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,26
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,77
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;126.537
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;123.051
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;124.651
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;121.661
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;119.284
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;115.224
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;116.763
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;115.213
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;112.351
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;112.699
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;111.658
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;108.576
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;108.476
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;107.919
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;104.715
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,15
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,94
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,44
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,28
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,63
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,13
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,06
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,74
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,1
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,73
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,7
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,01
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;343.584
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;338.395
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;331.642
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;330.729
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;327.108
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;323.882
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;319.965
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;317.248
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;313.358
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;308.115
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;306.907
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;302.721
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;297.837
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;295.568
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,26
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,66
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,66
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,13
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,75
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,49
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,68
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,69
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,28
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,01
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,12
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;216.045
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;213.820
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;209.854
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;208.665
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;207.087
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;205.320
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;202.374
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;201.180
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;199.124
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;195.216
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;195.011
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;192.790
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;189.626
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;188.426
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,58
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,85
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,84
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,67
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,09
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,89
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,36
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,2
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,87
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,68
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,79
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;127.539
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;124.575
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;121.788
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;122.064
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;120.021
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;118.562
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;117.591
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;116.068
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;114.234
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;112.899
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;111.896
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;109.931
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;108.211
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;107.142
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,71
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,34
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,35
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,2
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,17
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,8
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,52
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,82
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,26
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,86
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,97
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;345.358
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;341.840
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;335.283
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;332.210
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;329.648
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;322.852
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;318.870
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;317.833
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;311.071
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;307.918
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;303.411
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;298.700
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;295.530
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,19
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,43
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,29
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,33
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,98
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,78
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,08
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,49
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,38
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,14
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;217.082
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;215.631
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;212.483
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;209.400
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;208.364
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;205.088
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;201.381
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;201.378
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;198.038
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;195.494
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;193.361
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;190.169
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;188.699
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,46
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,63
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,52
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,77
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,39
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,2
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,66
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,19
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,81
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;128.276
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;126.209
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;122.800
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;122.810
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;121.284
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;117.764
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;117.489
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;116.455
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;113.033
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;112.424
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;110.050
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;108.531
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;106.831
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,74
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,1
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,9
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,59
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,27
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,05
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,08
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,62
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,99
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;343.669
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;341.388
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;335.420
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;329.076
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;328.123
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;322.026
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;317.404
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;313.546
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;307.278
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;304.819
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;298.407
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;296.886
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,75
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,11
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,01
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,97
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,48
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,01
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,88
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,41
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,51
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;216.024
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;215.129
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;212.426
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;207.253
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;207.269
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;204.410
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;200.902
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;199.238
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;195.077
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;194.088
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;189.902
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;189.350
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,94
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,35
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,23
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,39
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,79
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,68
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,37
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,27
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,14
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;127.645
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;126.259
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;122.994
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;121.823
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;120.854
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;117.616
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;116.502
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;114.308
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;112.201
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;110.731
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;108.505
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;107.536
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,44
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,72
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,63
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,27
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,94
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,87
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,03
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,94
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,43
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.652
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;21.613
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;17.846
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;20.920
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;20.246
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;15.435
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;19.371
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;18.896
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;14.841
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;18.105
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.655
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;14.018
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;16.873
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.563
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;13.170
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,35
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,68
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,49
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,52
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;87,43
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;83,16
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,93
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,69
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;78,55
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,49
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,63
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,8
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;13.916
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;13.312
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;11.023
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;12.878
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;12.456
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;9.603
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;11.982
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;11.658
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;9.253
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.237
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.950
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;8.774
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;10.475
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;10.277
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;8.277
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,54
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,57
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,12
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,1
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,58
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;83,94
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,75
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;82,26
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,6
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,27
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;77,2
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,09
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;8.736
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.301
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.823
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;8.042
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;7.790
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;5.832
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;7.389
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;7.238
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;5.588
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.868
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.705
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.244
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.398
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.286
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.893
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,06
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,84
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,48
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;84,58
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,19
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;81,9
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;78,62
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,77
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;76,86
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,24
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,73
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;71,71
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.330
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.368
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.025
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;18.669
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;17.827
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;17.240
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;17.325
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.481
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.170
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.989
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.342
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.105
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;14.333
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;14.361
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,83
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,04
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,64
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,22
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,09
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,71
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,65
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,21
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,8
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,67
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.540
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;11.981
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;11.197
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;11.561
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;11.047
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;10.726
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;10.786
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;10.271
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.094
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;9.956
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;9.582
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;9.456
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;8.974
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;8.981
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,19
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,2
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,79
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,01
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,73
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,15
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,39
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,98
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,45
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,9
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,21
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.790
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.387
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.828
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;7.108
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;6.780
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;6.514
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.539
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.210
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.076
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.033
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.760
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.649
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;5.359
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;5.380
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,25
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,78
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,4
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,94
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,07
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,99
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,45
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;77,97
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;82,73
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,55
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;78,79
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;21.611
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.889
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;19.276
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;19.754
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.979
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.754
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.147
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.535
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.479
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;16.308
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;15.622
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;15.212
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;14.756
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,41
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;90,86
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,1
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,97
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;83,94
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,49
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;78,07
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;81,04
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;72,82
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;76,55
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;13.386
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.895
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.037
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.283
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;11.764
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;11.098
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.289
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;10.916
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.322
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;10.178
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;9.777
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;9.554
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;9.275
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,76
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,23
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,2
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,33
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,65
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,75
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,93
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,22
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;74,09
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;77,05
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.225
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.994
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.239
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.471
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.215
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.656
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.858
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.619
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.157
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;6.130
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;5.845
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;5.658
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;5.481
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,83
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,26
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,95
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,38
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;82,8
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;85,05
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,68
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;80,74
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;70,78
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;75,71
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;22.195
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;21.512
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.364
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;20.305
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;19.738
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.737
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;18.317
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;17.694
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;17.032
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;16.635
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.990
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.651
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,48
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,75
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,01
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,15
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;86,89
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;79,17
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,69
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;74,33
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;76,86
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;13.718
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;13.239
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.627
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.559
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.190
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.634
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;11.349
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;10.986
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;10.609
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;10.365
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;9.997
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.789
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,55
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,08
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,14
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,72
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,13
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,09
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,51
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,52
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.477
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.273
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.737
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.746
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.548
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.103
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;6.968
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;6.708
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;6.423
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;6.270
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.993
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.862
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,38
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;91,24
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;91,81
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,23
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;86,7
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;77,64
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,04
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;72,44
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;75,77
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;62.078
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;62.351
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;60.543
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;59.289
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;60.240
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;55.705
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;56.736
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;58.037
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;54.340
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;54.654
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;56.139
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;52.433
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;52.576
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;54.178
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;50.466
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,51
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,61
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,01
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,39
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,08
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,75
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,04
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,04
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,6
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,69
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,89
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,36
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;36.772
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;37.463
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;36.180
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;35.166
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;36.221
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;33.531
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;33.755
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;34.964
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;32.774
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;32.605
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;33.888
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;31.717
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;31.443
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;32.742
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;30.615
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,63
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,68
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,68
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,8
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,33
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,59
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,67
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,46
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,66
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,51
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,4
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,62
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;25.306
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;24.888
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;24.363
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;24.123
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;24.019
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;22.174
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;22.981
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;23.073
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;21.566
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;22.049
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;22.251
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;20.716
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;21.133
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;21.436
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;19.851
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,33
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,51
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,02
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,81
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,71
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,52
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,13
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,4
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,03
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,51
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,13
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,48
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;58.429
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;59.185
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;59.861
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;55.645
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;56.723
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;58.286
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;53.426
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;54.611
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;56.040
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;51.168
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;52.475
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;53.779
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;50.486
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;52.294
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,24
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,84
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,37
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,44
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,27
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,62
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,57
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,66
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,84
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,3
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,36
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;34.417
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;35.250
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;35.895
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;32.866
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;33.855
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;35.026
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;31.618
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;32.640
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;33.780
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;30.370
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;31.404
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;32.502
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;30.273
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;31.637
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,49
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,04
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,58
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,87
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,6
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,11
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,24
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,09
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,55
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,88
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;88,14
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;24.012
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;23.935
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;23.966
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;22.779
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;22.868
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;23.260
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;21.808
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;21.971
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;22.260
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.798
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;21.071
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;21.277
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;20.213
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;20.657
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,87
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,54
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,05
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,82
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,79
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,88
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,62
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,03
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,78
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,45
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,19
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;59.453
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;60.592
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;61.083
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;56.747
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;57.986
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;58.446
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;54.140
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;55.503
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;55.913
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;53.273
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;54.302
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;51.314
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;52.637
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,45
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,7
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,68
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,06
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,6
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,54
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,92
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,9
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,69
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;86,17
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;34.956
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;36.077
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;36.770
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;33.434
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;34.562
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;35.270
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;31.994
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;33.127
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;33.816
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;31.856
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;32.878
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;30.767
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;31.929
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,65
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,8
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,92
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,53
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,82
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,97
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,3
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,42
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,28
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,83
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;24.497
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;24.515
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;24.313
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;23.313
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;23.424
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;23.176
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;22.146
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;22.376
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;22.097
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;21.417
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;21.424
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;20.547
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;20.708
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,17
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,55
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,32
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,4
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,27
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,89
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,36
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,12
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,81
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,17
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;59.878
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;61.204
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;61.773
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;56.968
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;58.387
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;58.874
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;55.955
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;57.066
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;53.746
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;55.175
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;51.891
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;53.513
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,14
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,4
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,31
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,42
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,38
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,81
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,32
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,78
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,63
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;35.196
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;36.368
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;37.162
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;33.573
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;34.732
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;35.489
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;33.335
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;34.432
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;32.108
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;33.357
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;31.074
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.415
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,39
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,5
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,5
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,66
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,65
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,29
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,76
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,44
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,23
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;24.682
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;24.836
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;24.611
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;23.395
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;23.655
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;23.385
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;22.620
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;22.634
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;21.638
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;21.818
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;20.817
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;21.098
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,79
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,24
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,02
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,08
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,97
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,12
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,65
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,82
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,73
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;109.517
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;109.226
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;109.559
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;106.176
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;106.624
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;102.611
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;102.982
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;103.866
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;100.693
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;100.349
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;101.544
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;98.209
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;97.664
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;99.013
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;95.688
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,95
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,62
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,66
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,03
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,09
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,91
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,63
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,97
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,64
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,18
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,65
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,34
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;69.318
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;69.524
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;69.615
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;67.384
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;67.950
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;65.541
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;65.592
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;66.344
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;64.427
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;64.067
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;64.923
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;62.979
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;62.462
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;63.433
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;61.490
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,21
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,74
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,15
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,62
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,43
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,55
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,42
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,38
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,47
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,11
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,24
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,33
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;40.199
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;39.702
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;39.944
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;38.792
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;38.674
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;37.070
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;37.390
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;37.522
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;36.266
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;36.282
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;36.621
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;35.230
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;35.202
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;35.580
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;34.198
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,5
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,41
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,8
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,01
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,51
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,79
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,26
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,24
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,2
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,57
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,62
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,61
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;107.496
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;107.904
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;107.395
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;103.898
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;104.802
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;105.251
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;100.943
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;102.199
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;102.420
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;97.984
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;99.353
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;99.565
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;96.840
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;97.668
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,65
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,13
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,9
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,71
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,37
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,15
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,08
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,71
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,75
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,94
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;67.702
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;68.474
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;68.288
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;65.704
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;66.630
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;67.043
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;63.980
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;65.043
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;65.392
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;62.223
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;63.368
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;63.708
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;61.939
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;62.583
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,05
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,31
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,18
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,5
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,99
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,76
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,91
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,54
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,29
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,46
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,65
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;39.794
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;39.430
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;39.107
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;38.194
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;38.172
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;38.208
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;36.963
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;37.156
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;37.028
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;35.761
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;35.985
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;35.857
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;34.901
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;35.085
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,98
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,81
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,7
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,89
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,23
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,68
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,87
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,26
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,69
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,51
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,72
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;108.069
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;109.055
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;108.804
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;104.494
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;105.850
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;105.456
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;101.125
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;102.569
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;102.265
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;99.841
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;100.229
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;97.306
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;98.074
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,69
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,06
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,92
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,57
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,05
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,99
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,55
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,12
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,23
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,14
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;68.079
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;69.128
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;69.302
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;65.990
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;67.190
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;67.323
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;64.001
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;65.270
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;65.436
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;63.711
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;64.225
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;62.277
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;62.972
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,93
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,2
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,14
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,01
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,42
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,42
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,16
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,67
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,09
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,87
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;39.990
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;39.927
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;39.502
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;38.504
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;38.660
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;38.133
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;37.124
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;37.299
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;36.829
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;36.130
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;36.004
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;35.029
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;35.102
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,28
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,83
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,53
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,83
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,42
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,23
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,49
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,14
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,73
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,86
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;107.750
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;109.240
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;109.110
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;104.045
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;105.580
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;105.465
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;102.641
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;103.208
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;99.833
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;100.817
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;97.420
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;98.715
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,56
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,65
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,66
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,96
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,59
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,39
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,4
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,18
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,47
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;67.846
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;69.162
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;69.460
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;65.664
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;67.009
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;67.310
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;65.320
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;65.963
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;63.740
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;64.576
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;62.339
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;63.306
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,78
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,89
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,9
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,44
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,97
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,16
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,97
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,13
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,14
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;39.904
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;40.078
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;39.650
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;38.381
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;38.571
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;38.155
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;37.321
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;37.245
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;36.093
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;36.241
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;35.081
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;35.409
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,18
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,24
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,23
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,12
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,93
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,06
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,4
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,53
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,3
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;101.185
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;98.090
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;99.963
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;98.797
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;96.173
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;95.042
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;96.402
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;94.217
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;93.533
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;94.480
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;92.561
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;91.622
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;92.305
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;90.738
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;89.764
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,64
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,05
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,08
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,27
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,05
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,57
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,37
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,36
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,66
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,22
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,5
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,8
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;64.942
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;63.143
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;64.177
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;63.515
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;61.978
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;61.291
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;62.143
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;60.790
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;60.404
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;61.011
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;59.782
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;59.301
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;59.724
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;58.683
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;58.187
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,8
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,15
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,5
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,69
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,27
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,12
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,95
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,68
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,4
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,97
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,94
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,67
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;36.243
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;34.947
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;35.786
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;35.282
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;34.195
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;33.751
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;34.259
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;33.427
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;33.129
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;33.469
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;32.779
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;32.321
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;32.581
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;32.055
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;31.577
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,35
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,85
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,31
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,53
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,65
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,58
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,35
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,8
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,32
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;89,9
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,72
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,24
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;104.225
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;101.595
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;98.227
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;101.477
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;99.342
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;96.575
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;99.255
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;97.447
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;94.353
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;96.775
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;95.339
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;92.286
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;93.470
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;90.849
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,36
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,78
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,32
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,23
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,92
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,06
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,85
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,84
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,95
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,49
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;66.850
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;65.373
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;63.221
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;65.282
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;64.015
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;62.249
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;63.964
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;62.856
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;60.935
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;62.494
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;61.580
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;59.691
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;60.474
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;58.824
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,65
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,92
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,46
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,68
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,15
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,38
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,48
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,2
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,42
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,51
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,05
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;37.375
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;36.222
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;35.006
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;36.195
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;35.327
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;34.326
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;35.291
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;34.591
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;33.418
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;34.281
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;33.759
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;32.595
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;32.996
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;32.025
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,84
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,53
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,06
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,42
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,5
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,46
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,72
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,2
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,11
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,09
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,48
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;104.201
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;101.972
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;98.862
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;101.472
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;99.599
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;96.254
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;98.667
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;97.231
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;93.954
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;95.240
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;92.427
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;93.278
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;90.839
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,38
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,67
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,36
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,69
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,35
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,04
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,4
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,49
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,47
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,88
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;66.849
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;65.468
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;63.653
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;65.248
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;64.060
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;62.119
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;63.584
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;62.631
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;60.727
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;61.459
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;59.807
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;60.321
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;58.849
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,61
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,85
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,59
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,12
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,67
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,4
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,88
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,96
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,14
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,45
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;37.352
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;36.504
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;35.209
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;36.224
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;35.539
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;34.135
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;35.083
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;34.600
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;33.227
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;33.781
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;32.620
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;32.957
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;31.990
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,98
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,36
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,95
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,93
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,78
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,37
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,54
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,65
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,28
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,86
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;103.462
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;101.590
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;98.497
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;100.413
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;98.945
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;95.887
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;96.799
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;94.200
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;94.678
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;92.472
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;92.895
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;90.934
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,05
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,4
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,35
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,28
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,64
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,2
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,88
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,44
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,32
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;66.442
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;65.214
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;63.424
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;64.626
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;63.624
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;61.851
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;62.358
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;60.837
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;61.141
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;59.797
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;60.095
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;58.864
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,27
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,56
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,52
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,62
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,92
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,75
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,28
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,15
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,81
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;37.020
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;36.376
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;35.073
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;35.787
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;35.321
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;34.036
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;34.441
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;33.363
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;33.537
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;32.675
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;32.800
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;32.070
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,67
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,1
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,04
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,68
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,12
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,2
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,16
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,17
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,44
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;46.148
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;43.688
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;50.485
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;44.278
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;41.912
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;46.885
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;42.489
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;40.190
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;45.360
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;40.674
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;38.499
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;43.398
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;38.108
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;36.584
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;41.095
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,95
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,93
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,87
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,07
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,99
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,85
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,14
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,12
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,96
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;82,58
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,74
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,4
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;30.095
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;28.475
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;32.750
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;28.856
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;27.306
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;30.488
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;27.745
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;26.237
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;29.558
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;26.643
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;25.197
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;28.333
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;24.946
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;24.022
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;26.899
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,88
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,89
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,09
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,19
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,14
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,25
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,53
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,49
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,51
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,89
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;84,36
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,13
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;16.053
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;15.213
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;17.735
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;15.422
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;14.606
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;16.397
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;14.744
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;13.953
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;15.802
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;14.031
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.302
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;15.065
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.162
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;12.562
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;14.196
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,07
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,01
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,46
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,85
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,72
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,1
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,4
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,44
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,95
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,99
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,57
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,05
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;53.104
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;50.343
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;48.134
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;51.040
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;48.414
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;46.530
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;49.016
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;46.510
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;44.375
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;46.199
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;44.398
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;41.986
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;42.708
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;40.396
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,11
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,17
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,67
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,3
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,39
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,19
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,19
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,23
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,83
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,92
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;34.536
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;32.742
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;31.253
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;33.252
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;31.540
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;30.276
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;32.026
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;30.370
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;28.923
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;30.173
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;29.077
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;27.433
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;27.966
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;26.401
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,28
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,33
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,87
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,73
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,76
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,54
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,37
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,81
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,78
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,41
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,48
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;18.568
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;17.601
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;16.881
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;17.788
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;16.874
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;16.254
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;16.990
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;16.140
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;15.452
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;16.026
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;15.321
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;14.553
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;14.742
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;13.995
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,8
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,87
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,29
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,5
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,7
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,53
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,31
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,05
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,21
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,76
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,9
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;52.024
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;49.332
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;47.258
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;49.743
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;47.234
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;44.942
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;46.791
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;44.995
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;42.460
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;43.256
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;40.831
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;41.590
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;39.224
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,62
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,75
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,1
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,94
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,21
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,85
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,68
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,4
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,31
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;33.812
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;32.063
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;30.721
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;32.445
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;30.788
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;29.278
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;30.513
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;29.434
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;27.737
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;28.290
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;26.674
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;27.250
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;25.674
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,96
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,02
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,3
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,24
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,8
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,29
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,23
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,83
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,99
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,57
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;18.212
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;17.269
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;16.537
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;17.298
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;16.446
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;15.664
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;16.278
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;15.561
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;14.723
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;14.966
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;14.157
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;14.340
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;13.550
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,98
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,23
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,72
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,38
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,11
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,03
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;86,66
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,61
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,04
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;81,94
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;50.384
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;47.842
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;45.676
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;47.345
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;45.473
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;43.063
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;43.692
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;41.378
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;41.989
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;39.720
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;40.211
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;38.073
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,97
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,05
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,28
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,33
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,59
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,77
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,96
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,05
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,35
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;32.822
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;31.146
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;29.753
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;30.831
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;29.714
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;28.126
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;28.540
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;27.020
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;27.479
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;25.993
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;26.397
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;24.976
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,93
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,4
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,53
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,63
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,81
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,23
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,36
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,75
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,94
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;17.562
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;16.696
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;15.923
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;16.514
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;15.759
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;14.937
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;15.152
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;14.358
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;14.510
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;13.727
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;13.814
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.097
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,03
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,39
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,81
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,75
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,17
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,91
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,21
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,74
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,25
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
10 Comunitat Valenciana;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;64.207
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;63.253
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;64.467
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;62.146
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;61.803
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;60.682
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;60.306
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;60.274
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;59.635
11 Extremadura;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;58.731
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;58.991
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;58.232
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;57.066
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;57.517
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;56.760
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,79
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,71
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,13
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,92
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,29
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,5
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,47
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,26
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,33
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,88
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,93
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,05
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;41.442
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;41.003
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;41.895
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;40.266
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;40.170
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;39.537
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;39.230
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;39.305
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;38.884
11 Extremadura;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;38.328
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;38.539
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;38.109
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;37.322
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;37.693
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;37.220
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,16
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,97
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,37
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,66
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,86
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,81
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,49
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,99
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,96
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,06
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,93
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,84
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;22.765
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;22.250
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;22.572
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;21.880
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;21.633
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;21.145
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;21.076
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;20.969
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;20.751
11 Extremadura;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;20.403
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;20.452
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;20.123
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;19.744
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;19.824
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;19.540
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,11
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,23
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,68
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,58
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,24
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,93
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,62
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,92
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,15
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,73
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,1
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,57
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;64.996
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;63.453
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;63.343
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;62.992
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;61.747
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;62.215
11 Extremadura;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;61.299
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;60.345
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;60.655
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;59.548
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;58.774
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;59.091
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;57.018
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;57.926
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Extremadura;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,92
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,31
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,22
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,31
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,1
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,76
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,62
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,63
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,29
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,86
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,45
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;41.752
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;41.210
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;41.003
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;40.612
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;40.233
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;40.306
11 Extremadura;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;39.633
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;39.390
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;39.427
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;38.581
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;38.482
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;38.480
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;37.508
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;37.835
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Extremadura;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,27
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,63
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,3
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,92
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,58
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,16
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,41
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,38
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,85
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,02
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,27
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;23.244
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;22.243
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;22.340
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;22.380
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;21.514
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;21.909
11 Extremadura;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;21.666
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;20.955
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;21.228
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.967
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.292
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;20.611
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;19.510
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;20.091
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Extremadura;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,28
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,72
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,07
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,21
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,21
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,02
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,2
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,23
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,26
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,71
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,93
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;64.520
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;63.958
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;63.808
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;62.495
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;62.284
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;61.966
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;60.545
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;60.545
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;60.234
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;58.720
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;59.023
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;57.094
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;57.699
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,86
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,38
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,11
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,84
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,66
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,4
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,81
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,5
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,27
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,43
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;41.563
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;41.512
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;41.411
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;40.378
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;40.496
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;40.332
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;39.184
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;39.453
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;39.247
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;38.434
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;38.570
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;37.508
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;37.828
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,15
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,55
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,39
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,28
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,04
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,77
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,59
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,14
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,35
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,35
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;22.957
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;22.446
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;22.397
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;22.117
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;21.788
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;21.634
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;21.361
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;21.092
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;20.987
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;20.286
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;20.453
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;19.586
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;19.871
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,34
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,07
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,59
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,05
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,97
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,7
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,38
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,32
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,26
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,72
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;63.917
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;64.084
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;63.687
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;61.804
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;62.153
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;61.733
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;60.252
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;60.425
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;58.547
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;59.023
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;57.051
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;57.802
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,69
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,99
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,93
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,02
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,88
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,36
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,68
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,03
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,76
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;41.193
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;41.479
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;41.381
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;39.895
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;40.310
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;40.142
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;39.244
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;39.397
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;38.278
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;38.608
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;37.424
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;37.884
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,85
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,18
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,01
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,61
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,21
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,28
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,3
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,22
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,55
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;22.724
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;22.605
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;22.306
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;21.909
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;21.843
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;21.591
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;21.008
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;21.028
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;20.269
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;20.415
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;19.627
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;19.918
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,41
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,63
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,79
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,94
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,27
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,67
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,52
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,83
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,29
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.683
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.654
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.175
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;4.350
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;4.455
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;3.746
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;4.128
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;4.220
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;3.631
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.925
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;4.010
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.464
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.729
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.805
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.311
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,89
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,72
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,72
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,15
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,67
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,97
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;83,81
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,16
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,97
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;79,63
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;81,76
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;79,31
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.788
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.809
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.541
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;2.614
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;2.695
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;2.274
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;2.482
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;2.565
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;2.214
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.361
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.438
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.132
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.249
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.326
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.042
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,76
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,94
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,49
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;89,02
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,31
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,13
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;84,68
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,79
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,9
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;80,67
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,81
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;80,36
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.895
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.845
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.634
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;1.736
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;1.760
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.472
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;1.646
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;1.655
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.417
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.564
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.572
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.332
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.480
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.479
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.269
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,61
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,39
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,09
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,86
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,7
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;86,72
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,53
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;85,2
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;81,52
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;78,1
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;80,16
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;77,66
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.243
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.990
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.272
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;4.021
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;3.754
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;4.136
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.831
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.537
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.946
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.651
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.337
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.777
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;3.077
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;3.641
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,77
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,09
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,82
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,29
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;88,65
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,37
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,05
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;83,63
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,41
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,12
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,23
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.560
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.415
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.574
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;2.418
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;2.280
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;2.504
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.299
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.151
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.410
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.197
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.040
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.310
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.909
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;2.237
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,45
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,41
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,28
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;89,8
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;89,07
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,63
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;85,82
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;84,47
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,74
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,05
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,91
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.683
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.575
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.698
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;1.603
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;1.474
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;1.632
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.532
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.386
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.536
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.454
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.297
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.467
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.168
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.404
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Extremadura;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,25
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,59
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,11
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,03
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;88
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,46
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,39
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,35
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,4
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;74,16
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,69
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.371
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.241
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.409
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.096
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.955
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.152
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.880
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.731
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.964
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;3.455
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;3.822
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;3.275
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;3.638
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,71
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;93,26
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,17
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,77
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,97
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,91
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;81,47
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,69
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;77,22
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,51
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.637
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.562
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.676
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.468
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.386
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.537
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.342
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.258
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.422
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;2.118
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;2.346
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;2.009
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;2.248
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,59
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,13
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,81
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,81
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;88,13
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,51
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;82,67
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,67
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;78,42
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;84,01
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.734
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.679
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.733
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.628
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.569
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.615
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.538
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.473
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.542
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.337
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.476
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.266
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.390
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;93,89
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;93,45
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,19
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,7
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;87,73
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,98
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,63
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,17
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,4
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;80,21
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.448
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.422
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.531
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.195
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.165
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.298
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;3.873
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;4.133
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;3.679
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;3.930
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.493
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.736
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,31
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,19
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,86
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,58
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,22
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;83,2
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,74
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;78,99
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,45
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.675
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.633
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.756
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.522
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.482
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.616
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;2.334
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;2.528
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;2.220
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;2.418
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.113
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.302
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,28
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,27
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,92
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,64
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,73
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;84,31
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,74
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;80,25
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,53
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.773
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.789
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.775
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.673
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.683
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.682
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;1.539
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;1.605
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.459
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.512
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.380
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.434
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,36
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,07
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,76
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,03
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,42
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,55
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,18
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,14
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;80,79
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;13.193
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.346
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.297
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;12.733
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;12.996
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;12.405
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;12.331
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;12.641
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;12.163
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.929
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.315
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.846
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.575
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.989
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.501
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,51
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,38
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,29
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,47
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,72
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,47
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,42
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,27
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,09
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,74
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,83
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,49
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.966
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.125
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.058
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;7.722
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;7.959
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;7.559
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;7.510
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;7.768
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;7.417
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.305
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.598
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.250
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.104
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.423
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.051
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,94
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,96
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,81
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,28
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,61
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,05
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,7
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,51
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,97
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,18
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,36
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,5
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;5.227
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.221
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;5.239
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;5.011
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;5.037
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;4.846
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;4.821
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;4.873
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;4.746
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.624
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.717
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.596
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.471
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.566
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.450
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,87
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,48
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,5
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,23
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,33
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,59
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,46
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,35
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,73
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,54
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,45
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,94
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.830
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.615
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.120
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;12.391
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;12.216
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;12.860
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.962
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;11.876
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.515
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.583
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.536
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.145
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;11.148
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;11.875
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,58
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,84
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,02
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,23
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,14
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,39
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,28
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,45
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,57
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,37
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,51
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.608
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;7.688
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.949
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;7.377
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;7.475
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;7.795
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.156
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.288
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.614
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;6.942
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.098
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.400
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;6.894
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;7.282
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,96
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,23
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,06
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,06
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,8
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,79
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,25
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,33
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,09
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,67
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,61
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;5.222
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.927
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;5.171
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;5.014
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;4.741
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;5.065
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.806
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.588
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.901
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.641
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.438
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.745
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;4.254
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;4.593
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Extremadura;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,02
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,22
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,95
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,03
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,12
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,78
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,87
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,08
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,76
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,34
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,82
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.802
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.869
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.278
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.301
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.467
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.878
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.885
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.086
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.459
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;11.682
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;12.175
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;11.329
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;11.875
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,09
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,88
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,99
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,84
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,92
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,83
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,78
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,69
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,03
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,43
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.622
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;7.833
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.079
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.357
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.612
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.861
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.119
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.393
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.604
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;7.179
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;7.474
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;6.991
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;7.318
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,52
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,18
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,3
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,4
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,38
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,12
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,65
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,51
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,25
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,58
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;5.180
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;5.036
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;5.199
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.944
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.855
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.017
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.766
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.693
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.855
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;4.503
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;4.701
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;4.338
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;4.557
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,44
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,41
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,5
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,01
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,19
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,38
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,42
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,42
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,14
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,65
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.711
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.991
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.358
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.254
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.554
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.894
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;12.126
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;12.582
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;11.758
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;12.259
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.381
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.951
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,4
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,64
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,53
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,34
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,19
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,51
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,77
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,61
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,47
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.583
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;7.901
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.164
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.324
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.643
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.874
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;7.418
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;7.723
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;7.222
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;7.551
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.029
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.394
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,58
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,73
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,45
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,89
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,6
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,41
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,49
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,96
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,57
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;5.128
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;5.090
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.194
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.930
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.911
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.020
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;4.708
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;4.859
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;4.536
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;4.708
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.352
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.557
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,14
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,48
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,65
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,5
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,55
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,12
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,64
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,5
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,74
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;19.395
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;19.266
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;19.437
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;18.866
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;18.921
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;18.382
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;18.354
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;18.557
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;18.140
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.969
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;18.291
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;17.818
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.584
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;17.945
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.467
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,27
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,21
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,57
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,63
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,32
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,33
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,65
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,94
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,67
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,66
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,14
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,86
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.648
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.630
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.743
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;12.349
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;12.428
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;12.082
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;12.072
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;12.229
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;11.937
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.852
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.067
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.766
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.643
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.880
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.568
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,64
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,4
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,81
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,45
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,83
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,67
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,71
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,54
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,33
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,05
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,06
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,78
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.747
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;6.636
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.694
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;6.517
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;6.493
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;6.300
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;6.282
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;6.328
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;6.203
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.117
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.224
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.052
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.941
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.065
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.899
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,59
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,85
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,11
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,11
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,36
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,67
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,66
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,79
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,41
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,05
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,4
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,12
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;19.264
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;19.110
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;19.082
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;18.710
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;18.690
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;18.816
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.283
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;18.378
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;18.471
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.885
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.997
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;18.089
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;17.559
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;17.824
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,12
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,8
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,61
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,91
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,17
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,8
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,84
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,18
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,8
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,88
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,41
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.433
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.509
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.453
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;12.133
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;12.278
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;12.295
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;11.882
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.094
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.105
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.665
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.887
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.889
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;11.652
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;11.742
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,59
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,15
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,73
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,57
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,68
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,21
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,82
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,03
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,47
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,15
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,29
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.831
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.601
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.629
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;6.577
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;6.412
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;6.521
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.401
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.284
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.366
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.220
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.110
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.200
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;5.907
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;6.082
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Extremadura;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,28
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,14
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,37
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,71
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,2
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,03
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,06
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,56
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,53
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,49
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,75
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;19.091
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;19.256
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;19.298
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;18.590
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.880
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;18.884
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;18.136
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;18.450
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;18.450
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;17.995
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;18.172
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;17.550
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;17.867
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,38
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,05
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,85
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,81
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,61
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,45
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,17
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,14
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,58
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.374
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.618
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.628
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.077
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.395
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.393
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.820
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.145
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.134
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;11.900
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;11.979
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;11.654
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;11.813
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,6
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,23
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,14
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,52
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,25
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,09
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,31
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,86
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,36
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,55
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.717
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.638
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.670
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.513
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.485
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.491
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.316
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.305
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.316
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;6.095
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;6.193
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;5.896
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;6.054
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,96
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,32
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,03
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,98
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,69
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,82
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,85
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,82
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,76
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.941
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;19.351
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;19.356
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.445
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.873
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;18.854
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;18.399
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;18.550
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;17.924
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;18.222
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;17.559
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;17.970
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,38
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,53
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,41
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,08
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,84
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,63
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,14
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,74
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,84
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.277
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.645
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.688
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;11.994
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.366
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.380
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;12.105
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;12.205
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;11.845
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;12.026
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.636
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.873
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,69
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,79
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,57
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,73
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,19
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,67
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,78
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,02
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,58
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.664
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.706
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;6.668
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.451
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.507
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.474
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;6.294
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;6.345
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;6.079
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;6.196
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.923
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.097
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,8
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,03
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,09
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,86
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,16
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,65
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,92
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,32
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,44
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.436
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.018
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;18.456
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;18.049
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;17.743
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;17.632
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;17.682
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;17.464
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;17.433
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;17.379
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;17.238
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;17.159
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;17.085
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.956
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;16.863
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,9
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,47
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,54
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,91
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,93
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,46
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,27
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,67
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,97
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,67
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,11
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,37
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.271
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.048
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;12.370
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;12.035
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;11.887
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;11.830
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;11.834
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;11.728
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;11.703
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.658
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;11.596
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.565
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.476
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.428
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.378
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,08
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,66
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,63
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,44
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,34
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,61
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,25
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,49
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,52
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,85
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,98
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;6.165
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;5.970
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;6.086
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;6.014
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;5.856
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;5.802
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;5.848
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;5.736
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;5.730
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;5.721
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;5.642
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;5.594
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;5.609
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;5.528
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.485
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,55
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,09
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,33
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,86
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,08
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,15
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,8
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,51
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,92
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,98
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,6
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,12
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;18.839
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;18.492
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;18.162
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;18.422
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;18.167
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;17.949
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;18.097
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;17.926
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;17.628
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;17.778
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;17.629
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;17.323
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;17.289
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;17.094
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,79
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,24
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,83
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,06
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,94
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,06
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,37
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,33
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,38
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,49
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,12
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.498
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;12.335
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;12.119
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;12.264
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;12.137
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;11.985
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.082
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;11.994
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;11.814
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.886
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;11.822
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;11.620
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;11.623
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;11.493
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,13
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,39
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,89
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,67
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,24
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,48
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,1
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,84
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,88
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,23
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,83
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;6.341
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;6.157
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.043
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;6.158
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;6.030
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;5.964
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.015
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;5.932
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;5.814
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;5.892
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;5.807
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;5.703
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;5.666
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;5.601
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Extremadura;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,11
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,94
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,69
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,86
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,35
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,21
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,92
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,32
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,37
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,03
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,69
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;18.689
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;18.555
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;18.271
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;18.301
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;18.260
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.887
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;17.933
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;17.920
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;17.544
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;17.566
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;17.305
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;17.242
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;17.053
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,92
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,41
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,9
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,95
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,58
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,02
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,67
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,71
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,92
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,33
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.437
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;12.356
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;12.224
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.212
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.176
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.004
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;11.977
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;11.969
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;11.781
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;11.759
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;11.646
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;11.581
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;11.504
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,19
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,54
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,2
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,3
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,87
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,38
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,17
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,27
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,73
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,11
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;6.252
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;6.199
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;6.047
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.089
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.084
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;5.883
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;5.956
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;5.951
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;5.763
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;5.807
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;5.659
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;5.661
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;5.549
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,39
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,14
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,29
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,27
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,3
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,68
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,58
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,32
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,76
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;18.533
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;18.509
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;18.189
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;18.136
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;18.139
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.800
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;17.774
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;17.545
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;17.436
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;17.287
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;17.146
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;17.069
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,86
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,86
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,03
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,46
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,2
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,04
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,64
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,84
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.351
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.323
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;12.190
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.095
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.098
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;11.933
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;11.880
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;11.785
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;11.694
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;11.639
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.527
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.511
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,93
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,17
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,89
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,41
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,68
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,9
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,48
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,54
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,43
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;6.182
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;6.186
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;5.999
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.041
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.041
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;5.867
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;5.894
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;5.760
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;5.742
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;5.648
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;5.619
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;5.558
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,72
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,66
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,8
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,28
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,02
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,82
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,15
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,83
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,65
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.500
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.969
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;9.102
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;8.148
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;7.688
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;8.517
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;7.811
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;7.392
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;8.268
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.529
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.137
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;7.945
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.093
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.822
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;7.618
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,86
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,47
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,57
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,89
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,76
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,84
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,58
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,56
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,29
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,45
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,61
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,7
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.769
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.391
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;6.183
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;5.546
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;5.201
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;5.792
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;5.332
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;5.015
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;5.613
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;5.152
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.840
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;5.396
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.850
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.636
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;5.181
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,13
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,48
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,68
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,43
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,03
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,78
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,3
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,78
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,27
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,07
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,79
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.731
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.578
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.919
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.602
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;2.487
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.725
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;2.479
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;2.377
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.655
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.377
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.297
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.549
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.243
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.186
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.437
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,28
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,47
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,35
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,77
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,2
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,96
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,04
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,1
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,32
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,13
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,79
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,49
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;9.820
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;9.246
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;8.707
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;9.448
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;8.920
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;8.454
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;9.126
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;8.628
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;8.095
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;8.651
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;8.275
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;7.757
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;7.945
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;7.492
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
11 Extremadura;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,21
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,47
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,09
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,93
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,32
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,97
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,1
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,5
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,09
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,93
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,05
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;6.653
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;6.263
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;5.908
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;6.420
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;6.063
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;5.727
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;6.214
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;5.863
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;5.484
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;5.891
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;5.635
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;5.261
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;5.430
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;5.081
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
11 Extremadura;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,81
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,94
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,4
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,61
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,82
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,55
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,97
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,05
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,7
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.167
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.983
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.799
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;3.028
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.857
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.727
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.912
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.765
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.611
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.760
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.640
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.496
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;2.515
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;2.411
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
11 Extremadura;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,61
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,78
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,43
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,95
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,69
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,28
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,15
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,5
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,17
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,31
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,14
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;9.567
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;9.037
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;8.552
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;9.207
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;8.722
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;8.165
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;8.711
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;8.358
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;7.817
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;8.022
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;7.549
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;7.698
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;7.266
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,24
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,51
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,47
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,05
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,49
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,41
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,77
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,27
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,18
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,96
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;6.493
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;6.143
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;5.804
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;6.264
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;5.927
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;5.537
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;5.926
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;5.688
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;5.306
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;5.478
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;5.125
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;5.273
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;4.945
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,47
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,48
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,4
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,27
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,59
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,42
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,17
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,3
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,84
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,2
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.074
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.894
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.748
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.943
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.795
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.628
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.785
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.670
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.511
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.544
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;2.424
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;2.425
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;2.321
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,74
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,58
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,63
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,6
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,26
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,38
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,91
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,21
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,79
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,46
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;9.284
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.811
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.253
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;8.774
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.422
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.887
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;8.080
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;7.615
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;7.750
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;7.325
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;7.472
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;7.076
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,51
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,59
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,57
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,7
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,27
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,96
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,76
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,8
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,74
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;6.307
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.977
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;5.583
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;5.960
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;5.721
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;5.339
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;5.507
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;5.156
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;5.297
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;4.974
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;5.119
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.804
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,5
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,72
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,63
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,14
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,35
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,62
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,09
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,64
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,05
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.977
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.834
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.670
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.814
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.701
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.548
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.573
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;2.459
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;2.453
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;2.351
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.353
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.272
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,52
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,31
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,43
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,79
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,1
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,56
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,05
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,03
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,09
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
11 Extremadura;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;179.630
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;177.553
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;180.521
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;174.518
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;173.723
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;171.642
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;169.930
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;169.901
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;168.257
12 Galicia;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;165.875
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;166.342
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;164.480
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;160.977
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;162.245
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;160.502
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,15
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,84
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,08
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,6
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,69
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,21
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,34
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,69
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,11
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,62
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,38
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,91
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;108.381
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;107.413
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;108.714
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;105.406
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;105.150
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;103.598
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;102.915
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;103.014
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;101.936
12 Galicia;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;100.684
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;100.975
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;99.901
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;97.860
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;98.672
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;97.683
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,26
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,89
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,29
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,96
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,9
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,77
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,9
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,01
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,89
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,29
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,86
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,85
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;71.249
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;70.140
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;71.807
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;69.112
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;68.573
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;68.044
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;67.015
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;66.887
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;66.321
12 Galicia;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;65.191
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;65.367
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;64.579
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;63.117
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;63.573
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;62.819
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,77
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,76
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,06
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,36
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,36
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,5
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,2
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,93
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,59
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,64
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,48
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;179.497
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;178.765
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;178.080
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;174.544
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;174.469
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;174.431
12 Galicia;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;170.210
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;170.599
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;169.787
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;165.056
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;166.209
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;165.527
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;162.090
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;162.545
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Galicia;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,24
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,6
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,95
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,83
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,43
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,34
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,95
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,98
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,95
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,67
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,28
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;108.181
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;108.134
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;107.227
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;105.469
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;105.699
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;105.412
12 Galicia;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;103.069
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;103.454
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;102.830
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;100.094
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;100.977
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;100.449
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;98.608
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;98.703
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Galicia;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,49
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,75
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,31
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,27
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,67
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,9
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,52
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,38
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,68
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,19
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,05
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;71.316
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;70.631
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;70.853
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;69.075
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;68.770
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;69.019
12 Galicia;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;67.141
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;67.145
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;66.957
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;64.962
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;65.232
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;65.078
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;63.482
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;63.842
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Galicia;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,86
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,37
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,41
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,15
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,06
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,5
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,09
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,36
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,85
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,88
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,1
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;180.034
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;180.045
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;178.268
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;174.824
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;175.425
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;172.959
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;169.084
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;170.568
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;168.380
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;166.196
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;165.261
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;162.262
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;162.064
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,11
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,43
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,02
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,92
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,74
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,45
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,31
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,7
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,12
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,91
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;108.433
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;108.855
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;107.823
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;105.553
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;106.168
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;104.836
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;102.255
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;103.440
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;102.252
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;100.913
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;100.414
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;98.755
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;98.626
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,34
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,53
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,23
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,3
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,03
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,83
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,7
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,13
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,72
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,47
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;71.601
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;71.190
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;70.445
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;69.271
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;69.257
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;68.123
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;66.829
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;67.128
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;66.128
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;65.283
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;64.847
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;63.507
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;63.438
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,75
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,28
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,7
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,34
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,29
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,87
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,7
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,05
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,21
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,05
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;178.824
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;180.177
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;177.765
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;172.599
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;174.775
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;172.592
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;170.125
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;169.188
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;165.928
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;165.706
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;162.100
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;162.423
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,52
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,09
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,42
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,18
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,09
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,22
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,97
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,37
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;107.792
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;108.830
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;107.584
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;104.210
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;105.779
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;104.648
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;103.079
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;102.635
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;100.787
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;100.689
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;98.686
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;98.808
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,68
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,2
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,27
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,72
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,4
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,61
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,59
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,68
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,84
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;71.032
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;71.347
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;70.181
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;68.389
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;68.996
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;67.944
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;67.046
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;66.553
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;65.141
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;65.017
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;63.414
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;63.615
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,28
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,7
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,81
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,97
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,83
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,3
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,64
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,88
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,64
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;9.034
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;8.792
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;7.215
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;8.449
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;8.336
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;6.433
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.937
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;7.904
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;6.211
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;7.436
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;7.473
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.867
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;7.016
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;7.085
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.588
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,52
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,81
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,16
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,86
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,9
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,08
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;82,31
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;85
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,32
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,66
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,58
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,45
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.428
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;5.358
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.390
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;5.077
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;5.090
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.947
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.780
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.832
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.830
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.504
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.570
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.626
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;4.260
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;4.341
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.477
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,53
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,91
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;88,06
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,18
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,24
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,98
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,29
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,6
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,48
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,02
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,2
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;3.606
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.434
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.825
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;3.372
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;3.246
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;2.486
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;3.157
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;3.072
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;2.381
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.932
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.903
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.241
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.756
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.744
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.111
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,51
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,53
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,55
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,46
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,28
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,31
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;84,54
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,33
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;76,43
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;79,91
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;74,73
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.756
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;7.767
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;7.406
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;7.234
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;7.257
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;7.132
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.742
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.779
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.697
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.336
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.383
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.365
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;6.038
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;6.121
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Galicia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;93,27
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,43
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,3
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,93
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,28
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;90,43
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;81,69
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,18
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;85,94
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,74
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,65
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.681
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.778
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.495
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;4.373
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;4.458
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;4.351
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.093
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.159
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.095
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.855
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.931
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.913
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.729
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.775
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Galicia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;93,42
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,3
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,8
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;87,44
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,04
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,1
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;82,35
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;82,27
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,05
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;78,05
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,98
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;3.075
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.989
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.911
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.861
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.799
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.781
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.649
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.620
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.602
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.481
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.452
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.452
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;2.309
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;2.346
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Galicia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,04
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,64
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,53
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,15
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,65
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,39
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;80,68
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,03
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,23
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;77,25
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,59
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;8.292
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;8.313
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;7.806
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.608
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;7.666
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;7.207
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;7.101
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;7.196
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.826
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;6.790
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;6.550
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;6.392
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;6.290
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,75
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,22
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,33
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;85,64
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;86,56
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,45
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;81,68
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,91
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,89
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;80,58
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.963
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;5.077
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.765
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.569
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.668
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.414
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.281
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.399
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.207
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;4.157
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;4.050
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.929
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.893
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,06
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;91,94
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,63
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,26
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;86,65
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,29
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;81,88
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,99
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;77,39
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,7
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;3.329
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;3.236
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;3.041
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;3.039
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.998
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.793
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.820
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.797
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.619
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.633
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;2.500
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;2.463
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;2.397
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,29
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,65
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,84
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,71
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,43
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,12
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;81,37
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,21
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;76,11
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,82
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.397
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;8.651
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;8.196
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.784
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;8.056
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;7.690
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;7.575
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;7.343
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;7.138
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;7.003
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.705
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.648
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,7
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,12
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,83
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,56
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,59
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,51
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,44
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,51
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;81,11
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.022
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;5.219
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.988
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.673
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.875
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.719
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.586
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;4.516
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;4.331
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;4.316
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;4.097
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;4.097
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,05
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,41
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,61
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;87,87
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,54
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;82,99
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,53
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,5
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,14
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.375
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;3.432
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.208
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;3.111
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.181
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.971
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.989
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.827
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.807
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.687
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.608
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.551
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,18
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,69
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,61
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,09
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,12
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,79
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,76
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,99
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,52
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;30.574
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;31.499
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;30.705
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;29.524
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;30.655
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;28.870
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;28.550
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;29.878
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;28.286
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;27.729
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;29.141
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;27.514
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;26.881
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;28.367
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;26.768
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,57
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,32
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,02
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,38
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,85
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,12
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,69
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,51
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,61
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,92
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,06
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,18
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.759
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;18.400
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;17.811
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;17.154
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;17.927
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;16.813
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;16.652
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;17.511
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;16.520
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;16.218
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.103
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.135
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;15.741
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;16.686
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.747
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,59
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,43
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,4
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,77
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,17
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,75
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,32
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,95
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,59
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,64
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,68
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,41
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;12.815
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;13.099
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.894
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;12.370
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;12.728
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;12.057
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;11.898
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;12.367
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;11.766
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;11.511
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;12.038
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;11.379
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;11.140
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;11.681
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;11.021
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,53
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,17
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,51
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,84
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,41
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,25
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,82
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,9
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,25
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,93
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,17
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,47
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.264
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;29.137
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;30.533
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;27.232
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;28.303
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;29.889
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.360
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.522
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;28.967
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.499
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.721
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;28.141
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;25.921
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;27.527
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Galicia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,35
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,14
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,26
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,46
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,87
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,22
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,71
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,17
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,96
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,15
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;16.340
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.969
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;17.727
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;15.789
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;16.516
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;17.396
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;15.319
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.068
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;16.929
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;14.836
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;15.635
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.496
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;15.182
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;16.157
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Galicia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,63
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,33
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,13
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,75
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,69
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,5
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,8
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,14
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,06
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,47
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,14
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;11.924
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;12.168
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;12.806
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;11.443
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;11.787
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;12.493
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.041
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.454
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;12.038
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.663
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;11.086
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;11.645
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;10.739
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;11.370
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Galicia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,97
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,87
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,56
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,59
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,13
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,42
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,11
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,93
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,26
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,79
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;28.690
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;29.848
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;30.866
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;27.653
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.903
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;29.831
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.680
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;27.984
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;28.937
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;27.110
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;28.279
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;26.324
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;27.662
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,39
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,83
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,65
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,99
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,76
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,75
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,83
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,62
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,19
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,62
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.585
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;17.388
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.013
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;16.021
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;16.837
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.464
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;15.472
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;16.343
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.989
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;15.846
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;16.614
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;15.438
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;16.290
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,6
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,83
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,95
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,29
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,99
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,32
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,13
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,23
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,79
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,43
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.105
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;12.460
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;12.853
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;11.632
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;12.066
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;12.367
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;11.208
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;11.641
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;11.948
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;11.264
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;11.665
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;10.886
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;11.372
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,09
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,84
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,22
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,59
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,43
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,96
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,4
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,76
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,37
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,48
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.712
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;30.205
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;31.107
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.638
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;29.171
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;30.091
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;28.222
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;29.358
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;27.354
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;28.676
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;26.595
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;28.024
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,26
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,58
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,73
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,43
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,38
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,56
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,19
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,05
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,09
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.610
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;17.572
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.177
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.995
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.010
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;17.621
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;16.468
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;17.208
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;16.021
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;16.848
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.620
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;16.488
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,3
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,8
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,94
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,72
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,67
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,17
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,69
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,89
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,71
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;12.102
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;12.633
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;12.930
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;11.643
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;12.161
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;12.470
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;11.754
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;12.150
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;11.333
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;11.828
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;10.975
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;11.536
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,21
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,26
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,44
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,04
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,97
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,71
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,48
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,88
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,22
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;57.397
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;57.327
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;57.319
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;56.011
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;56.344
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;54.744
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;54.794
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;55.338
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;53.952
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;53.826
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;54.505
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;53.023
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;52.696
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;53.493
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;52.108
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,59
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,29
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,51
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,46
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,53
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,13
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,78
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,08
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,51
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,81
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,31
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,91
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;34.808
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;34.766
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;34.692
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;34.074
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;34.203
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;33.228
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;33.448
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;33.683
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;32.820
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;32.918
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;33.216
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;32.333
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;32.290
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;32.662
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;31.836
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,89
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,38
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,78
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,09
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,88
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,6
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,57
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,54
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,2
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,77
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,95
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,77
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;22.589
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;22.561
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;22.627
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;21.937
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;22.141
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;21.516
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;21.346
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;21.655
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;21.132
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;20.908
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;21.289
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;20.690
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;20.406
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;20.831
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;20.272
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,11
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,14
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,09
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,5
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,98
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,39
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,56
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,36
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;91,44
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,34
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,33
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,59
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;55.999
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;56.550
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;56.703
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;54.670
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;55.425
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;55.831
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;53.627
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;54.507
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;54.657
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;52.408
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;53.405
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;53.662
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;52.298
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;52.906
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Galicia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,63
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,01
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,46
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,76
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,39
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,39
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,59
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,44
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,64
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,48
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,3
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;33.876
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;34.327
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;34.324
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;33.196
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;33.734
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;33.872
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;32.638
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;33.220
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;33.232
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;31.956
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;32.607
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;32.687
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;32.033
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;32.265
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Galicia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,99
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,27
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,68
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,35
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,78
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,82
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,33
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,99
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,23
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,32
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;22.123
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;22.223
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;22.379
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;21.474
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;21.691
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;21.959
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;20.989
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;21.287
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;21.425
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.452
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.798
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;20.975
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;20.265
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;20.641
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Galicia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,07
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,61
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,12
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,87
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,79
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,74
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,45
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,59
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,73
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,19
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,23
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;56.278
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;57.055
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;57.013
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;54.983
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;55.956
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;55.664
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;53.582
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;54.709
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;54.572
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;53.535
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;53.784
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;52.514
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;52.959
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,7
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,07
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,63
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,21
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,89
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,72
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,83
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,34
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,04
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,89
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;34.081
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;34.677
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;34.608
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;33.369
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;34.060
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;33.859
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;32.582
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;33.363
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;33.249
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;32.750
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;32.809
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;32.221
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;32.387
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,91
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,22
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,84
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,6
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,21
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,07
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,44
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,8
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,92
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,58
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;22.197
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;22.378
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;22.405
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;21.614
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;21.896
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;21.805
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;21.000
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;21.346
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;21.323
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;20.785
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;20.975
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;20.293
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;20.572
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,37
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,85
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,32
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,61
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,39
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,17
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,88
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,62
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,68
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,82
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;56.168
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;57.374
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;57.151
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;54.652
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;55.977
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;55.869
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;54.728
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;55.003
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;53.628
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;54.091
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;52.710
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;53.323
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,3
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,57
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,76
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,39
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,24
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,47
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,65
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,87
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,3
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;34.029
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;34.858
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;34.715
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;33.180
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;34.069
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;33.992
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;33.412
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;33.503
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;32.844
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;33.032
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;32.342
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;32.602
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,51
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,74
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,92
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,85
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,51
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,22
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,15
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,78
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,91
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;22.139
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;22.516
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;22.436
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;21.472
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;21.908
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;21.877
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;21.316
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;21.500
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;20.784
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;21.059
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;20.368
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;20.721
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,99
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,3
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,51
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,67
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,83
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,31
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,86
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,46
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,36
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;54.087
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;52.814
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;54.045
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;53.002
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;52.119
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;52.170
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;52.058
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;51.371
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;51.376
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;51.236
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;50.697
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;50.631
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;50.275
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;49.954
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.853
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,99
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,68
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,53
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,25
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,27
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,06
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,73
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,99
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,68
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,95
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,58
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,24
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;32.807
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;32.208
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;32.769
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;32.136
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;31.791
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;31.679
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;31.622
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;31.361
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;31.315
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;31.169
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;30.974
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;30.918
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;30.654
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;30.553
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;30.470
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,95
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,71
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,67
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,39
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,37
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,56
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,01
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,17
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,35
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,44
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,86
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,98
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;21.280
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;20.606
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;21.276
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;20.866
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;20.328
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;20.491
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;20.436
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;20.010
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;20.061
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;20.067
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;19.723
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;19.713
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;19.621
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;19.401
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;19.383
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,05
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,65
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,31
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,03
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;97,11
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,29
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,3
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,71
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,65
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,2
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,15
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,1
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;55.183
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;54.225
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;53.446
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;54.146
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;53.360
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;52.613
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;53.256
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;52.628
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;51.655
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;52.231
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;51.803
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;50.828
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;50.892
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;50.259
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Galicia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,12
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,4
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,44
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,51
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,05
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,65
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,65
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,53
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,1
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,85
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,04
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;33.395
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;32.953
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;32.410
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;32.830
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;32.457
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;32.024
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;32.326
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;32.042
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;31.480
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;31.765
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;31.570
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;31.003
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;31.017
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;30.667
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Galicia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,31
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,49
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,81
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,8
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,24
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,13
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,12
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,8
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,66
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,12
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,62
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;21.788
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;21.272
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;21.036
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;21.316
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;20.903
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;20.589
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;20.930
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;20.586
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;20.175
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;20.466
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;20.233
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;19.825
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;19.875
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;19.592
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Galicia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,83
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,27
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,88
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;96,06
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,78
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,91
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,93
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,12
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,24
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,43
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,14
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;55.169
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;54.359
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;53.359
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;54.106
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;53.468
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;52.251
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;52.946
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;52.558
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;51.348
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;51.604
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;50.758
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;50.791
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;50.093
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,07
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,36
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,92
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,97
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,69
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,23
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,93
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,13
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,44
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,88
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;33.354
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;32.984
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;32.516
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;32.769
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;32.483
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;31.884
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;32.133
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;31.971
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;31.356
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;31.388
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;31.005
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;30.932
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;30.615
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,25
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,48
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,34
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,93
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,43
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,16
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,35
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,78
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,15
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;21.815
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;21.375
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;20.843
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;21.337
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.985
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;20.367
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;20.813
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;20.587
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;19.992
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;20.216
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;19.753
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;19.859
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;19.478
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,81
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,18
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,72
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,41
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,31
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,92
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,58
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,77
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,91
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,45
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;54.831
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;54.247
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;53.053
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;53.573
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;53.256
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;52.050
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;52.261
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;51.414
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;51.395
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;50.706
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;50.606
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;50.067
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,71
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,17
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,11
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,34
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,91
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,74
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,58
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,29
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,37
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;33.178
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;32.918
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;32.348
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;32.477
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;32.359
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;31.760
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;31.746
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;31.378
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;31.266
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;30.966
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;30.832
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;30.601
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,89
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,3
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,18
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,44
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,98
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,73
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,66
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,6
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;21.653
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;21.329
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.705
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;21.096
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;20.897
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;20.290
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;20.515
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;20.036
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;20.129
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;19.740
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;19.774
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;19.466
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,43
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,97
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,18
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,77
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,37
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,34
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,71
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,02
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;28.538
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;27.121
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;31.237
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;27.532
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;26.269
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;29.425
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;26.591
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;25.410
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;28.432
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;25.648
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;24.526
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;27.445
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;24.109
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;23.346
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;26.185
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,47
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,86
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,2
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,18
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,69
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,02
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,87
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,43
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,86
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,48
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,08
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,83
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.579
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;16.681
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;19.052
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;16.965
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;16.139
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;17.931
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;16.413
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;15.627
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;17.451
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;15.875
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;15.112
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.889
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;14.915
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.430
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.153
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,51
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,75
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,12
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,37
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,68
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,6
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,31
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,59
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,65
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,85
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,51
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,78
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.959
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.440
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;12.185
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;10.567
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;10.130
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;11.494
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;10.178
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;9.783
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;10.981
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.773
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.414
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;10.556
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.194
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.916
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;10.032
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,42
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,03
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,33
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,87
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,71
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,12
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,18
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,17
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,63
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,89
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,4
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,33
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;32.295
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;31.086
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;29.992
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;31.262
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;30.124
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;28.966
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;30.225
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;29.163
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;27.811
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;28.582
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;27.897
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;26.531
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;26.941
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;25.732
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
12 Galicia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,8
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,91
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,58
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,59
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,81
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,73
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,5
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,74
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,46
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,67
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,8
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;19.889
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;19.107
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.271
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;19.281
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;18.534
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;17.769
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;18.693
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.965
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.094
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;17.682
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;17.234
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.350
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;16.647
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;15.839
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
12 Galicia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,94
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,25
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,99
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,02
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,56
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,9
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,2
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,49
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,13
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,69
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;12.406
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;11.979
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;11.721
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;11.981
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;11.590
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;11.197
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;11.532
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;11.198
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;10.717
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;10.900
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;10.663
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;10.181
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;10.294
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;9.893
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
12 Galicia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,57
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,75
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,53
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,96
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,48
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,43
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,86
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,01
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,86
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,93
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,4
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;31.605
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;30.470
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;29.224
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;30.474
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;29.432
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;28.006
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;28.775
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;28.121
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;26.697
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;27.157
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;25.890
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;26.241
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;25.060
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,42
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,59
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,83
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,05
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,29
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,35
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,13
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,59
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,12
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,75
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;19.450
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.729
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;17.921
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;18.825
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.120
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;17.215
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.787
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.364
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.451
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;16.772
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;15.936
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;16.235
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;15.441
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,79
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,75
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,06
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,45
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,71
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,8
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,55
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,92
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,68
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,16
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;12.155
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;11.741
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;11.303
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;11.649
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;11.312
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;10.791
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;10.988
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;10.757
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;10.246
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;10.385
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;9.954
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;10.006
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;9.619
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,84
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,35
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,47
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,4
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,62
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,65
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,45
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,07
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,22
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,1
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;30.716
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;29.700
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.258
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;28.952
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;28.315
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;26.892
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;27.339
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;26.070
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;26.413
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;25.230
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.484
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;24.361
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,26
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,34
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,17
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,05
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,26
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,93
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,28
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,8
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,21
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;18.953
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.263
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;17.356
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.885
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.466
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;16.556
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;16.867
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;16.030
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;16.325
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;15.527
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;15.795
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.020
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,37
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,64
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,39
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,36
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,36
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,39
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,46
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,49
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,54
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;11.763
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;11.437
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;10.902
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;11.067
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.849
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;10.336
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;10.472
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;10.040
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;10.088
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;9.703
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.689
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;9.341
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,08
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,86
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,81
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,56
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,09
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,2
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,72
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,68
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
12 Galicia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;410.028
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;400.372
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;403.971
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;394.336
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;387.783
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;375.413
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;379.906
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;374.671
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;366.637
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;368.423
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;364.049
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;356.084
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;355.967
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;352.799
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;345.133
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,17
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,86
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,93
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,65
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,58
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,76
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,85
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,93
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,15
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,82
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,12
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,44
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;262.316
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;258.656
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;260.630
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;252.943
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;250.877
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;243.508
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;244.580
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;242.945
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;238.331
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;237.781
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;236.429
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;232.041
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;230.306
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;229.430
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;225.320
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,43
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,99
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,43
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,24
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,93
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,44
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,65
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,41
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,03
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,8
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,7
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,45
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;147.712
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;141.716
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;143.341
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;141.393
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;136.906
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;131.905
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;135.326
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;131.726
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;128.306
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;130.642
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;127.620
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;124.043
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;125.661
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;123.369
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;119.813
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,72
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,61
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,02
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,61
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,95
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,51
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,44
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,05
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,54
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,07
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,05
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,59
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;411.625
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;404.496
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;394.549
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;395.447
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;389.437
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;384.480
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;382.794
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;377.559
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;372.299
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;369.253
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;365.247
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;360.208
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;353.587
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;351.103
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,07
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,28
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,45
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,34
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,36
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,71
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,3
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,3
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,41
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;88,99
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;262.865
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;260.835
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;255.153
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;253.478
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;251.707
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;249.084
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;245.974
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;244.419
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;241.737
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;237.865
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;236.783
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;234.348
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;229.766
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;228.781
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,43
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,5
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,62
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,57
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,71
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,74
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,49
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,78
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,85
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,09
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,66
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;148.760
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;143.661
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;139.396
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;141.969
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;137.730
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;135.396
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;136.820
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;133.140
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;130.562
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;131.388
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;128.464
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;125.860
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;123.821
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;122.322
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,43
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,87
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,13
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,97
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,68
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,66
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,32
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,42
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,29
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,19
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,75
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;411.730
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;406.863
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;396.510
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;397.277
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;393.100
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;382.916
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;382.308
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;379.363
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;369.878
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;366.662
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;360.147
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;355.086
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;349.896
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,49
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,62
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,57
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,85
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,24
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,28
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,12
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,83
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,27
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,24
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;262.951
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;261.829
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;256.806
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;254.378
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;253.385
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;248.567
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;245.432
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;244.891
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;240.561
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;237.252
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;234.574
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;230.423
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;228.352
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,74
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,77
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,79
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,34
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,53
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,67
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,61
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,34
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,01
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,92
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;148.779
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;145.034
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;139.704
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;142.899
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;139.715
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;134.349
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;136.876
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;134.472
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;129.317
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;129.410
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;125.573
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;124.663
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;121.544
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,05
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,33
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,17
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,72
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,56
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,23
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,89
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,95
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;411.283
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;407.566
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;397.796
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;394.726
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;392.302
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;382.998
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;378.543
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;372.196
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;365.833
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;360.762
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;355.410
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;351.233
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,97
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,25
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,28
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,88
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,56
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,76
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,69
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,2
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,29
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;262.460
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;261.760
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;257.566
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;252.577
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;252.337
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;248.484
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;244.099
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;241.810
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;236.641
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;234.883
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;230.453
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;229.021
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,23
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,4
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,47
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,25
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,88
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,4
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,19
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,04
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,92
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;148.823
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;145.806
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;140.230
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;142.149
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;139.965
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;134.514
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;134.444
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;130.386
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;129.192
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;125.879
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;124.957
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;122.212
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,52
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,99
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,92
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,21
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,98
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,61
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;89,77
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,7
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,15
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;29.355
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;27.814
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;23.062
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;27.060
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;26.046
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;20.230
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;25.206
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;24.152
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;19.437
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;23.646
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;22.580
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;18.393
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;22.197
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;21.185
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;17.391
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;92,18
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,64
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,72
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;85,87
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,83
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,28
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80,55
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,18
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,75
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,62
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;76,17
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,41
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.694
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;17.268
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;14.466
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;16.346
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;16.180
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;12.785
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;15.290
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;15.010
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;12.310
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;14.392
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.029
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;11.705
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;13.554
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;13.184
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.071
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,38
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,7
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;88,38
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,41
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;86,92
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;85,1
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;81,34
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;81,24
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;80,91
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;76,6
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,35
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;76,53
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;11.661
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.546
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.596
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;10.714
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;9.866
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;7.445
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;9.916
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;9.142
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;7.127
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.254
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.551
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.688
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.643
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.001
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;6.320
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;91,88
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,55
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;86,61
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,04
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;86,69
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,91
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,36
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;81,08
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;77,8
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;74,12
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,87
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,52
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;26.195
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.504
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;23.364
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;24.246
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;23.375
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;22.358
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;22.633
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;21.707
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;21.026
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;21.155
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;20.260
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.809
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;18.880
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;18.855
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,56
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,65
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,69
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,4
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;85,11
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,99
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,76
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;79,44
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,78
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;74,03
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,7
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;15.808
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;15.834
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;14.651
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;14.692
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;14.523
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;14.031
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;13.747
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.498
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;13.254
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.885
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.633
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.488
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;11.806
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;11.895
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,94
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,72
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,77
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,96
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,25
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,46
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,51
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;79,78
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,24
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,56
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;81,19
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.387
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.670
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.713
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;9.554
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;8.852
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;8.327
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.886
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.209
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.772
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.270
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.627
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.321
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;7.074
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;6.960
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,98
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,54
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,57
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,55
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;84,89
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,2
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,62
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,87
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,02
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,15
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,88
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.510
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.727
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.348
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;25.496
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;24.615
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.719
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;23.724
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.874
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.316
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;21.260
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;20.250
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;20.010
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;19.048
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,68
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,1
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,31
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,24
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,58
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;87,55
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;79,55
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;83,17
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,87
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,23
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.634
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;16.407
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.289
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;15.450
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.106
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.318
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;14.434
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;14.083
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;13.431
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;13.124
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;12.764
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;12.394
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;12.029
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,88
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,07
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,65
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,77
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,84
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;87,85
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;79,99
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;83,48
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,54
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,68
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.876
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.320
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.059
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;10.046
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.509
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.401
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.290
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.791
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.885
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;8.136
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;7.486
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;7.616
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;7.019
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,37
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,14
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,74
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,42
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,18
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,04
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;78,84
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,64
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;73,8
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,48
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.422
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;27.593
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;25.704
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;26.352
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;25.541
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;23.911
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;23.661
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;22.597
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;22.181
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;21.116
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.897
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.848
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,72
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,56
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,02
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,75
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,91
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,39
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;82,15
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,73
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,22
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.175
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;16.766
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;16.137
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.982
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;15.570
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.003
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;14.464
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;14.181
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;13.602
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;13.276
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;12.858
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.490
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,05
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,87
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,97
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,27
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,88
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;81,13
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;82,27
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;76,69
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,4
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;11.247
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.827
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.567
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;10.370
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.971
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.908
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;9.197
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;8.416
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;8.579
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;7.840
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.039
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.358
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,2
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,09
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,11
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;84,95
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,97
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,24
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;81,95
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,25
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,91
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;84.410
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;84.529
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;82.900
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;80.528
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;81.250
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;75.858
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;76.897
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;77.920
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;73.759
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;74.016
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;75.173
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;71.113
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;71.162
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;72.348
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;68.502
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,4
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,12
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;91,51
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,1
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,18
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,97
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,69
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,93
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,78
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,31
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,59
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,63
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;50.877
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;51.754
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;50.413
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;48.653
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;49.755
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;46.421
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;46.593
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;47.776
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;45.254
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;44.946
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;46.094
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;43.755
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;43.369
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;44.378
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;42.230
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,63
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,14
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,08
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,58
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,31
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,77
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,34
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,06
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,79
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,24
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,75
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,77
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;33.533
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;32.775
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;32.487
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;31.875
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;31.495
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;29.437
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;30.304
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;30.144
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;28.505
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;29.070
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;29.079
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;27.358
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;27.793
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;27.970
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;26.272
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,06
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,09
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,61
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,37
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,97
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,74
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,69
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,72
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,21
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,88
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,34
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,87
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;80.768
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;81.165
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;81.057
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;76.753
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;77.344
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;78.636
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;73.600
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;74.281
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;75.632
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;70.536
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;71.253
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;72.692
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;68.478
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;70.439
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,03
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,29
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,01
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,13
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,52
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,31
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,33
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,79
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,68
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,37
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,9
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;48.422
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;49.469
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;49.434
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;46.142
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;47.176
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;48.062
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;44.342
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;45.295
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;46.355
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;42.622
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;43.452
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;44.641
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;41.875
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;43.301
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,29
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,36
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,22
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,57
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,56
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,77
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,02
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;87,84
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,3
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,65
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;87,59
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;32.346
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;31.696
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;31.623
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;30.611
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;30.168
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;30.574
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;29.258
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;28.986
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;29.277
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;27.914
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;27.801
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;28.051
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;26.603
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;27.138
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,64
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,18
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,68
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,45
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,45
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,58
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,3
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,71
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,7
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;83,93
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,82
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;81.413
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;82.518
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;82.163
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;77.804
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;78.936
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;78.799
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;74.368
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;75.494
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;75.596
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;72.399
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;73.122
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;69.570
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;70.588
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,57
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,66
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,91
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,35
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,49
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,01
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,74
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,31
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,91
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;48.826
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;50.107
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;50.315
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;46.761
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;47.919
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;48.385
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;44.821
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;45.825
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;46.500
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;44.052
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;45.008
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;42.458
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;43.504
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,77
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,63
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,16
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,8
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,45
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,42
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,92
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,45
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,73
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,46
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;32.587
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;32.411
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;31.848
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;31.043
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;31.017
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;30.414
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;29.547
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;29.669
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;29.096
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;28.347
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;28.114
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;27.112
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;27.084
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,26
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,7
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,5
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,67
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,54
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,36
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,46
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,28
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,65
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;85,04
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;81.893
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;83.209
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;83.189
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;78.040
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;79.360
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;79.514
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;75.959
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;76.711
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;72.796
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;73.833
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;70.219
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;71.409
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,3
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,37
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,58
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,29
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,21
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,49
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,75
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,39
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,84
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;49.115
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;50.412
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;50.983
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;46.927
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;48.064
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;48.830
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;46.116
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;47.141
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;44.312
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;45.435
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;42.839
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;43.943
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,55
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,34
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,78
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,48
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,46
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,9
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,12
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,98
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,19
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;32.778
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;32.797
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;32.206
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;31.113
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;31.296
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;30.684
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;29.843
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;29.570
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;28.484
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;28.398
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;27.380
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;27.466
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,92
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,42
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,27
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,99
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,82
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,85
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,18
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,48
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;85,28
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;134.239
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;131.898
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;133.686
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;129.666
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;128.316
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;124.537
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;125.505
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;124.614
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;121.888
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;122.370
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;121.746
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;118.920
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;118.972
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;118.680
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;115.737
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,59
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,28
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,16
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,49
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,48
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,17
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,16
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,3
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,95
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,63
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,98
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,57
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;86.419
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;85.771
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;86.600
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;83.722
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;83.557
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;81.123
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;81.356
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;81.340
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;79.601
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;79.487
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;79.635
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;77.837
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;77.447
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;77.748
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;75.905
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,88
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,42
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,68
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,14
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,83
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,92
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,98
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,85
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,88
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,62
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,65
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,65
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;47.820
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;46.127
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;47.086
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;45.944
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;44.759
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;43.414
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;44.149
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;43.274
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;42.287
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;42.883
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;42.111
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;41.083
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;41.525
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;40.932
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;39.832
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,08
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,03
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,2
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,32
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,81
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,81
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,68
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,29
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,25
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,84
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,74
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,59
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;132.997
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;132.284
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;130.054
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;128.321
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;128.049
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;127.019
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;124.827
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;124.755
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;123.698
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;121.079
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;121.312
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;120.183
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;117.879
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;117.531
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,48
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,8
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,67
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,86
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,31
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,11
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,04
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,71
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,41
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,11
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,37
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;85.108
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;85.620
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;84.494
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;82.442
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;83.081
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;82.701
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;80.360
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;81.104
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;80.721
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;78.141
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;78.967
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;78.605
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;76.922
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;76.994
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,87
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,03
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,88
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,42
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,73
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,53
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,81
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,23
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,03
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,84
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,12
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;47.889
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;46.664
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;45.560
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;45.879
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;44.968
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;44.318
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;44.467
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;43.651
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;42.977
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;42.938
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;42.345
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;41.578
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;40.957
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;40.537
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,8
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,37
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,27
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,85
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,54
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,33
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,66
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,74
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,26
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,77
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,97
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;132.968
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;133.068
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;130.780
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;128.986
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;129.281
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;127.005
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;124.824
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;125.427
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;123.209
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;121.713
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;120.390
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;118.335
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;117.451
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,01
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,15
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,11
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,88
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,26
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,21
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,47
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,06
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,93
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,81
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;85.102
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;86.022
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;85.139
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;82.729
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;83.732
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;82.870
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;80.273
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;81.336
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;80.571
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;79.138
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;78.848
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;77.183
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;77.075
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,21
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,34
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,33
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,33
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,55
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,63
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,61
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,72
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,53
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;47.866
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;47.046
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;45.641
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;46.257
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;45.549
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;44.135
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;44.551
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;44.091
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;42.638
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;42.575
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;41.542
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;41.152
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;40.376
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,64
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,82
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,7
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,07
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,72
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,42
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,5
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,02
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,47
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,46
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;132.880
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;133.485
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;131.289
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;128.232
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;129.167
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;127.007
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;125.171
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;123.905
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;121.475
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;120.661
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;118.623
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;118.077
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,5
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,77
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,74
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,77
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,38
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,9
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,87
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,94
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;84.940
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;86.213
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;85.510
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;82.204
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;83.532
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;82.906
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;81.167
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;80.991
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;79.045
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;79.032
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;77.338
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;77.484
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,78
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,89
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,95
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,15
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,72
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,69
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,42
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;89,71
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,61
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;47.940
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;47.272
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;45.779
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;46.028
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;45.635
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;44.101
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;44.004
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;42.914
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;42.430
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;41.629
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;41.285
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;40.593
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,01
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,54
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,33
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,09
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,74
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,76
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,93
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,33
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,67
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;112.335
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;108.436
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;111.031
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;109.294
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;106.104
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;104.932
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;106.361
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;103.623
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;103.115
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;104.093
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;101.714
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;101.011
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;101.537
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;99.590
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;98.813
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,29
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,85
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,51
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,68
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,56
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,87
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,66
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,8
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,98
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,39
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,84
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;73.821
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;71.562
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;73.160
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;71.931
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;70.164
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;69.432
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;70.200
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;68.690
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;68.310
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;68.838
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;67.523
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;67.060
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;67.298
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;66.186
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;65.702
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,44
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,05
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,9
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,09
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,99
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,37
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,25
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,36
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,66
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,16
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,49
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,81
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;38.514
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;36.874
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;37.871
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;37.363
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;35.940
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;35.500
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;36.161
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;34.933
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;34.805
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;35.255
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;34.191
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;33.951
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;34.239
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;33.404
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;33.111
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,01
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,47
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,74
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,89
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,74
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,9
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,54
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,72
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,65
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,9
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,59
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,43
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;115.822
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;112.319
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;108.623
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;112.411
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;109.379
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;106.558
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;109.861
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;107.202
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;104.159
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;107.042
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;104.821
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;101.767
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;102.427
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;99.979
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,05
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,38
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,1
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,85
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,44
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,89
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,42
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,32
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,69
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,19
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,04
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;75.859
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;73.969
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;71.744
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;73.851
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;72.227
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;70.446
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;72.329
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;70.900
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;68.982
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;70.640
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;69.424
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;67.508
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;67.938
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;66.452
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,35
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,64
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,19
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,35
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,85
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,15
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,12
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,86
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,1
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,85
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,62
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;39.963
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;38.350
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;36.879
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;38.560
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;37.152
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;36.112
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;37.532
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;36.302
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;35.177
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;36.402
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;35.397
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;34.259
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;34.489
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;33.527
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,49
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,88
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,92
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,92
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,66
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,38
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,09
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,3
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,9
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,93
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,91
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;115.281
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;112.431
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;108.710
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;112.396
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;109.933
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;106.095
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;109.321
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;107.324
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;103.531
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;104.773
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;101.648
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;102.358
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;99.625
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,5
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,78
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,59
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,83
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,46
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,24
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,19
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,5
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,04
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,64
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;75.567
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;74.079
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;71.822
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;73.839
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;72.560
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;70.228
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;71.983
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;70.945
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;68.645
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;69.348
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;67.525
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;67.878
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;66.311
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,71
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,95
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,78
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,26
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,77
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,58
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,61
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,02
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,63
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,33
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;39.714
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;38.352
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;36.888
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;38.557
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;37.373
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;35.867
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;37.338
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;36.379
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;34.886
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;35.425
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;34.123
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;34.480
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;33.314
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,09
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,45
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,23
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,02
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,86
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,57
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,37
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,5
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,9
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,31
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;114.785
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;112.259
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;108.558
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;111.423
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;109.404
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;105.696
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;106.704
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;103.643
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;104.095
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;101.422
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;101.969
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;99.644
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,07
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,46
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,36
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,05
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,47
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,73
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,43
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,83
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,79
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;75.211
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;73.925
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;71.708
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;73.179
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;72.159
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;69.934
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;70.479
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;68.699
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;68.919
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;67.374
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;67.649
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;66.290
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,3
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,61
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,53
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,34
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,8
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,23
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,96
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,51
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,44
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;39.574
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;38.334
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;36.850
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;38.244
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;37.245
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;35.762
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;36.225
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;34.944
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;35.176
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;34.048
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;34.320
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;33.354
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,64
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,16
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,05
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,5
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,83
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,76
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,4
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,53
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,51
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;49.689
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;47.695
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;53.292
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;47.788
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;46.067
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;49.856
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;45.937
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;44.362
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;48.438
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;44.298
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;42.836
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;46.647
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;42.099
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;40.996
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;44.690
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,17
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,59
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,55
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,45
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,01
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,89
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,15
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,81
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,53
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,72
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,95
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,86
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;33.505
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;32.301
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;35.991
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;32.291
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;31.221
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;33.747
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;31.141
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;30.129
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;32.856
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;30.118
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;29.148
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;31.684
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;28.638
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;27.934
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;30.412
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,38
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,66
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,77
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,94
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,28
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,29
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,89
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,24
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,03
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,47
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86,48
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,5
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;16.184
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;15.394
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;17.301
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;15.497
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;14.846
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;16.109
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;14.796
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;14.233
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;15.582
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;14.180
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.688
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;14.963
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.461
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;13.062
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;14.278
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,76
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,44
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,11
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,42
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,46
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,06
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,62
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,92
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,49
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,17
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,85
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,53
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;55.843
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;53.224
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;51.451
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;53.716
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;51.290
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;49.909
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;51.873
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;49.614
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;47.784
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;49.441
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;47.601
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;45.757
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;45.923
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;44.299
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,19
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,37
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,89
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,22
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,87
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,54
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,44
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,93
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,28
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,1
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;37.668
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;35.943
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;34.830
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;36.351
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;34.700
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;33.844
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;35.196
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;33.622
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;32.425
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;33.577
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;32.307
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;31.106
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;31.225
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;30.139
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,5
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,54
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,17
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,44
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,54
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,1
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,14
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,88
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,31
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,87
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,53
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;18.175
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;17.281
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;16.621
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;17.365
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;16.590
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;16.065
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;16.677
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;15.992
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;15.359
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;15.864
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;15.294
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;14.651
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;14.698
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;14.160
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,54
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,65
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,76
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,54
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,41
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,28
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,5
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,15
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,05
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,19
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;54.558
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;52.119
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;50.509
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;52.595
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;50.335
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;48.298
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;50.071
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;48.244
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;46.226
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;46.517
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;44.737
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;44.813
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;43.184
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,4
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,62
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,78
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,57
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,52
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,25
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,57
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,98
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,5
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;36.822
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;35.214
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;34.241
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;35.599
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;34.068
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;32.766
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;33.921
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;32.702
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;31.414
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;31.590
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;30.429
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;30.510
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;29.433
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,68
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,75
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,69
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,12
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,87
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,74
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,71
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,87
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,64
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,96
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;17.736
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;16.905
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;16.268
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;16.996
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;16.267
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;15.532
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;16.150
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;15.542
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;14.812
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;14.927
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;14.308
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;14.303
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;13.751
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,83
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,23
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,48
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,06
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,94
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,05
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,3
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,95
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,61
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,53
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;53.303
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;51.020
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;49.056
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;50.679
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;48.830
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;46.870
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;47.048
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;45.340
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;45.286
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;43.730
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;43.702
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;42.255
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,08
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,71
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,54
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,21
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,42
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,76
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,14
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,66
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,14
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;36.019
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;34.444
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;33.228
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;34.285
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;33.012
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;31.811
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;31.873
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;30.798
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;30.763
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;29.766
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;29.769
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;28.814
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,19
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,84
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,74
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,54
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,69
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,31
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,58
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,43
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,72
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;17.284
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;16.576
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;15.828
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;16.394
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;15.818
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;15.059
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;15.175
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;14.542
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;14.523
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;13.964
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;13.933
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.441
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,85
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,43
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,14
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,55
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,88
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,61
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,22
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,06
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,92
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
13 Madrid, Comunidad de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;92.618
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;90.861
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;90.780
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;89.374
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;88.513
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;85.167
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;86.231
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;85.815
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;83.518
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;83.817
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;83.659
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;81.327
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;81.194
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;81.398
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;79.292
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,5
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,42
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,82
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,1
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,45
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,5
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,07
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,59
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,67
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,59
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,35
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;58.869
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;58.183
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;58.082
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;56.965
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;56.764
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;54.737
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;55.179
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;55.136
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;53.749
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;53.727
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;53.843
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;52.497
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;52.129
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;52.443
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;51.261
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,77
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,56
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,24
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,73
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,76
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,54
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,27
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,54
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,38
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,55
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,13
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,26
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;33.749
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;32.678
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;32.698
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;32.409
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;31.749
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;30.430
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;31.052
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;30.679
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;29.769
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;30.090
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;29.816
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;28.830
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;29.065
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;28.955
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;28.031
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,03
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,16
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,06
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,01
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,88
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,04
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,16
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,24
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,17
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,12
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,61
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,73
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;92.789
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;91.953
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;89.191
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;89.311
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;88.885
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;87.336
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;86.687
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;86.481
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;84.800
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;83.819
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;83.983
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;82.539
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;81.465
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;80.776
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,25
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,66
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,92
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,42
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,05
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,08
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,33
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,33
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,54
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,59
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,57
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;58.951
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;58.841
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;57.209
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;56.959
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;56.973
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;56.088
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;55.372
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;55.529
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;54.597
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;53.620
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;53.978
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;53.217
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;52.525
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;52.164
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,62
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,83
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,04
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,93
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,37
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,43
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,96
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,74
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,02
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,27
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,18
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;33.838
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;33.112
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;31.982
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;32.352
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;31.912
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;31.248
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;31.315
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;30.952
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;30.203
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;30.199
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;30.005
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;29.322
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;28.940
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;28.612
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,61
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,38
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,7
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,54
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,48
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,44
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,25
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;90,62
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,68
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,4
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,46
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;92.717
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;92.407
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;90.436
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;89.565
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;89.503
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;87.420
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;86.317
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;86.694
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;84.901
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;83.993
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;83.009
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;81.403
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;80.804
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,6
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,86
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,67
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,1
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,82
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,88
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,89
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,79
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,09
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,35
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;58.933
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;59.014
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;58.061
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;57.042
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;57.281
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;56.271
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;55.056
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;55.558
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;54.717
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;53.986
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;53.579
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;52.488
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;52.233
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,79
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,06
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,92
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,42
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,14
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,24
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,48
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,28
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,94
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,96
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;33.784
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;33.393
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;32.375
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;32.523
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;32.222
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;31.149
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;31.261
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;31.136
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;30.184
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;30.007
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;29.430
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;28.915
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;28.571
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,27
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,49
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,21
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,53
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,24
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,23
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,86
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,9
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,59
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,25
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;92.573
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;92.435
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;90.379
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;88.963
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;89.278
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;87.539
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;86.384
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;85.471
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;83.572
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;83.062
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;81.348
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;81.113
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,1
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,58
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,86
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,45
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,57
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,41
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,9
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,01
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,75
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;58.757
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;58.952
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;57.981
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;56.550
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;57.014
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;56.231
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;55.326
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;54.983
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;53.711
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;53.523
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;52.376
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;52.349
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,24
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,71
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,98
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,85
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,83
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,11
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,31
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,85
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,29
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;33.816
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;33.483
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;32.398
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;32.413
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;32.264
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;31.308
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;31.058
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;30.488
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;29.861
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;29.539
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;28.972
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;28.764
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,85
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,36
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,64
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,76
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,1
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,18
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,18
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,53
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,78
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.764
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.568
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;5.489
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;6.318
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;6.223
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;4.896
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;5.879
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;5.875
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;4.733
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.517
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.549
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.483
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.211
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;5.267
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.265
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,41
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,75
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;89,2
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,92
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;89,45
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;86,23
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,56
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,49
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;81,67
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;77,04
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,19
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;77,7
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.198
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.085
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.403
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;3.931
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;3.878
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.052
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;3.688
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;3.677
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;2.961
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.470
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.481
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.827
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.282
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.312
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.699
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;93,64
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,93
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,69
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,85
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,01
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,01
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,66
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;85,21
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;83,07
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;78,18
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;81,08
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;79,31
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.566
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.483
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.086
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;2.387
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.345
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.844
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.191
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.198
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.772
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.047
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.068
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.656
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.929
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.955
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.566
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,02
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,44
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,4
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,39
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,52
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,95
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,77
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,29
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,39
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,18
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,74
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;75,07
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;5.889
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;5.823
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;5.565
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;5.441
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;5.429
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;5.358
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.075
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.094
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.065
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;4.767
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;4.807
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.798
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;4.532
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;4.584
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,39
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;93,23
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,28
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;86,18
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;87,48
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,02
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;80,95
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,55
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,22
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,83
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,37
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.687
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.660
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.465
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;3.425
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;3.424
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;3.342
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.203
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.221
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.180
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.018
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.051
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.027
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;2.893
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;2.902
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,89
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;93,55
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,45
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,87
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;88,01
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,77
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;81,86
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;83,36
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,36
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;79,04
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,75
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.202
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.163
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.016
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.005
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.016
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.872
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.873
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.885
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.749
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.756
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.771
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.639
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.682
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,55
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,7
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,01
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,59
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,76
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,43
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;81,18
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,33
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;75,77
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,1
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.139
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.204
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;5.899
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;5.651
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;5.765
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;5.503
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.291
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;5.416
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.197
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;5.098
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;4.958
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;4.771
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;4.715
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;92,05
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,92
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;93,29
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,19
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;87,3
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;88,1
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;82,17
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,05
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;76,9
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,93
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.845
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.895
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.680
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.545
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.626
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.451
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.322
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.413
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.274
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.228
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.134
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.042
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;2.996
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,2
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;93,09
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,78
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;86,4
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;87,63
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,97
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;82,88
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,16
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;78,1
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;81,41
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.294
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.309
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.219
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.106
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.139
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.052
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.969
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.003
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.923
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;1.870
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.824
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.729
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.719
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,8
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,64
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,47
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;85,83
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;86,75
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,66
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;80,99
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;82,2
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;74,88
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,47
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.395
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.454
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.180
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;5.951
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.036
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.798
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;5.671
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;5.523
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;5.300
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;5.242
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;4.994
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;4.978
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,06
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;93,52
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,82
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;87,87
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;89,37
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;82,12
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;84,82
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;77,38
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;80,55
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.978
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.025
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.847
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.703
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.767
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.624
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;3.554
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;3.456
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;3.349
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.294
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.165
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.133
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,09
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;93,59
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,2
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;88,3
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;89,84
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;83,2
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;85,63
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;78,63
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,44
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.417
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.429
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.333
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.248
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.269
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.174
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.117
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.067
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;1.951
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;1.948
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.829
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.845
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,01
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,41
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,18
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,16
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,6
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,32
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,5
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,3
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;79,08
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;18.085
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;18.279
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;17.625
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;17.308
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;17.722
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;16.375
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;16.577
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;17.093
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;16.027
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;15.992
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;16.601
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;15.498
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;15.435
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;16.121
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;15.066
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,7
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,95
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,91
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,66
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,51
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,93
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,43
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,82
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,93
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,35
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,19
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,48
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;10.683
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;11.012
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;10.613
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;10.263
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;10.692
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;9.901
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;9.907
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;10.331
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;9.708
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;9.565
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;10.073
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;9.438
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;9.250
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;9.790
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;9.182
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,07
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,09
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,29
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,74
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,82
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,47
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,53
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,47
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,93
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,59
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,9
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,52
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.402
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.267
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;7.012
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;7.045
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;7.030
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;6.474
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;6.670
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;6.762
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;6.319
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.427
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.528
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;6.060
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.185
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.331
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;5.884
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,18
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,74
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,33
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,11
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,12
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,83
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,83
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,42
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,56
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,12
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,91
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;17.090
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;17.443
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;17.488
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;16.307
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;16.751
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;17.089
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;15.692
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;16.197
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;16.482
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;15.088
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;15.659
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;15.983
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;15.088
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;15.595
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,42
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,03
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,72
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,82
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,86
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,25
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,29
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,77
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,39
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,5
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,18
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;10.047
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;10.394
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;10.571
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;9.671
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;10.007
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;10.346
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;9.295
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;9.713
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;10.022
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.950
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;9.393
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;9.721
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;9.093
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;9.493
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,26
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,28
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,87
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,52
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,45
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,81
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,08
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,37
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,96
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,48
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,8
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.043
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.049
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;6.917
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;6.636
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;6.744
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;6.743
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;6.397
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;6.484
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;6.460
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;6.138
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;6.266
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;6.262
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;5.995
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;6.102
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,22
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,67
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,48
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,83
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,98
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,39
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,15
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,89
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,53
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,05
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,22
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;17.200
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;17.668
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;17.871
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;16.485
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;17.010
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;17.133
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;15.771
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;16.397
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;16.577
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;15.764
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;16.155
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;15.176
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;15.647
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,84
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,28
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,87
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,69
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,81
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;92,76
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,22
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;90,4
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,9
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,56
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;10.167
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;10.513
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;10.825
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;9.735
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;10.165
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;10.423
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;9.328
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;9.806
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;10.085
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;9.468
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;9.837
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;9.177
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;9.542
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,75
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,69
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,29
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,75
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,27
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,16
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,06
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,87
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,29
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,15
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.033
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.155
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.046
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;6.750
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;6.845
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;6.710
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;6.443
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;6.591
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;6.492
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;6.296
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;6.318
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;5.999
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;6.105
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,98
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,67
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,23
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,61
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,12
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,14
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,99
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;89,67
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,84
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,64
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;17.283
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;17.822
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;17.995
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;16.491
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;17.130
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;17.361
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;16.449
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;16.877
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;15.803
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;16.318
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;15.273
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;15.867
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,42
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,12
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,48
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,3
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,79
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,67
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,68
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,7
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,17
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;10.178
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;10.611
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;10.889
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;9.725
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;10.203
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;10.506
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;9.832
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;10.228
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;9.513
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;9.908
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;9.201
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;9.666
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,55
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,15
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,48
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,66
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,93
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,65
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,99
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,71
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,77
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.105
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.211
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.106
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;6.766
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;6.927
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;6.855
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;6.617
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;6.649
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;6.290
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;6.410
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.072
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.201
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,23
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,06
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,47
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,76
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,57
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,23
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,21
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,2
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,26
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;29.070
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;28.803
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;28.684
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;28.163
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;28.187
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;26.976
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;27.233
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;27.496
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;26.511
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;26.638
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;26.896
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;25.969
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;25.981
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;26.311
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;25.415
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,88
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,86
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,05
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,68
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,46
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,42
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,63
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,38
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,53
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,37
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,35
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,6
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;18.643
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;18.629
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;18.542
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;18.118
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;18.247
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;17.529
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;17.573
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;17.815
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;17.240
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;17.230
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;17.441
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.913
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.838
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;17.085
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;16.586
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,18
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,95
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,54
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,26
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,63
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,98
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,42
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,62
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,21
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,32
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,71
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,45
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.427
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.174
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;10.142
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;10.045
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;9.940
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;9.447
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;9.660
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;9.681
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;9.271
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;9.408
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.455
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;9.056
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;9.143
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.226
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.829
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,34
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,7
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,15
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,64
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,15
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,41
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,23
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,93
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,29
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,69
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,68
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,05
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;28.509
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;28.755
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;28.147
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;27.462
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;27.928
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;27.623
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.814
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;27.258
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;27.013
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;26.095
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;26.602
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;26.403
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;25.895
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;25.942
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,33
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,12
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,14
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,05
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,79
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,97
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,53
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,51
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,8
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,05
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,17
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;18.207
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;18.539
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;18.234
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;17.587
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;18.015
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;17.913
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.225
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;17.602
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;17.539
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.798
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;17.197
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;17.176
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;16.801
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;16.896
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,59
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,17
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,24
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,61
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,95
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,19
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,26
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,76
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,2
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,63
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,66
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;10.302
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;10.216
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.913
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;9.875
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;9.913
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;9.710
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.589
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;9.656
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;9.474
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.297
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;9.405
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;9.227
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;9.094
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;9.046
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,86
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,03
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,95
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,08
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,52
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,57
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,24
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,06
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,08
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,02
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;91,25
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;28.471
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;28.940
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;28.607
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;27.674
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;28.126
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;27.876
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.845
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;27.379
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;27.170
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;26.625
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;26.677
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;25.858
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;26.128
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,2
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,19
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,44
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,29
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,61
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,98
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;93,25
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,35
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;91,33
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;18.197
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;18.620
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;18.543
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.746
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;18.129
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;18.090
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.243
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;17.676
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;17.660
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;17.248
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;17.359
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;16.800
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;17.016
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,52
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,36
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,56
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,76
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,93
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,24
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,63
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;93,61
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,23
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;91,77
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;10.274
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;10.320
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;10.064
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.928
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.997
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.786
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.602
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;9.703
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;9.510
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;9.377
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;9.318
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;9.058
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;9.112
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,63
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,87
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,24
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,46
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,02
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,5
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,86
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,59
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,77
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,54
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;28.495
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;28.982
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;28.653
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;27.565
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;28.118
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;27.861
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;27.302
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;27.326
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;26.469
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;26.719
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;25.913
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;26.180
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,74
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,02
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,24
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,2
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,37
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,33
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,25
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,41
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,37
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;18.233
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;18.632
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;18.534
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.665
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;18.107
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;18.053
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;17.643
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;17.726
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;17.156
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;17.353
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.843
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;17.018
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,88
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,18
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,4
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,69
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,64
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,08
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,63
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,4
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,82
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;10.262
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;10.350
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;10.119
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.900
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;10.011
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.808
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;9.659
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;9.600
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;9.313
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;9.366
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;9.070
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;9.162
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,47
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,72
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,93
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,32
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,87
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,98
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,56
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;87,63
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,54
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;26.793
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;26.105
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;26.468
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;26.159
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;25.647
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;25.204
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;25.563
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;25.075
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;24.859
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;25.098
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;24.671
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;24.404
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;24.609
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;24.222
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;24.030
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,63
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,25
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,22
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,41
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,05
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,92
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,67
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,51
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,2
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,85
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,79
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,79
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;17.441
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;17.124
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;17.310
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;17.062
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;16.852
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;16.543
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;16.706
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;16.506
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;16.342
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;16.402
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;16.245
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;16.074
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;16.106
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;15.955
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;15.838
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,83
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,41
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,57
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,79
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,39
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,41
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,04
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,87
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,86
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,35
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,17
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,5
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;9.352
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;8.981
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.158
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;9.097
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;8.795
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;8.661
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;8.857
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;8.569
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;8.517
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.696
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;8.426
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.330
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.503
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;8.267
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.192
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,27
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,93
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,57
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,71
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,41
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,99
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,82
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,96
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,92
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,05
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,45
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;27.633
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;27.032
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;25.992
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;26.937
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;26.385
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;25.611
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;26.404
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;25.922
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;25.065
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;25.834
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;25.408
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;24.652
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;24.886
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;24.294
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,48
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,61
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,53
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,55
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,89
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,43
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;93,49
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,99
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,84
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,06
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,47
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.944
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;17.684
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;17.038
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;17.530
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;17.283
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;16.811
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;17.182
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;16.980
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;16.483
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;16.828
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;16.650
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;16.218
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;16.340
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;16.018
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,69
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,73
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,67
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,75
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,02
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,74
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,78
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,15
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,19
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,4
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,01
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.689
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.348
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.954
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;9.407
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;9.102
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;8.800
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;9.222
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.942
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;8.582
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;9.006
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.758
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.434
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;8.546
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;8.276
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,09
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,37
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,28
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,18
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,66
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,85
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,95
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,69
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,19
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,42
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,43
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;27.528
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;26.999
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;26.219
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;26.889
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;26.437
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;25.584
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;26.238
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;25.862
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;25.118
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;25.318
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;24.731
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;24.827
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;24.258
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,68
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,92
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,58
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,31
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,79
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,8
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,77
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,32
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,96
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,52
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;17.855
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;17.625
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;17.212
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;17.453
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;17.261
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;16.832
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;17.058
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;16.900
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;16.531
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;16.577
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;16.306
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;16.278
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;16.009
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,75
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,93
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,79
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,54
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,89
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,04
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,05
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,74
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,36
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,01
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.673
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.374
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.007
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.436
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.176
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;8.752
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;9.180
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.962
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;8.587
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;8.741
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;8.425
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;8.549
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;8.249
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,55
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,89
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,17
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,9
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,6
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,34
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,25
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,54
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;91,2
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,58
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;27.385
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;26.879
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;26.083
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;26.658
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;26.243
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;25.555
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;25.669
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;25.143
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;25.139
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;24.629
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;24.705
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;24.257
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,35
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,63
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,98
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,5
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,4
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,53
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,43
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,91
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;17.720
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;17.516
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;17.139
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;17.284
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;17.121
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;16.798
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;16.784
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;16.555
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;16.461
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;16.231
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;16.176
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;15.993
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,54
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,74
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,01
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,82
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,59
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,98
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,7
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,35
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,31
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.665
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.363
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;8.944
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.374
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.122
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;8.757
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;8.885
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;8.588
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;8.678
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;8.398
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.529
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.264
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,99
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,43
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,91
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,89
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,02
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,68
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,9
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,09
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;92,4
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;11.906
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;11.106
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.514
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;11.426
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;10.734
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;11.716
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;10.979
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;10.276
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;11.388
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;10.572
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;9.942
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;10.973
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;9.958
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;9.477
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;10.516
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,97
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,65
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,62
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,21
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,53
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,8
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,52
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,69
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,64
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,33
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;84,03
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.904
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.333
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.214
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;7.591
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;7.095
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;7.712
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;7.305
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;6.807
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;7.498
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.060
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;6.603
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.245
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;6.653
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;6.301
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;6.956
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,04
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,75
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,89
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,42
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,83
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,28
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,32
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,05
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,2
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,17
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,93
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,68
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.002
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;3.773
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.300
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;3.835
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;3.639
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;4.004
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;3.674
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;3.469
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;3.890
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;3.512
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;3.339
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;3.728
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;3.305
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;3.176
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;3.560
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,83
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,45
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,12
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,8
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,94
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,47
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,76
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,5
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,7
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;82,58
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;84,18
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,79
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;13.668
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.900
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;11.999
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;13.164
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;12.392
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;11.655
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.702
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.010
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;11.175
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.035
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.507
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;10.703
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;11.064
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;10.361
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,31
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,06
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,13
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,93
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,1
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,13
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,05
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,2
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;89,2
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,77
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,35
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;9.066
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.564
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;7.901
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;8.746
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;8.244
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;7.676
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;8.467
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;8.013
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.373
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;8.026
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.687
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.075
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;7.398
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;6.855
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,47
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,26
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,15
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,39
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,57
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,32
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,53
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,76
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,55
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,38
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,76
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.602
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.336
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.098
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;4.418
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;4.148
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;3.979
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.235
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;3.997
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;3.802
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.009
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;3.820
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;3.628
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;3.666
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;3.506
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,66
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,1
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,03
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,18
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,78
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,11
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,1
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,53
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,55
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;85,55
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;13.379
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.596
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;11.840
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.866
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.165
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;11.324
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.172
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;11.640
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;10.839
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;11.188
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;10.488
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;10.771
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;10.056
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,17
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,58
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,64
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,98
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,41
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,55
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,82
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,58
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,51
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,93
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.869
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.361
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;7.801
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.563
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.100
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.475
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;8.105
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.763
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.167
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;7.465
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;6.943
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;7.191
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;6.670
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,55
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,88
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,82
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,39
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,85
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,87
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,28
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,01
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,5
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.510
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.235
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.039
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.303
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.065
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;3.849
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.067
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;3.877
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;3.672
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;3.723
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;3.545
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;3.580
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;3.386
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,41
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,99
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,3
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,18
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,55
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,91
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,91
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,77
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,53
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,83
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;13.015
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.298
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;11.468
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.298
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;11.751
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;10.964
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;11.293
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;10.602
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;10.861
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;10.154
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;10.463
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;9.831
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,49
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,55
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,61
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,83
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,45
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,32
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,54
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,08
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,73
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.648
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.168
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.572
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.173
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.816
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.250
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;7.513
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;7.018
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;7.232
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;6.737
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;6.991
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;6.539
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,51
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,69
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,75
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,98
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,68
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,54
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,97
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,59
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,36
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.367
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.130
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;3.896
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.125
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;3.935
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;3.714
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;3.780
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;3.584
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;3.629
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;3.417
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;3.472
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;3.292
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,46
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,28
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,33
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,53
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,99
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,87
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,71
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;84,07
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,5
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
14 Murcia, Región de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;41.696
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;41.359
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;41.662
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;40.370
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;40.334
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;39.565
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;38.969
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;39.075
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;38.699
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;38.015
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;38.043
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;37.773
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;36.736
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;36.940
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;36.831
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,82
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,52
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,97
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,46
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,48
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,89
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,17
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,98
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,67
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,1
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,32
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;88,4
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;26.404
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;26.370
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;26.589
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;25.542
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;25.693
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;25.239
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;24.746
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;24.930
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;24.705
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;24.142
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;24.276
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;24.118
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;23.343
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;23.552
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;23.502
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,74
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,43
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,92
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,72
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,54
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,91
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,43
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,06
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,71
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,41
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;89,31
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,39
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;15.292
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;14.989
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;15.073
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;14.828
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;14.641
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;14.326
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;14.223
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;14.145
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;13.994
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;13.873
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;13.767
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;13.655
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;13.393
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;13.388
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;13.329
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,97
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,68
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,04
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,01
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,37
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,84
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,72
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,85
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,59
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,58
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,32
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,43
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;41.811
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;41.804
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;41.275
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;40.237
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;40.371
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;40.318
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;39.181
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;39.228
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;39.175
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;37.806
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;38.025
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;38.146
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;37.026
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;37.369
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,24
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,57
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,68
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,71
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,84
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,91
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;90,42
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,96
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,42
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,57
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,54
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;26.448
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;26.632
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;26.365
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;25.540
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;25.747
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;25.763
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;24.863
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;25.005
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;25.010
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;24.004
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;24.210
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;24.340
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;23.578
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;23.843
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,57
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,68
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,72
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,01
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,89
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,86
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,76
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,91
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,32
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,53
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,43
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;15.363
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;15.172
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;14.910
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;14.697
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;14.624
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;14.555
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;14.318
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;14.223
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;14.165
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;13.802
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;13.815
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;13.806
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;13.448
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;13.526
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,66
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,39
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,62
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,2
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,75
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,84
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,06
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,6
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,64
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,72
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;41.808
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;41.884
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;41.301
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;40.486
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;40.524
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;39.977
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;38.970
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;39.211
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;38.878
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;38.134
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;38.065
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;37.021
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;37.055
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,84
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,75
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,79
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,21
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,62
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,13
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,05
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,16
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,39
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,72
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;26.486
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;26.708
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;26.451
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;25.645
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;25.821
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;25.553
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;24.691
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;24.941
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;24.829
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;24.256
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;24.306
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;23.612
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;23.684
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,82
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,68
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,61
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,22
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,38
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,87
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,82
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,89
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;88,41
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,54
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;15.322
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;15.176
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;14.850
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;14.841
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;14.703
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;14.424
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;14.279
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;14.270
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;14.049
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;13.878
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;13.759
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;13.409
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;13.371
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,86
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,88
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,13
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,19
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,03
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,61
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,45
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,65
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,36
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,04
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;41.878
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;41.823
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;41.353
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;40.192
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;40.342
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;40.085
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;39.163
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;39.185
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;37.918
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;38.074
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;37.034
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;37.113
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,97
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,46
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,93
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,64
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,76
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;90,66
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,07
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,55
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,75
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;26.504
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;26.579
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;26.410
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;25.431
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;25.583
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;25.579
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;24.832
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;24.996
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;24.122
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;24.314
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;23.565
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;23.705
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,95
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,25
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,85
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,43
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,65
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,76
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,06
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,66
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,76
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;15.374
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;15.244
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;14.943
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;14.761
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;14.759
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;14.506
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;14.331
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;14.189
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;13.796
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;13.760
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;13.469
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;13.408
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,01
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,82
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,08
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,01
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,95
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;90,5
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,08
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;88,36
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,73
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;2.814
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;2.635
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;2.220
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;2.586
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;2.469
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;1.919
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;2.370
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;2.276
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;1.830
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.237
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.093
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.724
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.094
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.961
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.630
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;91,9
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;93,7
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,44
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;84,22
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;86,38
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;82,43
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;79,5
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;79,43
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;77,66
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;74,41
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;74,42
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;73,42
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.831
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.729
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.470
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;1.672
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;1.611
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;1.259
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;1.534
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;1.480
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;1.193
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.455
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.365
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.119
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.368
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.279
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.054
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;91,32
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,18
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,65
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;83,78
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;85,6
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;81,16
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;79,46
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;78,95
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;76,12
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;74,71
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;73,97
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,7
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;983
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;906
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;750
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;914
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;858
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;660
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;836
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;796
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;637
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;782
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;728
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;605
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;726
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;682
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;576
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;92,98
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,7
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;85,05
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;87,86
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,93
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;79,55
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;80,35
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,67
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,86
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;75,28
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;76,8
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;2.513
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;2.462
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;2.229
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;2.278
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;2.233
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;2.115
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.141
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.031
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.971
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.990
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.884
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.855
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;1.759
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;1.763
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,65
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;90,7
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;94,89
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,2
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;82,49
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;88,43
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,19
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;76,52
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,22
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;71,45
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;79,09
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.637
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.633
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.475
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;1.485
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;1.472
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;1.385
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.398
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.336
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.280
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.307
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.237
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.199
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;1.151
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;1.136
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;90,71
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;90,14
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;93,9
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,4
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;81,81
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;86,78
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,84
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;75,75
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;81,29
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;70,48
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;77,02
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;876
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;829
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;754
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;793
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;761
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;730
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;743
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;695
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;691
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;683
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;647
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;656
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;608
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;627
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;90,53
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,8
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,82
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,82
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;83,84
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,64
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,97
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;78,05
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;87
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;73,34
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;83,16
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;2.725
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;2.681
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;2.383
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.480
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;2.381
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;2.163
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.286
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.188
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;2.019
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;2.038
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;1.919
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;1.897
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;1.786
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,01
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;88,81
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;90,77
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,89
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;81,61
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;84,73
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;76,02
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;80,53
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;70,76
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;74,95
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.764
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.762
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.575
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.614
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.560
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.411
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.496
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.424
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.310
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;1.324
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;1.241
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;1.234
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;1.153
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,5
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;88,54
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,59
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,81
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;80,82
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;83,17
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;75,14
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;78,79
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;70,03
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;73,21
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;961
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;919
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;808
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;866
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;821
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;752
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;790
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;764
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;709
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;714
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;678
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;663
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;633
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,11
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;89,34
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,07
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;82,21
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;83,13
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;87,75
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;77,69
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,91
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;72,14
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;78,34
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;2.866
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;2.728
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;2.502
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.610
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;2.493
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;2.312
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;2.305
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;2.193
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;2.125
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;2.037
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.011
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.885
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,07
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,39
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,41
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;84,49
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,65
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;77,9
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;81,41
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;73,72
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;75,34
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.854
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.782
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.641
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.697
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.612
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.508
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;1.487
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;1.425
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;1.374
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;1.322
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.310
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.230
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,53
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;90,46
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;91,9
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;83,45
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;86,84
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,1
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;80,56
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;73,51
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;74,95
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.012
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;946
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;861
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;913
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;881
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;804
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;818
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;768
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;751
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;715
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;701
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;655
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,22
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,13
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,38
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;86,47
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;89,2
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;79,39
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,04
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;74,1
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;76,07
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;7.135
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.247
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.917
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;6.847
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;7.015
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;6.521
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;6.557
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;6.740
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;6.353
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.359
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.534
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.177
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.121
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.340
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.015
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,96
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,8
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,27
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,9
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,85
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,12
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,16
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,3
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,79
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,48
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,96
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.310
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.414
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.214
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;4.134
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;4.264
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;3.968
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;3.976
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;4.104
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;3.869
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.854
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.970
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.759
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.712
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.842
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.661
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,92
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,6
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,16
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,25
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,98
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,81
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,42
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,94
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,2
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,13
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,04
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,88
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.825
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.833
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.703
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;2.713
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;2.751
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;2.553
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;2.581
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;2.636
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;2.484
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.505
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.564
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.418
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.409
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.498
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.354
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,04
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,11
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,45
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,36
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,9
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,67
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,5
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,46
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,27
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,18
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;87,09
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.669
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.864
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.920
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;6.335
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;6.551
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;6.732
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.116
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.322
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.528
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.857
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.119
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.347
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;5.919
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;6.175
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,99
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,44
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,28
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,71
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,1
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,34
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,82
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,15
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,72
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,23
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,23
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.027
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.175
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.225
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;3.842
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;3.985
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;4.111
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.710
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.840
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.983
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.551
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.707
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.874
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;3.591
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;3.763
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,41
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,45
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,3
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,13
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,98
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,27
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,18
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,79
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,69
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,01
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,07
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.642
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.689
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.695
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;2.493
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;2.566
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;2.621
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.406
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.482
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.545
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.306
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.412
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.473
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;2.328
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;2.412
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,36
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,43
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,25
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,07
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,3
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,43
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;87,28
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,7
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,76
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,57
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,5
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.746
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.950
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.977
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.471
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.675
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.739
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.183
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.449
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.542
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;6.226
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;6.360
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;5.996
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;6.154
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,92
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,04
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,59
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,65
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,79
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,77
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,58
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,16
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,27
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,2
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.088
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.228
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.288
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.917
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.054
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.129
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.739
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.907
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.008
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;3.774
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;3.891
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;3.650
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;3.768
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,82
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,88
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,29
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,46
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,41
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,47
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,26
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,74
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,33
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;87,87
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.658
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.722
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.689
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.554
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.621
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.610
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.444
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.542
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.534
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;2.452
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;2.469
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;2.346
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;2.386
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,09
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,29
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,06
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,95
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,39
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,24
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,08
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,82
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,19
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,73
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.824
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.014
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.118
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.498
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.749
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.880
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;6.502
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;6.673
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;6.246
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;6.449
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;6.064
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.260
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,22
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,22
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,66
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,7
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,75
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,05
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,6
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,46
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,95
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.135
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.251
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.343
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.928
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.079
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.196
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;3.930
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;4.064
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;3.794
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;3.929
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.684
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.803
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,99
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,95
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,62
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,45
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,58
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,25
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,47
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,66
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,57
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.689
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.763
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.775
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.570
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.670
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.684
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;2.572
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;2.609
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;2.452
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;2.520
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.380
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.457
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,57
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,63
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,72
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,09
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,02
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,74
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,81
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,14
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,54
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.996
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;13.190
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;13.165
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;12.658
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;12.946
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;12.537
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;12.284
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;12.593
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;12.283
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;12.026
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;12.322
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;12.049
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.765
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;12.038
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.833
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,4
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,15
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,23
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,52
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,47
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,3
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,54
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,42
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,52
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;90,53
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,27
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,88
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;8.197
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;8.435
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.378
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;7.980
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;8.272
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;7.987
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;7.778
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;8.071
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;7.837
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.603
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.897
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.695
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.446
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.704
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.560
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,35
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,07
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,33
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,89
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,68
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,54
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,75
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,62
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,85
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;90,84
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,33
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,24
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.799
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.755
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.787
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;4.678
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;4.674
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;4.550
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;4.506
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;4.522
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;4.446
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.423
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.425
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.354
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.319
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.334
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.273
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,48
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,3
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,05
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,89
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,1
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,88
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,17
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,06
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,95
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,15
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;89,26
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.654
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.955
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;13.011
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;12.235
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;12.554
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;12.736
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;11.949
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.250
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.463
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;11.664
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;11.944
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.222
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;11.688
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;12.049
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,69
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,9
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,43
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,56
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,79
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,18
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,2
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;93,94
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,22
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;92,61
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;7.915
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.232
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.292
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;7.685
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;7.997
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;8.130
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.485
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.795
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.957
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.319
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.589
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.812
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;7.431
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;7.704
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,09
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,15
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,05
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,57
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,69
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,96
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,47
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,19
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;94,21
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,27
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;92,91
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.739
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.723
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.719
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;4.550
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;4.557
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;4.606
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.464
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.455
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.506
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.345
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.355
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.410
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;4.257
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;4.345
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,01
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,49
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,61
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,2
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,33
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,49
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;91,69
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,21
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,45
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,13
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,07
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.650
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.950
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;13.000
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.306
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.603
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.691
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;11.980
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.273
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.436
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;11.997
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;12.251
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;11.710
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;11.976
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,28
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,32
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,62
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,7
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,77
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,66
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,64
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,24
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,42
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,12
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;7.921
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.255
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.312
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;7.686
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;8.022
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;8.113
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.493
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.798
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.957
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;7.627
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;7.840
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;7.463
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;7.675
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,03
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,18
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,61
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,6
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,46
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,73
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,39
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,32
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,41
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,34
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.729
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.695
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.688
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.620
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.581
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.578
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.487
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.475
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.479
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;4.370
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;4.411
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;4.247
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;4.301
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,7
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,57
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,65
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;94,88
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,31
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,54
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,08
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,09
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,46
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,74
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.690
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.979
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;13.105
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.329
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.602
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.809
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;12.302
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;12.594
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;11.975
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;12.276
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.738
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;12.019
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,16
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,1
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,74
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,78
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,1
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,26
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;93,67
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;90,44
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;91,71
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;7.920
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.230
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;8.376
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;7.703
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.976
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;8.191
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;7.787
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;8.052
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;7.605
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;7.864
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.442
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.700
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,26
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,91
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,79
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,62
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,13
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,41
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;93,89
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,43
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,93
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.770
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.749
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.729
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.626
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.626
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.618
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;4.515
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;4.542
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;4.370
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;4.412
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.296
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.319
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,98
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,41
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,65
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,07
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,05
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92,02
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,3
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,46
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,33
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;12.579
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;12.475
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;12.669
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;12.323
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;12.295
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;12.261
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;12.046
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;12.074
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;12.104
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;11.889
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;11.890
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;11.930
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;11.703
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;11.695
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;11.773
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,96
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,56
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,78
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,76
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,79
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,54
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,51
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,31
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,17
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,04
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,75
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;92,93
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;7.998
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;7.957
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;8.083
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;7.840
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;7.838
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;7.830
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;7.684
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;7.702
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;7.736
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;7.589
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;7.591
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;7.629
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;7.474
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;7.463
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;7.531
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,02
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,5
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,87
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,07
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,8
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,71
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,89
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,4
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;94,38
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,45
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,79
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,17
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;4.581
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;4.518
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;4.586
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;4.483
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;4.457
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;4.431
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;4.362
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;4.372
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;4.368
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;4.300
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;4.299
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;4.301
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;4.229
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;4.232
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;4.242
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,86
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,65
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,62
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;95,22
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,77
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,25
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,87
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,15
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,79
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,32
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,67
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,5
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;12.859
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;12.702
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;12.627
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;12.552
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;12.450
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;12.453
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;12.356
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;12.256
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;12.211
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;12.146
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;12.035
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;12.038
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;11.817
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;11.891
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,61
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,02
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,62
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,09
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,49
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,71
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,46
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94,75
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,34
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,03
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,17
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;8.223
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;8.111
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;8.063
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;8.047
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;7.959
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;7.958
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;7.927
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;7.839
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;7.802
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;7.792
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;7.689
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;7.692
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;7.557
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;7.598
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,86
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,13
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,7
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,4
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,65
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,76
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,76
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,8
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,4
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;93,17
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,23
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;4.636
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;4.591
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;4.564
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;4.505
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;4.491
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;4.495
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;4.429
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;4.417
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;4.409
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;4.354
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;4.346
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;4.346
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;4.260
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;4.293
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,17
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,82
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,49
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,53
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,21
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,6
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,92
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,66
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,22
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,79
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,06
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;12.793
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;12.663
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;12.611
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;12.564
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;12.448
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;12.342
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;12.331
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;12.214
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;12.158
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;11.992
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;12.006
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;11.765
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;11.817
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,21
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,3
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,87
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,39
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,45
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,41
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,7
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,2
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,91
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,7
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;8.193
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;8.089
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;8.070
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;8.053
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;7.957
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;7.892
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;7.901
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;7.795
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;7.772
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;7.660
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;7.673
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;7.528
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;7.556
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,29
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,37
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,79
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,44
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;96,37
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,31
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,7
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,08
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;93,06
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,63
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;4.600
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;4.574
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;4.541
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;4.511
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;4.491
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;4.450
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;4.430
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;4.419
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;4.386
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;4.332
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;4.333
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;4.237
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;4.261
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,07
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,19
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,3
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,61
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,59
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,71
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,42
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,63
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,83
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;12.780
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;12.646
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;12.518
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;12.517
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;12.379
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;12.306
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;12.145
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;12.148
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;11.896
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;11.948
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;11.750
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;11.772
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,94
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,89
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,31
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,04
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,04
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,07
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,45
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,91
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,04
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;8.189
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;8.068
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;7.999
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;8.014
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;7.884
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;7.868
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;7.743
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;7.765
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;7.600
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;7.643
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;7.511
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;7.535
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,86
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,72
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,97
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,07
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;94,2
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;95,55
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,1
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,2
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;4.591
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;4.578
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;4.519
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;4.503
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;4.495
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;4.438
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;4.402
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;4.383
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;4.296
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;4.305
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;4.239
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;4.237
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;98,08
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,19
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,21
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,16
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,99
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,84
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,26
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,6
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,76
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.172
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;5.812
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.691
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;5.956
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;5.609
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;6.327
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;5.712
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;5.392
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;6.129
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;5.504
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;5.204
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.893
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.053
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;4.906
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;5.580
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,5
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,51
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,56
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,55
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,77
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,6
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,18
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,54
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,07
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,87
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,41
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,4
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.068
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.835
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.444
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;3.916
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;3.708
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;4.195
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;3.774
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;3.573
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;4.070
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.641
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.453
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.916
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.343
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.264
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.696
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,26
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,69
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,4
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,77
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,17
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,58
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,5
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,04
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,12
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,18
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,11
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;83,17
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.104
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.977
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.247
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;2.040
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.901
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;2.132
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.938
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.819
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;2.059
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.863
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.751
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.977
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.710
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.642
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.884
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,96
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,16
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,88
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,11
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,01
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,63
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,55
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,57
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,98
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,27
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,06
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,85
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.116
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.821
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.488
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;6.837
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;6.583
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;6.282
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.619
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.369
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.002
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.149
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.043
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.684
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;5.843
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;5.491
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,08
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,51
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,82
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,02
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,37
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,51
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,41
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,59
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,61
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,66
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,63
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.646
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.481
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.310
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;4.481
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;4.334
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;4.179
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;4.343
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;4.195
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.988
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;4.035
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.988
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.763
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;3.848
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;3.642
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,45
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,72
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,96
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,48
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,62
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,53
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,85
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,31
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,87
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,5
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.470
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.340
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.178
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;2.356
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;2.249
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;2.103
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.276
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.174
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.014
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.114
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.055
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.921
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.995
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.849
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,38
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,11
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,56
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,15
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,91
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,47
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,59
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,82
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,2
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,26
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,89
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.894
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.640
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.330
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.665
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.417
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.042
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.190
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.087
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.723
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;5.881
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;5.529
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;5.653
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;5.322
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,68
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,64
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,45
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,79
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,67
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,41
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,57
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,35
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,14
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,08
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;4.520
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.374
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.206
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.375
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.228
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.008
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.062
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.017
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.782
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;3.871
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;3.661
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;3.737
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;3.532
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,79
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,66
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,29
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,87
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,84
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;89,92
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,5
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,04
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,44
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,98
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.374
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.266
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.124
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.290
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.189
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.034
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.128
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.070
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.941
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;2.010
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.868
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.916
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.790
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,46
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,6
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,76
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,64
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,35
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,38
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,7
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;87,95
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;84,55
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;84,27
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.718
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.456
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.110
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.238
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.119
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;5.778
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;5.909
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;5.577
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;5.676
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;5.364
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.471
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.177
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,86
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,78
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,57
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,53
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,28
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,92
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;87,79
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,74
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,73
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;4.406
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.248
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.051
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.089
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.032
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.816
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;3.885
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;3.690
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;3.749
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;3.556
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.618
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.437
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,81
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,92
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,2
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,45
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,09
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,25
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;87,78
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,17
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;84,84
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.312
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.208
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.059
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.149
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.087
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.962
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;2.024
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.887
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.927
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.808
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.853
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.740
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,95
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,52
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,29
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,67
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,65
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,27
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,81
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,92
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,51
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
15 Navarra, Comunidad Foral de;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;162.259
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;162.316
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;165.309
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;157.753
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;158.550
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;157.955
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;153.060
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;154.440
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;154.848
16 País Vasco;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;149.408
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;151.106
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;151.207
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;144.756
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;147.279
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;147.458
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,22
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,68
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,55
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,33
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,15
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,67
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,08
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,09
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,47
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,21
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,74
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,2
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100.258
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100.937
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;102.931
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;97.466
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;98.620
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;98.441
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;94.866
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;96.204
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;96.819
16 País Vasco;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;92.672
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;94.163
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;94.642
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;89.797
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;91.782
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;92.321
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,22
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,7
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,64
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,62
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,31
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,06
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,43
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,29
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;91,95
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,57
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,93
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;89,69
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;62.001
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;61.379
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;62.378
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;60.287
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;59.930
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;59.514
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;58.194
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;58.236
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;58.029
16 País Vasco;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;56.736
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;56.943
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;56.565
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;54.959
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;55.497
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;55.137
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,24
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,64
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,41
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;93,86
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,88
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,03
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,51
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,77
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;90,68
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,64
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,42
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;88,39
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;162.278
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;162.859
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;163.307
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;157.122
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;158.311
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;159.973
16 País Vasco;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;153.154
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;154.656
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;155.820
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;148.207
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;150.569
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;151.779
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;147.059
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;148.753
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 País Vasco;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,82
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,21
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,96
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,38
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,96
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,42
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,33
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,45
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,94
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,3
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;91,09
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100.233
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;101.315
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;101.710
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;97.329
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;98.614
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;99.953
16 País Vasco;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;94.902
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;96.348
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;97.413
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;91.838
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;93.787
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;94.901
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;91.644
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;93.042
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 País Vasco;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,1
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,33
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,27
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,68
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,1
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,78
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,62
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;92,57
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,31
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,45
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,48
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;62.045
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;61.544
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;61.597
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;59.793
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;59.697
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;60.020
16 País Vasco;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;58.252
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;58.308
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;58.407
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;56.369
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;56.782
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;56.878
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;55.415
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;55.711
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 País Vasco;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,37
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,44
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,89
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,74
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,82
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,85
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,26
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,34
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,04
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,44
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;162.238
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;162.640
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;162.828
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;157.657
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;158.461
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;158.278
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;152.301
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;154.013
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;154.022
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;150.235
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;150.892
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;146.464
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;147.634
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,18
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,43
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,21
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,88
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,7
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,59
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,37
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,67
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,05
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,67
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100.257
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;101.214
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;101.789
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;97.448
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;98.589
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;98.976
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;94.114
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;95.790
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;96.313
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;93.473
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;94.400
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;91.251
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;92.353
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,2
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,41
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,24
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,87
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,64
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,62
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;92,35
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,74
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,16
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,73
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;61.981
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;61.426
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;61.039
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;60.209
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;59.872
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;59.302
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;58.187
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;58.223
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;57.709
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;56.762
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;56.492
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;55.213
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;55.281
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,14
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,47
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,15
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,88
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,79
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,54
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,41
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,55
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,89
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,57
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;161.835
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;162.378
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;162.184
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;156.108
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;157.554
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;157.518
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;153.505
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;154.161
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;149.418
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;150.636
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;146.025
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;147.578
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,46
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,03
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,12
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,54
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,05
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;92,02
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,88
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,93
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,99
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;99.876
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100.829
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;101.308
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;96.301
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;97.779
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;98.364
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;95.294
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;96.297
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;92.916
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;94.128
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;90.861
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;92.248
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,42
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,98
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,09
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,51
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,05
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,15
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,91
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,11
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;91,06
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;61.959
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;61.549
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;60.876
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;59.807
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;59.775
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;59.154
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;58.211
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;57.864
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;56.502
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;56.508
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;55.164
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;55.330
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,53
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,12
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,17
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,58
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,05
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,8
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,82
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,63
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,89
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;8.128
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;7.674
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.408
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;7.561
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;7.225
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;5.616
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;7.047
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;6.797
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;5.383
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.587
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.435
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;5.077
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;6.122
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.065
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;4.791
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;93,02
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,15
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;87,64
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;86,7
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,57
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,04
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;83,85
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;79,23
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;75,32
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;79,03
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,77
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;5.147
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.932
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.167
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;4.767
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;4.643
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;3.666
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;4.430
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;4.367
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;3.516
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;4.152
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;4.160
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.311
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.872
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.923
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.128
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;92,62
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;94,14
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;87,98
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;86,07
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;88,54
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,38
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;80,67
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,35
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;79,46
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;75,23
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,54
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;75,07
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.981
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.742
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.241
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;2.794
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;2.582
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;1.950
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;2.617
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;2.430
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;1.867
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.435
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.275
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.766
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.250
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.142
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.663
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,73
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,16
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,01
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,79
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,62
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,31
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,68
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,97
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,8
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;75,48
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,12
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;74,21
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;7.213
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.835
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.486
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;6.665
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;6.346
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;6.203
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.167
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;5.934
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;5.830
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.693
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;5.554
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;5.477
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;5.241
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;5.208
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;92,4
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,85
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,64
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,5
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,82
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,89
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,93
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;81,26
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,44
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;76,68
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,3
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;4.614
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.434
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.229
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;4.247
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;4.108
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;4.048
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.930
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.860
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.799
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.639
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.611
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.573
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;3.408
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;3.403
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;92,05
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;92,65
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;95,72
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,18
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;87,05
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,83
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;78,87
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;81,44
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,49
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;76,86
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,47
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.599
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.401
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.257
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;2.418
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;2.238
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;2.155
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.237
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.074
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.031
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.054
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.943
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.904
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;1.833
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;1.805
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 País Vasco;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,04
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,21
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,48
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;86,07
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;86,38
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,99
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;79,03
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;80,92
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,36
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;76,34
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;79,97
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;7.962
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;7.379
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.771
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;7.264
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.784
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.276
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.683
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.297
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;5.885
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;5.912
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;5.587
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;5.567
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;5.301
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,23
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;91,94
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,69
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,94
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;85,34
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,91
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80,12
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,51
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;75,44
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,29
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;5.034
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.740
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.416
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;4.586
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;4.368
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.093
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;4.223
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;4.054
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.840
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;3.803
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;3.657
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;3.574
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;3.466
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,1
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,15
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,69
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;83,89
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;85,53
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,96
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;80,23
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;82,81
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;75,4
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,49
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.928
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.639
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.355
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.678
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.416
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.183
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.460
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.243
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.045
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;2.109
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;1.930
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;1.993
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;1.835
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,46
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;91,55
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,7
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;84,02
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;84,99
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,84
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;79,92
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;81,95
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;75,52
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;77,92
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;8.349
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;7.685
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;7.161
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;7.671
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;7.109
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.658
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;6.646
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;6.303
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;6.232
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;5.959
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.846
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;5.668
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,88
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;92,5
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,98
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,48
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;88,02
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;81,09
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,21
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;76,07
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;79,15
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;5.294
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.936
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.651
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;4.867
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;4.558
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.321
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;4.254
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;4.097
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;3.977
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;3.871
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.736
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.703
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,93
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;92,34
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,9
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;86,18
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;88,09
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,57
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,23
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,69
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;79,62
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;3.055
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.749
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.510
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.804
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.551
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.337
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;2.392
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;2.206
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;2.255
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;2.088
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.110
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.965
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,78
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,8
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;93,11
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,01
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;87,89
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,03
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;83,19
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;76,76
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,29
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;25.174
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;26.186
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.379
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;24.207
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;25.404
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;23.893
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;23.219
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;24.511
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;23.315
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;22.526
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;23.837
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.617
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;21.791
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;23.109
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.988
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,16
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,01
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,14
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,23
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,6
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,87
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,48
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,03
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,12
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;86,56
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,25
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,64
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;15.103
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;15.900
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;15.402
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;14.535
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;15.431
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;14.551
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;13.999
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;14.919
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;14.263
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.585
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;14.497
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;13.845
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;13.170
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;14.071
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.474
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,24
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,05
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,47
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,69
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,83
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,6
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,95
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,18
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,89
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,2
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,5
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;87,48
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;10.071
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;10.286
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;9.977
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;9.672
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;9.973
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;9.342
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;9.220
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;9.592
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;9.052
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;8.941
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;9.340
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;8.772
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;8.621
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;9.038
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;8.514
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,04
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,96
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,64
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,55
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,25
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,73
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,78
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,8
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,92
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,6
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;87,87
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,34
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;23.410
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;24.305
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;25.286
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;22.346
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;23.376
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;24.648
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;21.627
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;22.640
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;23.855
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;20.810
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;21.860
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;23.142
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;21.132
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;22.556
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,45
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,18
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,48
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,38
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,15
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,34
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,89
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,94
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,52
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,95
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,2
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;14.015
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;14.778
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;15.386
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;13.432
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;14.233
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;15.054
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.992
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;13.771
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;14.577
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;12.524
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;13.310
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.151
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;12.889
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;13.810
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,84
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,31
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,84
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,7
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,19
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,74
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,36
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,07
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,97
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,22
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,76
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.395
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;9.527
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;9.900
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;8.914
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;9.143
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;9.594
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.635
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.869
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;9.278
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;8.286
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;8.550
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;8.991
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;8.243
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;8.746
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 País Vasco;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,88
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,97
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,91
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,91
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,09
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,72
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,2
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,74
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,82
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,52
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,34
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;23.802
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.584
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;25.420
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;22.966
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.740
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;24.536
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;22.047
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.871
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;23.765
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;22.069
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;23.155
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;21.311
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;22.493
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,49
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,57
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,52
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,63
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,03
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,49
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,77
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,09
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,69
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,49
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;14.250
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;14.949
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.544
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;13.742
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;14.416
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;15.005
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;13.214
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;13.898
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;14.537
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;13.432
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;14.180
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;12.996
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;13.775
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,44
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,43
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,53
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,73
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,97
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,52
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,85
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,22
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,94
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,62
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;9.552
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;9.635
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;9.876
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;9.224
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;9.324
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;9.531
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.833
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;8.973
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;9.228
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;8.637
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;8.975
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;8.315
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;8.718
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,57
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,77
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,51
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,47
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,13
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,44
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,64
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,88
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;86,3
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,27
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.139
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;24.824
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;25.637
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.135
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;23.866
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;24.761
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;23.000
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;24.091
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;22.164
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;23.353
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;21.533
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;22.765
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,84
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,14
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,58
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,65
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,97
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,28
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,09
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,74
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,8
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;14.418
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;15.006
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.683
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;13.833
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;14.432
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;15.147
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;13.933
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;14.745
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;13.452
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;14.302
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;13.075
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;13.936
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,94
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,17
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,58
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,85
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,02
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,64
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,19
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,13
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,86
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;9.721
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;9.818
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;9.954
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;9.302
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;9.434
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;9.614
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;9.067
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;9.346
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;8.712
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;9.051
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;8.458
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;8.829
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,69
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,09
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,58
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,35
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,89
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;88,73
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,93
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,15
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,7
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;52.716
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;54.332
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;54.578
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;51.552
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;53.433
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;52.551
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;50.229
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;52.298
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;51.628
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;49.329
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;51.487
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;50.767
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;48.294
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;50.599
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.862
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,79
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,35
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,29
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,28
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,26
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,59
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,58
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,76
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,02
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,61
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;93,13
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,36
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;31.892
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;33.043
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;33.212
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;31.188
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;32.495
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;31.991
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;30.522
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;31.878
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;31.598
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;30.003
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;31.386
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;31.109
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;29.369
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;30.831
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;30.558
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,79
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,34
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,32
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,7
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,47
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,14
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,08
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,99
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,67
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,09
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;93,31
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,01
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;20.824
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;21.289
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;21.366
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;20.364
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;20.938
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;20.560
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;19.707
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;20.420
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;20.030
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;19.326
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;20.101
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;19.658
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;18.925
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;19.768
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;19.304
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,79
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,35
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,23
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,64
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,92
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,75
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,81
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,42
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,01
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;90,88
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;92,86
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,35
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;50.359
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;52.388
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;54.052
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;48.901
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;51.114
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;53.064
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;47.903
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;50.225
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;52.093
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;46.827
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;49.247
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;51.109
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;48.374
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;50.431
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,1
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,57
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,17
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,12
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,87
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,38
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,99
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;94
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,56
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;92,34
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,3
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;30.412
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;31.914
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;32.884
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;29.648
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;31.213
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;32.456
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;29.067
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;30.656
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;31.888
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;28.403
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;30.034
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;31.286
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;29.523
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;30.871
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,49
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,8
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,7
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,58
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,06
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,97
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,39
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;94,11
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,14
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;92,51
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,88
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;19.947
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;20.474
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;21.168
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;19.253
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;19.901
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;20.608
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;18.836
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.569
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;20.205
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;18.424
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;19.213
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;19.823
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;18.851
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;19.560
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 País Vasco;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,52
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,2
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,35
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,43
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,58
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;95,45
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,36
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,84
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;93,65
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,07
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,4
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;50.272
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;52.367
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;53.950
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;49.115
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;51.354
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;52.883
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;47.924
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;50.283
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;51.829
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;49.334
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;51.121
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;48.308
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;50.288
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,7
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,07
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,02
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,33
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,02
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,07
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;94,21
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,76
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;92,25
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,21
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;30.413
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;31.962
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;33.019
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;29.734
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;31.312
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;32.380
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;28.992
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;30.625
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;31.728
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;30.061
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;31.297
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;29.477
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;30.786
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,77
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,97
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,06
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;95,33
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,82
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,09
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;94,05
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,78
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;92,23
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;93,24
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;19.859
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;20.405
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;20.931
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;19.381
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;20.042
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;20.503
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;18.932
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.658
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;20.101
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;19.273
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;19.824
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;18.831
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;19.502
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,59
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,22
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,96
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,33
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,34
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,03
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,45
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,71
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,29
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,17
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;50.260
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;52.504
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;54.018
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;48.953
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;51.323
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;52.854
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;50.296
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;52.077
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;49.172
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;51.164
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;48.336
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;50.427
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,4
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,75
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,85
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,79
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,41
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,65
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,72
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;92,06
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,35
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;30.344
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;31.952
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;33.047
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;29.528
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;31.192
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;32.314
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;30.578
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;31.838
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;29.963
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;31.298
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;29.476
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;30.849
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,31
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,62
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,78
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,7
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,34
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,78
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,71
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;92,25
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;93,35
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;19.916
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;20.552
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;20.971
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;19.425
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;20.131
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;20.540
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;19.718
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;20.239
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;19.209
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;19.866
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.860
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;19.578
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,53
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,95
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,94
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,94
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,51
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,47
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,73
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,77
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,36
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;53.293
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;52.195
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;53.188
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;52.387
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;51.488
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;51.715
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;51.428
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;50.741
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;51.098
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;50.667
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;50.087
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;50.379
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;49.752
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;49.298
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;49.654
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,3
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,65
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,23
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,5
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,21
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;96,07
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;95,07
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,96
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;94,72
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;93,36
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,45
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;93,36
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;33.098
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;32.678
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;33.306
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;32.547
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;32.270
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;32.431
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;32.037
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;31.857
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;32.104
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;31.606
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;31.477
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;31.693
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;31.045
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;31.018
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;31.253
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,34
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,75
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,37
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,79
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,49
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;96,39
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;95,49
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,32
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;95,16
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;93,8
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;94,92
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;93,84
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;20.195
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;19.517
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;19.882
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;19.840
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;19.218
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;19.284
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;19.391
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;18.884
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;18.994
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;19.061
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;18.610
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;18.686
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;18.707
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;18.280
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;18.401
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,24
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,47
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;96,99
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,02
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,76
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;95,53
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,38
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,35
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;93,98
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,63
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,66
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;92,55
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;54.655
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;53.759
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;52.839
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;53.596
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;52.913
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;52.180
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;52.765
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;52.218
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;51.310
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;51.821
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;51.421
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;50.545
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;50.682
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;49.946
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,06
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,43
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,75
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,54
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,13
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;97,11
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,81
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,65
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,66
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;94,28
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,52
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;33.778
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;33.424
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;33.107
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;33.213
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;32.948
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;32.760
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;32.727
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;32.549
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;32.234
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;32.160
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;32.074
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;31.763
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;31.629
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;31.413
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,33
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,58
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,95
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,89
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,38
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,36
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;95,21
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,96
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,94
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,63
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;94,88
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;20.877
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;20.335
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;19.732
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;20.383
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;19.965
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;19.420
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;20.038
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;19.669
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;19.076
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;19.661
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;19.347
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;18.782
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;19.053
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;18.533
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 País Vasco;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,63
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,18
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,42
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,98
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,72
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,68
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;94,18
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;95,14
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;95,19
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;93,7
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,92
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;54.384
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;53.560
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;52.687
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;53.452
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;52.781
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;51.748
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;52.441
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;51.932
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;50.944
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;51.158
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;50.328
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;50.377
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;49.717
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,29
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,55
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,22
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;96,43
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,96
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,69
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,52
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,52
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;94,06
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,36
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;33.653
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;33.341
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;33.096
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;33.102
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;32.880
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;32.516
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;32.488
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;32.370
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;32.019
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;31.903
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;31.661
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;31.455
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;31.300
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,36
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,62
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,25
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96,54
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,09
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,75
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,69
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,66
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,34
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,57
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;20.731
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;20.219
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;19.591
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;20.350
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;19.901
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;19.232
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;19.953
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;19.562
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;18.925
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;19.255
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;18.667
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;18.922
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;18.417
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;98,16
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,43
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;98,17
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;96,25
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,75
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,6
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;95,23
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;95,28
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;93,59
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;94,01
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;54.096
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;53.433
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;52.375
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;53.026
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;52.513
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;51.506
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;51.698
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;50.861
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;50.858
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;50.208
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;50.152
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;49.592
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;98,02
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;98,28
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,34
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,75
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,11
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;95,18
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,86
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,86
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,69
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;33.455
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;33.244
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;32.850
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;32.806
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;32.687
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;32.310
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;32.193
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;31.938
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;31.723
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;31.561
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;31.323
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;31.201
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;98,06
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,32
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,84
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,22
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,42
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,08
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;94,22
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;94,98
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;20.641
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;20.189
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;19.525
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;20.220
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;19.826
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;19.196
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;19.505
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;18.923
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;19.135
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;18.647
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;18.829
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;18.391
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,96
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;98,2
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;98,31
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,61
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,92
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,78
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,5
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;93,26
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,19
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;22.948
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;21.929
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;25.756
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;22.046
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;21.000
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;24.180
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;21.137
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;20.093
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;23.424
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;20.299
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.260
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;22.367
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.797
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.208
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;21.163
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,07
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,76
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,88
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,11
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;91,63
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,95
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,46
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;87,83
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,84
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,91
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;83,03
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,17
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;15.018
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;14.384
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;16.844
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;14.429
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;13.781
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;15.802
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;13.878
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;13.183
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;15.338
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;13.326
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.643
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;14.684
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;12.341
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.939
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;13.908
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,08
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,81
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,81
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,41
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,65
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,06
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,73
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;87,9
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,18
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,17
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;83
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,57
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.930
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.545
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.912
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;7.617
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;7.219
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;8.378
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;7.259
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;6.910
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;8.086
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;6.973
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;6.617
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.683
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;6.456
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;6.269
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.255
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,05
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,68
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,01
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;91,54
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;91,58
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,73
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,93
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,7
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,21
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,41
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,09
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;81,41
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;26.641
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;25.572
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;24.644
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;25.614
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;24.562
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;23.878
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;24.692
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;23.639
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;22.732
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;23.056
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;22.487
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;21.506
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;21.630
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;20.612
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
16 País Vasco;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,15
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,05
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,89
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,68
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,44
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,24
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;86,54
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,94
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,27
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;84,58
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;83,64
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;17.414
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;16.765
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;16.104
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;16.789
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;16.112
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;15.635
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;16.186
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;15.512
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;14.915
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;15.112
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;14.758
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;14.128
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;14.195
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;13.545
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
16 País Vasco;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,41
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,1
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,09
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,95
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,53
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,62
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,78
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,03
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,73
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,67
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,11
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;9.227
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;8.807
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;8.540
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;8.825
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;8.450
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;8.243
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;8.506
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;8.127
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.817
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.944
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.729
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.378
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;7.435
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;7.067
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
16 País Vasco;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,64
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,95
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,52
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92,19
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,28
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,53
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,1
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,76
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,39
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,42
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;82,75
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;25.818
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;24.750
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;24.000
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;24.860
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;23.802
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;22.835
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;23.206
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;22.630
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;21.599
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;21.762
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;20.701
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;20.901
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;19.835
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,29
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,17
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,15
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;89,88
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,43
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,93
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;86,25
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,45
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,65
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;16.907
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;16.222
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;15.714
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;16.284
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;15.613
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;14.982
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;15.197
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;14.843
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;14.189
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;14.274
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;13.605
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;13.749
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;13.026
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,32
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,25
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,34
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,89
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,5
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,3
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,99
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;86,58
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,76
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,89
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;8.911
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;8.528
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;8.286
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;8.576
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;8.189
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.853
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;8.009
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.787
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.410
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;7.488
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;7.096
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;7.152
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;6.809
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,24
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,02
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,77
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,88
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,31
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,43
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,8
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;85,64
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,86
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,17
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;24.991
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;23.932
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;22.993
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;23.323
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;22.743
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;21.739
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;21.865
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;20.829
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;20.992
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;19.952
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;20.158
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;19.126
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,33
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,03
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,55
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,36
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,59
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;87,72
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,77
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,23
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;83,18
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;16.365
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;15.691
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;15.077
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;15.267
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;14.910
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;14.272
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;14.336
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;13.679
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;13.801
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;13.096
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;13.251
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;12.559
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,29
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,02
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,66
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,36
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,73
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;87,95
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,86
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;84,45
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;83,3
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;8.626
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;8.241
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.916
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;8.056
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.833
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.467
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;7.529
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;7.150
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;7.191
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;6.856
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;6.907
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;6.567
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,39
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,05
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,33
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,36
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,32
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,26
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;86,61
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;83,81
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,96
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
16 País Vasco;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;20.794
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;20.839
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;21.422
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;20.264
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;20.371
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;20.202
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;19.692
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;19.841
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;19.798
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;19.211
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;19.371
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;19.308
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;18.571
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;18.838
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;18.805
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,45
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,75
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;94,3
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,7
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,21
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;92,42
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;92,39
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;92,96
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;90,13
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;89,31
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;90,4
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,78
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;12.879
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;12.975
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;13.307
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;12.541
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;12.681
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;12.581
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;12.193
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;12.380
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;12.351
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;11.935
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;12.088
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;12.068
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;11.553
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;11.763
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;11.766
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,38
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,73
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,54
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,67
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,41
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,82
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;92,67
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;93,16
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,69
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89,7
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,66
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,42
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;7.915
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;7.864
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;8.115
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;7.723
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;7.690
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;7.621
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;7.499
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;7.461
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;7.447
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;7.276
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;7.283
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;7.240
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;7.018
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;7.075
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;7.039
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,57
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,79
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,91
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,74
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,88
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,77
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;91,93
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,61
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,22
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;88,67
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,97
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,74
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;20.851
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;20.996
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;20.964
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;20.203
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;20.381
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;20.513
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;19.685
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;19.850
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;19.955
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;19.001
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;19.267
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;19.401
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;18.850
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;19.051
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,89
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,07
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,85
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,41
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,54
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;95,19
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,13
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;91,77
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,54
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;89,78
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,87
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;12.904
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;13.074
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;13.064
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;12.506
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;12.715
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;12.803
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;12.228
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;12.382
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;12.471
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;11.818
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;12.022
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;12.129
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;11.763
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;11.912
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,92
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,25
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,76
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,71
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,46
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;91,58
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;91,95
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,84
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;89,97
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,18
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;7.947
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;7.922
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;7.900
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;7.697
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;7.666
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;7.710
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;7.457
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;7.468
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;7.484
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;7.183
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;7.245
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;7.272
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;7.087
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;7.139
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;96,85
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,77
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,59
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,83
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94,27
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,73
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,39
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,45
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;92,05
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;89,46
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;90,37
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;20.834
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;20.991
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;20.973
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;20.207
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;20.367
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;20.339
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;19.443
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;19.716
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;19.749
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;19.273
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;19.374
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;18.824
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;18.964
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,99
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,03
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,98
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,32
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,93
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,16
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,82
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,38
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,68
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;90,42
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;12.869
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;13.069
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;13.097
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;12.523
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;12.681
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;12.719
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;12.072
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;12.281
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;12.351
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;12.005
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;12.116
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;11.732
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;11.873
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,31
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,03
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,11
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,81
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,97
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,3
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,86
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,51
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,77
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;90,65
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;7.965
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;7.922
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;7.876
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;7.684
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;7.686
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;7.620
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;7.371
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;7.435
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;7.398
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;7.268
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;7.258
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;7.092
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;7.091
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,47
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,02
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,75
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,54
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,85
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,93
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,74
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,15
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;89,52
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;90,03
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;20.679
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;20.903
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;20.948
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;19.848
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;20.183
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;20.261
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;19.705
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;19.851
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;19.201
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;19.398
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;18.753
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;18.964
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,98
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,56
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,72
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,27
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,76
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,86
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,6
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89,71
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,53
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;12.799
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;12.999
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;13.081
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;12.295
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;12.547
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;12.650
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;12.248
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;12.400
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;11.939
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;12.138
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;11.702
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;11.874
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,06
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,52
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,71
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,22
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,79
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,85
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,79
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,02
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,77
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;7.880
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;7.904
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;7.867
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;7.553
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;7.636
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;7.611
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;7.457
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;7.451
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;7.262
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;7.260
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;7.051
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;7.090
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;95,85
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,61
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,75
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;94,34
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,71
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;91,88
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;92,28
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;89,21
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;90,12
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.176
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.153
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;942
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;1.106
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;1.086
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;836
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;1.025
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;1.017
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;807
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;958
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;941
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;758
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;897
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;890
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;715
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,05
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;94,19
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;88,75
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;87,16
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;88,2
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;85,67
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;81,46
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;81,61
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;80,47
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;76,28
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;77,19
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;75,9
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;730
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;731
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;596
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;689
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;684
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;531
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;641
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;642
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;520
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;601
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;591
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;488
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;567
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;558
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;460
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,38
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;93,57
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;89,09
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;87,81
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;87,82
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;87,25
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;82,33
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;80,85
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;81,88
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;77,67
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;76,33
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;77,18
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;446
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;422
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;346
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;417
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;402
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;305
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;384
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;375
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;287
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;357
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;350
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;270
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;330
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;332
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;255
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,5
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,26
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;88,15
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,1
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;88,86
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;82,95
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;80,04
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;82,94
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;78,03
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,99
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;78,67
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;73,7
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.031
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.038
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;986
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;946
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;950
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;941
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;879
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;861
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;879
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;817
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;801
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;827
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;763
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;795
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,76
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,52
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,44
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,26
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;82,95
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,15
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;79,24
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;77,17
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;83,87
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;73,51
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;80,63
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;644
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;659
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;634
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;592
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;605
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;610
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;551
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;551
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;569
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;516
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;510
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;534
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;488
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;511
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,93
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,81
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,21
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;85,56
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;83,61
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;89,75
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;80,12
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;77,39
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;84,23
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,05
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80,6
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;387
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;379
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;352
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;354
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;345
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;331
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;328
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;310
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;310
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;301
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;291
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;293
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;275
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;284
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,47
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,03
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;94,03
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,75
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;81,79
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;88,07
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;77,78
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;76,78
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;83,24
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;72,56
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;80,68
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.090
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.114
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.035
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;992
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;986
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;948
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;912
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;905
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;890
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;862
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;851
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;814
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;814
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,01
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;88,51
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;91,59
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,67
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;81,24
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;85,99
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;77,38
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;82,22
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;73,07
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;78,65
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;686
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;705
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;675
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;627
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;630
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;617
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;581
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;575
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;577
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;550
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;550
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;521
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;527
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;91,4
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;89,36
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;91,41
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;84,69
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;81,56
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;85,48
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,01
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;81,48
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;73,9
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;78,07
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;404
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;409
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;360
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;365
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;356
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;331
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;331
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;330
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;313
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;312
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;301
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;293
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;287
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,35
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;87,04
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,94
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,93
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;80,68
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,94
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;76,28
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,61
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;71,64
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,72
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.098
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.124
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.095
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.007
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.025
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.009
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;972
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;962
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;904
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;916
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;849
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;850
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;91,71
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;91,19
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;92,15
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;86,48
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;87,85
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,43
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;83,65
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;75,53
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;77,63
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;699
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;714
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;710
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;643
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;645
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;654
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;614
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;621
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;573
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;592
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;540
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;548
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,99
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;90,34
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;92,11
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;85,99
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;87,46
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;80,25
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;83,38
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;75,63
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;77,18
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;399
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;410
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;385
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;364
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;380
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;355
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;358
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;341
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;331
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;324
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;309
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;302
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,23
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;92,68
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;92,21
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;87,32
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;88,57
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;80,73
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;84,16
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;75,37
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;78,44
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.261
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.331
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.321
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;3.162
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;3.238
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;3.077
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;3.025
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;3.122
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;3.002
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.941
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.055
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.921
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.852
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.969
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.832
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,96
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,21
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,65
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,76
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,73
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,39
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,19
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,71
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;87,96
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,46
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;89,13
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,28
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;1.869
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;1.964
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;1.961
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;1.818
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;1.907
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;1.829
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;1.733
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;1.838
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;1.787
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.690
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.793
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.740
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.637
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.744
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.687
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,27
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,1
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,27
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;92,72
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,58
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,13
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,42
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,29
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,73
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;87,59
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,8
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,03
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.392
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.367
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.360
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;1.344
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;1.331
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;1.248
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;1.292
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;1.284
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;1.215
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.251
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.262
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.181
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.215
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.225
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.145
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,55
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,37
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,76
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,82
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,93
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,34
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;89,87
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;92,32
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;86,84
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,28
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;89,61
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;84,19
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.020
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.145
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.249
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;2.863
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;3.015
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;3.168
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;2.777
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;2.927
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.077
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.690
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;2.832
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;2.969
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;2.760
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;2.906
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,8
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,87
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,51
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,95
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,07
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,71
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,07
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,05
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,38
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,76
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,44
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;1.735
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;1.844
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;1.922
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;1.638
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;1.765
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;1.878
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.596
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;1.704
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.823
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.542
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.648
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.756
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;1.611
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;1.717
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;94,41
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,72
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,71
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,99
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,41
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,85
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,88
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,37
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;91,36
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,36
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,33
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.285
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.301
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.327
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;1.225
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;1.250
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;1.290
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.181
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.223
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.254
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.148
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.184
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.213
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;1.149
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;1.189
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,33
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,08
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,21
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,91
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;94
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,5
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,34
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,01
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,41
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,32
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,6
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.024
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.165
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.277
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;2.916
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.063
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.170
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;2.812
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;2.953
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.055
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;2.871
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;2.989
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;2.773
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;2.905
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,43
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,78
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,73
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,99
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,3
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,23
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,71
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,21
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;87,61
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,65
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;1.725
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;1.849
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;1.943
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;1.670
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;1.780
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;1.877
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.610
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.715
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.805
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;1.673
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;1.764
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;1.614
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;1.712
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,27
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,6
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,33
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,75
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;92,9
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,48
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;90,79
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,29
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,11
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.299
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.316
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.334
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.246
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.283
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.293
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.202
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.238
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.250
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;1.198
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;1.225
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;1.159
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;1.193
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,92
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,49
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,93
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,53
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;94,07
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,7
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;91,03
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,83
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;88,07
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,43
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.037
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.211
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.314
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;2.912
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.086
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.180
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;2.992
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;3.104
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;2.878
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;3.008
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.800
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.951
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,88
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,11
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,96
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,18
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;93,66
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,63
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,77
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,2
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;89,05
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;1.736
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;1.854
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;1.963
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;1.660
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;1.780
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;1.878
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;1.732
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;1.834
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;1.661
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;1.776
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.621
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.739
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,62
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,01
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,67
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,42
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;93,43
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,59
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;90,47
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,43
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;88,59
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.301
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.357
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.351
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.252
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.306
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.302
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;1.260
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;1.270
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;1.217
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;1.232
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.179
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.212
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,23
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,24
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,37
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,85
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,68
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,19
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,88
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;89,71
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.448
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.597
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.625
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;6.307
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;6.470
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;6.303
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;6.167
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;6.340
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;6.219
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.046
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.221
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.108
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.915
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.096
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.004
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,81
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,07
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,14
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;95,64
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;96,1
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,87
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;93,77
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;94,3
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,2
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;91,73
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,41
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;90,63
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;4.087
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;4.192
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;4.213
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;3.988
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;4.108
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;3.993
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;3.899
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;4.041
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;3.944
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.841
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.967
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.884
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.756
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.888
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.826
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,58
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,78
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,4
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;96,4
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,62
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;93,98
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;94,63
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,19
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;91,9
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;92,75
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,81
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.361
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.405
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.412
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;2.319
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;2.362
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;2.310
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;2.268
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;2.299
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;2.275
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.205
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.254
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.224
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.159
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.208
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.178
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,22
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,21
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,77
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,06
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,59
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,32
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;93,39
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;93,72
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,21
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;91,44
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;91,81
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,3
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.287
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.431
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.525
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;6.124
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;6.267
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;6.428
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;5.983
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.135
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.300
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;5.827
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.005
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.183
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;5.890
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;6.082
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,41
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,45
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,51
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,16
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,4
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,55
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;92,68
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,38
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,76
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;91,59
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,21
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.967
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;4.088
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;4.141
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;3.863
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;3.994
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;4.084
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.789
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.907
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;4.010
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.691
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.822
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.941
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;3.745
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;3.875
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,38
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,7
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,62
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;95,51
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,57
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,84
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;93,04
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,49
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,17
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;91,61
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,58
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.320
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.343
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.384
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;2.261
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;2.273
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;2.344
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.194
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.228
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.290
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.136
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.183
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.242
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;2.145
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;2.207
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,46
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,01
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,32
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;94,57
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,09
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,06
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;92,07
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,17
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,04
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;91,55
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;92,58
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.302
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.446
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.570
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.128
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.287
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.420
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;5.950
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.138
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.288
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;6.017
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;6.179
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;5.905
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;6.075
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;97,24
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,53
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;97,72
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,41
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,22
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,71
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;93,34
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,05
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;91,61
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;92,47
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.961
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;4.103
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;4.183
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.866
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.998
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;4.097
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.755
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.901
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;4.018
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;3.818
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;3.945
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;3.748
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;3.888
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,6
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,44
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,94
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,8
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,08
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,06
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,05
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,31
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;91,35
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,95
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.341
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.343
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.387
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.262
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.289
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.323
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.195
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.237
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.270
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;2.199
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;2.234
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;2.157
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;2.187
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,63
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,32
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,76
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,48
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;95,1
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;93,85
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;93,59
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,06
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;91,62
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.256
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.442
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.595
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.064
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.275
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.437
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;6.147
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;6.319
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;6.021
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;6.206
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.912
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.096
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,93
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,41
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,6
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;95,42
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,82
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;93,46
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,1
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;91,77
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;92,43
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.937
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;4.100
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;4.204
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.815
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.987
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;4.103
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;3.898
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;4.027
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;3.819
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;3.968
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.769
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.901
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,9
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,24
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,6
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,07
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,79
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;93,15
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,39
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;91,93
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,79
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.319
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.342
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.391
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.249
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.288
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.334
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;2.249
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;2.292
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;2.202
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;2.238
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.143
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.195
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,98
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,69
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,62
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;96,03
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,86
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;94,02
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,6
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;91,5
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,8
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;6.385
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;6.420
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;6.583
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;6.277
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;6.337
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;6.301
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;6.157
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;6.236
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;6.220
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;6.053
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;6.155
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;6.112
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;5.916
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;6.055
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;6.028
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;98,31
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;98,71
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,72
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;96,43
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,13
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,49
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;94,8
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;95,87
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;92,85
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;92,65
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;94,31
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,57
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.901
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.901
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.971
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;3.830
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;3.857
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;3.807
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;3.765
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;3.804
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;3.771
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;3.704
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;3.758
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;3.709
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;3.627
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;3.710
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;3.666
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;98,18
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,87
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,87
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;96,51
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,51
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,96
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;94,95
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;96,33
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,4
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;92,98
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;95,1
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;92,32
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;2.484
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;2.519
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;2.612
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;2.447
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;2.480
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;2.494
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;2.392
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;2.432
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;2.449
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;2.349
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;2.397
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;2.403
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;2.289
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;2.345
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;2.362
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;98,51
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,45
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,48
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;96,3
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,55
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,76
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;94,57
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;95,16
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;92,15
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;93,09
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;90,43
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;6.517
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;6.477
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;6.455
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;6.382
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;6.373
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;6.364
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;6.269
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;6.287
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;6.245
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;6.130
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;6.171
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;6.154
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;6.084
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;6.090
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,93
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,39
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,59
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;96,19
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;97,07
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,75
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;94,06
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;95,28
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;95,34
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;93,93
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;94,35
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.987
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.945
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.903
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;3.911
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;3.893
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;3.861
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;3.850
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;3.842
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.792
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;3.768
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;3.785
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;3.743
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;3.733
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;3.712
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,09
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,68
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,92
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;96,56
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;97,39
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;97,16
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;94,51
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;95,94
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;95,9
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;94,63
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;95,11
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;2.530
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;2.532
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;2.552
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;2.471
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;2.480
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;2.503
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;2.419
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;2.445
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;2.453
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;2.362
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;2.386
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;2.411
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;2.351
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;2.378
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,67
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,95
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,08
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,61
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,56
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,12
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;93,36
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;94,23
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,47
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;92,85
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;93,18
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;6.492
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;6.456
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;6.461
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;6.364
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;6.363
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;6.332
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;6.209
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;6.237
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;6.234
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;6.147
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;6.165
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;6.046
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;6.086
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;98,03
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,56
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;95,64
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;96,61
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;96,49
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;95,21
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;95,42
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;93,65
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;94,2
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.974
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.936
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.918
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;3.904
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.880
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.845
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;3.815
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;3.819
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.790
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;3.764
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;3.756
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;3.708
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;3.712
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;98,24
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,58
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;98,14
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;96
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;97,03
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;96,73
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;95,63
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;95,87
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;94,21
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;94,74
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;2.518
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;2.520
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;2.543
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;2.460
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;2.483
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;2.487
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;2.394
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;2.418
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;2.444
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;2.383
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;2.409
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;2.338
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;2.374
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,7
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,53
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;97,8
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;95,08
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,95
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,11
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;94,56
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;94,73
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;92,78
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;93,35
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;6.453
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;6.434
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;6.440
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;6.283
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;6.297
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;6.324
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;6.203
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;6.250
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;6.097
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;6.163
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;5.995
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;6.086
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97,37
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,87
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;98,2
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;96,41
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;97,05
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;94,76
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;95,7
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;93,18
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;94,5
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.952
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.923
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.905
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;3.853
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;3.854
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.841
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;3.796
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;3.804
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;3.737
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;3.756
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;3.678
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;3.714
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,49
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;98,24
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;98,36
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;96,76
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;97,41
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;95,26
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;96,18
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;93,75
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;95,11
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;2.501
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;2.511
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;2.535
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;2.430
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;2.443
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;2.483
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;2.407
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;2.446
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;2.360
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;2.407
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;2.317
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;2.372
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,16
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;97,29
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,95
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,86
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,49
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;93,99
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;94,95
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;92,27
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;93,57
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.524
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.338
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.951
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;3.412
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;3.240
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;3.685
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;3.318
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;3.126
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;3.550
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.213
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;2.999
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;3.409
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.991
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.828
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.226
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,82
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,06
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,27
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,15
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,65
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,85
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,17
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,84
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,28
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,88
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,72
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,65
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.292
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.187
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.566
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;2.216
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;2.125
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;2.421
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;2.155
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;2.055
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;2.329
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.099
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.979
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.247
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.966
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.863
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.127
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,68
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,17
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,35
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,02
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,96
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,76
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,58
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,49
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,57
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,78
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,19
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,89
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.232
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.151
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.385
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;1.196
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;1.115
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;1.264
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;1.163
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;1.071
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;1.221
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.114
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.020
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.162
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.025
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;965
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.099
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;97,08
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,87
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,26
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,4
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,05
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;88,16
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;90,42
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,62
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;83,9
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,2
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,84
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;79,35
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.996
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.905
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.749
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;3.888
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;3.776
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;3.612
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.777
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.640
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.454
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.537
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.458
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.268
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;3.353
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;3.178
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;97,3
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,7
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,35
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;94,52
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,21
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,13
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,51
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,55
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,17
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,86
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,77
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.571
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.538
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.464
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;2.502
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;2.458
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;2.370
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.442
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.378
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;2.277
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.301
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.257
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.155
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;2.186
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;2.097
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,32
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,85
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,19
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,98
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,7
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,41
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,5
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,93
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,46
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,13
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,11
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.425
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.367
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.285
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;1.386
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;1.318
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;1.242
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.335
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.262
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.177
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.236
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.201
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.113
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;1.167
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;1.081
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
17 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,26
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,42
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,65
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;93,68
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,32
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;91,6
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,74
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;87,86
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,61
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,37
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,12
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.926
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.810
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.630
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.807
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.668
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.469
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.560
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.483
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.282
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;3.376
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;3.190
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;3.286
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;3.084
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,97
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,27
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,56
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,68
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;91,42
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,41
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,61
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,88
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,25
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,96
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.523
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.476
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.378
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.456
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.393
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.283
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.311
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.271
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;2.161
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;2.200
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;2.101
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;2.141
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;2.034
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,34
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,65
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,01
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,6
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,72
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,87
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,85
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,35
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,47
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,53
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.403
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.334
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.252
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.351
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.275
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.186
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.249
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.212
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.121
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;1.176
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;1.089
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;1.145
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;1.050
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,29
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,58
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,73
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,02
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,85
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;89,54
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;88,16
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,98
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,83
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,87
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.835
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.692
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.504
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.582
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.500
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.311
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;3.391
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;3.216
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;3.301
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;3.105
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.197
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.981
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;93,4
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,8
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,49
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,85
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,78
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,41
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,61
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,59
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,07
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.475
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.408
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.299
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.324
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.281
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.174
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;2.208
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;2.114
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;2.149
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;2.046
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.094
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.972
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;93,9
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,73
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,56
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,69
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,95
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,24
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,96
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,78
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.360
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.284
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.205
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.258
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.219
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.137
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;1.183
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;1.102
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;1.152
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;1.059
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.103
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.009
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;92,5
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,94
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,36
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,13
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,45
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,72
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,88
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,9
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,73
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
17 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;3.355
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;3.316
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;3.391
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;3.239
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;3.239
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;3.175
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;3.133
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;3.137
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;3.091
18 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;2.994
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.041
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;2.997
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;2.856
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;2.931
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;2.904
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,54
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,68
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,63
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,38
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,6
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,15
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,24
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,71
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;88,38
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;85,13
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,39
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,64
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;2.118
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;2.106
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;2.157
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;2.046
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;2.057
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;2.027
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;1.988
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;1.997
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;1.974
18 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;1.901
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;1.940
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;1.915
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;1.827
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;1.865
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;1.851
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,6
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,67
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,97
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,86
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,82
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;91,52
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,75
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,12
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;88,78
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,26
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;88,56
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,81
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.237
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.210
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.234
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.193
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.182
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.148
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.145
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.140
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;1.117
18 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.093
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.101
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.082
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.029
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.066
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.053
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,44
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,69
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,03
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,56
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;94,21
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,52
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,36
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,99
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,68
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;83,19
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;88,1
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,33
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;3.369
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;3.374
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;3.320
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;3.249
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;3.258
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;3.231
18 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;3.099
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;3.158
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;3.126
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;2.954
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.040
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;3.024
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;2.949
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;2.964
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,44
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,56
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,32
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,99
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,6
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,16
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,68
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,1
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,08
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,4
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;89,28
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;2.133
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;2.140
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;2.118
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;2.069
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;2.070
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;2.061
18 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;1.975
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.011
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;1.992
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;1.897
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;1.930
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;1.923
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;1.875
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;1.886
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,73
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,31
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,59
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;93,97
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,05
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,94
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,19
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;90,79
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;87,62
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;89,05
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.236
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.234
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.202
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.180
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.188
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.170
18 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.124
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.147
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.134
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.057
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.110
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.101
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;1.074
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;1.078
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,47
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,27
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,34
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,94
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,95
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,34
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,52
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,95
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,6
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;87,03
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,68
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;3.368
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;3.386
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;3.302
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;3.201
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;3.267
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;3.187
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.043
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;3.131
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;3.080
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;3.032
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;3.017
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;2.938
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;2.934
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,04
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,49
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,52
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,35
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,47
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,28
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,55
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,37
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,77
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,86
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;2.138
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;2.151
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;2.099
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.037
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;2.081
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;2.024
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;1.949
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;1.991
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;1.953
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;1.930
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;1.913
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;1.878
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;1.864
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,28
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,75
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,43
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,16
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,56
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;93,04
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;89,73
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;91,14
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,31
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;88,8
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.230
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.235
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.203
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.164
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.186
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.163
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.094
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.140
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.127
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;1.102
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;1.104
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;1.060
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;1.070
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,63
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;96,03
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,67
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;88,94
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,31
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;93,68
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,23
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;91,77
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,83
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,94
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;3.326
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;3.370
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;3.300
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;3.154
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;3.218
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;3.177
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;3.113
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;3.106
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;3.015
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;3.015
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;2.883
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;2.931
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,83
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,49
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,27
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;92,37
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;94,12
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,47
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,36
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,55
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,82
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;2.118
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;2.140
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;2.092
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.019
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.035
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;2.012
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;1.970
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;1.968
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;1.916
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;1.914
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;1.832
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;1.864
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,33
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,09
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,18
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,06
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;94,07
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,53
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;91,49
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,61
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;89,1
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.208
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.230
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.208
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.135
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.183
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.165
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.143
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.138
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;1.099
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;1.101
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.051
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.067
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,96
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,18
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,44
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,93
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,21
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,35
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,14
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,45
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,33
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;320
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;313
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;278
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;304
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;299
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;238
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;284
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;282
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;225
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;256
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;264
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;213
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;233
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;252
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;207
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,53
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;85,61
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;88,75
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,1
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;80,94
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;80
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;84,35
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;76,62
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;72,81
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;80,51
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;74,46
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;185
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;182
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;163
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;174
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;174
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;140
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;159
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;165
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;128
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;144
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;154
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;122
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;134
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;145
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;117
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;94,05
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,6
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;85,89
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;85,95
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;90,66
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;78,53
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;77,84
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;84,62
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;74,85
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;72,43
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;79,67
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,78
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;135
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;131
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;115
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;130
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;125
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;98
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;125
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;117
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;97
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;112
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;110
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;91
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;99
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;107
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;90
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,3
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,42
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;85,22
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,59
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,31
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;84,35
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;82,96
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;83,97
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;79,13
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;73,33
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;81,68
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;78,26
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;292
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;293
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;264
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;265
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;271
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;251
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;242
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;253
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;237
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;219
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;241
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;228
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;227
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;219
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;90,75
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;92,49
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;95,08
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;82,88
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;86,35
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,77
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;75
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;82,25
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;86,36
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;77,47
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,95
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;168
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;173
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;155
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;150
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;159
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;143
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;138
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;148
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;135
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;128
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;139
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;128
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;129
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;124
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;89,29
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,91
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;92,26
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;82,14
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;85,55
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;87,1
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;76,19
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;80,35
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;82,58
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;74,57
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;80
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;124
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;120
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;109
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;115
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;112
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;108
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;104
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;105
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;102
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;91
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;102
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;100
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;98
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;95
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,74
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;93,33
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;99,08
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;83,87
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,5
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,58
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;73,39
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,74
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,67
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,16
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;297
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;305
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;269
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;270
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;281
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;250
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;245
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;259
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;241
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;244
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;231
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;228
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;221
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;90,91
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;92,13
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,94
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;82,49
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;84,92
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,59
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;80
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;85,87
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;74,75
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;82,16
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;168
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;179
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;152
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;155
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;165
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;142
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;144
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;151
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;135
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;140
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;130
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;128
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;125
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,26
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;92,18
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;93,42
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,71
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;84,36
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;88,82
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;78,21
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;85,53
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;71,51
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;82,24
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;129
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;126
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;117
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;115
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;116
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;108
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;101
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;108
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;106
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;104
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;101
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;100
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;96
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;89,15
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;92,06
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;92,31
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;78,29
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;85,71
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,6
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;82,54
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,32
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;79,37
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,05
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;294
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;308
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;281
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;266
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;279
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;268
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;264
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;256
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;247
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;244
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;222
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;232
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,48
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;90,58
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,37
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;85,71
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,1
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;80,19
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;86,83
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;72,08
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,56
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;172
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;178
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;165
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;159
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;158
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;156
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;147
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;150
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;134
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;143
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;120
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;136
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,44
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;88,76
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;94,55
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;82,58
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,91
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;75,28
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,67
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;67,42
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;82,42
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;122
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;130
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;116
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;107
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;121
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;112
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;117
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;106
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;113
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;101
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;102
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;96
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;87,7
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;93,08
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,55
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;91,38
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,92
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;87,07
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;78,46
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,76
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;679
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;677
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;658
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;655
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;658
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;606
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;635
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;634
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;587
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;609
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;610
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;563
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;570
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;582
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;544
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,47
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,19
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;92,1
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;93,52
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,65
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;89,21
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,69
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,1
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;85,56
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,95
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;85,97
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;82,67
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;395
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;394
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;375
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;380
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;380
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;346
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;373
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;365
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;335
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;363
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;351
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;322
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;342
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;336
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;311
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,2
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,45
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;92,27
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,43
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,64
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;89,33
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,9
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,09
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;85,87
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,58
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,28
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;82,93
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;284
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;283
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;283
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;275
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;278
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;260
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;262
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;269
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;252
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;246
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;259
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;241
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;228
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;246
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;233
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,83
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,23
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;91,87
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,25
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,05
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;89,05
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;86,62
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;91,52
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;85,16
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,28
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,93
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;82,33
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;676
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;653
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;650
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;654
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;627
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;629
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;616
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;604
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;600
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;574
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;578
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;578
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;563
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;567
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,75
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,02
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,77
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,12
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,5
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,31
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,91
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;88,51
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,92
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,22
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;87,23
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;391
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;375
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;372
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;383
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;358
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;359
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;366
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;344
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;342
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;345
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;331
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;330
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;323
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;322
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,95
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,47
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,51
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,61
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,73
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;91,94
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,24
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,27
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,71
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,13
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,56
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;285
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;278
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;278
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;271
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;269
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;270
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;250
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;260
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;258
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;229
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;247
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;248
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;240
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;245
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,09
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,76
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,12
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;87,72
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,53
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,81
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;80,35
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,85
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;89,21
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;86,33
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;88,13
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;694
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;671
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;647
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;650
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;641
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;618
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;601
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;610
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;593
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;591
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;581
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;573
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;566
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;93,66
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,53
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,52
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;86,6
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,91
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,65
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;88,08
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;89,8
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,39
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;87,48
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;406
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;387
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;369
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;387
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;369
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;352
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;360
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;354
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;338
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;343
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;329
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;337
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;319
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,32
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,35
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,39
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;88,67
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,47
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,6
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,63
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;89,16
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;87,08
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;86,45
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;288
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;284
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;278
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;263
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;272
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;266
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;241
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;256
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;255
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;248
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;252
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;236
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;247
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;91,32
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,77
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,68
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;83,68
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;90,14
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,73
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,32
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,65
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;83,1
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;88,85
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;681
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;674
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;655
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;628
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;638
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;625
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;616
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;609
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;597
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;590
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;573
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;569
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;92,22
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,66
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,42
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,39
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,98
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,58
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,08
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,01
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;86,87
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;407
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;388
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;373
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;377
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;368
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;356
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;355
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;345
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;349
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;333
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;340
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;320
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;92,63
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,85
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,44
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;91,49
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,49
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,95
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,28
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,63
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,79
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;274
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;286
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;282
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;251
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;270
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;269
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;261
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;264
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;248
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;257
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;233
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;249
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;91,61
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,41
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,39
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,26
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,62
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;86,71
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,13
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,47
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;88,3
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;918
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;897
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;913
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;893
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;878
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;857
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;866
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;845
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;839
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;831
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;819
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;815
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;803
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;795
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;795
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;97,28
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,88
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,87
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,34
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,2
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,89
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,52
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;91,3
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,27
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;87,47
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;88,63
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;87,08
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;572
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;564
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;571
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;558
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;553
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;537
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;546
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;535
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;528
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;525
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;524
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;514
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;506
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;509
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;503
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,55
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;98,05
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,05
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;95,45
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,86
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,47
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,78
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,91
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;90,02
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,46
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;90,25
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;88,09
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;346
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;333
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;342
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;335
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;325
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;320
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;320
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;310
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;311
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;306
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;295
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;301
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;297
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;286
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;292
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;96,82
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;97,6
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,57
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;92,49
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,09
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,94
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,44
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;88,59
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,01
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;85,84
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;85,89
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;85,38
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;916
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;930
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;901
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;886
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;896
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;882
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;854
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;866
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;855
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;824
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;835
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;834
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;816
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;818
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,72
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,34
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,89
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,23
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;93,12
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,89
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;89,96
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,78
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;92,56
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;87,74
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,79
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;570
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;580
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;563
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;557
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;560
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;553
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;538
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;547
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;536
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;517
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;527
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;524
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;516
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;514
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;97,72
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,55
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,22
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,39
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,31
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;95,2
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;90,7
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,86
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,07
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,97
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;91,3
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;346
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;350
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;338
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;329
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;336
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;329
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;316
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;319
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;319
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;307
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;308
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;310
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;300
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;304
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95,09
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,34
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,33
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;91,14
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;94,38
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;88,73
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;91,72
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,71
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,94
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;913
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;928
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;898
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;878
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;894
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;868
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;846
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;861
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;847
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;841
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;831
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;818
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;799
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,17
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,34
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,66
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,66
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,78
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;94,32
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,63
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;92,54
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;88,15
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;88,98
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;574
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;579
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;564
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;553
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;563
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;545
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;530
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;541
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;533
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;530
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;523
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;520
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;506
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,34
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,24
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,63
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,33
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;93,44
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,5
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,54
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,73
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;89,81
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,72
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;339
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;349
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;334
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;325
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;331
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;323
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;316
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;320
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;314
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;311
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;308
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;298
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;293
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,87
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,84
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,71
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,22
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,69
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;94,01
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;89,11
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;92,22
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,39
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,72
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;925
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;925
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;899
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;889
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;889
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;876
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;867
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;858
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;842
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;825
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;809
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;800
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,11
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,11
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,44
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,73
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,44
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,03
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;91,77
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;87,46
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;88,99
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;577
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;582
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;562
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;551
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;557
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;549
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;545
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;538
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;534
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;520
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;514
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;509
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,49
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,7
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,69
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,64
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,73
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,75
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,53
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,32
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,57
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;348
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;343
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;337
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;338
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;332
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;327
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;322
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;320
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;308
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;305
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;295
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;291
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;97,13
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,79
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,03
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,88
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,96
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,8
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;90,5
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,01
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,35
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;951
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;971
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;999
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;915
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;963
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;966
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;898
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;946
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;949
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;873
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;934
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;934
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;842
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;901
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;913
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,21
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;99,18
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;96,7
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;94,43
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;97,43
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;94,99
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;91,8
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;96,19
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;93,49
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,54
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;92,79
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;91,39
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;627
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;645
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;665
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;604
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;639
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;646
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;593
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;626
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;637
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;573
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;617
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;625
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;558
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;593
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;609
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;96,33
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;99,07
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,14
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;94,58
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;97,05
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,79
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,39
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;95,66
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;93,98
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;89
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,94
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;91,58
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;324
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;326
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;334
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;311
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;324
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;320
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;305
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;320
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;312
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;300
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;317
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;309
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;284
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;308
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;304
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,99
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;99,39
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,81
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;94,14
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;98,16
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;93,41
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;92,59
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;97,24
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;92,51
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;87,65
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;94,48
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;91,02
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;930
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;970
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;990
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;913
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;951
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;971
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;885
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;938
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;955
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;854
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;906
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;933
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;877
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;926
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;98,17
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;98,04
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,08
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;95,16
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;96,7
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;96,46
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,83
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;93,4
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;94,24
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,41
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;93,54
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;620
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;640
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;664
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;610
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;629
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;654
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;588
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;620
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;641
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;572
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;597
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;624
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;579
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;619
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;98,39
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;98,28
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,49
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,84
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;96,88
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;96,54
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,26
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,28
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;93,98
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,47
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;93,22
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;310
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;330
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;326
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;303
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;322
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;317
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;297
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;318
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;314
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;282
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;309
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;309
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;298
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;307
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;97,74
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,58
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,24
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;95,81
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;96,36
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;96,32
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;90,97
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;93,64
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;94,79
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;90,3
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;94,17
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;927
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;967
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;990
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;895
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;952
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;972
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;863
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;919
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;948
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;888
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;940
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;872
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;925
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,55
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;98,45
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;98,18
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;93,1
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;95,04
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;95,76
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;91,83
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;94,95
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;90,18
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;93,43
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;616
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;641
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;662
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;592
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;631
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;647
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;576
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;608
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;630
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;588
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;624
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;577
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;612
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,1
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;98,44
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;97,73
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,51
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;94,85
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;95,17
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;91,73
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;94,26
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,02
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;92,45
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;311
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;326
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;328
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;303
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;321
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;325
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;287
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;311
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;318
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;300
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;316
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;295
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;313
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;97,43
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;98,47
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;99,09
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;92,28
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;95,4
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;96,95
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,02
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;96,34
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;90,49
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;95,43
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;910
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;964
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;984
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;876
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;930
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;955
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;898
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;947
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;882
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;931
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;857
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;920
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;96,26
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,47
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,05
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,15
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;96,24
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,49
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;94,61
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;88,9
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;93,5
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;605
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;639
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;653
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;587
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;615
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;633
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;594
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;627
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;583
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;615
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;563
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;607
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,02
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,24
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,94
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,96
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;96,02
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;91,24
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;94,18
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;88,11
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;92,96
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;305
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;325
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;331
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;289
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;315
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;322
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;304
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;320
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;299
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;316
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;294
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;313
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,75
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,92
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,28
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;93,54
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;96,68
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;92
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;95,47
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;90,46
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;94,56
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;487
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;458
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;543
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;472
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;441
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;508
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;450
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;430
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;491
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;425
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;414
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;472
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;408
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;401
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;445
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,92
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,29
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,55
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,4
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,89
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;90,42
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,27
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,39
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,92
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,78
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,55
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;81,95
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;339
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;321
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;383
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;330
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;311
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;358
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;317
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;306
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;346
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;296
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;294
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;332
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;287
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;282
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;311
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,35
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,88
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;93,47
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,51
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;95,33
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;90,34
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,32
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;91,59
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;86,68
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,66
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,85
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;81,2
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;148
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;137
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;160
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;142
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;130
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;150
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;133
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;124
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;145
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;129
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;120
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;140
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;121
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;119
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;134
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,95
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;94,89
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;93,75
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,86
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;90,51
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,63
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;87,16
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,59
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;87,5
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,76
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,86
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,75
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;555
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;528
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;515
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;531
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;513
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;498
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;502
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;497
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;479
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;483
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;480
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;451
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;466
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;434
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
18 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,68
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,16
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,7
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;90,45
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;94,13
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,01
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,03
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;90,91
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,57
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;88,26
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;84,27
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;384
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;372
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;364
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;369
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;364
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;352
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;345
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;352
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;338
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;335
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;336
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;317
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;328
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;307
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
18 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,09
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,85
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,7
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;89,84
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;94,62
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,86
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,24
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;90,32
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;87,09
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;88,17
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;84,34
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;171
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;156
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;151
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;162
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;149
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;146
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;157
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;145
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;141
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;148
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;144
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;134
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;138
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;127
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
18 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,74
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,51
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,69
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,81
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,95
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,38
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,55
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;92,31
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,74
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,46
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,11
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;537
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;515
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;498
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;508
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;499
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;479
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;488
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;482
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;451
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;468
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;434
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;447
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;423
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,6
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;96,89
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,18
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;90,88
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;93,59
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,56
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;90,87
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,15
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;86,8
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;84,94
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;374
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;365
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;352
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;350
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;353
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;338
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;339
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;337
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;317
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;329
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;307
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;316
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;302
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;93,58
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;96,71
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,02
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;90,64
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,33
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,06
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,14
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,22
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,58
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,8
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;163
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;150
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;146
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;158
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;146
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;141
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;149
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;145
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;134
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;139
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;127
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;131
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;121
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,93
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,33
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;96,58
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;91,41
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;96,67
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,78
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;92,67
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,99
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;87,33
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;82,88
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;516
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;499
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;481
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;495
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;482
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;453
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;468
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;436
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;447
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;425
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;422
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;410
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,93
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,59
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;94,18
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,79
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,64
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,58
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,36
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;84,57
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,24
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;357
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;353
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;339
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;345
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;337
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;318
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;329
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;308
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;316
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;303
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;295
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;292
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,64
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;95,47
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,81
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;93,2
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,86
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,52
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,38
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,57
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;86,14
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;159
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;146
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;142
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;150
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;145
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;135
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;139
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;128
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;131
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;122
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;127
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;118
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,34
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;99,32
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,07
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;95,21
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,14
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;89,73
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,92
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;86,99
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;83,1
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
18 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;4.434
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;4.523
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;4.683
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2022QI;4.215
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2021QI;4.352
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2020QI;4.398
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QII;4.014
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QII;4.173
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QII;4.299
19 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;3.864
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;3.992
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;4.072
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIV;3.702
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIV;3.839
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIV;3.902
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,06
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,22
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;93,91
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;90,53
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;92,26
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;91,8
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;87,14
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;88,26
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;86,95
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;83,49
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;84,88
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;83,32
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;3.091
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;3.221
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;3.346
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2022QI;2.954
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2021QI;3.097
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2020QI;3.160
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QII;2.835
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QII;2.973
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QII;3.089
19 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;2.737
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;2.849
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;2.940
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIV;2.626
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIV;2.752
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIV;2.822
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,57
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,15
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;94,44
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,72
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;92,3
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;92,32
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;88,55
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;88,45
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;87,87
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;84,96
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;85,44
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;84,34
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;1.343
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;1.302
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;1.337
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2022QI;1.261
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2021QI;1.255
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2020QI;1.238
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QII;1.179
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QII;1.200
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QII;1.210
19 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;1.127
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;1.143
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;1.132
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIV;1.076
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIV;1.087
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIV;1.080
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,89
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,39
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;92,6
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,79
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;92,17
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;90,5
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;83,92
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;87,79
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;84,67
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,12
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;83,49
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;80,78
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;4.387
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;4.536
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;4.695
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QII;4.172
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QII;4.344
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QII;4.582
19 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QIII;4.009
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QIII;4.147
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QIII;4.318
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;3.837
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;3.978
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;4.128
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2022QI;3.804
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2021QI;4.005
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,1
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;95,77
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,59
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;91,38
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;91,42
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;91,97
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,46
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;87,7
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;87,92
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;83,86
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;85,3
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;3.059
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;3.210
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;3.357
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QII;2.929
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QII;3.080
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QII;3.278
19 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QIII;2.826
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QIII;2.945
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QIII;3.103
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;2.711
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;2.838
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;2.970
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2022QI;2.726
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2021QI;2.875
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,75
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;95,95
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,65
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,38
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,74
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;92,43
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;88,62
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,41
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,47
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;84,92
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;85,64
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;1.328
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;1.326
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;1.338
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QII;1.243
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QII;1.264
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QII;1.304
19 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QIII;1.183
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QIII;1.202
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QIII;1.215
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;1.126
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;1.140
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;1.158
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2022QI;1.078
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2021QI;1.130
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,6
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;95,32
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,46
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;89,08
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;90,65
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;90,81
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;84,79
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;85,97
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;86,55
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;81,3
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;84,45
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;4.371
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;4.548
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;4.682
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QIII;4.181
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QIII;4.313
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QIII;4.406
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIV;3.993
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIV;4.130
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIV;4.208
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;3.944
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;4.077
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QII;3.767
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QII;3.921
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;95,65
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,83
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;94,11
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,35
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;90,81
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;89,88
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;86,72
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;87,08
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;82,83
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;83,75
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;3.069
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;3.201
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;3.347
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QIII;2.952
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QIII;3.035
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QIII;3.163
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIV;2.828
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIV;2.921
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIV;3.025
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;2.802
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;2.924
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QII;2.699
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QII;2.811
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,19
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;94,81
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;94,5
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;92,15
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;91,25
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,38
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;87,54
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,36
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;84,32
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;83,99
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;1.302
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;1.347
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;1.335
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QIII;1.229
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QIII;1.278
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QIII;1.243
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIV;1.165
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIV;1.209
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIV;1.183
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;1.142
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;1.153
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QII;1.068
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QII;1.110
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;94,39
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,88
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;93,11
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;89,48
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,76
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;88,61
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,78
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;86,37
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;79,29
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;83,15
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;4.339
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;4.465
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;4.559
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIV;4.125
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIV;4.265
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIV;4.335
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2022QI;4.066
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2021QI;4.194
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;3.881
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;4.030
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QIII;3.737
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QIII;3.868
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,07
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;95,52
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,09
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,06
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;91,99
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;86,92
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;88,4
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;83,7
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;84,84
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;3.059
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;3.117
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;3.258
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIV;2.917
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIV;2.993
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIV;3.103
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2022QI;2.870
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2021QI;2.996
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;2.764
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;2.879
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QIII;2.670
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QIII;2.770
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;95,36
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,02
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,24
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,08
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;91,96
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;88,68
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;88,37
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;85,66
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,02
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;1.280
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;1.348
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;1.301
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIV;1.208
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIV;1.272
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIV;1.232
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2022QI;1.196
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2021QI;1.198
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;1.117
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;1.151
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QIII;1.067
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QIII;1.098
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,38
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,36
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,7
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,72
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;92,08
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;82,86
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;88,47
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;79,15
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;84,4
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;492
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;549
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;481
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2022QI;443
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2021QI;509
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2020QI;418
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QII;409
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QII;466
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QII;405
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;381
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;418
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;364
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIV;355
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIV;381
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIV;334
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;90,04
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;92,71
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;86,9
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;83,13
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;84,88
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;84,2
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;77,44
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;76,14
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;75,68
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;72,15
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;69,4
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;69,44
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;303
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;352
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;294
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2022QI;275
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2021QI;324
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2020QI;255
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QII;253
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QII;297
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QII;248
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;239
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;269
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;226
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIV;224
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIV;249
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIV;210
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;90,76
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;92,05
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;86,73
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;83,5
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;84,38
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;84,35
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;78,88
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;76,42
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;76,87
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;73,93
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;70,74
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;71,43
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;189
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;197
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;187
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2022QI;168
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2021QI;185
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2020QI;163
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QII;156
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QII;169
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QII;157
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;142
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;149
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;138
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIV;131
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIV;132
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIV;124
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;88,89
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;93,91
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;87,17
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;82,54
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;85,79
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;83,96
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;75,13
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;75,63
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;73,8
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;69,31
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;67,01
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;66,31
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;419
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;478
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;513
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QII;385
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QII;438
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QII;495
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QIII;358
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QIII;393
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QIII;441
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;329
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;355
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;402
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2022QI;321
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2021QI;386
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;91,89
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;91,63
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;96,49
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;85,44
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;82,22
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;85,96
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;78,52
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;74,27
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;78,36
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;67,15
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;75,24
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;259
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;301
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;322
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QII;238
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QII;276
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QII;312
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QIII;223
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QIII;247
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QIII;280
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;207
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;226
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;256
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2022QI;209
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2021QI;243
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;91,89
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;91,69
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;96,89
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;86,1
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;82,06
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;86,96
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;79,92
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;75,08
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;79,5
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;69,44
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;75,47
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;160
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;177
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;191
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QII;147
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QII;162
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QII;183
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QIII;135
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QIII;146
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QIII;161
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;122
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;129
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;146
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2022QI;112
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2021QI;143
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;91,88
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;91,53
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;95,81
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;84,38
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;82,49
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;84,29
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;76,25
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;72,88
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;76,44
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;63,28
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;74,87
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;433
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;505
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;524
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QIII;397
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QIII;439
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QIII;467
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIV;363
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIV;396
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIV;425
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;356
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;405
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QII;328
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QII;375
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;91,69
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;86,93
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;89,12
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;83,83
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;78,42
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;81,11
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;70,5
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;77,29
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;64,95
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;71,56
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;269
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;322
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;329
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QIII;248
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QIII;274
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QIII;296
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIV;229
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIV;251
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIV;272
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;229
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;256
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QII;212
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QII;236
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;92,19
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;85,09
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;89,97
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;85,13
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;77,95
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;82,67
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;71,12
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;77,81
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;65,84
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;71,73
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;164
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;183
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;195
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QIII;149
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QIII;165
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QIII;171
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIV;134
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIV;145
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIV;153
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;127
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;149
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QII;116
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QII;139
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;90,85
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;90,16
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;87,69
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;81,71
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;79,23
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;78,46
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;69,4
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;76,41
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;63,39
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;71,28
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;442
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;482
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;532
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIV;402
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIV;432
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIV;477
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2022QI;389
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2021QI;451
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;360
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;416
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QIII;336
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QIII;377
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;90,95
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;89,63
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;89,66
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;80,71
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;84,77
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;74,69
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;78,2
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;69,71
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;70,86
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;275
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;297
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;336
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIV;251
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIV;270
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIV;304
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2022QI;246
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2021QI;284
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;229
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;262
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QIII;217
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QIII;241
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;91,27
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;90,91
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;90,48
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;82,83
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;84,52
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;77,1
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;77,98
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;73,06
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;71,73
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;167
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;185
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;196
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIV;151
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIV;162
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIV;173
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2022QI;143
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2021QI;167
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;131
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;154
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QIII;119
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QIII;136
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;90,42
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;87,57
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;88,27
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;77,3
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;85,2
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;70,81
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;78,57
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;64,32
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;69,39
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;955
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;985
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.024
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2022QI;903
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2021QI;944
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2020QI;931
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QII;855
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QII;893
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QII;907
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;817
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;850
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;842
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIV;778
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIV;815
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIV;800
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;94,55
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;95,84
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;90,92
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;89,53
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;90,66
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;88,57
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;85,55
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;86,29
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;82,23
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;81,47
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;82,74
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;78,13
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;606
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;640
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;661
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2022QI;576
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2021QI;614
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2020QI;603
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QII;554
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QII;584
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QII;588
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;531
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;553
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;548
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIV;502
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIV;531
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIV;519
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,05
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;95,94
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;91,23
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,42
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;91,25
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;88,96
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;87,62
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;86,41
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;82,9
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;82,84
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;82,97
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;78,52
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;349
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;345
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;363
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2022QI;327
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2021QI;330
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2020QI;328
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QII;301
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QII;309
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QII;319
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;286
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;297
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;294
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIV;276
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIV;284
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIV;281
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;93,7
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;95,65
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;90,36
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;86,25
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;89,57
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;87,88
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;81,95
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;86,09
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;80,99
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;79,08
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;82,32
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;77,41
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;914
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;971
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.011
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QII;862
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QII;913
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QII;981
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QIII;815
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QIII;867
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QIII;908
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;773
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;825
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;859
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2022QI;783
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2021QI;833
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;94,31
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;94,03
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,03
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;89,17
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;89,29
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;89,81
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;84,57
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;84,96
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;84,97
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;80,64
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;82,39
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;573
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;629
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;654
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QII;547
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QII;597
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QII;635
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QIII;523
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QIII;568
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QIII;590
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;494
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;542
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;558
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2022QI;515
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2021QI;543
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,46
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;94,91
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,09
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;91,27
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;90,3
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;90,21
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;86,21
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;86,17
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;85,32
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;81,88
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;83,03
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;341
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;342
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;357
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QII;315
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QII;316
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QII;346
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QIII;292
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QIII;299
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QIII;318
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;279
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;283
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;301
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2022QI;268
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2021QI;290
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;92,38
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;92,4
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;96,92
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;85,63
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;87,43
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;89,08
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;81,82
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;82,75
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;84,31
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;78,36
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;81,23
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;925
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;975
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.017
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QIII;871
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QIII;922
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QIII;938
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIV;823
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIV;875
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIV;884
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;831
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;855
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QII;788
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QII;811
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;94,16
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;94,56
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;92,23
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;88,97
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;89,74
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;86,92
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;85,23
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;84,07
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;80,82
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;79,74
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;589
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;629
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;666
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QIII;561
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QIII;594
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QIII;616
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIV;529
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIV;566
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIV;579
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;539
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;561
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QII;518
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QII;533
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;95,25
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;94,44
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;92,49
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;89,81
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;89,98
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;86,94
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;85,69
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;84,23
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;82,35
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;80,03
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;336
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;346
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;351
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QIII;310
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QIII;328
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QIII;322
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIV;294
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIV;309
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIV;305
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;292
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;294
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QII;270
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QII;278
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;92,26
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,8
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;91,74
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;87,5
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;89,31
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;86,89
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;84,39
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;83,76
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;78,03
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;79,2
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;913
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;967
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;977
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIV;859
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIV;914
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIV;917
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2022QI;865
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2021QI;885
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;821
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;840
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QIII;784
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QIII;802
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,09
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;94,52
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;93,86
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;89,45
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;90,58
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;84,9
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;85,98
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;81,08
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;82,09
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;586
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;615
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;641
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIV;551
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIV;582
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIV;601
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2022QI;554
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2021QI;581
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;533
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;552
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QIII;511
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QIII;525
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,03
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;94,63
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;93,76
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;90,08
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;90,64
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;86,67
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;86,12
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;83,09
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;81,9
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;327
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;352
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;336
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIV;308
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIV;332
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIV;316
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2022QI;311
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2021QI;304
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;288
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;288
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QIII;273
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QIII;277
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,19
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;94,32
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;94,05
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;88,35
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;90,48
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;81,82
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;85,71
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;77,56
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;82,44
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.223
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.249
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.306
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2022QI;1.164
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2021QI;1.201
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2020QI;1.241
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QII;1.116
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QII;1.163
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QII;1.216
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;1.077
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.127
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.163
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIV;1.039
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIV;1.088
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.126
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;95,18
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;96,16
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,02
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;91,25
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;93,11
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,11
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;88,06
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;90,23
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,05
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,96
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;87,11
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;86,22
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;870
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;916
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;971
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2022QI;828
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2021QI;880
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2020QI;924
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QII;799
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QII;852
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QII;905
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;775
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;828
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;866
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIV;750
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIV;799
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIV;837
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;95,17
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,07
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;95,16
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;91,84
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,01
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;93,2
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;89,08
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;90,39
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,19
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;86,21
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;87,23
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;86,2
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;353
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;333
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;335
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2022QI;336
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2021QI;321
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2020QI;317
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QII;317
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QII;311
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QII;311
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;302
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;299
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;297
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIV;289
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIV;289
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIV;289
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,18
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;96,4
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,63
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;89,8
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;93,39
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;92,84
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,55
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;89,79
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,66
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;81,87
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,79
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,27
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.217
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.241
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.308
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QII;1.164
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QII;1.198
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QII;1.282
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.125
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.150
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.219
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;1.083
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.111
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.179
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2022QI;1.060
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2021QI;1.136
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,65
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,54
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;98,01
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,44
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,67
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;93,2
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;88,99
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,52
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;90,14
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;85,41
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,85
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;859
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;897
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;968
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QII;826
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QII;866
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QII;949
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QIII;800
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QIII;833
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QIII;903
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;772
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;805
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;871
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2022QI;767
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2021QI;837
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,16
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,54
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;98,04
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;93,13
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;92,87
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,29
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;89,87
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;89,74
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;89,98
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;85,51
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,47
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;358
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;344
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;340
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QII;338
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QII;332
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QII;333
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QIII;325
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QIII;317
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QIII;316
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;311
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;306
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;308
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2022QI;293
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2021QI;299
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;94,41
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;96,51
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,94
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;90,78
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;92,15
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,94
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;86,87
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;88,95
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,59
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;85,17
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;87,94
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.218
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.239
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.305
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.175
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.183
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.240
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.131
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.142
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.200
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;1.090
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;1.157
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QII;1.048
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QII;1.121
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,47
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,48
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,02
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;92,86
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,17
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;91,95
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;87,97
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,66
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;84,58
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,9
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;867
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;889
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;965
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QIII;840
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QIII;852
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QIII;917
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIV;812
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIV;822
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIV;885
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;784
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;851
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QII;759
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QII;824
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,89
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,84
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,03
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;93,66
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,46
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;91,71
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;88,19
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;88,19
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;85,38
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,39
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;351
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;350
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;340
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QIII;335
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QIII;331
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QIII;323
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIV;319
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIV;320
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIV;315
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;306
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;306
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QII;289
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QII;297
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;95,44
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;94,57
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,88
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;91,43
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;92,65
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,43
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;82,57
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;87,35
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.209
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.225
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.266
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.159
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.182
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.220
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2022QI;1.126
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2021QI;1.176
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;1.080
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;1.138
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QIII;1.042
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QIII;1.105
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;95,86
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,49
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;96,37
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;91,92
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,89
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;88,16
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;89,89
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;85,06
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;87,28
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;866
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;879
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;934
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIV;834
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIV;849
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIV;897
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2022QI;810
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2021QI;863
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;783
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;835
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QIII;760
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QIII;813
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;96,3
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,59
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;96,04
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;92,15
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,4
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;89,08
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,4
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;86,46
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;87,04
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;343
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;346
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;332
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIV;325
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIV;333
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIV;323
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2022QI;316
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2021QI;313
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;297
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;303
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QIII;282
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QIII;292
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;94,75
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;96,24
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;97,29
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;91,33
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;94,28
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;85,84
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,27
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;81,5
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;87,95
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;1.092
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;1.082
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;1.146
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2022QI;1.055
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2021QI;1.059
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2020QI;1.112
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QII;1.015
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QII;1.032
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QII;1.091
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;990
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;1.008
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;1.053
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIV;962
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIV;988
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIV;1.023
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,61
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,87
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;97,03
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,95
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;95,38
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;95,2
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;90,66
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;93,16
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;91,88
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;88,1
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;91,31
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;89,27
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;796
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;806
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;856
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2022QI;773
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2021QI;788
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2020QI;835
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QII;747
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QII;765
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QII;817
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;727
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;747
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;793
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIV;707
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIV;737
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIV;773
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,11
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;97,77
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;97,55
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,84
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;94,91
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;95,44
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;91,33
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;92,68
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;92,64
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;88,82
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;91,44
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;90,3
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;296
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;276
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;290
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2022QI;282
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2021QI;271
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2020QI;277
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QII;268
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QII;267
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QII;274
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;263
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;261
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;260
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIV;255
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIV;251
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIV;250
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;95,27
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,19
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;95,52
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;90,54
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;96,74
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;94,48
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;88,85
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;94,57
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;89,66
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;86,15
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;90,94
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;86,21
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;1.084
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;1.118
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;1.144
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QII;1.045
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QII;1.090
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QII;1.121
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QIII;1.016
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QIII;1.065
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QIII;1.082
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;994
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;1.038
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;1.051
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2022QI;1.011
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2021QI;1.030
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;96,4
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;97,5
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,99
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;93,73
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;95,26
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;94,58
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;91,7
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;92,84
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;91,87
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;90,43
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;90,03
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;784
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;821
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;855
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QII;760
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QII;798
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QII;836
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QIII;740
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QIII;780
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QIII;811
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;725
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;765
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;790
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2022QI;747
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2021QI;772
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;96,94
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;97,2
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,78
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;94,39
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;95,01
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;94,85
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;92,47
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;93,18
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;92,4
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;90,99
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;90,29
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;300
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;297
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;289
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QII;285
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QII;292
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QII;285
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QIII;276
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QIII;285
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QIII;271
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;269
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;273
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;261
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2022QI;264
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2021QI;258
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;95
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;98,32
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;98,62
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;92
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;95,96
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;93,77
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;89,67
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;91,92
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;90,31
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;88,89
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;89,27
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;1.071
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;1.115
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;1.129
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QIII;1.037
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QIII;1.088
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QIII;1.089
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIV;1.013
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIV;1.059
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIV;1.058
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;1.029
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;1.037
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QII;995
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QII;1.010
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,83
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;97,58
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;96,46
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;94,58
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;94,98
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;93,71
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;92,29
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;91,85
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;89,24
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;89,46
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;780
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;810
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;839
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QIII;757
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QIII;790
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QIII;813
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIV;740
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIV;774
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIV;792
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;754
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;774
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QII;734
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QII;751
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;97,05
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;97,53
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;96,9
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;94,87
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;95,56
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;94,4
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;93,09
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;92,25
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;90,62
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;89,51
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;291
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;305
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;290
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QIII;280
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QIII;298
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QIII;276
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIV;273
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIV;285
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIV;266
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;275
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;263
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QII;261
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QII;259
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,22
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;97,7
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;95,17
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;93,81
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;93,44
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;91,72
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;90,16
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;90,69
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;85,57
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;89,31
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;1.065
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;1.100
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;1.101
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIV;1.033
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIV;1.070
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIV;1.069
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2022QI;1.039
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2021QI;1.048
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;1.004
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;1.021
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QIII;979
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QIII;998
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;97
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;97,27
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;97,09
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;94,45
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;95,19
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;91,27
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;92,73
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;89
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;90,64
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;778
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;797
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;821
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIV;755
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIV;780
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIV;799
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2022QI;760
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2021QI;781
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;739
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;758
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QIII;719
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QIII;741
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;97,04
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;97,87
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;97,32
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;95,36
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;95,13
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;92,72
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;92,33
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;90,21
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;90,26
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;287
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;303
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;280
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIV;278
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIV;290
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIV;270
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2022QI;279
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2021QI;267
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;265
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;263
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QIII;260
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QIII;257
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;96,86
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,71
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;96,43
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;92,08
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;95,36
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;87,46
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;93,93
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;85,81
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;91,79
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;672
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;658
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;726
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2022QI;650
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2021QI;639
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2020QI;696
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QII;619
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QII;619
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QII;680
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;599
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;589
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;650
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIV;568
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIV;567
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIV;619
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2022QI;100
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2021QI;100
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2020QI;100
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2022QI;96,73
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2021QI;97,11
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2020QI;95,87
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QII;92,11
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QII;94,07
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QII;93,66
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QIII;89,14
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QIII;89,51
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QIII;89,53
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIV;84,52
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIV;86,17
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIV;85,26
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;516
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;507
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;564
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2022QI;502
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2021QI;491
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2020QI;543
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QII;482
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QII;475
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QII;531
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;465
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;452
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;507
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIV;443
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIV;436
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIV;483
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2022QI;100
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2021QI;100
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2020QI;100
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2022QI;97,29
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2021QI;96,84
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2020QI;96,28
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QII;93,41
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QII;93,69
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QII;94,15
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QIII;90,12
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QIII;89,15
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QIII;89,89
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIV;85,85
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIV;86
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIV;85,64
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;156
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;151
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;162
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2022QI;148
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2021QI;148
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2020QI;153
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QII;137
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QII;144
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QII;149
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;134
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;137
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;143
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIV;125
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIV;131
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIV;136
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2022QI;100
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2021QI;100
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2020QI;100
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2022QI;94,87
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2021QI;98,01
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2020QI;94,44
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QII;87,82
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QII;95,36
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QII;91,98
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QIII;85,9
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QIII;90,73
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QIII;88,27
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIV;80,13
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIV;86,75
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIV;83,95
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;753
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;728
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;719
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QII;716
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QII;705
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QII;703
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QIII;695
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QIII;672
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QIII;668
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;658
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;649
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;637
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2022QI;629
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2021QI;620
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QII;100
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QII;100
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QII;100
19 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QII;95,09
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QII;96,84
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QII;97,77
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QIII;92,3
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QIII;92,31
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QIII;92,91
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIV;87,38
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIV;89,15
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIV;88,6
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2022QI;86,4
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2021QI;86,23
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;584
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;562
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;558
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QII;558
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QII;543
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QII;546
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QIII;540
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QIII;517
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QIII;519
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;513
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;500
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;495
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2022QI;488
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2021QI;480
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QII;100
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QII;100
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QII;100
19 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QII;95,55
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QII;96,62
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QII;97,85
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QIII;92,47
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QIII;91,99
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QIII;93,01
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIV;87,84
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIV;88,97
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIV;88,71
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2022QI;86,83
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2021QI;86,02
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;169
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;166
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;161
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QII;158
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QII;162
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QII;157
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QIII;155
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QIII;155
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QIII;149
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;145
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;149
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;142
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2022QI;141
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2021QI;140
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QII;100
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QII;100
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QII;100
19 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QII;93,49
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QII;97,59
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QII;97,52
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QIII;91,72
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QIII;93,37
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QIII;92,55
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIV;85,8
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIV;89,76
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIV;88,2
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2022QI;84,94
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2021QI;86,96
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;724
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;714
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;707
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QIII;701
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QIII;681
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QIII;672
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIV;663
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIV;658
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIV;641
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;638
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;623
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QII;608
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QII;604
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QIII;100
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QIII;100
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QIII;100
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QIII;96,82
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QIII;95,38
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QIII;95,05
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIV;91,57
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIV;92,16
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIV;90,66
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2022QI;89,36
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2021QI;88,12
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QII;85,15
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QII;85,43
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;564
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;551
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;548
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QIII;546
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QIII;525
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QIII;521
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIV;518
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIV;508
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIV;497
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;496
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;482
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QII;476
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QII;467
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QIII;100
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QIII;100
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QIII;100
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QIII;96,81
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QIII;95,28
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QIII;95,07
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIV;91,84
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIV;92,2
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIV;90,69
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2022QI;90,02
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2021QI;87,96
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QII;86,39
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QII;85,22
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;160
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;163
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;159
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QIII;155
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QIII;156
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QIII;151
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIV;145
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIV;150
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIV;144
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;142
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;141
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QII;132
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QII;137
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QIII;100
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QIII;100
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QIII;100
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QIII;96,88
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QIII;95,71
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QIII;94,97
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIV;90,63
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIV;92,02
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIV;90,57
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2022QI;87,12
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2021QI;88,68
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QII;80,98
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QII;86,16
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;710
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;691
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;683
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIV;672
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIV;667
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIV;652
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2022QI;647
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2021QI;634
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;616
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;615
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QIII;596
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QIII;586
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIV;100
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIV;100
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIV;100
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIV;94,65
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIV;96,53
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIV;95,46
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2022QI;93,63
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2021QI;92,83
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QII;89,15
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QII;90,04
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QIII;86,25
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QIII;85,8
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;554
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;529
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;526
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIV;526
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIV;512
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIV;502
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2022QI;500
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2021QI;487
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;480
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;472
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QIII;463
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QIII;450
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIV;100
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIV;100
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIV;100
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIV;94,95
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIV;96,79
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIV;95,44
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2022QI;94,52
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2021QI;92,59
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QII;90,74
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QII;89,73
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QIII;87,52
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QIII;85,55
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;156
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;162
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;157
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIV;146
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIV;155
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIV;150
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2022QI;147
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2021QI;147
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;136
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;143
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QIII;133
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QIII;136
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIV;100
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIV;100
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIV;100
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIV;93,59
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIV;95,68
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIV;95,54
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2022QI;90,74
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2021QI;93,63
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QII;83,95
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QII;91,08
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2020QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QIII;82,1
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2022QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QIII;86,62
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2021QI;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIV;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QIII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QII;""
19 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2020QI;""